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Abstract 
Background: Population health interventions by their nature affect an entire population 
and are typically delivered outwith of health services and within the community, such as 
in schools. An example of such interventions are those that aim to improve children’s 
social and emotional wellbeing, which have demonstrated effectiveness in the short-term 
and potentially the long-term. However, challenges arise when conducting economic 
evaluations of population health interventions, most notably the difficulties of identifying, 
measuring, and valuing broader intersectoral costs, health, and non-health outcomes. 
Economic evaluation in an education context is relatively novel, but could provide 
decision-makers with information to help them make transparent and consistent 
decisions about how to allocate limited funds. This thesis examined the role for economic 
evaluation in school-based interventions and sought to determine appropriate methods 
for its implementation in addition to examining appropriate child-focused outcome 
measures. Thus, the overarching research question asked, ‘How should the cost-
effectiveness of school-based, population health interventions aimed at children be 
determined?’ 
Methods: A mixed methods approach to this thesis was used:  
(i) a systematic literature review and narrative synthesis to determine which 
evaluation methods (economic and non-economic) are currently being used in 
school-based population health interventions;  
(ii) a case study to illustrate an economic evaluation (including cost-utility and 
cost-effectiveness analysis) of a school-based intervention to reflect on the 
advantages and disadvantages for decision making in this context; and  
(iii) an exploration of outcome measures (through mapping validation) for valuing 
child health and social and emotional wellbeing in school-based programmes 
to support future evaluation work in this context.  
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Data for the economic evaluation and mapping validation study were available from a 
cluster randomised controlled trial of the Roots of Empathy programme in Northern 
Ireland (Ref: 10/3006/02).  
Results: The systematic review found that the methods currently being utilised to 
evaluate school programmes are varied (including economic evaluation, cost only, and 
effectiveness only studies), with poor quality reporting for the economic evaluations. Of 
the few cost-utility analyses in school-based settings identified, none had directly 
measured health-related quality of life using child measures or values. The case study 
cost-utility analysis using Child Health Utility 9D of a school-based intervention was found 
to be cost-effective from the National Health Service perspective with an incremental 
cost-effectiveness ratio of £11,000 per quality-adjusted life year (confidence interval: -
£95,500 to £147,000), however the wide confidence interval demonstrates considerable 
uncertainty. This uncertainty is likely due to a lack of statistically significant effect that 
remained at the 36-month follow-up. Cost-effectiveness analysis using child behavioural 
descriptive measure, the Strengths and Difficulties Questionnaire, resulted in an 
incremental cost-effectiveness ratio of  £197 per unit decrease in total difficulties score 
(confidence interval: £77 to £471). The Strengths and Difficulties Questionnaire is suitable 
for measuring social and emotional wellbeing, but is less advantageous for cost-
effectiveness decision-making as no consensus has been reached as to what a clinically 
meaningful change in score represents, nor has a cost-effectiveness threshold been 
defined. It remains uncertain how these cost-effectiveness results will be interpreted in 
an education decision-making context where cost-effectiveness thresholds have not been 
set up. The mapping validation study validated a mapping algorithm to convert the 
Strengths and Difficulties Questionnaire into child health utility. Using this algorithm 
provides an option for valuing incremental changes in health-related quality of life against 
a generally accepted cost-effectiveness threshold from a health service perspective.  
Conclusions: Given the findings from the various aspects of work undertaken for this 
thesis to address population health issues, this thesis identified cost-benefit analysis as 
currently the most  comprehensive method for determining the value for money of 
school-based public health interventions. Cost-benefit analysis incorporates monetary 
valuation of multisector outcomes in a final net benefit/loss result allowing clear, 
consistent, decision-making criteria to be set. Other methods such as cost-consequence 
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analysis, cost-utility analysis, and multi-criteria decision analysis may also be suitable 
depending on the decision-making context and problem. This thesis demonstrates a lack 
of clear decision-making criteria in place for funding allocation decisions in education (e.g. 
education specific cost-effectiveness thresholds). Furthermore, there is no equitable 
method currently in place for apportioning the cost of funding public health interventions 
that generate benefits for multiple sectors. From a health service perspective, directly 
measuring child health utility using the Child Health Utility 9D is preferred as it is the only 
preference-based measure developed specifically for children and valued by young 
people. Mean child health utility can be predicted by mapping from the Strengths and 
Difficulties Questionnaire. This affords the opportunity to estimate longer-term utility by 
utilising long-term cohort data that routinely collects the Strengths and Difficulties 
Questionnaire, as long-term cost-effectiveness of school-based preventive programmes is 
an area in need of further research. The school setting plays an important role in shaping 
our young people’s futures. Economic evaluation of school-based population health 
interventions is justified, as schools need to maximise their existing resources in order to 
give children the best start in life. 
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1 Introduction 
In a current socio-political climate where pressures on healthcare costs ensure that 
physical wellbeing and reactive treatment take precedent, mental health is a key, yet 
often ignored component of health and wellbeing, and the younger generation is no 
exception.1 Social and emotional wellbeing (SEW) allows children to build and maintain 
positive relationships and handle interpersonal situations constructively. It also lays the 
foundations for healthy behaviours and educational attainment by preventing 
behavioural and mental health problems from developing.2 The importance of children’s 
SEW is gaining increased attention in educational and policy circles with growing evidence 
linking early SEW to later academic performance and various health outcomes including 
mental health.3-5 Research suggests social-emotional competency at a young age is 
associated with increased wellbeing and school performance, while problems with these 
competencies can lead to personal, social, and academic difficulties.6, 7 Children with 
emotional and behavioural problems are more likely to develop mental health disorders,8 
be involved in crime or violence,9 practice unsafe sex, and misuse drugs and alcohol.10 
Children with low levels of SEW may also display antisocial behaviours which have been 
linked to poorer overall health and increased odds of developing cardiovascular 
problems, wheezing, cancer, and serious injury as an adult.11 Children with a clinical 
diagnosis of a mental health disorder are also more costly to society, with significantly 
higher public sector costs and lower overall quality of life.12 
Given this plethora of negative outcomes arising from low SEW, the role of school-based 
social and emotional learning (SEL) programmes to improve SEW as a means to promote 
children’s success in school and life are of increasing interest. SEL programmes help 
children recognise and manage their emotions, understand the perspective of others, and 
make responsible decisions.13 Various SEL programmes have demonstrated positive 
impacts on social emotional competencies and academic performance, as well as 
reductions in problem behaviours such as antisocial conduct and hyperactivity.14-16  The 
You Can Do It! Early Childhood Education Program (YCDI)14 found that the programme 
increased social and emotional competence, wellbeing, and reading achievement, while it 
decreased problem behaviours such as externalising, internalising, and hyperactivity. The 
Fast Track PATHS (Promoting Alternative Thinking Strategies)16 programme found modest 
positive effects on increases prosocial behaviour and decreased aggressive behaviour. 
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Students who participated in Project Attitude15 self-reported positive results in social 
awareness, self-control, self-esteem, social isolation, and social anxiety; these results 
were replicated by teacher-report. None of the previous examples examined cost-
effectiveness, and as will be seen in Chapter 3, very few SEL/SEW programmes have been 
evaluated with economic evaluation methods. Schools have long been recognised as an 
ideal setting for health education and promotion as they are efficient in reaching the 
majority of young people and play an important role in developing and maintaining 
children’s social lives and interactions.17 A recent meta-analysis (Durlak et al.) of school-
based SEL programmes found participants to have significantly improved social and 
emotional skills, attitudes, behaviours, and academic performance.18 In this analysis, the 
effects diminished at follow-up, but remained statistically significant for six months after 
intervention.18 Few studies report follow-up longer than six months18 and there is little 
evidence of cost-effectiveness and long-term effectiveness. The Department for 
Education’s overall school budget in the United Kingdom (UK) is relatively protected, but 
does not increase in line with inflation, and projected increased student numbers results 
in schools needing to make up an estimated £3 billion in savings to alleviate these cost 
pressures.19 These real-term reductions to publically funded education have resulted in 
scarce resources needing to be maximised to their full potential.  
Economic evaluation (further detail in section 2.1) can help education decision-makers 
make more informed decisions about how to allocate limited funds.  The Durlak et al. 
meta-analysis18 highlighted a gap between the research on effective school-based SEL and 
actual practice and implementation of these programmes. Additionally, the study 
highlighted the need to document costs and benefits of SEL programmes as well as the 
fact that future studies must include cost analyses in their evaluation designs. This 
demonstrated need for cost-effectiveness evidence in the area of SEW identifies a gap in 
the current knowledge, leaving decision-makers less informed about the cost-
effectiveness of new SEL programmes they might choose to implement. The majority of 
practical economic evaluations have been conducted in healthcare and related settings, 
as well as transport sectors. In healthcare settings, cost-effectiveness decisions are based 
on health outcomes, whereas the transport sector typically  values outcomes in monetary 
units.20 Decision-making across sectors (e.g. involving both health and education sectors), 
and how to appropriately value different sectoral outcomes are key concepts to be 
investigated throughout this thesis.  The long-term broader impacts of school-based SEW 
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programmes on educational outcomes, health behaviours, adult unemployment, crime, 
and health related outcomes are important to identify as these potential impacts inform 
any comprehensive economic evaluation of SEW programmes. 
SEL/SEW programmes are considered population health interventions (PHIs) because they 
have the potential to impact on an entire school population. Population and public health 
are often used interchangeably and for the purpose of this thesis, PHI is defined as 
‘…policy and program interventions that operate within or outside of the health sector 
and have the potential to impact health at the population level.’21 A formal definition of 
population health is given later in section 2.2. A recent systematic review of the return on 
investment (ROI)a of PHIs found cuts to public spending in high-income countries 
representing a false economy.22 Short-sighted policy decisions may contribute to this 
phenomenon as PHIs often have broader, long-term effects to society that may never be 
fully realised if funding is cut due to a lack of or small effectiveness gains in short-term 
outcomes.23 
Pre-school and early years interventions aimed at low-income and socially deprived 
children have demonstrated long-term effectiveness24-26 and cost-effectiveness.27 
Comprehensive education, family, and health services delivered in the early pre-school 
years have demonstrated higher rates of high school and education completion, lower 
rates of juvenile and violent arrests, and fewer school dropouts at age 18 and later.24, 28 
If school-based SEL programmes have the potential to impact on immediate and longer-
term adult outcomes, investment in such programmes would appear to be warranted. 
However, simply allocating more money to education does not necessarily result in 
increased education attainment,29 and it is important that these new SEL programmes are 
vigorously evaluated for cost-effectiveness, particularly in times of constrained education 
budgets, as is the case today. The overall aim of economic evaluation is to aid decision 
makers to maximise benefits, given the resources available, and make sure no resources 
are wasted in the process.23 Decision-making across and between multi-sectoral budgets 
is a challenge (as will be described in section 2.2.3) and this thesis will examine 
                                                     
a Formal definition of return on investment give in section 2.1.1 
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appropriate methods to deal with these challenges as compared to decision making in the 
healthcare sector. 
Economic evaluation within the healthcare sector has long been established, however this 
is rarely the case in education sectors where new education initiatives may involve 
significant expenditure.29 As will be seen in Chapter 3, current examples of economic 
evaluation in school settings are limited and of varying quality. There is much scope for 
broadening decision-making and reporting of school-based economic evaluation and this 
thesis will discuss this through an example case study of a comprehensive economic 
evaluation of a school-based SEW programme. These points are significant as the novelty 
of school-based economic evaluation brings opportunities for more informed decision-
making and resource allocation in school settings. The school is a novel setting for 
economic evaluation, and with this novelty comes new challenges, for example 
establishing the most appropriate multi-sector funding strategy when SEL programmes 
give rise to education and health benefits. UK guidance states, ‘no standard method has 
yet been devised to apportion costs - and who should bear them - when more than one 
government department (or, indeed, local authority) is involved. This may prove 
particularly difficult when one national or local authority department secures the benefits 
of a public health intervention, but another is required to fund it’ (p. 530).   
In education economics literature, fundamental work on human capital theory by 
Schultz,31 Becker,32 and Mincer33 has long made the economic case for education. Human 
capital theory is based on the assumption that education serves as an investment into 
individual knowledge and skills,34 which then contribute to individual successes in the 
labour market and productivity. Investment in SEL can therefore be viewed as investment 
in human capital as well as health and wellbeing. This investment gives rise to multiple 
benefits in various sectors of society as detailed above. It is therefore difficult to expect 
the onus of investment in SEL programmes to rely solely on the education sector. To 
implement a new SEL programme might require additional time and resources to be 
diverted away from traditional school subjects, negatively affecting students’ learning in 
those other areas.35 Therefore, an important question arising is, ‘Who should pay for 
implementing PHIs when multiple sectors stand to benefit from the intervention?’ The 
school could potentially be compensated by the health sector if the resulting health 
benefit is greater than the loss to other education subjects.35 This approach, referred to 
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as ‘cofinancing,’ has been suggested by Remme, et al.35 as a means of redistributing parts 
of the healthcare budget to other sectors that achieve health gains more efficiently than 
then would be accomplished within the health sector. This would work the other way as 
well with other sectors (such as education) transferring some of their budget to PHIs 
which generate benefits that they are interested in. This approach will be explored 
further in section 5.7. 
Economic evaluation of PHIs provide their own separate set of challenges as they often 
produce health and non-health benefits which are difficult to identify and value 
appropriately. The longer-term outcomes produced by a preventative PHI could span 
multiple sectors such as health, education, justice, housing, transport, and the broader 
economy; identifying appropriate outcomes to measure in the short-term can be 
challenging in addition to valuing these health and non-health outcomes.36 This is a clear 
distinction from a traditional economic evaluation in a healthcare setting where all 
outcomes are often more narrowly focused on health.  Generally, however, the primary 
outcomes from a SEL programme will be health related.  
Exploring the use of appropriate paediatric outcomes measures is also important for 
establishing the cost-effectiveness of SEL programmes because the development of 
outcomes specifically aimed at children has lagged behind the development of adult 
measures.37 It is important to establish which child health outcomes are appropriate for 
measuring generic preference-based health-related quality of life (HRQoL) and 
intervention specific outcomes of SEL programmes as each will have implications on the 
type of economic evaluation that can be performed (to be covered more thoroughly in 
sections 2.1.3 and 2.1.4). Preference-based child HRQoL measures are useful because 
they can be compared within and across health related areas.38 Research into these types 
of outcomes has typically been limited due to challenges of in obtaining preference-based 
valuation from children.37 In establishing effectiveness of SEL programmes, decision-
makers may also be interested in descriptive measures of SEW, or often times a common 
descriptive measure will have been used in a trial which lacked a preference-based 
measure. Mapping from a descriptive measure to a preference-based measure has been 
suggested as a way to derive utilities (and therefore make comparisons across health 
related areas) in situations where preference-based measures have not been collected.39  
Child outcomes research is an important area within the PHI school-based context as they 
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can generate a broader range of benefits; therefore, to avoid underestimating the 
benefits of a PHI,35 suitable outcomes need to be identified and appropriately measured. 
These and other challenges (including those related to economic evaluation within a 
school setting) will be addressed throughout this thesis. The school plays an important 
role in shaping our young people’s futures. With public funding consistently under stress, 
now more than ever, schools need to maximise their existing resources. 
The remainder of this chapter will introduce Roots of Empathy (RoE), which is a school-
based SEL programme that is the focus of this thesis. There are many existing SEL 
programmes as evidenced by the meta-analysis mentioned above (n=213), 18 and more 
are currently being developed. However, RoE benefits from having extensive 
effectiveness evidence, 40-46 as it has been an established programme for over 20 years. 
Its effectiveness has also been established internationally, but it has never been 
evaluated for cost-effectiveness so this is an important area of research that will be 
covered in later chapters. SEL and SEW programmes are numerous18 making the task of 
choosing and implementing the right programme for individual school needs difficult for 
decision-makers and funding bodies. Additionally, there is the cost of implementing and 
running the programme that needs to be considered, so having that information 
combined with effectiveness evidence is a key component in the decision-making 
process. As will be seen in Chapter 3, very few SEW programmes have been evaluated for 
their cost-effectiveness (n=8 identified from systematic review), so providing one of the 
first economic evaluations of a SEW programme (in Chapter 4 and 5) will be key to 
assisting decision-makers and funders in education. Following on from the RoE 
introduction, section 1.2 reports the aim and research question for this thesis. The final 
section concludes with an outline of what will follow in each remaining chapter.  
1.1 Roots of Empathy 
A substantial body of evidence now exists to suggest that well designed school-based 
prevention programmes can be effective in improving a variety of social, health, and 
academic outcomes.47, 48 Several reviews have been conducted on SEL programmes and 
the consensus is that they positively impact on child outcomes such as improved self-
esteem, positive social behaviour, social skills, academic performance; and reduced 
aggressive or disruptive behaviour, conduct problems, suicide, and emotional distress.49-52 
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Roots of Empathy (RoE) is a universal school-based SEL programme that was originally 
developed and implemented in Canada over 20 years ago and was only recently 
introduced into the UK.  It aims to increase empathy, prosocial behaviour, and decrease 
aggressive behaviour in children.53 At the heart of the programme is the development of 
empathy. Empathy is the ability to identify and to some extent experience the feelings 
and thoughts of others. It forms the basis of helping and prosocial behaviours and is 
essential to building successful social relationships during all stages of life. In contrast, the 
absence of empathy leads a person to consider their own needs without consideration of 
the feelings of others resulting in asocial or antisocial behaviour.54 
RoE is amongst a small number of named universal school-based SEL programmes that 
has an existing evidence base regarding its effectiveness as referenced above. A number 
of evaluations of RoE have been conducted to date and details are provided elsewhere.55 
RoE is delivered on a whole-class basis for a single academic year and consists of a 
monthly classroom visit by an infant and parent, typically recruited from the local 
community, whom the class 'adopts' at the start of the school year. Children learn about 
the infant’s growth and development via interactions and observations with the infant at 
these monthly visits. A characteristic of RoE is that it is a mentalisation-based 
programme. Mentalisation is the ability to focus on mental states in oneself and others to 
understand behaviour.56 The labelling of feelings and exploration of the relationship 
between feelings and behaviour is achieved through observation of the mother-infant 
interaction in the classroom. Clearly, the infant cannot communicate in words and can 
only express his/her feelings through their behaviour. For this reason, the infant in RoE 
provides an ideal opportunity for children to learn mentalisation skills through 
interpreting and labelling the infant’s emotions. This then helps them identify and label 
their own emotions and those of others. They learn affective and cognitive components 
of empathy, enabling them to empathise with others.  
In total, the programme consists of 27 lessons delivered throughout the academic year. 
Each month a trained RoE instructor, who is not the class teacher, visits the classroom 
three times for a pre-family visit; the visit of the parent and infant; and a post-family visit. 
In the cluster randomised controlled trial of RoE in Northern Ireland,55 instructors 
undergo a total of four days intensive training that is delivered directly by a specialist RoE 
trainer from Canada. The specialist trainer also provides on-going mentoring support via 
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regular telephone calls to all instructors. In addition, on-going support is also available to 
each instructor through each Health and Social Care Trust’s lead RoE coordinator. Each 
RoE lesson takes place in the classroom with the teacher present but not actively involved 
in delivery. The programme provides opportunities to discuss and learn about the 
different dimensions of empathy such as emotion identification and explanation; 
perspective-taking; and emotional sensitivity. The parent-infant visit serves as a 
springboard for discussions about understanding feelings and infant development and 
effective parenting practices. The intervention is highly manualised and any adaptation or 
tailoring of either the content or method of delivery is discouraged by the RoE 
organisation.  
RoE is considered a PHI because if implemented year after year, the whole school 
population would be impacted by the intervention. PHIs can often be complex, with 
multiple interacting components. This can make identifying the ‘active ingredients’ which 
are responsible for the success of an intervention difficult.57 Complexity can refer to two 
different constructs, the complexity of the intervention and/or the complexity of the 
system in which the intervention is given; distinguishing between the two can have 
important consequences for economic evaluation.58 When the intervention is complex, as 
long as health economists can quantify the inputs and outputs appropriately it does not 
matter how the intervention works. However, if the system is complex, evaluating 
efficiencies from changing components of the system is much more complicated.58 
Implementation issues within complex systems continues to be a substantial challenge for 
PHIs.59 Complex health system interventions are characterised by the presence of several 
characteristics such as: 1.) having several interacting components; 2.) targeting groups or 
organisations versus individuals; 3.) having numerous and variable outcomes; 4.) the use 
of feedback and a degree of flexibility or tailoring of the intervention permitted; and 5.) 
the effectiveness may be impacted by the behaviours of those delivering or receiving the 
intervention.60 RoE is susceptible to all of these characteristics, even number 4 as it has 
been implemented worldwide and a certain degree of flexibility is necessary to adapt the 
programme to specific cultural and social contexts. This complexity means that RoE may 
not fit neatly within the current methods of economic evaluation which focus on 
maximising health gains61 as there are other non-health outcomes which may be 
impacted such as those relating to education attainment. A content analysis of published 
evaluations of complex interventions found the interaction between the intervention and 
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its context to be a main source of complexity as the people involved may be key to the 
intervention’s success.62 The analysis also found an emphasis on moving away from the 
use of primary outcome measures to a multi-criteria framework that can acknowledge 
multiple objectives of a complex intervention. Complex interventions require complex 
evaluations, therefore ample time and resource needs to be allocated to the economic 
evaluation of such programmes.63 The effectiveness of RoE has been established in 
different contexts globally, however to date the cost-effectiveness of the programme has 
never been evaluated. There are additional costs relating to ensuring programme fidelity 
when RoE is implemented outside of Canada, therefore determining cost-effectiveness is 
a key concern in a UK context.  
As was mentioned in the previous section, economic evaluation of school-based 
programmes is relatively novel, yet it would provide decision-makers with important 
information regarding cost-effectiveness of school programmes under consideration for 
implementation. If establishing longer-term benefits of a programme is a key concern, 
appropriate outcome measures must be identified to evaluate the programme. Ideally, 
these measures would be established in longitudinal evidence available in the literature. 
1.2 Research question and aims 
This thesis will examine the role of economic evaluation in school-based interventions 
and determine appropriate methods and outcomes for its implementation. Specifically 
the overarching research question asks, 
‘How should the cost-effectiveness of school-based, population health 
interventions aimed at children be determined?’ 
To understand how cost-effectiveness should be determined, this thesis is split into three 
main empirical works which together aim to answer this research question. Each 
empirical work has an associated overall aim; these aims are to:  
(i) determine what evaluation methods (economic and non-economic) are 
currently being used to evaluate school-based population health interventions;  
10 
 
(ii) illustrate a good practice example of a thorough cost-utility and cost-
effectiveness analysis of a school-based intervention (the RoE programme) to 
reflect on the advantages of such practice and disadvantages that remain, such 
as decision-making in multisectoral settings; and  
(iii)  explore which outcomes are appropriate for children in the SEW and 
economic evaluation context to support future evaluation work in this context.  
The first overall aim will be addressed through systematic review and narrative synthesis 
of evaluation methods that are currently being implemented in school-based PHIs 
available in the literature. The second aim will be address through a case study of a 
comprehensive economic evaluation of RoE. This case study will demonstrate the 
advantages of conducting economic evaluation in a school-based SEL setting as well as 
identify the issues that remain when applying the traditional methods of health economic 
evaluation to an intervention in an education setting. The final aim will explore 
appropriate outcome measurement in relation to the cost-utility and cost-effectiveness 
analyses of RoE to support future evaluation work including modelling long-term cost-
effectiveness of SEL programmes. This work is facilitated through the validation of 
mapping from a SEW specific outcome measure to a generic child HRQoL measure.  In 
addition to the overarching research question and aims, each of the three empirical 
works individually have their own specific aims and research questions, which are 
addressed separately within each section.  
1.3 Thesis outline 
As outlined earlier, there is a clear need for the economic evaluation of PHIs in school-
based settings due to the lack of cost-effectiveness evidence in the SEW context. 
Additionally, because school-based PHIs are aimed at children, appropriate paediatric 
measures are needed for evaluation. Chapter 2 introduces these and the main concepts 
to be covered in this thesis. It consists of two parts; the first is an introduction to the 
various methods of economic evaluation. The chapter starts with a brief introduction to 
economics as a disciple and gives definitions for key terms used throughout this thesis. 
This is followed by a brief history of the early development of economic evaluation 
methods for healthcare programmes populated with examples throughout history prior 
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to the 1970s. Next, each method for economic evaluation is detailed in turn covering: 
cost-effectiveness analysis (CEA), cost-utility analysis (CUA), cost-benefit analysis (CBA), 
cost-minimization analysis (CMA), and cost-consequence analysis (CCA). Finally, the role 
of economic evaluation within a UK healthcare context and internationally is described. 
The second part of Chapter 2 details economic evaluation of PHIs, a main concept of this 
thesis. Determining the cost-effectiveness of PHIs is covered by detailing appropriate and 
emergent methodologies for evaluation of such programmes. PHIs are often preventative 
by nature, and thus the economic case for prevention is detailed as well as the challenges 
of conducting economic evaluation of these types of programmes. The final section in 
Chapter 2 details economic evaluation in a school setting while drawing upon educational 
economics literature. 
Chapter 3 explores the current state of evaluation of school-based PHIs within the 
published and grey literature. A systematic review and narrative synthesis is presented to 
determine what economic and non-economic evaluation methodologies are currently 
being used for school-based programmes. As economic evaluation in this setting is novel, 
a broad approach was taken to identify all evaluation methodologies. This would help 
inform the practical application of an economic evaluation of the RoE programme.  
Using the results from Chapter 3 (and identified gaps in the literature), a comprehensive 
economic evaluation of the RoE programme was designed to provide a case study of an 
example of one of the first comprehensive economic evaluations of a school-based SEL 
programme. The purpose of this case study within this thesis is to demonstrate the 
advantages economic evaluation can bring to school settings while identifying potential 
challenges to consider for future evaluations in this context. Chapters 4 detailed the 
methods and Chapter 5 described the results of the economic evaluation of the RoE 
programme. Chapter 4 starts by describing economic evaluation in child health and key 
considerations that differ from the evaluation of adult interventions, particularly the need 
for paediatric outcome measures, such as those specific to SEW as well as generic health 
outcome measures. The RoE trial is detailed along with the methods for the economic 
evaluation. Chapter 5 details the results starting with a descriptive analysis followed by 
the costs, outcomes, missing data analysis, and cost-effectiveness results of all sensitivity 
analyses performed. A thorough discussion follows highlighting the advantages and 
12 
 
challenges of implementing economic evaluation in a school setting, as well as the 
limitations and conclusion of this case study.  
Determining appropriate outcomes for child-focussed economic evaluation in the SEW 
context is one of the overall aims of this thesis. Paediatric, child-focussed economic 
evaluation outside of a healthcare context (school setting) is novel and as highlighted 
previously, appropriate child outcomes are needed to measure these benefits. 
Specifically, for cost-utility analysis, UK guidance advises use of a standardised and 
validated preference-based HRQoL measure that has been designed specifically for use in 
children.64 This is because there are risks of compromising validity and psychometric 
properties when modifying adult measures for use with children.37  
Chapter 6 details the final empirical work, which examines the appropriate use of 
paediatric outcomes in cost-utility analysis. A commonly used non-preference based 
outcome measure, the Strengths and Difficulties Questionnaire (SDQ), was mapped to the 
generic, preference-based, Child Health Utility 9D (CHU9D) using previously developed 
mapping algorithms to validate and explore their generalisability in an external dataset. 
This has implications for the economic evaluation of future child-focussed and school-
based PHIs as the SDQ is routinely collected in many large datasets. The work in this 
chapter,  which validates the use of these mapping algorithms, allows analysts the 
opportunity to conduct CUA using a non-preference based outcome measure which is 
commonly used in SEW research. As cost-effectiveness evidence in SEW is lacking, this 
final empirical work provides a potential solution to allow both retrospective and 
prospective cost-utility analysis of SEL/SEW programmes which used the SDQ.  
Chapter 7 summarises each previous chapter and discusses the strengths and limitations 
of each of the three methodological works in turn. A critique of the methods critically 
appraises the work of the author, this thesis, and that of other authors in related fields. 
Chapter 8 provides the overall conclusions for this body of work including implications for 
policy and practice, recommendations, and areas for further research.  
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2 Economic Evaluation and Population Health 
Economic Evaluation 
Modern advances in health care have led to marked increases in life expectancy and 
quality of life.65 However, as a result, healthcare costs are rising worldwide and many fear 
the rising costs will be unsustainable.66, 67 In order to combat rising healthcare costs, 
government and national bodies need to make tough choices about how to organise 
scarce health resources and which treatments and services should be offered to the 
public. Economic evaluation in the healthcare context exists to aid decision makers in 
making these tough choices. 
Economic evaluation is a relatively new discipline, with many of the methods being 
developed in the last 50 years, and a majority of the practical application of the methods 
appearing in the published literature within the last 20 to 30 years.68 Traditional methods 
of economic evaluation have focused on health benefits and have often used a narrower 
health provider perspective, focusing on ways to value health benefits by eliciting 
preferences from the general public.68 Economic evaluation of PHI’s represents a marked 
transition from the traditional more ‘clinical’ evaluation.36  
In the most general sense, population health refers to the health outcomes of a defined 
group of people and how those outcomes are distributed among that group. Therefore, a 
PHI is an initiative that affects a whole population. In the first chapter, SEL/SEW 
programmes were introduced as PHIs for children. Another example might be a national 
policy change to encourage healthier behaviour in the population such as an indoor 
smoking ban. An example of a PHI aimed at children might be a school-based programme 
to encourage healthy diet and physical activity of schoolchildren. There are distinct 
differences and challenges to consider when conducting economic evaluation of PHIs 
because there will be wider health and non-health benefits arising from these types of 
initiatives. This chapter introduces two main themes of this PhD thesis, traditional 
methods of economic evaluation in a healthcare context and considerations for how 
those methods should be adapted for PHIs. 
The chapter starts by introducing basic fundamental concepts of economics and defines 
key terms used throughout this thesis. A brief history is given of the beginnings of health 
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economics before the discipline was formally recognised, followed by a description of the 
formal methods of economic evaluation and its role in national and international decision 
making contexts. The second part of this chapter (2.2) covers PHIs; detailing appropriate 
methodologies, the economic case for promoting preventive population health initiatives, 
and the challenges associated with the conduct of economic evaluation of PHI’s. 
2.1 Economic evaluation methods 
2.1.1 Introduction and definitions 
What is economics? A good starting point is the well-established definition by Lord 
Robbins in 1932; economics is ‘the science which studies human behaviour as a 
relationship between ends and scarce means which have alternatives uses.’ A more 
modern definition from an introductory economics textbook is simply ‘the study of how 
society manages its scarce resources.’69 Economics derives from the Greek word 
'oikonomia’ meaning ‘household management.’70  
 There are many definitions of economics available; in all, the fundamental concepts are 
the same. Fundamental concepts of economics are scarcity and opportunity costs. 
Scarcity is the concept that resources are limited in such a way that there are not enough 
resources available to satisfy every person’s wants or demands. Scarcity of societal 
resources is unavoidable and universal.  Opportunity cost is the value of the alternative 
foregone. Because resources are scarce, choices have to be made between one or more 
options, and the value of the option foregone is an opportunity cost. For example, if a 
school only had space for one hour of health education in its timetable, the scarce 
resource is time and the value of the outcome relates to health gains. The school may be 
considering using the hour to provide healthy lifestyle and nutrition education, or to 
provide physical education. The opportunity cost in this example, is the value of the 
choice that is forgone (i.e. the outcomes from nutrition education or physical activity). If 
resources are scarce, individuals and society need to decide the most efficient way of 
allocating those scarce resources; understanding that there will be an opportunity cost 
associated with every decision. In a healthcare setting, fixed budgets mean that limited 
resources i.e. doctors, nurses, health technologies, need to be allocated in such a way 
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that society deems most cost-effective; understanding that each decision that will 
potentially benefit a patient group, will result in benefits forgone by other patient groups. 
The World Bank defines health economics as, ‘the study of how scarce resources are 
allocated among alternative uses for the care of sickness and the promotion, 
maintenance and improvement of health, including the study of how healthcare and 
health-related services, their costs and benefits, and health itself are distributed among 
individuals and groups in society.’  One of the earliest definitions given by Selma Mushkin 
in 1958 was, ‘a field of inquiry whose subject matter is the optimum use of resources for 
the care of the sick and the promotion of health. Its task is to appraise the efficiency of 
the organization of health services, and to suggest ways of improving this organization.’71  
In free markets, laissez-faire economics (or freedom from interference) allows markets to 
achieve equilibrium naturally. However, the provision of health care is different, as it 
experiences market failure.72 Disruptions in the supply and demand for the provision of 
health care contribute to this market failure. Supply for example, is restricted because 
entry into the healthcare market requires licensing and training. This is a barrier to 
healthcare supply because only medical professionals, who are trained and have specialist 
knowledge and information, are able to provide health care. Another market failure is 
referred to as asymmetric information whereby the medical professional has knowledge 
and information that the patient does not. The patient puts their trust in the medical 
professional, trusting that the treatment they receive is going to improve their health. 
The power in the patient-provider relationship is unbalanced with the provider holding 
more power due to their increased specialist knowledge. This creates inefficiencies in the 
market, as markets are most efficient when knowledge is perfect and shared equally by 
everyone. This is common in any profession, and contributes to market failure.  On the 
demand side, demand for health care is said to be a derived demand for health, or ‘good 
health.’73 Derived demand is the demand for a good or service (in this case health care) 
which is actually a consequence of a demand for something else, i.e. good health. As 
such, the demand for health care is irregular, sporadic, and unpredictable. Consequently, 
there is a need to correct this market failure, and the study of the allocation and 
consumption of health care is a branch of economics termed health economics. 
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2.1.1.1 Priority setting, HTA, and economic evaluation in health care 
 Corrections to healthcare market failure might come in the form of government 
intervention to allocate scarce healthcare resources to maximise health. This need for 
government intervention is now giving rise to the need for priority setting to efficiently 
allocate scarce resources to meet the rising demand for health care. Rationed health care, 
a more politically charged way to describe priority setting, is necessary to make decisions 
about how to fairly allocate scarce healthcare resources, and it is a global issue. 
Worldwide there are differences in healthcare systems and how they are financed, but 
the issue of scarcity is always the same. Priority setting in some countries comes in the 
form of developing principles that guide prioritisation; examples include Norway, 
Sweden, Denmark, and the Netherlands.74 Other countries such as the UK, New Zealand, 
and Israel establish bodies that make recommendations for which treatments and 
services should be offered in the healthcare system.74 
In the UK, the National Institute for Health and Care Excellence (NICE) is an independent 
organisation that provides evidence-based guidance and advice to improve health and 
social care for England (and generally the rest of the UK). NICE was set up in 1999 as the 
National Institute for Clinical Excellence, as a special health authority to reduce variation 
in availability and quality of National Health Service (NHS) treatments and care.75 NICE 
issues evidence-based guidance on safety, effectiveness, and cost-effectiveness of health 
technologies through their technology appraisals guidance. The recommendations that 
NICE make regarding cost-effectiveness, inform government decision-making and priority 
setting in health care in the UK. Scotland has its own Scottish Medicines Consortium 
(SMC), which provides advice to local NHS boards about the status of newly licenced 
drugs. The remit of the SMC’s advice is confined to prescription medications only.  
A health technology is any device, medication or service that aims to improve health. 
Examples are drugs, diagnostic procedures, medical devices such as scanning or 
monitoring equipment, surgical procedures, medical interventions, services, and health 
promoting activities. Health technology assessment (HTA), is therefore the assessment of 
new health technologies for safety, effectiveness, and cost-effectiveness. An early 
definition of health technology assessment is given below, 
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‘We shall use the term assessment of a medical technology to denote any 
process of examining and reporting properties of a medical technology used in 
health care, such as safety, efficacy, feasibility, and indications for use, cost, 
and cost-effectiveness, as well as social, economic, and ethical consequences, 
whether intended or unintended.’ (Institute of Medicine 1985) 
A more recent definition from the HTA glossary is given as, 
‘The systematic evaluation of the properties and effects of a health 
technology, addressing the direct and intended effects of this technology, as 
well as its indirect and unintended consequences, and aimed mainly at 
informing decision making regarding health technologies. 
Note: HTA is conducted by interdisciplinary groups that use explicit analytical 
frameworks drawing on a variety of methods.’76 
Economic evaluation is one way to address the cost-effectiveness component of HTA. It is 
a mechanism that can be used to inform resource allocation decisions. Economic 
evaluation is concerned with two key components: inputs and outputs, or costs and 
consequences.77 When making decisions about whether or not to adopt a new healthcare 
technology, device, treatment, or service it is important to not only consider the cost of 
the new technology, but health benefits including prevention, compared to what is 
already currently available, additionally considering the benefits forgone from any 
potential displacement resulting in adoption of the new technology. Economic evaluation 
is defined by Dummond et al,68 ‘as the comparative analysis of alternative courses of 
action in terms of both their costs and consequences.’  In any economic evaluation, the 
basic tasks include identifying, measuring, and valuing the costs and consequences of the 
alternatives considered. Full economic evaluations explicitly consider relative costs of the 
alternatives and compare them to the relative consequences.68 
Economic evaluation is used as an input for reimbursement and decision-making.78 The 
overall aim of economic evaluation is to aid decisions about efficient and equitable 
resource allocation by comparing cost and benefits of health intervention.68 Resource 
allocation decisions in the hospital setting might include diagnostic, treatment, and 
patient management. For example, the use of resources for treatment of one particular 
condition, means that those resources cannot be used for treatment of other conditions 
(opportunity cost), and economic evaluation aims to help decision makers identify the 
most efficient and equitable allocation of limited healthcare resources. Typically in the 
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UK, economic evaluation will be carried out from the health (NHS) and personal social 
services (PSS) perspective,64 however NICE has recognised the importance of broader 
societal perspectives when considering economic evaluation of public health 
programmes.79 This is because outside of the hospital setting, population health 
programmes might include a variety of resource allocation decisions from multisectoral 
funding streams, e.g. which programme should be run to improve children’s SEW? The 
funding might come partly from the local education authority and partly from the local 
health board, further complicating the evaluation of such programmes, and thus requiring 
a broader public sector or societal perspective.  
This section introduced the fundamental concepts of economics such as scarcity and 
opportunity costs. Important definitions of key concepts of this thesis were defined 
including economics, health economics, HTA, and economic evaluation. Background 
information was given as to why the field of health economics developed (due to market 
failures) and the use of economic evaluation (to aid decision makers). The next section 
provides a brief history of economic evaluation before each type of economic evaluation 
is outlined in turn. 
2.1.2 A brief history of economic evaluation 
The field of health economics is a relatively new one with many of the economic 
evaluation methodologies used today being developed in the last 50 years. However, 
scarcity and opportunity cost in healthcare is not a new phenomenon; attempts have 
been made to value human life in monetary terms beginning in the Victorian era.80 One of 
the earliest forms of cost-benefit analysis comes from Gary N. Calkins, writing in the 
American Statistical Association in 1891.81 Calkins quantified the costs and effects of 
England’s Public Health Act 1875 that included sanitary improvements to water drainage 
and clean water supply. He quantified the cost of the improvements in US dollars (USD) 
which were given as $583,500,000. He then assumed the difference in annual mortality in 
the 10-year period before the works and the 10-year period after the works would be 
directly contributed to the Act, resulting in 856,804 lives saved. The value he placed on 
each life saved came from an estimate from William Farr’s work in Vital Statistics, (p.61) 
which was estimated at £159 per head or $770 USD (at the time). Thus, the total value of 
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lives saved over a 10-year period after the passage of the Act was over $650,000,000 and 
the benefits outweighed the costs. 
Charles Value Chapin was one of the first to consider the need for what is thought of as 
the modern day economic evaluation.80 He read before the Institute of Medicine, 
Chicago, in 1917,  
“Money is the measure of most effort, and appropriations are limited. In what 
way shall the appropriation for the health department be expended so as to 
save the most lives and prevent the most sickness? Are our municipal health 
departments making the best apportionment of their funds? Are health 
officials devoting the most effort to that which will best conserve the health 
of the people?”82  
Chapin considers how institutions are slow to break away from traditions of the past, and 
if you started over with a new health care budget, you would probably end up with a 
different allocation of resources based on current knowledge of costs and effectiveness. 
This is still true today as old inefficiencies in the health system are difficult to break away 
from; it is very difficult to convince stakeholders to disinvest in traditional methods of 
care that are no longer cost-effective. He concludes,  
“Until there are unlimited money and unlimited talent available, let us 
earnestly study to do that which pays best.”82 
Selma Mushkin as mentioned in section 2.1.1, was one of the first authors to define 
health economics in 1958.71 Her work stemmed from the advancing medical techniques 
at the time, and the challenges of financing these new advancements. The official 
recognition of health economics as a discipline is often credited to Kenneth Arrow83 in his 
1963 paper ‘Uncertainty and the welfare economics of medical care.’84 In his seminal 
paper, Arrow discusses the economics of the medical care industry (not health) and how 
it satisfies the needs of society in a way that differs from the ‘normal’ economic model; 
these differences stemming mainly from risks and uncertainty.84 
Herbert Klarman was a Polish immigrant in the United States of America (USA).80 He was a 
professor of public health administration from 1962 to 1969 at John Hopkins during which 
time he published the first health economics textbook, Economics of Health.85 He also 
published an early cohort decision model for the treatment of chronic renal disease.86 
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This was the first study to apply quality adjustment to life years gained, or the first study 
to use a QALY as it is referred to in modern day terms. In his chronic renal disease study, a 
quality adjustment was applied to account for the quality differences between life after 
transplantation and life on dialysis.86  
This brief history introduced some of the earliest works in economic evaluation, before 
the disciple had been formally recognised. One of the earliest forms of economic 
evaluation was a cost-benefit type analysis of England’s Public Health Act 1875. In 1917, 
appropriately named Charles ‘Value’ Chaplin, recognised that institutions have a hard 
time breaking away from traditions of the past, creating inefficiencies in the health care 
system. Selma Mushkin is one of the first to define health economics in 1958 before 
Kenneth Arrow, who is often credited with the recognition of health economics as a 
discipline in 1963. Herbert Klarman wrote the first health economics textbook, and was 
the first make a quality adjustment of life years gained. From the 1970s onward, methods 
for modern economic evaluation were developed and the rest of this section details 
methods and definitions for modern use of the different types of economic evaluation. A 
number of recommendation guidelines, documents, and texts have emerged since the 
1990s on the design and conduct of health economic evaluation. These recommendations 
have helped to standardise the basic elements of economic evaluation and analytic 
techniques.37 Many countries already have their own country specific HTA guidance in 
place for conducting economic evaluation.87  
The types of economic evaluation are mainly differentiated by the outcomes used to 
measure benefits. There are three types of full economic evaluation as classified by 
Drummond et al.68 which are cost-effectiveness analysis, cost-utility analysis, and cost-
benefit analysis. Cost-consequence analysis and cost-minimization analysis are not always 
considered full economic evaluations. Sections 2.1.3 through 2.1.7 go over each type of 
economic evaluation individually. 
2.1.3 Cost-effectiveness analysis (CEA) 
Cost-effectiveness analysis (CEA) is a type of economic evaluation where effects are 
measured in natural units. CEA is used in situations where a decision maker with a limited 
budget, is considering a limited range of options within a given field.77 Examples of 
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natural units that may be used as a measure of health outcome could be ‘cases detected,’ 
‘improved mental health status,’ or ‘life years gained.’ It is important that the health 
outcome chosen is a reliable measure for the desired objective.77 Take for example the 
evaluation of two cancer drugs, drug A the standard drug and drug B the newly developed 
drug. Treatment with drug A and B share the same outcome of interest, life years gained, 
but they may have differential success in achieving this outcome as well as differential 
costs. Evaluators would be interested in the incremental cost per unit of effect, i.e. life 
years gained. CEAs are often expressed in terms of an incremental cost-effectiveness ratio 
(ICER) which is a ratio of the incremental difference in costs between two alternatives and 
the incremental difference in effectiveness between the same two alternatives.88 The 
ICER formula is given below where ∆ represents the difference in mean costs and effects 
between groups. 
Equation 1: ICER formula 
𝑰𝑪𝑬𝑹 =
∆𝐂𝐨𝐬𝐭
∆𝐄𝐟𝐟𝐞𝐜𝐭𝐬
 
 
In CEA, the result of interest is typically expressed as cost per unit of effect gained (e.g. 
cost per life year gained), but it could also be expressed as effect per unit of cost (e.g. life 
years gained per pound spent).68 An example of a CEA might look at the number of 
quitters in a smoking cessation programme. The ICER would be expressed as the 
incremental cost per successful quitter. There are many examples of CEA published in the 
literature, one such example examined home visiting to improve parenting and health 
and social outcomes for children.89 The outcome of interest was unit increases in 
maternal sensitivity and infant cooperation components of the CARE Index, an outcome 
that measures mother and child interaction. The results were expressed as £2,723 and 
£2,033 per increased unit of maternal sensitivity and infant cooperativeness 
respectively.89   
The cost-effectiveness (CE) plane is used to plot the difference in effects (∆E) along the 
horizontal axis against the difference in costs (∆C) per participant along the vertical axis.90 
The plane is split into four quadrants labelled using the points of a compass NE, SE, SW, 
and NW (see Figure 1). If an ICER falls in the SW quadrant, the new treatment dominates 
in that it is more effective and less costly. If it falls in the NW quadrant, the new 
22 
 
treatment is said to be dominated because it is more costly and less effective. If it falls 
within the NE or SW quadrant a trade-off has to be made between costs and effects.38 
Some decision makers might specify a willingness-to-pay threshold (WTP) which is a value 
judgement usually denoted by λ. NICE for example, uses a WTP threshold of £20,000 to 
£30,000 per quality-adjusted life year (QALY) to determine cost-effectiveness of health 
technologies.64 The QALY as a concept will be discussed further in the next section, 2.1.4. 
A WTP threshold can be specified for any unit of effect the decision maker deems 
relevant, and the amount may be context specific and based on a value judgement. In 
Figure 1, the line that passes through the origin of the CE plane, denoted by λ, represents 
a hypothetical WTP threshold; i.e. the maximum WTP per unit of effect.77 When an ICER 
falls in the NE or SW quadrant, decision makers must decide if the additional health 
benefits of the more effective treatment are worth the additional cost. If a WTP threshold 
has been specified, the additional cost is capped by this ceiling value. This decision rule is 
expressed in Equation 2 below. 
Equation 2: Cost-effectiveness decision rule  
𝑫𝒆𝒄𝒊𝒅𝒆 𝒕𝒐 𝒊𝒎𝒑𝒍𝒆𝒎𝒆𝒏𝒕 𝒏𝒆𝒘 𝒑𝒓𝒐𝒈𝒓𝒂𝒎𝒎𝒆 𝒊𝒇: 
∆𝐂𝐨𝐬𝐭
∆𝐄𝐟𝐟𝐞𝐜𝐭𝐬
< 𝛌 
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Figure 1: Cost-effectiveness plane  
 
It is important to note that negative ICERs that fall within different quadrants have vastly 
different interpretations. A negative ICER can have the same value, but depending on 
whether it falls in the SE or NW quadrant can be the difference between the treatment 
being dominated (where effects are negative in the NW quadrant), to the new treatment 
dominating the old treatment (where the costs are less in the SE quadrant). This is why 
negative ICERs are generally not reported; instead they are reported in relation to what 
quadrant they fall, or in terms of dominated or dominates.91 Negative ICERs are an issue 
when bootstrapping cost and effect pairs to analyse uncertainty around the point 
estimates, as the pairs will be ordered from low-to-high in a distribution when estimating 
confidence intervals.92 To overcome this problem, the decision rule can be rearranged 
into linear functions net monetary benefit (NMB) and net health benefit (NHB) given 
below in Equation 3 and Equation 4. Estimating NMB or NHB is also useful when 
comparing three or more comparators as each comparator can be ranked and selected 
based on which comparator provides the most NHBs within the maximum threshold. 
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Equation 3: Net monetary benefit (NMB) 
λ ∗  ∆E − ∆C >  0 
Equation 4: Net health benefit (NHB) 
∆E −  
∆C
λ
 >  0 
NMB allows more meaningful presentation of cost-effectiveness results, but relies on the 
WTP threshold (λ) being known. In cases where λ is unknown or unspecified, a range of 
values can be estimated. Because of the use of specific measures of effects, one of the 
biggest limitations of CEA is the difficulty in quantifying the opportunity cost (or the 
benefits forgone) of the displaced programmes covered under the same budget.68  
2.1.4 Cost-utility analysis (CUA) 
Cost-utility analysis (CUA) is often referred to as a variant of CEA because the only 
difference is that CUA uses a generic measure of health gain. Many authors of economic 
evaluations do not always distinguish between the two, particularly in the USA.77 Thus, it 
is common to see variation in the use of the terms in the literature. Drummond and 
colleagues68 characterise CUA as a special case of CEA which is expressed as a ‘cost per 
healthy year gained.’ The most common measure of years in full health is the QALY.38 The 
QALY is a year of life adjusted for its quality or its value. QALYs are calculated by 
weighting length of life by health-related quality of life (HRQoL). The QALY is essentially 
what ‘utility’ refers to in cost-utility analysis. A utility is a generic measure of health gain 
and is valued to reflect population preferences. In this sense, ‘utility’ refers to preferences 
individuals or society has for a particular set of health outcomes or health states.68 A year 
in perfect health is considered equal to 1’88 and death is considered 0. There are health 
states considered worse than death so negative utility values are possible. A terminal 
illness that causes a lot of pain, immobility, or a decreased quality of life that the patient 
deems worse than death might give rise to a negative utility value. QALYs are used as the 
primary outcome in CUAs for a couple of reasons. First, they are generic, thus facilitate 
the comparison of very different programmes or interventions on a single effectiveness 
measure. Second, they are weighted by the population’s preferences hence, they not only 
prioritise interventions that extend length of life, but those that improve overall quality of 
life. 
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2.1.4.1 Eliciting preferences 
There are two components for estimating quality adjustment of QALYs; a description of 
the possible health states being measured, and a valuation of those health states.38 A 
generic preference-based measure such as the EuroQol EQ-5D,93 the Health Utilities Index 
(HUI),94 or the SF-6D95 have health state descriptive systems that are accompanied by a 
set of health state utility values (health-utilities) that were elicited using preference-
based valuation techniques.38 More recently, the Child Health Utility 9D (CHU9D)96 has 
been developed specifically for children. Briefly, the CHU9D is the only HRQoL measure 
that has been developed specifically for children and has been valued by adolescents. All 
other HRQoL outcomes for children are missing one or both of these circumstances 
(further detail in section 4.2.1). There are a number of methods for obtaining these 
preferences; the standard gamble (SG), the time trade-off (TTO), and the rating scale and 
its variants being the most common.77 These methods allow for the valuation of the 
health states described in by the generic preference-based measures mentioned above 
(i.e. EQ-5D, HUI, and SF-6D).   
The SG technique derives directly from expected utility theory, in which a rational 
individual will make decisions, or act in such a way to maximise their utility. The SG 
presents participants with two choices, a certain outcome or a gamble. For example, 
participants might be asked to imagine that they have a chronic disease where they 
experience limited mobility, some pain, and some problems with performing usual 
activities. They are then presented with a gamble, they can either stay in their current 
health state or take a gamble in which they have a 70% chance of being cured or a 30% 
chance of dying immediately. The probability of a cure is then varied until the participant 
is indifferent between their current health state and probability of a cure. This point of 
indifference represents the utility the participant places on the cure.97 
The TTO method was developed by Torrance and collegues98 and involves asking 
participants to state their choice between two certain outcomes at different lengths of 
time. Choice A might be life in full health for 8 years followed by death, and Choice B is 
life in a particular health state (like the one described above) for 10 years followed by 
death. The participant must choose which is preferred. If it is Choice A, the times are 
divided by one another and that is the preference given to health state B (i.e. 8/10 = 0.8). 
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If the answer is Choice B, the time in Choice A is shortened until, it is selected (e.g. four 
years in perfect health is preferred to the health state in B; 4/10 = 0.4). 
Rating scales and visual analogue scales are one of the simplest methods for obtaining 
preferences. Participants are presented with a scale, and they are asked to rank a number 
of health outcomes on the scale, with intervals between the outcomes representing the 
differing preference for those health states. There are measurement biases associated 
with these types of scaling tasks when compared to choice-based tasks such as SG or TTO. 
These include end-of-scale bias in which participants tend to avoid placing outcomes at 
the high and low end of the scale, and context bias where participants tend to evenly 
space outcomes regardless of if their preferences align.68 NICE recommends using a utility 
measure that uses a choice-based method to elicit the public’s preferences.64 
Because the QALY is a generic HRQoL measure, it is possible to compare programmes 
with very different objectives to one another because effectiveness outcomes are all 
being valued in the same way. A variant of the QALY is the disability-adjusted life year 
(DALY) which is commonly used in developing countries. A DALY is ‘a measure to adjust 
life years lived for disease related disability, age and time preference.’88  Other 
alternatives to the QALY are the healthy years equivalent99 and the saved-young-life 
equivalent100 HRQoL measures attempt to quantify and measure all possible health 
states. The more detailed a questionnaire (more dimensions and levels), the more 
possible resulting health states. These health states will have been valued using 
population preferences obtained from SG, TTO, or other methods. There are many 
different HRQoL measures available and the same individual filling in different 
questionnaires can end up with markedly different utility values, depending on the 
questionnaire and the method used to value the population’s preferences. Thus, in order 
to facilitate comparability between evaluations for decision making, NICE recommends 
use of a single measure,64 the EQ-5D.93 
2.1.4.2 EuroQoL EQ-5D 
The EQ-5D consists of the following five dimensions: mobility, self-care, usual activities, 
pain/discomfort, and anxiety/depression. There is the 3L and 5L version where the ‘L’ 
stands for levels, which describes varying levels of problems within each dimension. 
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Participants are asked to select the level of severity for each of the five dimensions, which 
makes up their unique health state. Preferences from the relevant population can then be 
applied to value the QALY. Country specific value sets are available from the EuroQol 
website.101 Box 1 below gives an example of the EQ-5D-3L. 
Box 1: Example of EQ-5D-3L from EuroQol website
 
 
2.1.4.3 Calculating QALYs 
Since the EQ-5D incorporates the two components of a QALY, the health state description 
and its valuation, QALYs can now be calculated. If utilities are plotted on a graph; utility 
values are plotted along the y-axis and time runs along the x-axis. In a very simple 
example, the EQ-5D is measured at baseline, and at 1 year (t1 = 0 and t2 = 1, where t 
represents time). The utility at each time point is 1, perfect health (u1 = 1 and u2 = 1, 
where u represents the utility value). The area under the curve (AUC), in this case a flat 
By placing a tick in one box in each group below, please indicate which statements 
best describe your own health state today. 
Mobility 
I have no problems in walking about       □ 
I have some problems in walking about       □ 
I am confined to bed         □ 
 
Self-Care 
I have no problems with self-care        □ 
I have some problems washing or dressing myself     □ 
I am unable to wash or dress myself       □ 
 
Usual Activities (e.g. work, study, housework, family, or leisure activities)  
I have no problems with performing my usual activities    □ 
have some problems with performing my usual activities    □ 
I am unable to perform my usual activities      □
   
Pain/Discomfort 
I have no pain or discomfort        □ 
I have moderate pain or discomfort       □ 
I have extreme pain or discomfort        □ 
 
Anxiety/Depression 
I am not anxious or depressed        □ 
I am moderately anxious or depressed       □ 
I am extremely anxious or depressed       □ 
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horizontal line, is the QALY gained over that time. The AUC is calculated as the product of 
the time difference and the average of the two measures as given in Equation 5.102 
Equation 5: Area Under the Curve  
𝑨𝑼𝑪 = (𝒕𝟐 − 𝒕𝟏) ×
(𝒖𝟏 + 𝒖𝟐)
𝟐
 
In this simple example the AUC is 1, so the QALY gained is one, see Figure 2. 
 
Figure 2: Simple example of individual QALY gain 
 
A more complex example is displayed in Figure 3. Note the grey area is the QALY gained 
without the intervention (in the control) and white area between the two series 
represents the QALY gains from the intervention, which is simply the difference between 
the two.  
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Figure 3: QALY gains from a comparison of two alternatives 
 
Once QALYs are calculated for each alternative, the resulting ICER is expressed as a cost 
per QALY in CUA. CUAs are now the most common form of economic evaluation in the 
UK,68 partly due to the official requirements set out in the NICE reference case.64 The 
reference case sets out the methods to be used in health technology appraisals submitted 
to NICE, as a way to promote consistency and quality in determining cost-effectiveness of 
health technologies. Specifically, the reference case states that, ‘health effects should be 
expressed in QALYs. The EQ-5D is the preferred measure of health-related quality of life 
in adults’64 (p 29). The use of a generic QALY measure provides a uniform ‘yardstick’ 
measure for which all health technologies regardless of disease area can be compared. 
Additionally, NICE has an established cost-effectiveness threshold based on 
improvements in QALYs, making for ease and consistencyb in the healthcare decision-
making process.64 This is in line with the extra-welfarist view, which has a sole focus on 
maximising health utility through a QALY framework.103 
Many major funding bodies in the UK now require or expect to see an economic 
evaluation built into primary research study grant applications. The National Institute for 
Health Research (NIHR) was created in 2006 under a 2005 English Government strategy to 
improve research in the health field and consolidate existing research programmes, one 
                                                     
b Funding allocation decisions are not based-solely on the cost-effectiveness threshold of £20,000 
to £30,000 per QALY. Other factors play a role such as patient safety and ethics, and in some 
cases a higher threshold is warranted such as at the end of life.64  
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of which was the HTA programme.104 Three years into the existence of the NIHR, the 
Public Health Research programme was introduced to fund research and generate 
evidence of the delivery on non-NHS interventions that improve public health and reduce 
inequalities. The NIHR stipulates that most primary research projects applying for funding 
are expected to include an economic evaluation.105 The Chief Scientist Office (CSO) is a 
major funding body for Scottish health research. Through their contribution to the NIHR 
funding pool, researchers in Scotland are able to apply for most research programmes 
funded by the NIHR including the HTA and Public Health Research programmes. CUAs are 
now built into many of these funding applications due to these requirements and 
expectations of determining not only effectiveness, but cost-effectiveness as well. 
2.1.5 Cost-benefit analysis (CBA) 
Cost-benefit analysis (CBA) differs from CEA and CUA in that all effects or benefits as well 
as costs are valued in monetary terms. An intervention is considered worthwhile if all the 
benefits (valued in monetary units) exceed the costs (i.e. there is a positive net benefit.)  
CBA addresses the question of whether an intervention is worthwhile to society rather 
than restricting it to the health services’ budget.38 It is often considered the gold standard 
as it is the most comprehensive form of economic evaluation.106 With monetised benefits 
readily compared to costs, CBA allows decision makers to directly address if it is 
worthwhile expanding the healthcare budget, as opposed to how to best allocate an 
existing budget as is the case with CEA and CUA.68 A decision to expand a programme 
from a CEA or CUA has an opportunity cost in terms of benefits forgone to other health 
technologies covered in the same programme.68 CUA is based on the notion that those 
who gain, could compensate the losers. Additionally, CBA’s measure of benefit is more 
comprehensive including non-health benefits.38 The results of a CBA might be presented 
as a ratio of costs to benefits, or a simple sum of the net benefit (or loss) of one 
programme over another. 
CBA has a long history outside of health in sectors such as the environment and 
transport.68 In fact, CBA can facilitate the comparison of healthcare technologies to 
programmes from multiple sectors of the economy such as the education, environment, 
and transport sectors. Because outcomes are expressed in monetary units, it is possible to 
determine net monetary gains to society. For example, the net benefit of a surgical 
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procedure can be compared to the net benefit of an educational programme to improve 
maths learning in schools, which can also be compared to the net benefit of improved 
public transport links if CBA methodologies are used in each case. This comparison is not 
possible with CEA or CUA because health benefits and costs are measured with different 
units so to attempt to compare a cost per QALY outcome to a monetary transport 
outcome would be like attempting to compare apples to oranges.  The main challenge 
with CBA is placing a monetary value on human life and health benefits, and this is a main 
reason why CEA and CUA have been utilised more in the health sector.106 Additionally, 
CBA requires more time and resources to conduct (not to be confused with cost savings 
analysis – see section below). This is due to a larger burden placed on measuring a 
broader spectrum of outcomes (health and non-health) which also need to be valued in 
monetary terms. Lack of standardisation in elicitations methods, stated-preference biases 
(see section below), and the considerable measurement burden (as CBA needs to be 
tailored for each intervention) are some of the practical barriers of CBA.107 
2.1.5.1 Valuing benefits in monetary terms 
There are a number of ways to place a monetary valuation on human health. They are 
broadly divided into two main categories: the human capital approach and approaches 
based on individual observed or ‘stated preferences.’ The human capital approach 
estimates the present value of an individual’s future earnings. Benefits are valued in 
terms of how the health changes impact an individual’s labour productivity. This approach 
has been favoured in legal applications that require estimates of damages.108 An example 
may be a pay out to a former employee who suffered a work place accident that 
prevented them from returning to work. The human capital approach does not directly 
measure an individual’s ‘willingness-to-pay’ to avoid ill health or their ‘willingness-to-
accept’ as compensation.108 The second approach to valuing health benefits uses 
observed preferences that are revealed in markets, or asks individuals to state their 
preferences in monetary terms. Where functioning markets do not exist (e.g. health care), 
individuals can express their hypothetical willingness-to-pay (or accept) health outcomes. 
This is a conventional economic concept in which an individual’s WTP for a good is an 
indicator of the strength of their preference for such good or attribute of the good.72 As 
well, the hypothetical nature of the task is similar the SG and TTO approaches mentioned 
in section 2.1.4.1 for eliciting utility preferences. The techniques used to elicit such 
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preferences come under the broad heading of ‘stated preference’ methods or contingent 
valuation where the valuation poses a set of contingencies to determine the individual’s 
WTP for the desired benefit. There are a number studies in the literature that assess 
individual’s WTP for a health technology, however, few comprehensive CBAs that 
incorporate these values are published.68, 72 Another method for eliciting and valuing 
preferences are discrete choice experiments (DCE). A DCE is an attributed-based 
technique for collecting stated preferences involving a sequence of hypothetical scenarios 
or choice sets for the respondent to choose from.109 Depending on the complexity, DCE 
choice sets can quickly multiply leading to more cognitive burden for the respondent, and 
the possibility of ‘irrational’ stated preferences which cannot be used.109 As stated above, 
there is a lack of standardisation in eliciting these stated preferences as well as biases 
that go along with asking an individual to state their preferences. This is a challenge when 
undertaking CBA and is one potential reason why few comprehensive CBAs have been 
published in the literature.  
CBA should be distinguished from a related technique, cost-savings analysis, which 
involves the comparison of costs and benefits that are easily converted into monetary 
units with other effects ignored. Cost-savings analysis is and continues to be more 
commonly used in the evaluation of social welfare services.110 An example is comparing 
the costs of an intervention to the savings generated from reductions in crime. This type 
of analysis is less sound than CBA because it does not attempt to value all relevant 
outcomes.110 
2.1.6 Cost-minimization analysis (CMA) 
Cost-minimization analysis (CMA) assumes two or more alternatives are equivalent in the 
health benefits produced, and thus CMA is simply a costing exercise to determine which 
programme costs less. CMA has often been criticised for failing to explore uncertainty 
around determining equivalence in treatment outcomes of two different treatment 
options and in 2001 Briggs and O’Brien111 announced the ‘death of the cost-minimisation 
analysis.’ CMA was historically recommended for trials finding no statistically significant 
differences in effectiveness because of its simplicity and ease of interpretation.112 With 
the ‘death of CMA’ Briggs and O’Brien111 argued researchers should instead conduct CEA 
or CUA to estimate the joint density of cost and effect differences and present 
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uncertainty on cost-effectiveness acceptability curves. More recently Dakin and 
Wordsworth113 conducted a literature review to examine how the use of CMA has 
changed since 2001, if CMA was appropriate in non-inferiority trials, and if CMA gives 
biased results. Through examples of simulated and trial data, they found CMA does bias 
measures of uncertainty, and even when the bias is negligible in non-inferiority trials, 
where there is a large difference in cost, it is still necessary to collect and analyse data on 
costs and effects to assess this bias. They went on to conclude,113 ‘The remit of CMA in 
trial-based economic evaluation is therefore even narrower than previously thought, 
suggesting that CMA is not only dead but should also be buried.’ CMA has since fallen out 
of health economics textbooks as a recommend form of full economic evaluation.38, 68, 77 
2.1.7 Cost-consequence analysis (CCA) 
Cost-consequence analysis (CCA) is not considered by Drummond et al.77 as a full 
economic evaluation because the trade-offs between costs and consequences have not 
been made explicit. It has since fallen out of the latest version of Drummond ‘blue 
book.’68  However, public health guidance issued by NICE in 2012, stated more emphasis 
would be placed on CCA and CBA than has been in the past due to local governments 
being responsible for implementing public health programmes and having a larger remit 
than the health services sector.79 NICE began focusing on public health in 2005 in order to 
avoid ill health and promote healthier lifestyles. The first public health guidance was 
issued in 2006 relating to smoking interventions and referrals.114 The significance of 
decision-making in public health contexts will be covered further in section 2.2.1. 
CCA was developed from scepticism that all relevant considerations could be summarised 
in a single outcome such as incremental cost per unit of effect or a net benefits 
approach.38 Instead all relevant costs and effects are presented in a table, but there is no 
single resulting figure to enable ranking of different treatment options; decision rules are 
left up to the decision maker. Decision makers may be more interested in seeing 
disaggregated costs and outcomes of the two or more alternatives because there may be 
multiple objectives of the programme.77 Presenting an array of costs and outcomes leaves 
the decision maker to decide on the trade-offs between costs and effects. This is keeping 
in line with the traditional notion of economic evaluation as an aid to decision makers. 
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The main disadvantage of CCA is that the basis for the decision may be unclear or not 
made explicit.  
Sections 2.1.3 to 2.1.7 described the different types of economic evaluation 
methodologies and gave examples of outcomes that distinguish the different types and 
situations where certain methods may be more appropriate. CUA, a form of CEA, is the 
most commonly used type of economic evaluation in the UK due to NICE guidance 
specifically calling for this type of evaluation in the reference case. CBA is the most 
comprehensive form of economic evaluation, but due to complications with valuing 
health outcomes in monetary terms, comprehensive CBAs with stated preferences are 
still rarely published. CMA should no longer be used due to problems and biases that 
present from attempting to determine total equivalence in effectiveness of two or more 
alternatives. Finally, CCA is not always considered a full economic evaluation, however it 
provides decision makers the option of deciding themselves the appropriate trade-offs 
that need to be made in terms of costs and benefits. The final subsection of section 2.1 
describes decision making in the UK and internationally. There are additional methods 
that are becoming more popular in the economic evaluation context such as multi-criteria 
decision analysis (MCDA), and the use of natural experiments in population health, but 
these will be covered later in section 2.2.1.2. 
2.1.8 The role of economic evaluation in healthcare decision 
making in the UK and internationally 
Economic evaluation methodologies were developed to aid decision making in the 
context of prevalent market failure in health care markets. In the last 20 years, annual 
growth rate of public health spending exceeded GDP growth in all OECD countries.115 
While this has led to improved health outcomes, there is concern over the sustainability 
of the trend. Rising health expenditure is mainly due to new technologies, rising incomes, 
and population aging.115  NICE is the only public body to specifically state a cost-
effectiveness threshold of £20-£30,000/QALY116 that is used in aiding decision making of 
the potential cost-effectiveness of new health technologies. This threshold has been 
maintained since appearing in NICE’s methods guidance since 2004.117 However, it is 
important to note that cost per QALY is not the only criterion considered when making 
decisions on whether to accept or reject new health technologies. The origins of the 
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threshold figures are  not based on empirical evidence.118 Appleby and colleagues state, 
‘the uncomfortable truth is that NICE’s threshold has no basis in either theory or 
evidence’ (p358).119  This has led some to consider the threshold may be too high.119 In 
2008, the House of Commons Health Select Committee stated, 
‘The affordability of NICE guidance and the threshold it uses to decide 
whether a treatment is cost-effective is of serious concern. The threshold is 
not based on empirical research and is not directly related to the NHS budget. 
It seems to be higher than the threshold used by PCTs [primary care trusts] for 
treatments not assessed by NICE. Some witnesses, including patient 
organisation and pharmaceutical companies, thought NICE should be more 
generous in the cost per QALY threshold it uses, and should approve more 
products. On the other hand, some PCTs struggle to implement NICE guidance 
at the current threshold and other witnesses argued that a lower threshold 
should be used. We recommend that the threshold used by NICE in its full 
assessments be reviewed; further research comparing thresholds used by 
PCTs and those used by NICE should be undertaken. An independent body 
should determine the threshold used when making judgements of the value 
of technologies to the NHS.’ (p6)120 
The lack of evidence around this value-based threshold poses problems for primary care 
trusts struggling to implement new guidance from NICE, while on the other hand patients 
and drug providers are arguing the threshold is too low. As per the recommendation of 
the House of Commons Health Select Committee, Claxton and colleagues118 have 
attempted to value the threshold based on technical fact rather than informal judgement. 
The aim of the work was to re-estimate the NICE threshold using routinely available data. 
The work encountered major technical challenges as well as challenges from fellow 
academics.121 The final estimate which is closer to £13,000/QALY is surrounded by 
considerable uncertainty, however one could argue the same of the informal judgment 
made around the original value of the threshold. However, now that the precedent of the 
£20-£30,000/ QALY has been set and practiced for nearly two decades, real life 
implications for a drastic lowering of the threshold may not be acceptable to the 
healthcare system or the public. Sir Andrew Dillon, NICE’s chief executive, argues that the 
use of the new threshold would mean the NHS would not be able to provide most new 
treatments as he does not believe drug companies would be willing to lower their prices 
in an unprecedented way.122 He believes the balance between accepting new costly 
treatments and displacing other effective healthcare treatments from the NHS has been 
achieved with the current threshold, and it would be up to a debate in the government, 
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NHS, NICE, and the public to determine if the current threshold should be adjusted. There 
are the practical issues to consider as well including if NICE would need to reissue all 
guidance that was now over the £13,000/QALY threshold. There would also be issues with 
implementation of all the new guidance in the NHS. The concept that it is difficult to 
break away from the status quo, as described by Charles Value Chapin in section 2.1.2, is 
echoed here in a modern day example. Despite this, the new lower threshold should not 
be forgotten completely, and wider discussion of the potential outcomes should 
continue. In the words of Charles Value Chapin, “let us earnestly study to do that which 
pays best.” 
Outside of the UK, the World Health Organization (WHO) has been using average per 
capita income as a means for establishing cost-effectiveness thresholds in low and middle 
income countries.123 Cost-effectiveness is determined as cost per DALY averted, and 
those interventions which cost less than three times the average per capita gross 
domestic product (GDP) is considered cost-effective. Those that cost less than the 
average per capita GDP is considered very cost-effective. Marseille and colleagues124 
argue this approach has major shortcomings. Ultimately, the value placed on the 
threshold should come from the collective values of the society. 
Australia was the first country to use an element of HTA in routine decision-making 
regarding pharmaceuticals in 1993.125 Since January of 1993, economic analyses were a 
requirement to support applications to list new pharmaceuticals on the Australian 
schedule of pharmaceutical benefits. HTA submissions are considered by the 
Pharmaceutical Benefits Advisory Committee in Australia. Canada soon followed in issuing 
its first set of guidelines in November 1994.126 HTA submissions are considered by the 
Canadian Agency for Drugs and Technologies in Health. For an updated table of country-
specific pharmacoeconomic guidelines please see the International Society for 
Pharmacoeconomics and Outcomes Research (ISPOR) website at: 
https://www.ispor.org/PEguidelines/index.asp. 
In the US, the Panel on Cost-Effectiveness in Health and Medicine released its first 
guidance in 1996 recommending the use of QALYs as a standard metric for identifying and 
assigning value to health outcomes.127 The Second Panel on Cost-Effectiveness in Health 
and Medicine128 convened 20 years later to update the recommendations. In the second 
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set of recommendations, QALYs were still recommended, but in terms of interpreting 
results in comparison to a threshold,  
‘Comparison with 1 specific threshold should be avoided (unless appropriate 
for the decision context); analysis should instead highlight how clinical or 
policy recommendation might change with consideration of a range of 
thresholds.’128 
Additionally, the Patient Protection and Affordable Care Act,129 a landmark health policy 
reform in the US, created a Patient-Centered Outcomes Research Institute to conduct 
comparative-effectiveness research, but prohibited this institute from developing or using 
cost-per-QALY thresholds.130 The Act states, 
‘The secretary shall not utilize such an adjusted life year (or such a similar 
measure) as a threshold to determine coverage, reimbursement, or incentive 
programs…’129 
Reasons for this resistance are complex, but likely rooted in many individuals’ fear of 
rationed care. Many individuals in the US have a distrust of the government meddling in 
affairs of individuals, including healthcare, despite the existence of government 
sponsored healthcare programmes such as Medicaid and Medicare, which contribute to a 
considerable proportion of healthcare spending. Individuals in the US are likely to 
minimise the underlying problem of resource scarcity and the need to explicitly ration 
care.128 This might be due to the current ability to ‘choose’ the heath care they desire 
based on their ability to pay. Any attempts to reform the system would be viewed by 
many as the government imposing limits on their individual liberties. The lack of concern 
for making sure everyone has access to affordable health care may not stem from a lack 
of altruism, but a genuine belief that the status quo in America is the most efficient way 
to deliver health care at the highest quality. 
Some countries, such as USA, outright disagree with use of a threshold – not public 
money spent on health care system. Other countries see the benefit of a value yet there 
remains an ongoing debate over the appropriateness of this due to a lack of theoretical 
and empirical evidence.116 It is unclear whether they should represent normative values 
or real resource constraints within a health care system.37 Even if the use of a threshold is 
welcome, there are differing views of what it represents. Vallejo-Torres and colleagues116 
write, ‘The two main conceptual perspectives include the view that the threshold should 
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reflect 1) society’s monetary valuation of health gains, or 2) the opportunity cost resulting 
from the disinvestment required to adopt a new technology.’ The author believes both 
perspectives are valid, because society understands rising healthcare costs are 
unsustainable, so there should be a monetary valuation of health gains based on society’s 
collective values. At the same time society should also understand that this valuation is 
equivalent to the disinvestment in health or social care services elsewhere in the 
healthcare system. This opportunity cost will result in health losses for individuals 
elsewhere who are often less visible than the families who might campaign to make a 
new (and expensive) drug available on the NHS. The cuts to mental health and social care 
are often in the news, but it is rarely equated to the opportunity cost of investing in new 
medical technologies elsewhere in the health care budget (assuming social care fell within 
this remit). The public may be outraged when NICE decides to reject a new cancer drug; 
however, what is left out of the conversation is the trade-off that would have been made 
if they decided to accept the new drug. According to a WHO report131 mental illness cost 
the UK economy £110 billion in 2008 but only accounted for 10.48% of the 2008/9 NHS 
budget. This equates to roughly £10.1 billion spending on mental health services of the 
approximate £96.4 billion NHS budget in 2008/9.132 There is a clear discrepancy between 
what mental illness is costing the UK economy in health service use and labour 
productivity and what is actually being spent by the NHS on mental health services. 
Health care costs are rising and the trend is unsustainable. There needs to be a systematic 
process in place for deciding how society’s scarce healthcare resources will be allocated. 
The use of economic evaluation is one such way to do this. Specifically, the use of a 
threshold, even if value-based, provides a means for making allocation decisions in a 
consistent fashion. As NICE explicitly states a cost-effectiveness threshold, this threshold 
is used in the economic evaluation described in Chapter 4. As will be seen in section 2.2.1, 
the threshold as it relates to PHIs is still the same £20,000 to £30,000 per QALY as stated 
in methods guides for the appraisal of health technologies in the healthcare setting. 
2.1.8.1 Vehicles for conducting economic evaluation  
Economic evaluation can be conducted in various ways. These include alongside trials; in 
a decision modelling context; or a mix of both methodologies. The mixed methodology 
approach might include an economic evaluation alongside a trial with a long-term model 
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to extend the within trial time horizon. Or a pre-trial decision analytic model may be 
employed to inform the potential cost-effectiveness of a new health technology and to 
determine if a large-scale trial-based economic evaluation is required. More recently, 
emerging methodologies for economic evaluation such as multi-criteria decision analysis 
(MCDA) and economic evaluation alongside natural experiment designs are developing 
further vehicles for conducting economic evaluation (further information in section 
2.2.1.2).  
Economic evaluation alongside pragmatic randomised controlled trials (RCT) have 
traditionally been accepted as the best vehicle for economic studies.68, 91, 133 The RCT is 
considered the ‘gold standard’ in effectiveness studies because the design leads to high 
levels of internal validity. Randomisation is a powerful tool that minimises selection bias 
between groups. Thus, there are three distinct advantages to conducting trial-based 
economic evaluation.68 The first, as previously described is the internal validity. Second, 
given the high cost of conducting an RCT and collecting clinical data, the marginal cost of 
collecting economic data is minimal.134 Finally, the RCT data (with economic data 
collected alongside) may be the most recent and rapidly available relevant evidence for 
conducting economic evaluation.68  
It is important to recognise however, that all available evidence should be utilised in 
health care decision making; to rely solely on a single RCT as the vehicle for economic 
evaluation could pose potential bias in decision making.135 Sculpher and colleagues135 
argue that any economic analysis aims to inform two key questions. First, whether to 
adopt a new health technology given existing evidence, and second, to determine if more 
evidence is needed to support the decision in the future.  
Additionally, trial-based economic evaluations may suffer from design issues, they are 
often conducted ‘alongside’ clinical trials which means the economic analysis is not 
typically the primary purpose of the study.135 The sample size calculations are often based 
on the primary clinical outcome and may be potentially underpowered for the economic 
analysis. Because economic evaluations are often considered a secondary aim of the 
research, health economists must maintain regular contact and engagement with the trial 
coordinator to ensure timely and correct collection of health economic data. 
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Trial-based economic evaluation often only compares two alternatives; the new health 
technology in question compared to the standard existing technology. However, there 
may be more alternatives than those included in the trial and failure to incorporate all 
relevant alternatives could bias decision making.135 Trials are also very expensive to run, 
and thus follow-up may be limited to a year or two. The trial time horizon may be 
truncated in terms of the relevant time horizon for the economic evaluation,135 which is 
often the participant’s lifetime. Also, the results observed in strictly controlled 
environments are not always replicated in the real world. Examples include the 
Hawthorne Effect, in which individuals behave differently simply because they are being 
observed, or there may be practical implications of implementing an intervention in a less 
controlled real world situation. Therefore, even though the RCT is considered the ‘gold 
standard’ there are limitations to its use. These are all important considerations for 
decision makers who are presented with economic evidence based primarily on a single 
RCT. 
The next vehicle for economic evaluation is the use of decision analytic modelling. A 
decision analytic model ‘uses mathematical relationships to define a series of possible 
consequences that would flow from a set of alternative options being evaluated.’ (Briggs 
et al., 2006).136 
‘Decision models provide a structure within which evidence from a range of 
sources can be directed at a specific decision problem for a defined 
population and context. Being clear about this distinction between 
measurement (undertaken in trials and other primary studies) and decision 
making (which needs an analytical structure within which to direct the 
evidence at the decision problem being addressed) emphasises that models 
and trials are complements, not substitutes.’ (Sculpher et al., 2006)135 
Sculpher and colleagues135 therefore argue that trials should been seen as a source of 
inputs into, versus a vehicle for economic evaluation. One of the downsides to conducting 
a trial is the expense and time involved; decision modelling can make use of existing 
evidence at a much lower cost (the cost of the analyst’s time). It can address many of the 
limitations of trial-based economic evaluations such as consideration of all relevant 
alternatives, appropriate time horizon, evidence synthesis, and management of 
uncertainty.136 
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Models are often criticised for being ‘black boxes’ whereby the inner workings are not 
transparent therefore making it difficult to assess the validity of the model results. For 
models to be useful, decision makers need to be confident in the results. This confidence 
comes from transparency in terms of model structure, parameters, and assumptions and 
validation, or how well the model represents reality.137 
One of the first stages in developing a decision model is the conceptualization of the 
model. This involves specifying the decision problem and its components136 followed by 
model conceptualization which incorporates these components through a choice of a 
particular analytic method.138 These methods might include a decision tree, Markov 
model, discrete event simulation, or dynamic transmission model. The next step involves 
identifying and synthesising available evidence through a systematic approach. The final 
steps include dealing with uncertainty and assessing if there is value in undertaking 
additional research.136 Uncertainty is often a major consideration in decision making and 
how the analyst handles uncertainty is important. A decision maker who adopts a do 
nothing approach in response to an evaluation with too much uncertainty is still a 
decision not to implement the new health technology. What if that was the wrong 
decision? A way to quantify the value of acquiring additional information to inform a 
decision problem is through value of information analysis.139 The potential benefits of 
further research (reduced uncertainty) are compared to the costs of further investigation 
to help with prioritisation of research recommendations (e.g. invest in further research 
because uncertainty is large and the value of making the wrong decision it too great, or 
use those funds elsewhere because there is currently enough information to make an 
informed decision). 
With healthcare spending increasing worldwide many countries have adopted use of 
economic evaluation to aid decision making about which health technologies to fund, as 
well as, to combat the unsustainable increases in spending. The UK specifically adopts a 
£20,000 to £30,000 per QALY threshold to aid decision making. The WHO uses a multiple 
of the average per capita income to determine cost-effectiveness in low and middle-
income countries. The US chooses not to set a threshold, instead preferring to adopt a 
range of thresholds that are considered in relation to clinical and policy 
recommendations; there is no requirement to abide by any of these thresholds. Other 
country specific guidance can be found by visiting the ISPOR website at: 
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https://www.ispor.org/PEguidelines/index.asp. Finally this subsection, concluded by 
describing the various vehicles for economic evaluation. They can be conducted alongside 
trails, in a decision analytic framework, or a mix of both methodologies and the 
advantages and disadvantages of each were described. 
2.1.9 Summary 
Section 2.1 introduced fundamental concepts of economics, health economics, and a 
brief history of discipline.  The various methods of economic evaluation were introduced; 
the three full economic evaluation methodologies being CEA, CUA, and CBA, with CCA 
and CMA being considered partial economic evaluations. The final section detailed the 
role of economic evaluation in decision making in the UK and internationally. This was 
described in terms of cost-effectiveness thresholds and trial-based, model-based, and 
mixed economic evaluation methodologies. This section introduced the general methods 
of economic evaluation in a typical clinical trial hospital based economic evaluation. The 
next section details economic evaluation of PHIs, which often take place outside of the 
hospital setting where a wider perspective is more appropriate than that of the health 
services perspective. RoE falls into this category. 
2.2 Economic evaluation of population health 
interventions 
What is population health? The Population Health Intervention Research Initiative for 
Canada has defined population health as, 
‘…policy and program interventions that operate within or outside of the 
health sector and have the potential to impact health at the population 
level.’21  
PHIs are characterised similarly as population or community-oriented programmes 
intended to promote, protect, and prevent ill health.60 They may be delivered in the 
community, workplace, or school and are usually considered different from health service 
and clinical interventions which are intended to treat illness in individuals. However, it is 
recognised that public health agencies and health care services must work together 
closely to provide early intervention.60 The terms population and public health are often 
used synonymously. In those who make a distinction between the two, it is usually to 
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define public health as the actions of local public health departments to prevent disease 
and promote healthy behaviours, whereas population health is defined more broadly as 
the health outcomes of a group of individuals, including the distribution of such outcomes 
within the group.140, 141 In any case, a PHI aims to improve outcomes at the population 
level. Policy changes aimed to improve health, might include taxes to reduce 
consumption of foods and substances related to ill health such as cigarette, alcohol, and 
sugar taxes. Or policy changes might directly target food producers, such as requirements 
to lower salt in processed food, or requirements to clearly label certain products such as 
monosodium glutamate (MSG) on food packaging. Other government initiatives might 
include increasing green space or providing cycle and walking paths to increase active 
transport and physical activity. Interventions may take place at the school level affecting 
the school-age population. In each of these examples, the intervention is aimed at the 
population versus specific individuals. 
The rest of this section is split into four subsections. The first subsection describes 
evidence for the cost-effectiveness of PHIs and appropriate methodologies for evaluating 
population health programmes. The next subsection deals with the economics of 
prevention and introduces the prevention paradox while making a case for investing in 
preventive programmes such as a PHI. The third subsection details to current challenges 
of performing economic evaluation of population health programmes, and how this thesis 
aims to address these challenges. The final subsection summarises the themes introduced 
in section 2.2. 
2.2.1 Cost-effectiveness of PHIs 
In addition to improving outcomes, PHIs have the potential of being cost-effective 
through efficiencies that are achieved through providing health intervention at the 
population level. These efficiencies can be achieved by spreading the cost (and potential 
savings) over an entire population as well as by reaching a whole population with one 
initiative. As costs are spread out over the population, so too are the outcomes of the PHI 
which may result in minimal changes at the individual level (more on this concept 
described in section 2.2.2.1). A WHO report estimates that population level approaches 
cost on average five times less than individual intervention.131 Additionally, investing in 
‘upstream’ preventive activities aimed at the population is more effective at reducing 
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health inequalities than ‘downstream’ approaches.142 Upstream refers to the prevention 
of the causes of ill health before healthcare services are needed, while downstream refers 
to the services received to treat ill health. Public health policy makers understand the 
tension of breaking away from the medical model to divert funds into the investment of 
more upstream prevention activities.142 Often times the evidence-base is less strong for 
upstream approaches, policy makers can be short-sighted and target driven, and there is 
too much pressure from the current patients needing treatment to address the 
prevention of the condition.142  
“Medicine is failed prevention.” – Sir Michael Marmot143 
It is worth noting however, that while prevention can save lives and increase net health 
benefit, it does not always save money. A microsimulation model for chronic disease 
prevention targeting diseases of obesity and physical inactivity was developed as a WHO 
and Organisation for Economic Co-operation and Development (OECD) initiative.144 It 
found that school-based interventions are likely to have only modest effects, and they 
might not even be meaningful for another 40 or 50 years. The model did look at other 
interventions that were found to be cost saving in the long-term such as fiscal measures, 
food advertising and regulation, and food labelling.144 However, it is also worth pointing 
out that there seems to be an expectation that population health or preventative 
measures need to be evidenced as cost saving in order to justify the investment.145 
Medical intervention such as surgery, or new drugs are not subjected the same 
expectation.145 We do not normally expect the effects of a drug to continue to last long 
after the drug is stopped; and therefore eventually save money to the health service. 
Once the drug is stopped, the effects stop, and if continued effectiveness is desired, then 
continued investment in the drug is required.  
Return on Investment (ROI) originates from a business context and is the direct financial 
return received from an investment.146 Calculation of ROI is given in Equation 6. If an 
initial investment of £50 returned £75, the ROI would be a 50% ROI. 
Equation 6: Return on Investment 
 
𝑅𝑂𝐼 =
£ 𝐺𝑎𝑖𝑛𝑒𝑑−£ 𝐶𝑜𝑠𝑡 𝑜𝑓 𝐼𝑛𝑣𝑒𝑠𝑡𝑚𝑒𝑛𝑡
£ 𝐶𝑜𝑠𝑡 𝑜𝑓 𝐼𝑛𝑣𝑒𝑠𝑡𝑚𝑒𝑛𝑡
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By viewing population health initiatives simply in terms of ROI, potential health and 
wellbeing gains over the long-term could be disregarded because they fail to save money 
in the short-term.23 Based on this thinking, many valuable public goods should also be 
abandoned, such as public libraries, parks, and museums.30 There is a need to correct this 
misguided notion that prevention must be cost-saving in the long run, and instead invest 
more resources into preventive measures that prevent patients from developing the 
resource-intense chronic diseases that require long-term contact with the health service. 
To illustrate this point further, NICE advice on judging whether public health interventions 
offer value for money states that, ‘public health interventions cannot, however, be 
viewed solely in terms of value for money because of the broader and longer-term impact 
they have on general wellbeing – not only for individuals but also the wider 
community’(p. 1).23 Now that the concept of prevention being cost-effective has been 
introduced, the next section discusses the appropriate types of economic evaluation for 
the evaluation of PHIs. 
2.2.1.1 Economic evaluation methodologies for population health 
Section 2.1 described the types of economic evaluation, in this subsection each type will 
be discussed in terms of its use in population health. As there is a distinction between 
population health and healthcare interventions, there is also a distinction between 
economic evaluations of both types of interventions. This has been formally recognised 
by NICE when developing separate guidance for technology appraisals of PHIs.79 The 
guidance recognises the differences in the nature and scope of population based 
interventions which require different methods for technology appraisal particularly, in 
relation to perspective, type of economic evaluation and discount rate used for both costs 
and effects.79 The guidance places more emphasis on the use of CCA and CBA 
methodologies than it has in previous methods manuals, however the use of QALYs and 
CUA will still be required routinely as a ‘yardstick’ measure of effectiveness comparable 
across health and disease areas. The guidance also points out that all NICE programmes 
should include the use of a common method of economic evaluation that allows 
comparison between programmes. Indeed, in some cases of population/public health 
interventions almost all benefits are health benefits, and therefore if inclusion of further 
analysis such as CCA or CBA is unlikely to change a decision (because there is a clear 
indication of cost-effectiveness or ineffectiveness), their use is not required.79 The main 
46 
 
limitation of using CUA in population health is its narrowness, or its inability to capture a 
broad ranging set of non-health outcomes. Many PHIs result in non-health benefits that 
would not be captured in a narrow cost per QALY outcome. An example is increased 
labour productivity as a result of a workplace intervention. Healthier people take less sick 
leave and are more productive in the workplace; however, this outcome would be missed 
in a CUA. A published CUA of a public health intervention is the economic evaluation of 
the Football Fans in Training programme.147 The physical activity programme was run 
across Scotland in football stadiums and included a classroom-based heathy diet and 
lifestyle component. A CUA was employed as the programme was primarily focused on 
improving the health outcomes of the men, and the evaluation was also in line with NICE 
recommendations. However, important spillover effects were not captured in the 
economic evaluation, such as the impact that the men’s lifestyle changes had on changing 
their partner and/or family’s lifestyle, which included healthier family behaviours.147 
The use of CEA in population health has many of the same disadvantages to CUA; an 
additional disadvantage is that a non-QALY outcome does not provide the advantages of 
using a common ‘yardstick’ measure that QALYs provide. An advantage is that if there is 
not enough data to estimate QALYs, a natural unit such as a disease specific outcome, or 
cases averted may be used which might capture more appropriate health benefits of the 
intervention. An attempt can be made to capture more health outcomes by conducting 
multiple CEAs of various health and non-health outcomes that are available. However, 
interpretation of CEA ICERs can be difficult and place more burden on decision makers to 
interpret cost-effectiveness of different outcomes (e.g. deciding appropriate cost-
effectiveness thresholds for each outcome). 
Population health economists argue that economic evaluation should not be equated 
with CUA; CCA and CBA may be better frameworks to capture and value health and non-
health outcomes with broader aims.36, 79 CBA encompasses all cost and benefits, 
therefore incorporates societal interests. Also, expressing benefits in monetary terms 
avoids interpretation difficulties of non-aggregated outcomes such as those in CCA, or in 
the case described above with the use of multiple CEAs of different outcomes. However, 
there are concerns over the monetary values that survey participants place on 
outcomes148 as well as individual preferences not being expressed through the market.107 
Indeed, CBA is often mentioned by experts as an alternative to CUA,107 but it is still not 
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often used in economic evaluation of PHIs due to practical and methodological reasons.36 
Lack of standardisation in elicitations methods, stated-preference biases, and the 
considerable measurement burden (as CBA needs to be tailored for each intervention) 
are some of the practical barriers of CBA.107 To address some of these issues New 
Economy, a research support group based in Manchester, developed in depth guidance 
on how to conduct CBA in a local public services context where analytical and research 
resources may be limited.149 The guidance is also supported by an example excel-based 
CBA model and unit cost database with more than 600 unit cost estimates. While this is a 
useful resource and a good starting point to encourage CBA in the public services and 
population health context, analysts may still be limited by the unit cost estimates that are 
available in the database. The database would benefit from cost estimate contributions 
from reputable sources (e.g. government, academic, etc.) as its use grows. 
Finally, the advantages of employing CCA in population health is that welfare and quality 
of life can measured more broadly with this methodology. Relevant outcomes do not 
need to be converted in any way as they are reported in their natural form, and broader 
outcomes that decision makers might find useful can be included, such as spillover effects 
into other sectors of interest. CCA does have its disadvantages, the difficulty in 
aggregating outcomes mentioned previously is one. It also takes more time and resources 
to measure broad outcomes versus a single QALY measure. Individuals may rank 
outcomes differently resulting in allocation decisions that may be less transparent and 
systematic, which is why NICE still requires CUA, but considers alternate forms of 
economic evaluation due to the stated advantages. CCA is still a relatively uncommon 
type of economic evaluation method used in recent literature of PHIs. This is partly 
explained by the disadvantages mentioned above, and also may partly be due to lack of 
familiarity with the method as it has since fallen out of the latest version of the 
Drummond ‘blue book’68 as mentioned in section 2.1.7. 
In 2014, NICE published an updated manual for developing NICE guidelines which 
incorporated reference case guidance for interventions with outcomes in NHS, public 
health/public sector, and social care settings.150 Table 1 replicates Table 7.1 provided in 
this updated guidance. In the table, CMA is included as a type of economic evaluation 
that NICE would consider, however the guidance specified that this is rarely used because 
it is unusual to find two interventions that provide exactly the same health benefits.    
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Table 1: NICE reference case side-by-side comparison summary. Replicated from 
Developing NICE guidelines: the manual (PMG 20)150 
Element of 
assessment 
Interventions with 
health outcomes in 
NHS settings 
Interventions with 
health and non-health 
outcomes in public 
sector and other 
settings 
Interventions 
with a social care 
focus 
Defining the 
decision problem 
The scope developed by NICE 
Comparator Interventions 
routinely used in the 
NHS, including those 
regarded as current 
best practice. 
Interventions routinely 
used in the public 
sector, including those 
regarded as best 
practice. 
Interventions 
routinely 
delivered by the 
public and non-
public social care 
sector.1 
Perspective on 
costs 
NHS and PSS. Public sector – often reducing to local 
government. Societal perspective (where 
appropriate). Other (where appropriate); 
for example, employer. 
Perspective on 
outcomes 
All direct health 
effects, whether for 
people using services 
or, when relevant, 
other people 
(principally family 
members or informal 
carers.) 
All health effects on 
individuals. For local 
government and other 
settings, non-health 
benefits may also be 
included. 
Effects on people 
for whom 
services are 
delivered (people 
using services 
and/or carers.) 
Type of economic 
evaluation 
Cost-utility analysis. Cost-utility analysis.  
Cost-effectiveness analysis. 
Cost-consequences analysis. 
Cost-benefit analysis. 
Cost-minimisation analysis. 
 
Synthesis of 
evidence on 
outcomes 
Based on a systematic review. 
Time horizon Long enough to reflect all important differences in costs or 
outcomes between the interventions being compared. 
Measuring and 
valuing health 
effects 
QALYs: the EQ-5D is the preferred measure of health-related 
quality of life in adults. 
 
2 ‘Social care QALY’ with parallel evaluation based on capability 
measures where an intervention results in both capability and 
health or social care outcomes. 
ASCOT instruments may be used as measures of social care quality 
of life and ICECAP instruments may be used to measure capability 
Measure of non-
health benefits 
Not applicable. Where appropriate, to 
be decided on a case-
by-case basis. 
Capability 
measures where 
an intervention 
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results in both 
capability and 
health or social 
care outcomes. 
Source of data for 
measurement of 
quality of life 
Reported directly by people using services and/or carers. 
Source of 
preference data 
for valuation of 
changes in 
health-related 
quality of life 
Representative sample of the UK population. 
Discounting The same annual rate for both costs and health effects (currently 
3.5%). Sensitivity analyses using rates of 1.5% for both costs and 
health effects may be presented alongside the reference-case 
analysis. In certain cases, cost-effectiveness analyses are very 
sensitive to the discount rate used. In this circumstance, analyses 
that use a non-reference-case discount rate for costs and 
outcomes may be considered. 
Equity 
considerations: 
QALYs 
A QALY has the same weight regardless of the other characteristics 
of the people receiving the health benefit. 
Equity 
considerations: 
other  
Equity considerations relevant to specific topics, and how these 
were addressed in economic evaluation, must be reported. 
1 Social care costs are the costs of interventions which have been commissioned or paid 
for in full, or in part by non-NHS organisations. 
2 Guidance from The social care guidance manual (PMG10)151 
 
2.2.1.2 Emerging methodologies for facilitating economic evaluation of PHIs 
In response to the requirements for evaluation of PHI’s there has been an emergence of 
new evaluation approaches. Natural experiments are one such emergent research design, 
which have long existed as an observational study design. To date there is no 
comprehensive guidance for conducting economic evaluation alongside natural 
experiments; it is an emerging field of study. Natural experiments are defined as,  
‘Naturally occurring circumstances in which subsets of the population have 
different levels of exposure to a hypothesized causal factor in a situation 
resembling an actual experiment. The presence of a person in a particular 
group is typically non-random; yet for a natural experiment, it suffices that 
their presence is independent of (unrelated to) potential confounders.’ (Porta, 
2014 p 193)152 
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Natural experiments are not a new experimental design methodology; an early example is 
the investigation of the distribution of cholera cases in London by John Snow, often 
deemed “the father of epidemiology.”152 By tracing the source of the drinking water for 
those who recently developed cholera and those who did not, he was able to identify the 
source of the contaminated water supply. It was a single water pump that he disabled, 
which therefore prevented any further cases in that epidemic. 
A key difference between natural experiments and RCTs is that the researcher cannot 
control the group allocation or input into the data that is collected. It is a type of 
observational study that is reliant on the use of secondary data, which might come from 
routinely collected sources, surveys, administrative, or census data.  Natural experiments 
may arise from policy changes, e.g. a policy affecting only Scotland where England would 
be considered a natural comparison group. The non-randomisation element is a threat to 
internal validity, which is when one can draw inference from the observed outcomes of a 
study and infer they were actually caused by differences in relevant explanatory 
variables.153 Systematic reviews assessing the agreement between non-randomised 
intervention studies and RCTs of the same clinical question find differences in the results 
of the two different study types.154, 155 Non-randomised intervention studies tended to 
overestimate treatment effects, and caution is needed when interpreting results of 
natural experiments due to the potential presence of residual bias. 
Despite these biases and threats to internal validity, natural experiments have several 
positive aspects that are attractive when considering economic evaluation. Although 
researchers cannot directly input into data collection, they can exploit the use of existing 
data, which saves on time and resources needed to collect new data. If data linkage is 
available, researchers could access a multitude of existing health and resource use data, 
both within the hospital and GP setting, and including prescriptions. This is often more 
accurate than self-recall and over a longer time horizon than RCTs which are usually 
limited to short follow-ups of not more than a year. Routinely collected data sources are 
also likely to reduce the loss to follow-up and low response rates that are observed in 
trials. Finally, the observed data is practical, real-world, data. There are concerns that 
effects observed in RCTs are not always replicated in real life due to implementation 
issues as well as the potential bias from the Hawthorne Effect. 
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 Another emerging methodology for conducting economic evaluation of PHIs is multi-
criteria decision analayis (MCDA). MCDA has been defined as, ‘a set of methods and 
approaches to aid decision-making, where decisions are based on more than one 
criterion, which make explicit the impact on the decision of all the criteria applied and the 
relative importance attached to them.’156 Recently, health economists have been turning 
to MCDA with the aim of improving transparency in decision making with more explicit 
scores and weights for different consequences considered in a decision problem.157 A 
main critique of CUA within PHIs is that benefits that go beyond the QALY are not 
captured. PHIs will likely take place in a community setting rather than a hospital setting 
giving rise to non-health benefits in education, transport, housing, labour, and criminal 
sectors. MCDA attempts to aid decision makers considering multiple criteria in an explicit 
and transparent manner.158 
If MCDA were to be adopted by an organisation like NICE for example, a decision would 
have to be made if a generic or appraisal specific approach will be taken. A generic 
approach would involve pre-specified criteria and subsequent weights. It may improve 
comparability, however there is the risk that relevant benefits specific to certain 
appraisals will not be captured, as is the case currently with the QALY. An appraisal 
specific approach would not use generic criterion or weights, however, this would involve 
significant cognitive burden on decision makers as they will need to identify and provide 
preference weights of all relevant benefits.157 To date, MCDA methods have not been 
widely adopted in health care decision-making.159 In 2014, an Emerging Good Practices 
Task Force was established by ISPOR to develop good practice guidelines for conducing 
MCDA in health care decision-making. The first task force illustrated the many different 
types of MCDA methods available for different decision-making contexts and provided a 
list of steps in the value measurement process (see Figure 4).160 The second task force 
reports guidance on how to implement MCDA in healthcare decision-making including a 
checklist () with accompanying guidance.161 However, specific guidance relating to how 
MCDA should be used in HTA still requires further research. 
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Figure 4: List of steps to perform MCDA from Thokala et al.160 ISPOR task force 
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Figure 5: MCDA checklist from Marsh et al.161 ISPOR task force 
 
Natural experiments and MCDA although still in development in a HTA context, provide 
novel opportunities for the economic evaluation of PHIs. As these methods are further 
developed and guidance issued, some of the first economic evaluations using these study 
designs are likely to start appearing in the literature. Earlier, this subsection introduced 
the concept of ‘prevention being better than cure’ as well as the potential cost-
effectiveness of preventive PHIs. CBA and CCA may be more appropriate methodologies 
for evaluation of PHIs, however, their use in the recent literature is still low due to them 
being resource intense to conduct (CBA), and placing more cognitive burden on decision 
makers (CCA) as well as for other reasons. Additionally, difficulties evolving from the 
status quo, primarily the use of CUA, may also be contributing to their restricted use. 
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NICE specifically requires CUA in addition to considering other methodologies such as CBA 
and CCA, but states if most of the benefits of PHIs are health benefits and the additional 
analyses are unlikely to change the decision, they will not require CBA or CCA. The next 
subsection sets up the economic case for investing in preventive measures. 
2.2.2 Economics of prevention 
PHIs are preventive by nature; they aim to prevent ill health and illnesses that need 
treatment in medical centres. In addition to the health advantages, there are economic 
advantages to preventing illness and disease. On the most basic level, one case of disease 
prevented, saves all health and social care resources that would have been spent in 
treating the disease. Most prevention efforts are aimed at changing unhealthy behaviours 
and lifestyles (such as smoking, being overweight, obese, or inactive) that are associated 
with increasing risk of disease. An economic approach to prevention looks at health 
behaviours functioning much like goods consumption functions in market places. Many 
external influences impact on individual choices such as cost, opportunity, incentives, and 
constraints and economists see individual health behaviours being influenced in much the 
same way as choices for goods consumption are influenced by market forces.162 However, 
sometimes markets fail to operate efficiently. There are market failures that create an 
economic rationale for government intervention as a means to increasing societal 
welfare. Individual health behaviours may lead to costs beyond the individual that society 
bears such as diseases and fatalities related to second hand smoke or traffic fatalities 
from driving under the influence of alcohol. Economists call these externalities and prices 
will not reflect these impacts in the free market.162 Perfect or sound information about 
lifestyle choices may not always be available, or individuals may not be able to make 
rational choices due to addictive behaviours for example, substance abuse. Additionally, 
individuals may be myopic, choosing to enjoy an unhealthy lifestyle today and highly 
discounting their future risks. They may also plan and fail to make a future change.162  
Government intervention is therefore acceptable if it increases social welfare even at the 
expense of individual choice. Examples include indoor smoking bans, taxes on alcohol, 
tobacco, sugary drinks, and lowering the drink drive limit, as was recently implemented in 
Scotland. These population initiatives aim to improve population health and as an added 
benefit reduce health expenditure by encouraging healthy behaviour change that leads to 
55 
 
reductions in overall disease prevalence. These policy initiatives are not always causally 
linked to reductions in disease prevalence, but they certainly do help to reduce the 
unhealthy behaviour.   
2.2.2.1 The Prevention Paradox 
The prevention paradox was coined by Geoffrey Rose, 1981163 as, 
‘a measure that brings large benefits to the community offers little to each 
participating individual.’ 
Rose refers to a ‘mass strategy,’ which today might be referred to as a population health 
approach. A mass strategy involves endeavouring to lower the distribution of risk over the 
entire population. The individual gains little, but the small individual benefits add up to 
significant community level benefits. This is opposed to a ‘high-risk’ strategy in which 
those at highest risk are identified and offered intervention.163 Figure 6 depicts the 
differences between a population level and high-risk approach to prevention. 
 
 
 
 
 
 
 
 
As can be seen in Figure 6, the population approach aims to shift the entire distribution of 
risk, therefore shifting everyone out of the high-risk category, but also shifting a larger 
proportion of the population into the moderate and low risk categories. The high-risk 
Low 
risk 
Moderate 
risk 
High risk 
Population 
Approach 
Low 
risk 
Moderate 
risk 
High risk 
High-risk 
Approach 
Target high-risk 
only 
Figure 6: Shifting the distribution of risk in the population approach versus a targeted high-risk 
approach  
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approach only targets those at highest risk, which leaves the majority of the rest of the 
population in moderate risk, with only a small proportion in low-risk. Conversely, if the 
intervention poses any potential harm or unwanted side-effects, the population approach 
would subject more of the population to these unwanted side-effects. If the risk is high 
and a treatment poses a small risk of harm, then a trade-off is usually taken if the benefits 
outweigh the risks. But if the risk is low or moderate to begin with, the trade-off of 
benefits may not always outweigh the risks so it is important that population level 
approaches do not cause any harm and are safe163 because of the potential for a 
subsection of the population being exposed to unnecessary harm. 
One of the most successful examples of a population health approach to prevention is the 
North Karelia Project in Finland. In the 1970s, mortality from coronary heart disease in 
Finland was the highest in the world, particularly in the eastern part where North Karelia 
is located.164 The project, established in 1972, was the first large-scale community-based 
prevention programme for cardiovascular disease. From 1972-2012, a 40-year period, 
smoking prevalence, serum total cholesterol, and systolic blood pressure declined 
immensely164 due to the efforts of the project to change the population’s lifestyle. This 
correlated with an 82% decrease in coronary heart disease mortality in working-age men, 
and an 84% decrease in mortality for working-age women. 
In the Netherlands, a study aimed to compare population and high-risk strategies to 
prevention in regards to their impact on population health between 1970 and 2010.165 
Twenty-two preventive programmes were identified during that period and classified as 
either population or high-risk if they specifically targeted groups based on their risk of 
disease. The study found considerably larger health gains from population approaches 
such as tobacco control and road safety measures, versus high-risk approaches such as 
hypertension detection and cancer screening.165 
These examples clearly demonstrate the benefits of adopting a population approach to 
intervention. If the entire population is exposed to a safe intervention, then the entire 
distribution of risk in that population can be shifted placing more people in low and 
moderate risk than would be the case if only the high-risk group was targeted. However, 
the prevention paradox states the individual benefits may be insignificant or non-existent, 
but those small benefits added up over the population could result in significant 
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community or population benefits. This is particularly relevant for RCTs of PHIs or public 
health interventions as measures are collected at the individual level. Often effect sizes 
are small and/or diminishing, and this could partly be explained by the prevention 
paradox. PHIs evaluated in a cluster RCT framework typically only include a subset of the 
whole population, and therefore the sum of the combined effect may not reach 
significance, as the entire population was not included in the study. Investing in 
preventive and effective measures of the population have the potential to bring large 
community benefits, as well as being cost-effective. However, as economic evaluation 
moves from a narrow NHS setting to a broader public sector/societal perspective, 
challenges start to emerge. 
2.2.3 Challenges of economic evaluation of PHIs  
Section 2.2 focused on the appropriate types of economic evaluation methodologies for 
population health initiatives, as well as introducing key concepts of the economics of 
prevention such as the prevention paradox. A recent synthesis of methods guidance for 
undertaking economic evaluation of PHIs identified only four guidance documents (with a 
fifth being identified during the publication process).166 Amongst the guidance identified, 
there was heterogeneity in approaches to deal with the challenges of evaluating PHIs and 
variations were unjustified. The author suggested the lack of consensus may be due to 
insufficient development of methods to evaluate PHIs.166 This current section highlights 
the main challenges of conducting economic evaluation of PHIs. A pivotal piece of work 
by Weatherly and colleagues36 identifies four key challenges of conducting economic 
evaluation of public health interventions. Difficulties arise in moving from the strict 
clinical setting of CUA alongside clinical trials from the health care perspective, to a 
broader public sector perspective of non-clinical and often cluster RCTs. Economic 
evaluation has long been recognised as necessary in clinical health care settings, but until 
recently, there seems to have been less appreciation for it in public health even though 
there is a clear need for it.167 Weatherly et al.36 identifies key methodological challenges 
as: i.) attribution of effects, ii.) measuring and valuing outcomes, iii.) identifying 
intersectoral costs and consequences and iv.) incorporating equity considerations. The 
following details each of these challenges separately. 
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2.2.3.1 Attribution of effects 
There is a preference for economic evaluation to be conducted alongside the gold 
standard RCT comparing all relevant alternatives.64 However, relatively few complex 
interventions delivered at the population level have been evaluated in an economic 
evaluation RCT framework.36 The relatively short trial follow-up poses problems in 
economic evaluation as health economists are interested in lifetime costs and benefits of 
an intervention and prevention programmes may impact on health over the long term. 
The value of prevention is more difficult to assess than evaluating treatment of 
established disease because the long time horizon introduces considerable uncertainty 
around potential benefits of prevention.168 Weatherly et al.36 recommends when 
extrapolating outcomes beyond the trial follow-up, the outcomes used in the trial should 
be the same as those available in long-term observational studies. With a broader 
spectrum of public health intervention outcomes, observational studies over the life-
course may not exists for all outcomes of interest, particularly paediatric outcomes which 
involve a longer lifetime follow-up. Longer time horizons coupled with fragile causal 
relationships in preventive care, results in higher levels of uncertainty that need to be 
modelled appropriately.169 This may require a variety of analytic assumptions to be made 
and these should be reported clearly to allow for replication and/or further extrapolation 
of the findings.170 
This is perhaps where the reliance on RCT as the ‘gold standard’ for conducting economic 
evaluation needs to be re-evaluated as mentioned in section 2.1.8.1 when recognising 
that the economic evaluation alongside RCT should not be the sole vehicle for economic 
evaluation and the use of other emerging methodologies (section 2.2.1.2) and modelling 
may be appropriate. Because of the prevention paradox, population or public health 
interventions evaluated alongside an RCT may show small or diminishing effect sizes that 
might disappear at follow-up. This is particularly troublesome when attempting to model 
some time into the future, as assumptions need to be made about these highly uncertain 
long-term outcomes, which in many cases may be inappropriate. 
2.2.3.2 Measuring and valuing effects 
Because public health interventions typically take a broader public sector perspective,79 
challenges arise when attempting to measure the non-health outcomes in the various 
59 
 
sectors the intervention might impact (i.e. crime, education, or transport). Ideally, a 
societal perspective should be taken and all costs and benefits should be measured and 
valued, no matter to whom they are accruing.77 However, in many cases this is impossible 
or impractical to do so.167  
Additionally, there may be spillover effects into different sectors that weren’t targeted by 
the intervention (i.e. a more informed public); some of these effects may fit well within 
the QALY framework and some may not.36 It has been suggested that QALYs may be less 
appropriate in public health interventions aimed at addressing behaviour change and 
inequalities in health.167 The extra-welfarist view, with a sole focus on maximising health 
utility through a QALY framework may not be appropriate for population health because 
it may result in underestimates of the benefits gained.103 There have been proposals for a 
broader utility measure such as the ‘capability-QALY,’171 the ‘super-QALY’172 or the WELBY 
(wellbeing adjusted life years)173 as a way to capture non-health benefits.174 Other 
approaches might include a return to welfare economics by adopting CBA, CCA, 
behavioural economics, taking a capabilities approach, 103, 145 or using MCDA.107 While 
these alternatives exist to incorporate non-health outcomes, experts cannot agree on a 
single preferred alternative method as revealed in a recent qualitative study that 
interviewed experts on their views of the incorporation of non-health outcomes in 
economic evaluation.107 
Identifying and measuring the appropriate additional non-health outcomes in PHIs is 
time-consuming and with NICE still requiring a cost per QALY as a ‘yardstick’ metric to 
compare all other evaluations, researchers may be tempted to forego additional analyses 
using other perhaps more appropriate methodologies (such as CCA or CBA) due to 
resource constraints. The lack of consensus for a preferred alternative may also defer 
researchers from investing their research resources in explorative methodologies that 
have less concrete evidence-bases as they may not be accepted by certain funders and 
journal editors. Careful planning at the outset of an economic evaluation needs to take 
into consideration, the time, effort, and resources required to identify and measure the 
additional health and non-health outcomes that are relevant to a wider public sector or 
societal perspective. This planning will feed into the appropriate choice of type of 
economic evaluation that will be performed. 
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2.2.3.3 Identifying intersectoral costs and consequences 
The impact of public health interventions can be wide ranging with costs and benefits 
falling into different sectors of industry. Just as measuring these spillover effects proves 
challenging, so too does identifying them in the first place. There may be knock-on effects 
where expenditure in some sectors may reduce expenditure in others,36 e.g. expansion in 
public transport may increase physical activity, thereby reducing obesity related illness 
and health care utilisation. Therefore, it is important to clearly state the perspective of 
the analysis as the costs and consequences included in the analysis should reflect the 
perspective of the analysis. Ideally, the evaluation should span several sectors as many 
agencies may be involved in provision of PHIs, particularly early childhood intervention, 
and benefits may be felt across several domains.175 
In their review of economic evaluation of public health interventions, Weatherly et al.36 
identifies numerous costs that fall outside of health care services including: productivity 
losses, out-of-pocket, social care, criminal justice, voluntary, education, housing, 
environment and transport. Compelling arguments for differential discount rates of costs 
and benefits exists,176 however current NICE guidance suggests a discount rate of 3.5% 
applied to both cost and health effects with a sensitivity analysis using a 1.5% rate.150 
Claxton et al.177 propose a compensation test for interventions with multisectoral effects 
which involves preferences based on net benefits falling on different sectors. Outcome 
valuation would then be based on shadow prices of existing budget constraints. A final 
approach to consider is a general equilibrium approach where consequences of different 
interventions across all sectors of the economy are considered simultaneously.36 A 
macroeconomic approach may be more suitable for capturing spillover effects whereas a 
traditional microeconomic approach focusing only on the healthcare sector may mis-
specify benefits and underestimate costs.178 
As is the case in the previous section, identifying intersectoral costs and consequences is 
time consuming and with little consensus, one might wonder when to stop collecting and 
measuring intersectoral costs and consequences as population health initiatives may have 
small but broad societal effects. A balance must be struck between available research 
resources and comprehensive measurement of intersectoral costs and consequences. 
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2.2.3.4 Incorporating equity considerations 
Reducing inequalities in health are often an aim in public health interventions. However, 
health economists rely on the value judgement that ‘a QALY is a QALY is a QALY’ i.e. all 
QALYs are weighted equally regardless of to whom they accrue. There are notable 
exceptions to this rule; namely NICE’s decision in January 2009 to consider giving greater 
weight to QALYs achieved in late stages of terminal disease at the end of life.179 However, 
typically, the goal of economic evaluation is to maximise health over the population and 
not necessarily capture how health is distributed in terms of equity.60 But there is 
evidence that a majority of the general public prefer to give greater weight to health 
gains accruing in children, the severely ill and to a lesser extent, the materially 
deprived.180  
Clearly, equity considerations conflict with the strict economic evaluation goal of 
maximising health gains. Economic evaluation of public health interventions usually fails 
to identify and measure impacts on health inequality let alone value them.180 From a 
review conducted by Weatherly et al.,36  none of the interventions identified had 
outcomes that were explicitly equity-weighted. Furthermore, there is no field in the NHS 
Economic Evaluation Database abstract template to record equity considerations. More 
research is needed in public and stakeholder views on equity-weighting so that guidance 
can be issued to policy makers about how much efficiency, or total population health, 
should be sacrificed to pursue equity goals.36 
Theoretically, providing a population health programme that is available to everyone 
should in itself, help to reduce inequalities. Practically however, this is not always the 
case when the most deprived fail to take up the intervention and those who are least 
deprived end up benefiting more and therefore increasing inequality. Inequality in health 
is much researched, but practical solutions are still yet to be agreed and implemented as 
evidenced by the increasing inequalities in health in the UK since the 1980 Black 
Report.181  
To summarise this subsection, the four main challenges of conducting economic 
evaluation of PHIs are i.) Attribution of effects; ii.) Measuring and valuing effects; iii.) 
Identifying intersectoral costs and consequences; and iv.) Incorporating equity 
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considerations. In this thesis, an economic evaluation of PHI, RoE, was undertaken which 
aimed to address these challenges (see Methods in Chapter 4). The first challenge relates 
to more complex policy driven PHIs that cannot be evaluated in an RCT context. RoE is 
delivered at the school level, so it was possible to evaluate its effectiveness in a cluster 
RCT design. The other issue of the small and sometimes diminishing effects, related to the 
prevention paradox, is an important challenge to note when evaluating public and PHIs. 
The second challenge of measuring and valuing the broad ranging effects is something 
that needs to be dealt with in the design stage of an economic evaluation. In the RoE trail, 
efforts were made to capture any spillover effects that the school programme potentially 
had on parents by measuring parental EQ-5D. Even so, the QALY may not always be the 
best measure of effect in population health, so a separate CEA was conducted on a child-
specific behaviour outcome measure, the Strengths and Difficulties Questionnaire (SDQ). 
Briefly, the SDQ is a behavioural screening tool which is being used recently as a measure 
of SEW (more detail to follow in section 4.2.1.4). To keep in line with current NICE 
guidance, the main analysis was a CUA with a cost per QALY outcome. The third challenge 
of identifying intersectoral costs and consequences is as challenging as the second, as it 
can be difficult to determine all appropriate costs and outcomes that the intervention 
may affect outside of the health sector. To address this, the RoE economic evaluation 
took a broader public sector perspective which included health, social service, and local 
education authority costs and resource use. The final challenge of incorporating equity 
considerations conflicts with the extra-welfarist goal of CUA to maximise health benefit 
regardless of who accrues the benefits. Determining how to measure equity 
considerations in a PHI is still a challenge. As RoE was give on a whole class basis, the 
most deprived children are able to access the benefits of the intervention as equally as 
less deprived children. Sensitivity analysis exploring the effects of RoE by deprivation is a 
starting point for exploring if and how RoE affects inequalities. 
2.2.4 Economic evaluation in school settings 
Up until this point, this chapter has focused mainly on reviewing the methods for 
economic evaluation as applied in healthcare and population health settings. This thesis is 
specifically concerned with economic evaluation of school-based interventions which is a 
subset of PHIs. As the methods for economic evaluation of PHIs are less well established 
than those of clinical hospital-based evaluation, the methods for school-based 
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interventions have even less consensus. The use of a threshold for cost-effectiveness in a 
healthcare setting was covered in section 2.1.8, in the UK and worldwide. Decision-
making in population health settings in the UK still follow the same £20,000 to £30,000 
threshold, with additional analyses such as CCA and CBA being considered.79 Generally, 
PHIs tend to be cost effective; Owen and colleagues found 85% of the 200 public health 
interventions analysed to be cost-effective at the £20,000 threshold.182 This would 
support the idea that the threshold could be lowered in the population health setting so 
as not to increase the opportunity cost of prioritising one intervention over another 
unnecessarily (see below for the author’s interpretation of the value of a cost-
effectiveness threshold). Perhaps the £13,000/QALY estimate by Claxton and colleagues 
mentioned in section 2.1.8 is not so far off as it would prioritise more preventive, 
community and PHIs.  
However, as will be noted in Chapter 3, there is no consensus as to what constitutes a 
cost-effectiveness threshold in an education decision-making context. This is perhaps an 
opportunity to learn from agencies like NICE when establishing a transparent and 
consistent decision-making process (more on estimating a cost-effectiveness threshold 
outside of the health sector in section 5.7). As stated previously, the author of this thesis 
believes the value of the threshold should represent the opportunity cost resulting from 
investing in a new cost-effective programme. While the new investment will bring about 
benefits to those impacted by the programme, disinvestment may be required in another 
area of the education budget to adopt the new programme, resulting in potential losses 
to other areas (opportunity cost). Examples of these disinvestments might take the form 
of cuts to areas of education which are not considered core academic subjects, such as 
the arts, languages, sports and recreation, and “softer skills” such as SEL programmes. 
These other areas are at risk of disinvestment without their cost-effectiveness being 
established because it is likely that only new programmes will be evaluated for cost-
effectiveness if economic evaluation of school-based programmes are deemed necessary 
in the future (as has been the case for new pharmaceuticals and health technologies in 
the healthcare sector).  
As mentioned previously, a number of practical challenges have limited the use of CBA in 
healthcare contexts such as measurement burden and challenges and biases with 
preference elicitation. In the education setting, similar practical challenges, insufficient 
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training of researchers, and a lack of demand from policy-makers has limited the use of 
CBA in education.183 Additionally, as a threshold has not been established in the 
education context, there is scope to incorporate flexibility to consider other methods of 
evaluation such as MCDA, CCA, and CBA. The QALY may not be the most appropriate 
outcome to base an education cost-effectiveness threshold, as health outcomes are less 
likely to take priority over education outcomes. Examples of effectiveness outcomes for 
CEA in education depend on the programme objective; generic examples of effectiveness 
outcomes might include: the number of students completing the programme, dropouts, 
graduates placed in appropriate jobs, college placements, and test scores.184 However, as 
there is little consensus over a threshold in education, more research is required to 
determine how decision-making in education should be made consistent and transparent.  
There are also calls from academics and policy makers to expand the use of economic 
evaluation in education policy.185 Early examples of CEA in education focus solely on the 
head-to-head comparison of cost-effectiveness ratios (not ICER) of two competing 
alternatives while considering other criteria without focusing on an actual threshold.184 
CEA in education settings that use intervention specific outcomes, such as the SDQ, may 
be more attractive to decision-makers who may have more knowledge of descriptive 
measures versus preference-based measures. As alluded to earlier, CBA in its current 
form has limitations for practical application in the healthcare literature, the same is the 
case in education. CBA does not easily deal with issues of equity distribution, ethical 
consistency, and educational appropriateness, instead focusing on efficiency.185 At any 
rate, all of the different types of economic evaluation require the use of child outcomes 
to measure effectiveness, and as the development of child outcomes has typically lagged 
behind adult outcomes, research in this area is necessary. Child outcomes will be 
explored further in Chapters 4-6. 
2.2.5 Summary 
Section 2.2 introduced and defined the concept of a PHI. The economics of prevention 
were discussed setting up the economic case for investing resources to prevent disease 
and ill health versus spending those resources later on in treatment. The concept of the 
prevention paradox was introduced and how PHI has the potential to impact population 
outcomes on a large scale. The next section covered the challenges of conducting 
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economic evaluation of population and public health interventions. Finally, this section 
concluded with reflections of decision-making in population health and education settings 
and the potential use of a cost-effectiveness threshold and flexibility to allow researchers 
to explore the use of other methodologies (in addition to CUA) in the education setting. 
2.3 Conclusion 
The fundamental concepts of scarcity and opportunity cost combined with market failure 
in the healthcare setting has led to the study of health economics. Scarce healthcare 
resources means that societies need to decide the most efficient way to use those 
resources understanding there is an opportunity cost to every decision. In the brief 
history (section 2.1.2), Chapin’s idea that institutions find it difficult to break away from 
traditions of the past82 was a theme that reoccurred throughout this chapter. In 1917, he 
hypothesised that if healthcare institutions were to start over with a new health care 
budget, they would probably end up with a different allocation of resources based on 
current knowledge of costs and effectiveness. However, starting over is difficult to do, 
and examples of this notion are the reluctance of NICE to consider a lower cost-
effectiveness threshold, as well as a reluctance to break away from the standardised 
method of economic evaluation, the CUA. 
The traditional methods of economic evaluation introduced in the first half of this chapter 
are fairly well developed and standardised. The second half focused on PHIs and how 
those traditional methods could be applied to deal with broader perspectives, inclusion of 
non-health outcomes, and other challenges. Additionally, the prevention paradox sets the 
case for large population-level benefits that can be achieved through PHI, however the 
individual will see little or no benefit themselves which can be problematic in smaller 
contexts such as RCT design frameworks. CBA and CCA might be a more appropriate way 
to deal with these challenges, and emerging methodologies such as MCDA and economic 
evaluations alongside natural experiment study designs may become more prominent in 
the future. However, in the UK, there is still a major focus on the CUA. Arguably, we may 
be coming full circle in reconsidering CBA for PHIs, as one of the first records of economic 
evaluation was a CBA of England’s Public Health Act in 1875. The key concepts of this 
thesis were introduced in this chapter including those necessary for economic evaluation 
of RoE, a PHI, which is delivered at school. The next chapter unpicks the appropriate 
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methodologies of conducting economic evaluation in school settings. To reiterate from 
Chapter 1, schools are ideal settings for PHI as they have the ability to reach the majority 
of young people making the delivery of school-based PHIs efficient. Schools play an 
important role in developing and maintaining children’s SEW, which is one reason why 
this thesis considers economic evaluation of a school-based SEL programme. Additionally, 
the theoretical basis, advantages, and challenges of conducting economic evaluation in 
this setting are explored. A systematic review of school-based economic and non-
economic evaluation methodologies follows in Chapter 3. 
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3 School-based intervention evaluation 
methodologies: a systematic review 
3.1 Introduction 
CUA is a useful and preferred tool150 for health care evaluation as the cost per QALY 
outcome provides a uniform measure to make comparisons across health areas. It can 
also be used in non-health settings where the intervention may give rise to health 
benefits, such as the community or school setting. The downside is that the current QALY 
framework does not take into account any non-health outcomes. CUA of a school-based 
programme (and economic evaluation in general) is a novel concept due to challenges 
associated with identifying, measuring, and valuing child health and broader, non-health 
outcomes. Schools are an ideal setting to promote children’s health and wellbeing 
because school-based interventions can reach most children. However, decision-makers 
in education may be less willing to invest their limited resources in the promotion of 
health and wellbeing versus activities related to core education, even more so when they 
are under pressure to demonstrate added value.186 In order to make informed decisions 
about how to best allocate funds, education decision-makers need complete information 
about the relationship between expenditures and pupil outcomes of interest, which 
includes details of how services are delivered.187 
School-based health economic evaluation is uncommon partly due to the fact that until 
recently there were not many validated paediatric outcome measures, much less 
preference-based HRQoL measures. Selecting appropriate outcomes for children need to 
take into account the differences between children and adults and go beyond the 
assumption that children are simply small adults; very few studies address the 
appropriate choice of paediatric outcomes in clinical trials.188 There are well validated and 
accepted preference-based measure for adults, but until recently, there has been less 
research into child preference-based measures of health.96 Schools are continually being 
constrained by budget cuts, so economic evaluation could prove a useful decision making 
aid for prioritisation of school programmes.185 Funding cuts leave teachers with fewer 
resources and less time to provide a comprehensive education. This scarcity means that 
only the most cost-effective school programmes should be prioritised, and the current 
preferred method for determining cost-effectiveness from a healthcare perspective is the 
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CUA. In education settings, the preferred outcome of economic evaluation still needs to 
be established (this idea is discussed further in Chapters 5, 7, and 8).  
The combined effect of the challenges relating to economic evaluation of PHIs and a lack 
of research into child preference-based measures results in a novel and ‘uncharted area’ 
for economic evaluation methodology of school-based PHIs. Thus, because of the lack of 
clear methods guidance for undertaking economic evaluation in a school setting, a 
systematic literature review was conducted to identify evidence of economic and other 
evaluation methodologies that currently exist for the evaluation of school-based 
programmes. This review was conducted to gain an understanding of the methods of 
evaluation currently being practiced in school-based PHIs and to help inform the 
appropriate methodology for the economic evaluation of school-based interventions.  
This chapter consists of four main parts. The first part describes the aim and the research 
question, the second part describes the methods used to conduct the review, the third 
part presents the results followed by the discussion and conclusion of the review. At the 
time of undertaking, this was the first study to systematically review school-based 
evaluation methods. Mounting pressure on educational decision makers to increase 
student achievement while constrained by education budgets, means that economic 
evaluation is an ideal tool to aid prioritisation.29 However, the application of these 
methodologies is limited. The types of evaluation methods of school-based programmes 
will be explored to further understand if and how economic evaluation of school-based 
interventions is currently being conducted, and what types of preference-based child 
utility measures (if any) are being utilised. 
3.1.1 Aim 
The aim of this chapter is to systematically review all available evidence on evaluation 
methodologies for programmes that are delivered in a school or pre-school setting. Given 
the dearth of evidence anticipated, a broad definition of ‘evaluation methodologies’ was 
adopted to include economic and non-economic methodologies, which might include cost 
analyses or non-economic evaluation associated with a generic preference-based utility 
measure. This wide selection was deliberate because an initial scoping review revealed 
that the literature on school-based economic evaluation is much more limited than 
69 
 
clinical trial-based economic evaluation, and thus a broader search would minimise the 
risk of not identifying key studies as well identify key methodologies used to evaluate 
school-based intervention. School-based economic evaluation is a novel area; its use is 
limited in the education economics literature and the use of economic evaluation 
terminology differs slightly between the education and health economic literature. For 
example, ‘cost-effectiveness analysis’ in the education literature may be focused solely on 
which programmes ‘can achieve particular objectives at the lowest cost’184 which differs 
from the interpretation of CEA in health care which aims to maximise health within a 
certain threshold or budget. The education economics literature may also use the term 
‘cost-effectiveness ratio’ to refer to average costs and effects per unit of outcome (which 
is not that same as an ICER) as well as to also refer to ‘additional or marginal’ costs and 
effects (which is similar to an ICER).184 Because of these differences in terminology, it is 
unknown what methodologies are currently used, economic and non-economic (in 
addition to those outlined earlier). The decision was made to intentionally leave the type 
of school-based program or intervention undefined in order to maximise the 
identification of any existing evidence related to the aim of this review. 
3.1.2 Research Question 
This systematic review aimed to answer the following research question: 
What evidencec currently exists around economic and other evaluation methodologies of 
school-based interventions and/or programmes? 
 
3.2 Systematic Review Methods 
The systematic review was conducted in line with recommendations from the Centre for 
Reviews and Dissemination (CRD) guidance for undertaking reviews in healthcare.189 
Inclusion criteria were defined (section 3.2.1) and a search strategy was developed, 
piloted and revised several times through an iterative process before the final strategy 
                                                     
c Evidence is referred to in its broadest form and includes economic and non-economic evaluation 
evidence of studies that attempt to collect costs or resource use for the intervention, and/or a 
generic HRQoL measure. Please refer to Box 2. 
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was conducted to provide a comprehensive review of the existing literature (section 
3.2.2).  
The review team consisted of the author and two supervisors. All members of the team 
were involved in the design and final approval of the review. The author solely conducted 
the piloting, searching and reviewing, so to help mitigate bias in the review process, a 
series of validity checks were performed by all reviewers which is detailed in section 
3.2.3.  
Appropriate data were extracted, appraised (section 3.2.4), and synthesised through use 
of a narrative synthesis as detailed in section 3.2.5. The narrative synthesis was 
performed using guidance from the Economic and Social Research Council (ESRC) 
guidance for conducting a narrative synthesis.190 
3.2.1 Inclusion Criteria 
An initial search strategy was developed and subsequently revised after it was piloted 
with a specialist subject librarian. It was then revised further after input from the other 
two reviewers (PhD supervisors). After three iterations of piloting and revising the 
strategy, a final search strategy was agreed. The search strategy inclusion criteria were 
determined using a Participants, Interventions, Comparators, Outcomes191 and Study type 
(PICOS) framework189 (see Box 2). The search defined participants as children who took 
part in any programme or intervention given at the school or during pre-school. The type 
of intervention was not defined; it was left open to capture a range of economic or non-
economic evaluation methodologies for school-based programmes. Comparators were 
also left undefined to capture a broader range of studies. The lack of a comparator was 
not an explicit exclusion criterion as the goal of this review was to identify all evaluation 
methodologies of school-based programmes.  
The following range of standard economic evaluation terms were adapted from the 
Scottish Intercollegiate Guidelines Network (SIGN) economic filter192 for the purpose of 
this review: utility, quality of life, health related quality of life, quality adjusted life year, 
disability adjusted life year, net benefit, cost, resource use, fund, benefit, effect, 
contingent valuation, WTP, and human capital. The truncation wildcard (*) was used at 
the end of root words to represent any number of characters. For example, cost* would 
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represent cost, costs, costing, or costings. The (?) wildcard was used to represent zero or 
one character, most commonly used to return studies in both British and American 
English. For example, p?ediatric would return pediatric and paediatric. Finally, the study 
type for the search included any sort of economic evaluation, cost analysis, or non-
economic evaluation associated with HRQoL outcomes including: CUA, CEA, CBA, decision 
analytic models, and partial economic evaluations – cost and/or outcome descriptions, 
and cost analyses. The frameworks for economic evaluation differ mainly by outcome 
measurement, therefore, CUAs were classified as such if they reported a cost per QALY or 
cost per DALY.  CEAs were classified as such if they reported any cost per natural unit of 
effect other than QALY or DALY. Modelling studies were classified as CUA or CEA if they 
met classification conditions described above. CBAs were classified as such if they 
reported a cost-benefit or benefit-cost ratio, reported outcomes in monetary units, or 
reported ROI results. All other approaches were deemed partial economic evaluations 
and were classified as cost analyses if they had a component of cost, but did not meet the 
classification criteria set out for full economic evaluations as described above. Studies 
were classified as non-economic evaluation if only HRQoL was estimated, or there was no 
actual cost element reported.  
Additionally, other evaluation and analytical methodologies were considered such as: 
social return on investment (SROI), social impact assessment (SIA), health impact 
assessment (HIA), MCDA, discrete choice experiments (DCE), and studies using stated 
preference survey methodologies. Study protocols that indicated a planned economic 
evaluation were also included and classified into one of the five categories described 
above (CEA, CUA, CBA, cost analysis, or non-economic). The trial timeline indicated in 
each protocol was checked, and if the study was due to be complete at the time of thesis 
write-up, a search was conducted to find any main trial publications. 
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Box 2: PICOS Criteria 
Review objective 
To examine current evaluation methodologies (economic, costing, and non-economic 
studies associated with generic HRQoL) that have been used to assess school-based 
interventions or programmes and collate the retrieved evidence from these studies.  
 
Participants 
Children under the age of 18. 
 
Interventions 
Any intervention or programme delivered at a school or pre-school setting. 
 
Outcomes 
 A range of economic costs and outcomes: utility, quality of life, health related quality 
of life, quality adjusted life year, disability adjusted life year, net benefit, net present 
value, cost*, resource use, fund*, benefit*, effect*, contingent valuation, willingness-
to-pay, and human capital 
 
Study type 
Full and non-economic evaluations: CUA, CEA, CBA, cost analyses, and non-economic 
evaluations 
 
3.2.1.1 Exclusion Criteria 
Studies were excluded if the programme or intervention was not delivered at the school 
or pre-school setting. Due to limited time and resources, studies were also excluded if 
they were not in English language or if they were abstract only or the full paper was 
unavailable through the University of Glasgow Library. 
3.2.2 Database and Search Strategies 
A range of databases were selected to ensure a comprehensive search of the literature 
would be conducted. No date restrictions were placed on the eight databases that were 
systematically searched provided on the following page: 
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CINAHL - Cumulative Index of Nursing and Allied Health Literature 
The Cochrane Library 
ERIC - Education Resources Information Centre 
MEDLINE (Ovid) 
PsychINFO 
Web of Science 
NHS EED, HEED, and HTA database (CRD York) 
EconLit 
 
Using guidance from the CRD,189 these databases were selected to reflect an extensive 
literature base to capture relevant studies. Searching commenced in June 2015 and the 
final strategy was carried out in July 2015. Relevant medical subject headings (MeSH) 
were searched to identify any evaluation methodology of school-based interventions. The 
general strategy is outlined in Box 3 which was adapted to each database to account for 
differences in MeSH terminology between databases. 
Box 3: General search strategy adapted to each database 
1. (emotion* OR social*) AND (learn* OR wellbeing OR “well being”) 
2. (improve OR develop) AND (health OR academ* OR mental* OR physical*) 
3.  crim* OR (“criminal justice”) OR famil* 
4. 1 OR 2 OR 3 
5. school* OR educat* OR academ* 
6. (primary OR secondary OR elementary OR junior OR middle OR high) AND (school*) 
7. child* OR adolescent OR p?ediat* 
8. program* OR intervention OR curriculum OR course 
9.  3 AND 4 AND 5 AND 6 AND 7  
10. (economic*AND eval*) OR (“cost effective*”) OR (“cost benefit”) OR (“cost utility”) 
OR (“cost consequence”) OR model* OR (“decision tree”) OR (“health impact 
assessment”) OR (“return on investment”) OR (“social return on investment”) OR 
(social impact assessment”) OR (“discrete choice”) OR (“stated preference”) OR 
(“multi-criteria decision analysis”) 
11.  utility* OR (“quality of life”) OR (“health related quality of life”) OR (“quality adjusted 
life year”) OR (“disability adjusted life year”) OR (“net benefit*”) OR cost* OR 
(“resource use”) OR fund* OR benefit* OR effect* OR “contingent valuation” OR 
“willingness-to-pay” OR “human capitol” 
12. 10 AND 11 
13. 9 AND 12 
 
Details of each database search including database specific MeSH can be found in 
Appendix 1. Evidence is not just found in the published literature that is indexed by 
electronic databases. Grey literature makes up a huge body of evidence produced by 
governments, academics, businesses, and industry that have not been published in an 
academic journal that would be identified in an electronic database search. In order to 
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identify published, unpublished, and grey literature not indexed by an electronic 
database, additional relevant articles were identified by: 
 Visually scanning reference lists 
 Hand searching specified search terms in key educational, psychological, economic 
journals, and conference proceedings - Education Economics, Economics of Education 
Review, and International Journal of Education Economics and Development 
 Key author search – e.g. Heckman, James was identified as an influential economist in 
early childhood education programmes 
 Key website search – Personal Social Services Research Unit (PSSRU), NICE, 
Collaborative for Academic, Social, and Emotional Learning, Community Guide, and 
the Joseph Rowntree Foundation were identified from suggestions from the college 
subject librarian. 
These additional searches help to identify evidence that is very recently published and 
has not yet been indexed by electronic databases, as well as, compensating for poor or 
inaccurate database indexing.193 Results from the database searches were exported to 
EndNote X7 reference managing software or manually added if identified from sources 
other than an electronic database. Duplicates were excluded, and remaining records were 
screened at title and abstract by applying the inclusion criteria set out in Box 2. Remaining 
records had their full-texts screened applying inclusion and exclusion criteria. Validity 
checks were performed as described below in section 3.2.3. The studies that remained 
after the full-text screening were included in the systematic review. After an initial 
review, eight (10%) of the top studies included in review were selected for a Web of 
Science citation search (described further in section 3.2.4). A citation search involves 
reviewing the citations of a relevant study to identify additional studies to include in 
review while providing an additional check that the search strategy is thorough. At the 
time of thesis write-up all protocols included in review had studies that had been 
completed. A further search for the publications of these studies was conducted to 
determine if they had been published and explore potential reasons for not being 
published. 
3.2.3 Mitigating bias 
To mitigate bias throughout the review process, two validity checks were performed by 
the entire review team. The first validity check took place at the screening of title and 
abstract stage. Twenty randomly selected records that were being screened at title and 
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abstract were sent to each member of the review team. Using inclusion criteria specified 
in Box 2, each reviewer independently assessed each record for inclusion in the next stage 
of the review (full-text screening) and the results were checked and discussed. When 
assessing records at the title and abstract stage for inclusion in the full-text screening 
stage, two filters were created, Filter 1 and Filter 2. Studies were included in Filter 1 if 
they met some but not all of the inclusion criteria, because all criteria may not be 
apparent from title and abstract. Filter 2 included studies that appeared to have met all 
inclusion criteria from title and abstract, and were very likely to be included in review. 
These records were still reviewed at full-text screening stage.  
The second validity check took place at the full-text screening stage. Ten randomly 
selected records from the pool of papers whose full text were being reviewed were sent 
to each member of the review team. Each reviewer then independently assessed each 
record for inclusion in the final review using the inclusion criteria specified in Box 2. The 
results of the independent assessments were then checked, discussed, and agreed upon 
amongst the review team. These validity checks helped ensure the selection process was 
systematic and is found in Appendix 2. 
3.2.4 Data Extraction and Study Appraisal 
A data extraction form was created using CRD guidance189 to extract general information 
as well as economic specific data from each article included for review (Appendix 3). 
General information extracted included the following: study identification features, study 
characteristics, participant characteristics, intervention and setting, outcome measures, 
follow-up, results, and conclusions. Additionally, economic data was extracted from all 
full and partial economic evaluations which included: type, costs, perspective, time 
horizon, description of competing alternatives, resource use, effectiveness data, 
preference based measure used, measure of benefit, discounting, currency, ICER, analysis 
of uncertainty, and key model parameters.  
Several study appraisal tools to evaluate the conducting and reporting of economic 
evaluations exist. A systematic review of quality assessment tools spanning from 1991 to 
2012 identified ten such instruments.194 Some of the most commonly used appraisal tools 
identified by the review are the British Medical Journal (BMJ) checklist as described by 
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Drummond et al.,195 the Quality of Health Economic Studies (QHES) List,196 and the 
Consensus on Health Economic Criteria (CHEC) List.197 Scoring of checklists allows studies 
to be compared and ranked quantitatively by quality, but many checklists do not have a 
scoring system to qualify them as a quality assessment tool. To add up and score items on 
most checklists (that are not intended as a quality assessment tool) would require the 
assumption that each item has equal weight. This then does not take into account the 
relative importance of each criterion.194 The QHES checklist is the only assessment tool 
for economic studies to apply a grading system that weights different criteria based on 
their level of importance. However, there has been no evidence generated to validate this 
scoring system, or describe its generalisability,194 thus it is still subjective by nature. The 
CHEC List does not have any items related to modelling studies, however it is useful in 
that it is easily adaptable to different study designs, as it was designed to assess clinical 
trials and observational studies. The Drummond checklist was recommended in Cochrane 
reviews and was one of the more commonly used checklists adapted and used by the BMJ 
and other journals. It is simple and brief, as it consists of only 10 items. Like the CHEC list, 
it is less well suited to evaluating modelling studies as it did not distinguish between 
economic evaluation alongside clinical trials and decision analytic modelling methods; it 
also does not have a grading or scoring mechanism. It became outdated as it did not 
capture any of the new analytical techniques to support economic evaluation such as 
multiple imputation (MI) for missing data, extrapolation, and methods for pooling data. 
The systematic review of quality assessment tools concluded that ‘the choice of an 
appropriate checklist should be made with the understanding that quality assessment 
tools will continue to evolve over time and must improve in reliability and validity for all 
decision makers over time.’194 
The most recently developed and consolidated assessment tool is the Consolidated 
Health Economic Evaluation Reporting Standards (CHEERS) checklist.170 This checklist aims 
to consolidate and update the previous checklists mentioned above into a single useful 
reporting standard. The CHEERS checklist consists of 24 items and has been co-published 
in 10 health economics and medical journals.170 The checklist was developed in 2013 for 
researchers reporting economic evaluations and editors or peer reviewers assessing them 
for publication. It is more recent and can be seen as an improvement to the Drummond 
checklist for critical appraisal of published articles.77, 195 CHEERS is a modern checklist that 
incorporates items that represent the advances in analytical methods used in current 
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economic evaluation. Because of its recency and improvement upon the other checklists 
available, the CHEERS checklist was used to assess the quality of reporting of the articles 
included for review (Appendix 4). The choice for using the CHEERS checklist was also 
justified due to its recommendation by ISPOR,198 the BMJ,199 The EQUATOR Network,200 
Value in Health,170 and other notable organisations within and outwith health economics. 
A copy of the CHEERS checklist is given below in Figure 7.  
The studies included in the review were heterogeneous and made up of a variety of 
evaluation methodologies; thus, not every item of the CHEERS checklist was suited to the 
studies included in review. Because the checklist is intended for full economic 
evaluations, partial (cost analyses) and non-economic evaluations were identified as such 
in the first item of the checklist. This was to avoid misinterpreting a partial economic 
evaluation as having poor quality reporting simply because the items did not apply. It 
should be emphasized that the CHEERS checklist is intended to assess the quality of 
reporting, the items are a minimum amount of information to be included when reporting 
an economic evaluation today to  improve reporting and health care decisions.170 Counts 
from the CHEERS checklist were given by item and by study, but these counts were for 
descriptive purposes only as well as to identify the eight studies included for the citation 
search referred to in section 3.2.2. To add up or score the items makes the assumption 
that each item has equal importance. Therefore, even though the counts are given, they 
will not be used to make judgements of the quality of how studies were conducted. Some 
items are more important for assessing quality, and many of the studies included for 
review pre-date the CHEERS checklist. 
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Figure 7: CHEERS Checklist From Husereau et al. Value in Health 16 (2013) 231-250 
79 
 
 
 
Figure 5 (cont.): CHEERS Checklist From Husereau et al. Value in Health 16 (2013) 231-250 
 
3.2.5 Data Synthesis 
Data synthesis is a process that involves collation, combination, and summarising of the 
findings of the individual studies included in a systematic review.189 It can be done 
quantitatively by formal pooling of results with statistical techniques such as meta-
analysis.201 This is often done when pooling effectiveness results from multiple studies. 
Sometimes however, formal pooling of results is inappropriate due to heterogeneity in 
how studies were conducted and within the effectiveness measures used to report 
results. In these cases a narrative approach may be taken.189  As mentioned above, the 
study design, population, and outcomes of the included studies were heterogeneous, 
therefore undertaking meta-analysis was deemed inappropriate. Additionally, the 
purpose of the review was not to look at any one type of school-based intervention and 
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pool their effectiveness results, it was to explore the different methodologies used for 
school-based evaluation. 
 Even when meta-analysis is possible, certain aspects of narrative synthesis are required 
to interpret the evidence.189 Guidance on the conduct of narrative synthesis190 was used 
to define narrative synthesis as ‘an approach to the systematic review and synthesis of 
findings from multiple studies that relies primarily on the use of words and text to 
summarise and explain the findings of the synthesis.’ Narrative synthesis is a form of 
storytelling and telling a trustworthy story is the aim of a narrative sythensis.190 It is not to 
be confused with narrative review which is a phrase sometimes used to describe a more 
traditional literature review that is not systematic or transparent in their approach to 
synthesis.202 
The current review question dictated inclusion of an extensive range of research designs 
producing varied findings for which quantitative approaches to synthesis are 
inappropriate.190 To further justify this method, CRD guidance suggests a narrative 
approach to data synthesis when formal pooling of results is inappropriate.189 Therefore, 
a narrative synthesis was conducted which was descriptive in nature and objective in 
summarising findings. Historically, there has been little consensus on how to carry out 
narrative synthesis and the elements to establish credibility.189, 190 A general framework 
comprising the following elements can be applied to help maintain transparency and add 
credibility to the process:190  
 Developing a preliminary synthesis of findings of included studies 
 Exploring relationships within and between studies 
 Assessing the robustness of the synthesis. 
The preliminary synthesis comprised of tabulated details of study characteristics including 
study type (methodology), years of publication, country of origin, age of participants, and 
intervention type. Studies were then grouped by methodology: economic evaluation 
which included CEA, CUA, CBA; cost analyses which only included costs or did not directly 
value benefits instead assuming cost savings; and non-economic evaluation studies which 
did not include costs but may have included a generic HRQoL measure. CEAs, and CUAs 
included trial and model-based studies and were classified as such if the results were 
expressed as an ICER. Relationships between studies within and across groups were 
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explored, identifying patterns and exploring heterogeneity between studies. A concept 
map was developed to give a visual representation of the patterns and relationships 
identified between included studies.  Finally, robustness was assessed through critical and 
systematic review of the quality of reporting of the included studies so that an overall 
assessment of the strength of the evidence could be made. A descriptive synthesis of the 
CHEERS checklist items was conducted and the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) checklist was completed. 
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3.3 Results 
The results of the systematic review are organised into three subsections as described in 
the methods section, the preliminary synthesis; exploration of relationships within and 
between groups; and the assessment of the robustness of the synthesis. The counts of 
search records identified from each database are summarised in Table 2. Further details of 
the database searches are in Appendix 1. The rest of the study selection process is detailed 
in Figure 9 which is a flow chart as recommended in the PRISMA statement.203 The validity 
checks to mitigate bias in the data selection process are found in Appendix 2. Completed 
data extraction form and CHEERS checklist are found in Appendix 3 and 4 respectively and 
completed PRISMA checklist in  
Appendix 5. Study characteristics are summarised in Table 3. 
Table 2: Number of records identified by each database searched 
Database No. of Records Exported to Endnote 
CINAHL 16 
The Cochrane Library 419 
ERIC 264 
MEDLINE using OVID interface 99 
PsychINFO 28 
Web of Science 200 
HTA Database, DARE, and NHS EED 166 
EconLit 149 
Total 1,341 
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Figure 9: Flow chart of study selection process 
Records identified from 
database searches  
n= 1,341 
 
Duplicates excluded 
n=95 
Records screened at title 
and abstract 
n= 1,246 
 
Potential publications identified 
and full-text screened for 
inclusion in review 
n= 302 
 
Records excluded 
after applying 
inclusion criteria 
n=944 
Included in review 
n= 76 
 
Total excluded after 
more thorough full-
text examination   
n=231 
Cost analysis 
n= 24 
 
CBA 
n= 9 
 
CUA 
n= 25 
 
CEA 
n= 16 
 
Additional studies 
identified through 
hand and citation 
searching 
 n=5 
Non-economic 
n= 2 
 
Economic evaluation 
n= 50 
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3.3.1 Preliminary synthesis 
The methodology groupings from the preliminary synthesis are displayed in Figure 9. 
Economic evaluations comprised CEA, CUA, and CBAs. CEA and CUAs were classified as 
such if they reported an ICER and according to classification criteria set out in section 
3.2.1. Modelling studies were also included in those classifications if they reported an 
ICER. The next group was cost analyses which included all studies that mainly focused on 
the cost side of an evaluation and did not formally combine costs and effects to meet the 
definition of a full economic evaluation as defined in Chapter 2. Studies included in this 
category may not have directly measured outcomes, or made assumptions about 
expected outcomes being cost savings. They may have reported all the necessary 
elements to conduct an incremental analysis but failed to complete and report ICERs. The 
final category was non-economic evaluations, which included studies that measured 
HRQoL, but did not measure any costs. 
The preliminary synthesis study characteristics are displayed in Table 3. Economic 
evaluations outnumbered cost analyses and non-economic evaluations. When breaking 
down economic evaluations by type, CUAs were the most common (n=25) followed by 
cost analyses (n=24). The next most common study type was a CEA (n=16), followed by 
CBA (n=9), followed by non-economic evaluations (n=2). The database searches were 
conducted in 2015 and the majority of the included studies were published within the last 
five years. There were 44 studies published between 2010 and 2015. Next, there were 16 
studies published from 2005 to 2009. There were 14 studies published from 2000 to 
2004. Finally, there were two studies published before 2000 included for review. Most 
studies included for review originated in the USA; 34 out of the 76 included. The next 
most common country of origin was the UK with 12 studies included for review. The 
following lists the rest of the countries with their respective counts indicated in 
parentheses: Australia (5), Germany (3), New Zealand (3), Canada (3), the Netherlands (3), 
Italy (2), Egypt (2), Japan (2), China (2), Sweden (1), Tanzania (1), Kenya (1), Zimbabwe (1), 
and the Philippines (1). Classifying the study’s country of origin by continent results in 
most studies originating in North America (48%), followed by Europe (28%), Australasia 
(10%), and Africa (7%) and Asia (7%) (Table 3). The following lists the age categorisations 
with their respective counts: preschool (n=6), primary school (n=22), secondary school 
(n=21), combination of age groups (n=18), age not specified (n=9). The type of 
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programme or intervention that was most common was focused on increasing physical 
activity and fruit and vegetable intake or preventing obesity (n=18). Next were school-
based screening or vaccination programmes to prevent infectious diseases (n=11). The 
rest of the studies fell into the following categories: mental health/ SEW (n=8), asthma 
(n=7), illicit substance abuse/misuse (n=7), sexual health (n=6), early 
intervention/parenting programmes (n=4), food insecurity (n=4), dental health (n=3), and 
generic education programmes (n=8). 
Table 3: Study characteristics  
Study Type No. (%) 
CEA 16 (21%) 
CUA 25 (33%) 
CBA 9 (12%) 
Cost analysis 24 (31%) 
Non-economic 2 (3%) 
Country of Origin (classified by continent) 
Continent 
North America 37 (48%) 
Europe 21 (28%) 
Australasia 8 (10%) 
Africa 5 (7%) 
Asia 5 (7%) 
Year of Publication 
 
Pre-2000 2 (3%) 
2000 to 2004 14 (18%) 
2005 to 2009 16 (21%) 
2010 to 2015 44 (58%) 
Age 
Pre-school (age > 5) 6 (8%) 
Primary-school (ages 5 to 11) 22 (29%) 
Secondary school (ages 12 to 18) 21 (27%) 
Age not specified 9 (12%) 
Combination of age groups covered 18 (24%) 
Intervention Type 
Physical activity/nutrition education/obesity prevention 18 (24%) 
Infectious disease screening/prevention/vaccination 11 (14%) 
Mental health and wellbeing 8 (11%) 
Asthma 7 (9%) 
Illicit substance abuse/misuse 7 (9%) 
Sexual health 6 (8%) 
Early intervention/parenting 4 (5%) 
Food insecurity/nutrition 4 (5%) 
Dental health 3 (4%) 
Generic/education programmes 8 (11%) 
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3.3.2 Exploring relationships within groups and between studies 
The following section 3.3.2 details the findings and relationships identified through the 
synthesis of the studies included in the review. As can be seen in Figure 9, the studies 
were grouped into three broad methodologies, with a further three categorisations 
specifying the type of economic evaluation. Each methods group is discussed in terms of 
the findings and relationships found within the group. Following that, findings across the 
groups are discussed. Finally, a concept map follows which gives a visual representation 
of the findings detailed in this section. 
3.3.2.1 Economic Evaluations 
Cost-effectiveness analyses 
 
There were 16 studies included for review that were classified as CEAs. The majority 
originated from North America (n=9),204-212 four were from Europe,213-216 two from 
Africa,217, 218 and one from Asia.219 The majority of CEAs were published fairly recently; 12 
were published in the last 5 years.204, 205, 207, 209, 211-217, 219 The rest were published within 
the last 15 years.206, 208, 210, 218 The majority of CEAs were aimed at primary school children 
(n=7),204, 210-213, 215, 217 four were a combination of school age groups,206, 207, 209, 214 two 
were not specified,218, 219 and three were aimed at secondary school children.205, 208, 216 
The types of interventions varied from infectious disease screening/vaccination (n=4),208, 
217-219 to physical activity/obesity prevention (n=4),210-212, 215 mental health/SEW (n=3),206, 
213, 214 substance abuse/misuse (n=2),205, 216 generic education programmes (n=1),207 
dental health (n=1),204 and asthma (n=1).209 Only two studies report the results of their 
intervention as being ‘not cost-effective.’206, 219 The authors made these judgements 
based on context-specific WTP thresholds. The rest report relatively low costs per unit of 
effect, but as the outcomes vary and there is no established threshold for CEAs, no 
further comment is made on the ‘cost-effectiveness’ of the remaining studies. 
Cost-utility analyses 
 
There were 25 studies included for review that were classified as CUAs. Most studies 
originated from Europe (n= 8)220-227 and North America (n=8),228-235 followed by 
Australasia (n=7).236-242 There was one study originating from both Africa243 and Asia.244 
The majority of studies were published within the last 5 years (n=18), and the rest within 
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15 years.221, 225, 228, 230, 233, 234, 237 Most CUAs were aimed at secondary school children 
(n=10).220, 222, 223, 225, 233, 234, 236, 242-244 Five were aimed at primary school children,224, 227, 229, 
237, 240 six covered a combination of age groups,228, 230, 232, 235, 238, 239 and two were aimed at 
preschool children.221, 226 There were two studies where the age was not specified.231, 241 
The type of intervention that was most common within this group was physical 
activity/nutrition/obesity prevention programmes.224, 226, 231, 237-240 There were five 
programmes aimed at sexual health,220, 223, 236, 242, 243 three programmes dealing with 
infectious disease screening/prevention,232, 244, 245 illicit substance misuse,225, 233, 234 and 
generic or education programmes.228, 230, 241 There were two aimed at mental health222, 235 
and wellbeing, and one asthma229 and dental health intervention.227 Only one study 
directly measured HRQoL using the Shona-language version of the EQ-5D.243 The rest of 
the studies use different methods for estimating and modelling QALYs. Cost estimates 
vary as there was a large variation in types of currencies used (as evaluations were 
included from around the globe). Many authors were hesitant to comment on their 
study’s cost-effectiveness, using terms such as ‘may be cost-effective,’222, 224 ‘appears,’236 
‘seems,’221 ‘could be,’220 or ‘relatively’240 cost-effective. Or they may have stated the 
results were cost-effective, but with a caveat of uncertainty in effectiveness estimates.225, 
231 There were studies that stated outright they were cost-effective230, 233, 234, 238, 244 or not 
cost-effective.228, 229, 237, 239, 242, 243 Comparisons of cost-effectiveness between studies 
included in this group is cautioned as costs and effect estimation methodologies varied 
widely. 
Cost-benefit analyses 
 
There were nine studies included for review that were classified as CBAs. Six originated 
from North America.27, 28, 246-249 There was one from Europe,250 Asia251 and Australasia.252 
There was a wide range of publication dates, ranging as early as 1985246 to 2014.252 Three 
studies looked at the same intervention, but had different analyses based on continued 
follow-up.27, 28, 246 Four studies were aimed at pre-school children,27, 28, 246, 247 one at 
primary school252 and two at secondary school,248, 250 and the rest were aimed at a 
combination of age groups.249, 251 Four of the studies were evaluating early 
intervention/parenting interventions.27, 28, 246, 247 There was one of the following studies: 
nutrition education,252 asthma,249 illicit substance misuse,250 sexual health248 and food 
insecurity/nutrition.251 All CBAs reported that their interventions were cost saving or had 
88 
 
a positive net present value. All but two reported their results in a benefits-cost ratio as 
given in Equation 7.249, 253 The amount saved per every $1 invested ranged from $2.65248 
to $12.90.28 The results were subject to uncertainty around the valuation of benefits in 
each study. None of the studies stated if they used a human capital approach or a stated 
preference approach for valuing benefits, thus although they have been classified as a 
CBA, they are more likely to fit into the category of cost-savings analysis as mentioned in 
section 2.1.5. 
Equation 7: Benefits-cost ratio 
Benefits-cost ratio = (
𝐵𝑒𝑛𝑒𝑓𝑖𝑡𝑠
𝐶𝑜𝑠𝑡𝑠
) 
3.3.2.2 Cost analyses 
There were 24 studies included for review that were classified as cost analyses. Twelve 
studies, or half, originated in North America.254-265 Eight originated in Europe266-273 and 
two from Africa274, 275 and Asia.276, 277 All studies were published post 2000, with exception 
to one which was published in 1966.254 Eight studies were aimed at primary school 
students,255, 261, 262, 264, 265, 269, 275, 278 six at secondary school,257, 266-268, 272, 279 five were a 
combination of age groups256, 259, 260, 273, 276 and five weren’t specified.254, 258, 270, 271, 274 
There were six studies related to physical activity/obesity prevention,255, 258, 261, 264, 276, 278 
four screening/vaccine programmes,259, 262, 274, 275 three of the following: mental health 
and SEW,267, 268, 280 asthma,257, 272, 279 food insecurity/nutrition,270, 271, 273 and generic 
health/education programmes.254, 265, 269 There was one dental health intervention,256 and 
one illicit substance misuse prevention programme.266 Three studies reported cost-
effectiveness ratios (CER) which fail to take the incremental costs and effects between 
groups into account.255, 264, 278 One study267 was nearly classified as a CUA, but did not 
report an ICER so was not classified as such. This study did however directly measure 
HRQoL from adolescents using the EQ-5D. A few studies report negative results260, 267, 268, 
272, 273 and the rest report ‘appropriate’ use of funds, cost savings, or cost-effectiveness. 
3.3.2.3 Non-economic evaluations 
There were two studies included for review that were classified as non-economic 
evaluations. They both originated from North America281, 282 The years of publication 
ranged from 2006281 to 2008.282 One study was aimed at primary school children,281 and 
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the other was aimed at combination of age groups (Kindergarten to grade 8).282 One was 
an asthma281 programme and the other a generic health programme looking at the effect 
of school-based health centres on students’ HRQoL.282 The HRQoL measures used were 
the Pediatric Quality of Life Inventory (PedsQL) 4.0282 (detailed further in section 4.2.1) 
and the Pediatric Asthma Caregiver’s Quality of Life Questionnaire.281 The latter study 
found few improvements in health outcomes including the Caregiver’s QoL, however the 
former found significant improvement in student-reported HRQoL over the comparison 
group. 
3.3.2.4 Relationships across groups 
All studies were preventative by nature in that the programme or intervention being 
evaluated aimed to prevent future problems or prevent current problems from 
escalating. They could all be considered PHIs. The most common types of programmes 
were obesity prevention and screening programmes which is perhaps a reflection of how 
childhood obesity is a pressing issue facing children all over the globe as well as the 
school being an ideal setting for mass screening programmes. The groups that included 
the oldest studies were the CBA and cost analysis groups. Therefore, it could be said that 
these types of methodologies have been used the longest in school-based evaluation, or 
they simply were the most common type of methodology employed that would have 
been published during that time. CUAs and CEAs are more recent school-based economic 
evaluation methodologies to appear in the literature. They all start to appear after the 
year 2000, so within 15 years of the search being conducted. The ‘youngest’ type of 
publication methodology is the protocol, as they were all published within the last five 
years. The need for transparency around the conduct of RCTs has contributed to this 
recent phenomenon.283  
Not all defined PICOS criteria (see Box 2) were identified in the literature. ‘Contingent 
valuation’ and ‘human capital’ were terms specified under the outcomes criterion that 
were not identified in any of the studies screened. Likewise, many study designs that 
were defined were also not identified in the literature such as, SROI, SIA, HIA, MCDM, DCE 
or any stated preference methods.  
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There was great uncertainty across groups particularly in measuring and valuing 
effectiveness or benefits. This is particularly true in the CUA and CBA groups. Only one 
study in the CUA group directly measured HRQoL, therefore as the rest were modelled 
from other sources, huge uncertainty remains around the effectiveness results. As there 
was no valuation of benefits (either using a human capital approach or contingent 
valuation) stated in any of the CBAs, benefits were estimated as likely cost savings due to 
prevention of future problems. This places a lot of uncertainty on the effectiveness of 
studies as results are dependent on many assumptions, mainly that the intervention will 
prevent these future problems from occurring and subsequent costs. These methods 
deviate from the CBA methods described in section 2.1.5 as there is little attempt to value 
benefits observed from the studies, and are more likely to be classified as cost-savings 
analysis despite being labelled otherwise. In terms of costs, the main cost drivers are the 
cost of providing the intervention in the short-term. If the study modelled a longer-term 
time horizon, these costs may be spread over a longer period, but then the uncertainty 
around the extrapolation increases. 
The concept map detailed in Figure 10 below gives a visual representation of the 
relationships identified between and within groups. It also identifies some of the main 
findings of this synthesis. Figure 10 demonstrates the hierarchical relationships of the 
studies included. It starts by indicating that all 76 studies included were preventative 
school-based programme evaluations.  Downward arrows describe the methodological 
groupings. The green boxes indicate economic evaluations and findings are outlined in 
blue. The relationships between groups are indicated by arrows pointing to the findings 
highlighted in the diagram. The number of studies which directly measured HRQoL is 
indicated as well as those that incorporated children’s preferences. The types of 
evaluation methodologies that had uncertainty in effectiveness estimates and evaluated 
obesity prevention programmes are indicated by arrows to each finding. 
Study Protocols 
Of the eight study protocols included, half originated in the UK.213, 226, 227, 266 All studies 
were published within the last five years. All state that the study design will be a RCT, and 
two are pilot studies.226, 266 Not all studies explicitly stated the type of economic 
evaluation that was planned; four stated CEA212, 213, 217, 241 and one stated CUA,226 the rest 
did not give enough detail. In general, much detail was missing, only one study reported 
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that they would use discounting241 or justify why it was not needed. Only two226, 266 of the 
eight studies are taking place in a pre-school or secondary school, the rest are based in a 
primary school setting. Three studies state they will use an outcome measure that directly 
measures HRQoL in children.226, 227, 241 Two will use the PedsQL226, 241 (detailed further in 
section 4.2.1) and two will use the CHU9D.227, 241 
The search for the published protocol studies that were included in review returned three 
publications284-286 and one report.287  Two studies were still ongoing with NIHR 
publication dates in April 2017227 and September 2018.213 One study had recently finished 
in December 2016, but no publication had been found at the time of write-up.241 Only 
one study could not be accounted for.276 The protocol was published in 2010, so plenty of 
time had passed for the results of the study to have been published. This protocol did not 
provide many details of the methods that would be undertaken, so a potential reason for 
it not being published may be due to poor reporting or poor study quality. Furthermore, 
there is a publication bias in which editors are more favourable to publishing studies with 
positive results, so the study may have been victim to this bias if the results were not 
positive.
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Figure 10: Concept map representing relationships and findings from the narrative synthesis 
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3.3.3 Assessing the robustness of the synthesis. 
The counts of the CHEERS checklist are presented in Table 4 and Table 5. Table 4 presents 
the counts of checklist items by study, in ascending order. Table 5 presents the counts 
across all studies by item number. These counts are reported for descriptive purposes 
only. Table 4 shows that none of the studies reported all 24 checklist items. The most 
reported was n=21, shared by three studies.236-238 The fewest number of items was 
n=2.281 Table 5 shows that all studies include CHEERS checklist item number 3, which says, 
‘Provide an explicit statement of the broader context for the study. Present the study 
question and its relevance for health policy or practice decisions.’ The item that had the 
fewest studies report it was item number 20a which says, ‘Single study-based economic 
evaluation: Describe the effects of sampling uncertainty for the estimated incremental 
cost and incremental effectiveness parameters, together with the impact of 
methodological assumptions (such as discount rate, study perspective).’  
Many studies predate the publication of the CHEERS checklist, so the counts of items 
should not be used as a judgement of quality for individual studies. Fifty-four of the 76 
studies were published prior to 2013 when CHEERS was published. Of the remaining 23, 
nine studies reported 15 or more of the CHEERS items. These counts are reported for 
descriptive purposes only; any inference of quality should be made with caution as there 
is publication lag time to consider as well. However, when describing the quality of 
reporting for the studies as a whole, the economic evaluations would not hold up to 
today’s reporting standards. Many reviewers and editors would require authors to report 
all of the CHEERS checklist items as a minimum. The studies that reported 18 or more of 
the CHEERS checklist items all came from high-income, primarily English speaking 
countries: Australia, New Zealand, Germany, USA, UK, and the Netherlands. This indicates 
that geography may be impacting how a study was conducted, or how well it was 
reported. Again it should be noted that many of the studies reviewed were not 
considered full economic evaluations, so they would not normally need to be assessed by 
CHEERS. All studies in this current review were assessed by CHEERS for consistency. 
Because the overall level of reporting, methodology used, and study design variation, 
assessing the robustness of the review findings is challenging. In terms of the systematic 
review process followed, the synthesis is robust. However, the different methodologies 
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included in review, and the accompanying challenges of analysing those heterogeneous 
studies, resulted in an inherently less robust review. This trade-off was made to keep the 
scope of the review broad in order to identify the most wide-ranging types of 
methodologies used to evaluate school-based programmes.  To address this trade-off, 
efforts have been made to follow a review process that is systematic, as detailed in 
section 3.2.
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Table 4: CHEERS checklist totals by study 
Study 
No. 
Author, Year Total 
17 Bruzzese, J; 2006 2 
1 Abt, C; 1966 3 
22 Curtale, F.; 2005 3 
13 Boyle, J; 2007 4 
53 Newbury-Birch, D.; 
2013 
5 
64 Shemilt, I; 2004 5 
9 Beets, M; 2014 6 
72 Wade, T; 2008 6 
78 Young, T; 2003 6 
3 Ansell, J.; 2002 7 
14 Brassard, P; 2006 7 
27 Foster, J; 2013 7 
44 Li, Y; 2010 7 
4 Atherly, A; 2009 8 
23 Eckermann, S; 2014 8 
62 Salisbury, C.; 2002 8 
6 Barber, S; 2013 9 
19 Chestnutt, I; 2012 9 
29 Gelli, A; 2009 9 
30 Gelli, A; 2011 9 
32 Gesell, S; 2013 9 
33 Glewwe, P; 2001 9 
38 Joseph, C; 2007 9 
54 Nishura, H; 2014 9 
5 Babey, S; 2014 10 
10 Belfield, CR; 2005 10 
15 Brooker, S; 2010 10 
21 Crowley, D; 2014 10 
24 Ford, T; 2012 10 
68 Tai, T; 2010 10 
34 Guay, M.; 2003 11 
36 Hoeflmayr, D; 2006  11 
58 Quach, J.; 2013 11 
63 Scherrer, C; 2006 11 
7 Barnett, S; 1985 12 
18 Carabin, H.; 2000 12 
45 Liping, M; 2013 12 
2 Anderson, R; 2014 13 
Study 
No. 
Author, Year Total 
26 Foster, E; 2010 13 
39 Kesztyues, D; 2013 13 
67 Stallard, P; 2013 13 
71 Vijge, S; 2008 13 
74 Wang, L; 2001 13 
75 Wang, L; 2003 13 
16 Brown, H; 2007 14 
20 Cooper, K.; 2012 14 
28 Frick, K; 2004 14 
35 Heckman, J; 2010 14 
11 Bertrand, E; 2011 15 
50 Moodie, M; 2010 15 
52 Muenning, P; 2014 15 
56 Pearson, A; 2014 15 
57 Philipsson, A.; 2013 15 
69 te Velde, S; 2011 15 
73 Wang, L; 2000 15 
76 Wang, L; 2008 15 
8 Barrett, J; 2015 16 
41 Kowada, A; 2012 16 
51 Muenning, P; 2007 16 
77 Wang, L; 2011 16 
25 Foster, E; 2006 17 
47 Miller, T.; 2013 17 
55 Noyes, K; 2012 17 
60 Reynolds, A; 2011 17 
61 Rush, E; 2014 17 
31 Gerald, J; 2010 18 
37 Hollingworth, W.; 
2012 
18 
59 Rein, D; 2012 18 
65 Shepherd, J; 2010 18 
66 Simon, E; 2013 18 
70 Tengs, T; 2001 18 
43 Levaux, H; 2001 19 
40 Konig, H; 2004 20 
12 Blakely, T; 2014 21 
48 Moodie, M; 2009 21 
49 Moodie, M; 2013 21 
96 
 
Table 5: CHEERS checklist totals by item 
Item No. Description Total 
Title 1 Identify the study as an economic evaluation or use more 
specific terms such as “cost-effectiveness analysis”, and 
describe the interventions compared. 
61 
Abstract 2 Provide a structured summary of objectives, perspective, 
setting, methods (including study design and inputs), results 
(including base case and uncertainty analyses), and conclusions. 
55 
Intro Background 
and objectives 
3 Provide an explicit statement of the broader context for the 
study. Present the study question and its relevance for health 
policy or practice decisions. 
76 
Methods Target pop 
and subgroups 
4 Describe characteristics of the base case population and 
subgroups analysed, including why they were chosen. 
22 
Setting and location 5 State relevant aspects of the system(s) in which the decision(s) 
need(s) to be made. 
72 
Study perspective 6 Describe the perspective of the study and relate this to the 
costs being evaluated. 
50 
Comparators 7 Describe the interventions or strategies being compared and 
state why they were chosen. 
56 
Time Horizon 8 State the time horizon(s) over which costs and consequences 
are being evaluated and say why appropriate 
41 
Discount rate 9 Report the choice of discount rate(s) used for costs and 
outcomes and say why appropriate. 
42 
Choice of health 
outcomes 
10 Describe what outcomes were used as the measure(s) of 
benefit in the evaluation and their relevance for the type of 
analysis performed. 
59 
Measurement of 
effectiveness 
11a Single study-based estimates: Describe fully the design features 
of the single effectiveness study and why the single study was a 
sufficient source of clinical effectiveness data. 
12 
 
11b Synthesis-based estimates: Describe fully the methods used for 
identification of included studies and synthesis of clinical 
effectiveness data. 
20 
Measurement and 
valuation of 
preference based 
outcomes  
12 If applicable, describe the population and methods used to elicit 
preferences for outcomes. 
4 
Estimating 
resources and costs 
13a Single study-based economic evaluation: Describe approaches 
used to estimate resource use associated with the alternative 
interventions. Describe primary or secondary research methods 
for valuing each resource item in terms of its unit cost. Describe 
any adjustments made to approximate to opportunity costs. 
10 
 
13b Model-based economic evaluation: Describe approaches and 
data sources used to estimate resource use associated with 
model health states. Describe primary or secondary research 
methods for valuing each resource item in terms of its unit cost. 
Describe any adjustments made to approximate to opportunity 
costs. 
19 
97 
 
Currency, price 
date, and 
conversion 
14 Report the dates of the estimated resource quantities and unit 
costs. Describe methods for adjusting estimated unit costs to 
the year of reported costs if necessary. Describe methods for 
converting costs into a common currency base and the 
exchange rate. 
44 
Choice of model 15 Describe and give reasons for the specific type of decision-
analytical model used. Providing a figure to show model 
structure is strongly recommended. 
14 
Assumptions 16 Describe all structural or other assumptions underpinning the 
decision-analytical model. 
23 
Analytic methods 17 Describe all analytical methods supporting the evaluation. This 
could include methods for dealing with skewed, missing, or 
censored data; extrapolation methods; methods for pooling 
data; approaches to validate or make adjustments (such as half 
cycle corrections) to a model; and methods for handling 
population heterogeneity and uncertainty. 
10 
Study Parameters 18 Report the values, ranges, references, and, if used, probability 
distributions for all parameters. Report reasons or sources for 
distributions used to represent uncertainty where appropriate. 
Providing a table to show the input values is strongly 
recommended. 
24 
Incremental costs 
and outcomes 
19 For each intervention, report mean values for the main 
categories of estimated costs and outcomes of interest, as well 
as mean differences between the comparator groups. If 
applicable, report incremental cost-effectiveness ratios. 
24 
Characterising 
uncertainty 
20a Single study-based economic evaluation: Describe the effects of 
sampling uncertainty for the estimated incremental cost and 
incremental effectiveness parameters, together with the impact 
of methodological assumptions (such as discount rate, study 
perspective). 
3 
 
20b Model-based economic evaluation: Describe the effects on the 
results of uncertainty for all input parameters, and uncertainty 
related to the structure of the model and assumptions. 
21 
Characterising 
heterogeneity 
21 If applicable, report differences in costs, outcomes, or cost-
effectiveness that can be explained by variations between 
subgroups of patients with different baseline characteristics or 
other observed variability in effects that are not reducible by 
more information. 
11 
Discussion Study 
findings, 
limitations, 
generalisability, and 
current knowledge 
22 Summarise key study findings and describe how they support 
the conclusions reached. Discuss limitations and the 
generalisability of the findings and how the findings fit with 
current knowledge. 
63 
Other Source of 
funding 
23 Describe how the study was funded and the role of the funder 
in the identification, design, conduct, and reporting of the 
analysis. Describe other non-monetary sources of support. 
58 
Conflict of interest 24 Describe any potential for conflict of interest of study 
contributors in accordance with journal policy. In the absence of 
a journal policy, we recommend authors comply with 
International Committee of Medical Journal Editors 
recommendations. 
36 
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3.4 Discussion 
3.4.1 Summary of findings 
This systematic literature review identified a wide range of evaluation methodologies for 
school-based interventions and programmes. The majority of studies identified were 
economic evaluations and cost analyses. However, the two studies included in the non-
economic evaluations provided useful information on HRQoL; including what and how 
measures were being used. Around two-thirds were classified as full economic 
evaluations. The quality of reporting of these economic evaluations varied, and most 
would not be up to today’s standards of reporting as defined by the CHEERS checklist.170 
Geography did seem to impact on quality of reporting as the studies that reported the 
most checklist items all originated from high-income countries. 
The review did not identify any studies originating from South America. Instead, the 
majority originated from North America and Europe. The review only identified two 
studies that were published pre-2000; a CBA246 and a cost analysis.254 This demonstrates 
the relative novelty of the school-based economic evaluation. The wide range of methods 
employed and the varying quality of reporting also demonstrate the novelty of a school-
based economic evaluation, as there is no standardised global guidance for this type of 
evaluation. Protocols make up some of the more recent additions to the literature as 
every protocol reviewed, was published within the last five years from when the search 
was undertaken. Two protocols stated they would use the CHU9D as a direct measure of 
HRQoL for children, however, to date the full studies have not yet been published to 
verify the use of this measure (and if adolescent values were used to value utilities).  
Only four published studies were identified that directly measured HRQoL. Two used the 
EQ-5D,243, 267 an adult measure which was used on adolescents, and the other two were 
non-economic evaluations using the PedsQL282 and a disease specific caregiver’s quality of 
life instrument.281 The use of an adult measure in an adolescent population is concerning 
because it ignores the developmental changes in adolescents which means the values 
they place on certain health attributes may differ from adult values.288 Similarly, a 
systematic review of paediatric CUAs, found most evaluations used an adult preference-
based measure despite NICE guidance stating they should be developed specifically for 
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children.289 The review also found the measurement of QALYs to have the greatest 
variability between studies.289 Additionally, there may not be a common set of health 
attributes that are applicable across all age groups.290 It is an interesting finding that the 
only studies to incorporated child-specific HRQoL were non-economic evaluation studies. 
In CUA, it has been deemed preferable to directly measure HRQoL from participants 
versus relying on an indirect method for obtaining utility (e.g. mapping or ‘crosswalking’ 
algorithms,291 more detail in Chapter 6). There is a paucity of evidence in the published 
literature of CUA of school-based interventions that directly measure HRQoL using 
appropriate, child-specific measures. The review identified zero published studies that 
directly measured HRQoL in children (using a measure designed specifically for children) 
and which used children’s preferences; the only measure to fulfil both of these 
conditions, at the moment, is the CHU9D. None of the published studies reviewed 
incorporate this measure. Therefore, use of the CHU9D in this context is an important and 
novel contribution to the literature as it would be the first school-based economic 
evaluation to incorporate the CHU9D with adolescent values (currently there are no 
values from younger children available).  
There were eight studies included in review that intended to promote SEW in 
schoolchildren. This finding provides justification for leaving the intervention type open, 
as to restrict it to SEW interventions would have limited the results included in review. 
There was one study protocol identified that had a similar aims to RoE to improve the 
SEW of primary school students. It is the Incredible Years programme which is a 
classroom management programme which also uses the SDQ as the primary outcome 
measure (which is the case with RoE).213  This study is still ongoing, so it will be interesting 
to see the results of this CEA once they are available. An important difference between 
this study and RoE is that there was no utility outcomes included which means there can 
not be a direct calculation of QALYs without the use of a mapping or ‘crosswalk’ function. 
The methodologies used in RoE will be a novel contribution to the existing evidence base. 
Most programmes being evaluated were aimed at primary and/or secondary school 
students. Few studies were aimed at pre-school children, but those that were, were all 
classified as CBAs. The most common types of interventions or programmes being 
evaluated at the school level, were obesity prevention and screening/vaccination 
programmes. The rising levels of global childhood obesity is reflected in this finding.292 
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The next most common programme type was screening or vaccination programmes. 
Schools are an important setting for health promotion because of their ability to reach a 
large number of children at once;293 thus, the school has long been thought as the ideal 
place to provide mass screening/vaccination, and determining the cost-effectiveness of 
such strategies is warranted. This is a reason intervention at the school level is considered 
a PHI, and if effective, may have the potential to bring about school-wide benefits 
because of its reach. The next most common intervention type addressed mental health 
and wellbeing, which is where RoE would be categorised. This finding relates to the rising 
awareness of the need to promote and look after children’s SEW.5  
The review did not identify certain PICOS items such as ‘contingent valuation’ and ‘human 
capital.’ Likewise, many study designs that were defined were not identified such as, 
SROI, SIA, HIA, MCDM, DCE or any stated preference methods. Contingent valuation, 
human capital, DCE and stated preference are all search terms that relate to CBA. The fact 
that they are missing from this review is potentially down to the practical and time-
consuming issues of CBA that were mentioned in section 2.2.1.1 on appropriate 
methodologies for economic evaluation of PHIs. MCDM is an emerging methodology for 
PHIs, so its absence from the literature is understood. The other evaluation designs such 
as SROI, SIA, HIA must be unusual or inappropriate in some way for this context. The lack 
of these analytical methodologies and study designs are important findings from this 
review.   
The main cost drivers in the evaluations reviewed were the costs of delivering the 
programme. Some studies included hospital and medical costs if they were relevant, and 
some collected very detailed health and resource use cost data. The main causes for 
uncertainty in results were around the effectiveness of the interventions. Particularly in 
the CUAs and CBAs the effectiveness estimates were based on many assumptions. QALYs 
were modelled from other sources in all but one of the CUAs. The CBAs relied on 
assumptions for the accurate valuing of health benefits in monetary terms as not a single 
CBA performed a contingent valuation or used a human capital approach. In many of the 
cost analyses, benefits were valued as cost savings that were based on assumptions of 
the intervention’s effectiveness. As thresholds in other countries may not be as clearly 
defined as in the UK, there was a reluctance for some authors to comment directly on the 
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intervention’s cost-effectiveness. This reluctance could also have resulted from 
uncertainty in the effectiveness results, which was a common theme across studies. 
3.4.2 Limitations 
The author undertook the review of all studies, data extraction, and synthesis. Having 
only one reviewer, the supervisory team attempted to mitigate any bias (section 3.2.3) by 
contributing to the search strategy and performing validity checks on samples during the 
evidence gathering process.  
The review question was quite broad which meant a wide range of evaluation 
methodologies were included. This adds to the difficulty in evaluating quality with a single 
appropriate yet comprehensive tool. The CHEERS checklist was an appropriate 
assessment tool; however, because of the broad range of evaluations included, the non-
economic evaluations and cost analyses had items that did not apply. The broad range of 
methodologies also posed difficulties in evidence synthesis, as the included studies were 
heterogeneous. However, heterogeneity was dealt with through narrative synthesis and 
followed a systematic process that included preliminary synthesis, exploring relationships 
within and between groups, and assessing the robustness of the synthesis. The initial 
scoping review was more focused; the inclusion criteria was much narrower only focusing 
on economic evaluation of school-based interventions. This initial review identified few 
studies, so a broader approach was taken to make sure a comprehensive review of all 
available evidence was conducted.  
The review found no use of alternative methods MCDA, SROI, SIA, or HIA, even though 
they have been suggested as appropriate alternatives for capturing broader outcomes.157, 
294-296 As mentioned previously in section 2.2.1.2, MCDA approaches have not been 
widely adopted in healthcare decision-making and this systematic review has 
demonstrated that this is also the case in education decision-making. As further research 
into how MCDA should be used in HTA for healthcare settings is still required, the same is 
true for the use of MCDA in education decision-making contexts. SROI has been 
suggested for PHIs as they can allow the measurement of broader outcomes; however, no 
record of the use of these methods in school-settings has been identified. During the 
scoping review to identify appropriate methodologies to include in the search strategy, 
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SIA and HIA were identified, however it is noted that these methods have not appeared in 
any recent literature. Thus, it is less surprising that these methods were not identified in 
this review. The lack of results indicating methods such as MCDA or SROI in school-based 
evaluations are important findings in themselves, as it speaks to need for further 
development or guidance for applying these methods. This is particularly relevant to 
MCDA as ISPOR has issued several recent guidance documents.160, 161 There may be a 
research time-lag in the use of MCDA, or the existing guidance may not be sufficient for 
researchers new to the method to confidently conduct MCDA. 
3.5 Conclusion 
Evaluation methodologies of school-based programmes are varied and widespread. This 
systematic review, revealed the types and state of economic evaluation of school-based 
interventions as well as the non-economic evaluation methodologies, which comprised 
mainly of costing studies. Economic evaluation is a relatively novel concept in the school 
setting despite the need for efficient resource allocation in budget constrained education 
boards.19 Thus, the quality of methods used in the identified economic evaluations was 
not quite up to the standards that might be expected in the clinical trials-based medical 
literature. Few studies directly measured HRQoL in children leading to uncertainty in the 
intervention’s effectiveness estimates. In most CUAs, QALYs were not estimated from 
utilities directly collected from the children, but were modelled based on estimates from 
other sources, usually taken from adult studies. No published studies were identified that 
directly measured HRQoL in children which was also valued by children using the CHU9D. 
This is an important avenue for future research that this thesis intends to address; 
whether it is worth considering children’s values in decisions that will ultimately affect 
them. 
Improvements can be made in the quality of reporting of economic evaluations of school-
based programmes as low quality of reporting was prevalent. As a minimum, economic 
evaluation should report each of the applicable CHEERS checklist items and this review 
did not identify any studies that reported on each item. As the methods for school-based 
economic evaluation develop, the quality of reporting should improve as well. 
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The purpose of this systematic review was to gain and understanding of how economic 
evaluation (and other evaluation methodologies) of school-based programmes are 
currently being conducted and the types of preference-based child utility measures that 
are currently being utilised through a comprehensive review of existing evidence around 
evaluation methodologies. The review revealed relatively few high quality existing studies 
and zero published studies that incorporated children’s preferences in CUA. The review 
also revealed that alternative methods, which have been suggested for evaluation of PHIs 
such as MCDA and SROI, are not being implemented in a school-based evaluation context. 
The next two chapters aim to address this paucity of existing evidence in the literature by 
describing the methods and results of a CHEERS compliant CUA which directly measures 
children’s HRQoL and incorporates adolescent values into the calculation of QALYs.   
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4 RoE Economic Evaluation Methods: a Case 
Study 
4.1 Introduction 
Economic evaluations of school-based PHIs are relatively uncommon, especially those 
that aim to improve children’s social and emotional wellbeing (such as RoE), as was 
demonstrated in the previous chapter. Yet there is growing consensus of the value of 
investing in children’s health.297, 298 By improving the overall health and wellbeing of 
children, they may perform better in school; reduce the use of costly healthcare services; 
and ultimately be better prepared and successful in adulthood in terms of labour and 
employment outcomes.297, 298 Additionally, social, emotional, and psychological health 
affect physical health and can also protect children against emotional and behavioural 
problems, violence, crime, teenage pregnancy and drug misuse.5, 10 Beyond the health 
and social benefits to the individual, such outcomes have long-term economic impacts to 
society which need to be evidenced in order to justify investment in such interventions. 
Economic evaluation has been typically used to aid allocative decision-making in the 
health sector, as healthcare costs continue to rise and NHS resources are consistently 
under pressure. The education sector faces many of the same financial constraints as the 
health sector and stands to benefit from consistent and transparent allocative decision-
making. In order to address some of the shortcomings of economic evaluation of school-
based PHIs identified in the previous chapter, this chapter presents the methods of a 
thorough economic evaluation of the RoE programme. This case study will demonstrate 
and illustrate key components of a school-based economic evaluation, which will be the 
first of its kind in this specific context; therefore providing a novel example of the 
advantages and challenges that remain for economic evaluation in the education sector. 
The chapter describes in detail, the methods used for the main trial economic evaluation 
of the RoE programme. It is broadly split into three sections. The first section details 
economic evaluation in child health interventions introducing some of the main paediatric 
outcome measures in use, including the outcomes used in this economic evaluation. The 
second section provides background and contextual information to the RoE trial. The final 
section provides a detailed description of the analytic methods which were used in the 
economic evaluation of the RoE programme.  
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4.2 Economic evaluation in child health 
Interventions aimed at children have great potential of being cost-effective because of 
the longer time-frame over which health benefits can be gained.186 A child’s development 
is marked by physical, emotional, and cognitive changes; the trajectory of this 
development has distinct vulnerable periods where appropriate care is essential for 
growth and healthy development.37 Poor health in childhood may lead to adverse effects 
in adulthood, such as limited educational attainment and labour market opportunities, as 
well as poorer health outcomes.186 Early intervention is more effective as it aims to 
prevent problems from developing verses merely treating the problems once they 
manifest. They aim to provide the appropriate care during those vulnerable 
developmental stages. Advantages gained from early intervention are better sustained 
when they are continued with high quality learning experiences as depicted in Figure 11 
below.299 
 
 
Figure 11: Marginal increase in investment at different stages of the life cycle - adapted from 
Heckman, 2008299 
106 
 
 
The methods for economic evaluation that were described in Chapter 2 were developed 
for the economic evaluation of health technologies intended for adults. Considering the 
differences between children and adults, simply applying the same methods of economic 
evaluation may not be entirely appropriate. Traditionally, outcome measures developed 
for adults were administered to children without alteration. However, modifying an adult 
measure risks compromising the validity and psychometric properties of the instrument.37 
That is why it is important to develop child specific outcome measures for use in 
economic evaluation. The following describes paediatric outcome measures that have 
currently been developed specifically for children. The first subsection describes generic 
measures, which is then followed by preference-based measures. Next, the CHU9D, a 
generic preference-based measure specifically developed for children, is formally 
introduced. Finally, in the last subsection of 4.2.1, the SDQ, a child SEW outcome measure 
is detailed. 
4.2.1 Paediatric Outcome Measures 
4.2.1.1 Generic measures of outcome 
Generic patient-reported outcome measures (PROMs) are appropriate for anyone as a 
means for reporting their health. They are useful in that they can be applied to measure 
health in conditions that do not have a specific outcome measure, as well as, to make 
comparisons across conditions. If two or more different conditions are measured using 
the same generic PROM, they can easily be compared as they will have the same unit of 
outcome in common. A recent systematic review of generic PROMs for children identified 
29 such measures.300 These types of measures may often provide measurements for each 
domain or dimension separately, as opposed to a single score summarising them all. This 
could result in possible conflicts, where an intervention may result in improvements in 
one domain, but deteriorate in other domains when comparted to the control or other 
alternatives. Additionally, generic PROMs have not been valued with society’s 
preferences, so they cannot be used to make adjustments in quality of life. In other words 
they cannot be used in CUA because the ‘Q’ in QALY is missing. 
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4.2.1.2 Preference-based generic measure of HRQoL 
To put the ‘Q’ in QALY, a generic health measure must be preference-based; or the health 
state descriptive system must be accompanied by a set of utility values that were elicited 
using preference-based valuation techniques as described in section 2.1.4.1. There are 
challenges when evaluating paediatric QoL; direct elicitation of preferences may be 
preferred, however, the child’s ability to complete a SG or TTO may be restricted by 
cognitive and age limitations.301 The systematic review on generic PROMs for children 
mentioned above, identified six preference-based measures: 16 Dimensional (16D),302 
Assessment of Quality of Life Mark 2 6D adolescents (AQoL-6D),303 Child Health Utility 9D 
(CHU9D),96 EuroQol 5D Youth (EQ-5D-Y),304 Health Utilities Index 2 and 3,305 and 
Comprehensive Health Status Classification System – Preschool (CHSCS-PS).306 The 16D 
was adapted from the 15D adult measure. It is intended for children aged 12-15 and has 
been valued by 15-18 year olds using a visual analogue scale. The AQoL-6D uses adult 
valuations that were calibrated with TTO responses from 15-18 year olds.  The youth 
version of the EQ-5D (EQ-5D-Y) is available for children 7-12 years, but there is no UK 
valuation set available. The existing social value sets for EQ-5D cannot be assumed 
appropriate preference weights for paediatric populations307 as the EQ-5D-Y is a distinct 
instrument from the standard adult version. Thus, this missing value set is a limitation to 
use of the EQ-5D-Y in economic evaluation. Likewise the HUI-2 and CHS-CS-PS have not 
been valued by children or adolescents.  
Additionally, there is also the PedsQL first mentioned in section 3.3.2.3 as it was identified 
as an HRQoL measure used in the literature of school-based evaluation. It is a brief, 23 
item, HRQoL measure for children and adolescents aged 8-12 which can be completed by 
children themselves or by parent proxy.308 While it was developed with children and for 
children, there are currently no paediatric values available to estimate child health 
utility.309 However, Khan and colleagues309 have developed mapping algorithms which 
map to EQ-5D to estimate health utility. There is ongoing research by Stavros and 
colleagues310 to develop a preference-based index for the PedsQL, however this was not 
yet available at press time. The CHU9D is the only preference-based measure to have 
been developed specifically for children versus being adapted from an adult measure, as 
well as being valued by adolescents to estimate health utilities.  
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For paediatric economic evaluation, NICE advises use of a standardised and validated 
preference-based health related quality of life measure that has been designed 
specifically for use in children.64 This advice is sound due to the risks of compromising 
validity and psychometric properties when modifying adult measures for use with 
children. Since the CHU9D is the only preference-based measure that was not adapted 
from an adult measure, it is the only measure that can meet NICE’s specifications of being 
‘designed specifically for use in children.’64 The advantage the CHU9D brings to CUA 
contribute to, and warrant further research into the limited paediatric outcomes 
evidence. More on this point will be explored in Chapter 6, which validates algorithms 
that map from the SDQ to the CHU9D to facilitate CUA in line with NICE guidance.64 
Another important consideration is whose values should be used to value health states? 
Typically, a sample from the general population is used to value generic preference-based 
measures because in most cases decisions are made on a societal basis and members of 
society are all contributing to the funding of the health care system through taxation, 
especially in countries such as the UK where there is a national health service. But some 
might argue for the preferences of the patients being used as they are the actual 
recipients of what is being evalutated.68 It may be difficult for a member of the general 
public to value a health state they have never actually experienced. However, using a 
representative sample of the general population reflects the societal preferences of the 
population of interest. Should these representative samples include children and 
adolescents? Children are not typically considered rational, informed, or autonomous, 
and legally they are treated differently than adults and do not participate in the labour 
force.37 Thus, their preferences are not deemed to be relevant to societal decision-
making. Additionally, it is debatable whether or not children have the cognitive 
development to actually complete SG or TTO direct preference elicitation tasks, and 
whether it is ethical to do so as they may be subjected to questions about death.311 On 
the other hand, adult values have been deemed inconsistent312 and irrational so there is 
scope for incorporating children’s preferences. Ideally, there would be one preference-
based HRQoL measure (such as the EQ-5D) that is appropriate for all ages to fill in, and 
has been valued by the general population including children. However, this is not 
possible due to the significant differences between the two groups as well as cognitive 
and age limitations; thus, the reason child-specific measures have been developed. A 
study by Ratcliffe and colleagues288 found when applying adolescent and adult values to 
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the same CHU9D health states, the differences would likely impact the assessment of 
cost-effectiveness. Differences between child and parent proxy preferences for health 
outcomes poses risks for delivery and evaluation of paediatric programmes as children’s 
attitudes towards interventions are linked to their compliance and adherence.312 If the 
differences in preferences are apparent between, children, adolescents and adults, the 
question remains, whose values should be used? Given the shortcomings of proxy 
preferences, adolescent values were used in the base-case analysis because it is justified 
that the preferences of young people should be incorporated in decisions that ultimately 
affect them. 
4.2.1.3 The Child Health Utility 9D 
The CHU9D is a relatively new generic preference-based health-related QoL instrument 
suitable for use with children ages 7-17.313-315 It was developed by Kathrine Stevens, at 
the University of Sheffield, who carried out over 70 interviews with children, from two 
schools in Sheffield, to determine what dimensions of HRQoL would be included in the 
descriptive system. This descriptive system was then piloted with 150 children in schools, 
and a further 95 children from a clinical population from the Sheffield Children’s Hospital 
which helped to further refine the descriptive system. The final descriptive system 
comprised of nine dimensions with five levels each. The nine dimensions are worried, sad, 
pain, tired, annoyed, school work/homework, sleep daily routine, and ability to join in 
activities. The five levels range from 1 to 5 and represent increasing severity. The full 
descriptive system is given in Table 6.   
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Table 6: CHU9D descriptive system 
Dimension Level Description 
1 I don't feel worried today 
2 I fell a little bit worried today 
3 I feel a bit worried today 
4 I feeling quite worried today 
5 I feel very worried today 
1 I don't feel sad today 
2 I feel a little bit sad today 
3 I feel a bit sad today 
4 I feel quite sad today 
5 I feel very sad today 
1 I don't feel annoyed today 
2 I feel a little bit annoyed today 
3 I feel a bit annoyed today 
4 I feel quite annoyed today 
5 I feel very annoyed today 
1 I don't feel tired today 
2 I feel a little bit tired today 
3 I feel a bit tired today 
4 I feel quite tired today 
5 I feel very tired today 
1 I don't have any pain today 
2 I have a little bit of pain today 
3 I have a bit of pain today 
4 I have quite a lot of pain today 
5 I have a lot of pain today 
1 Last night I had no problems sleeping 
2 Last night I had a few problems sleeping 
3 Last night I had some problems sleeping 
4 Last night I had many problems sleeping 
5 Last night I couldn't sleep at all 
1 I have no problems with my daily routine today 
2 I have a few problems with my daily routine today 
3 I have some problems with my daily routine today 
4 I have many problems with my daily routine today 
5 I can't do my daily routine today 
1 I have no problems with my work today 
2 I have a few problems with my work today 
3 I have some problems with my work today 
4 I have many problems with my work today 
5 I can't do my work today 
1 I can join in with any activities today 
2 I can join in with most activities today 
3 I can join in with some activities today 
4 I can join in with a few activities today 
5 I can join in with no activities today 
111 
 
 
The CHU9D has demonstrated itself as a practical and valid measure for use in economic 
evaluation of child and adolescent healthcare programmes.314, 315 Valuation of the CHU9D 
was directly elicited from an adult and adolescent population. Preference weights were 
derived from 300 members of a UK adult population using a SG technique for use in 
children 7-11.313 Subsequently, through collaborative work with Julie Ratcliffe at Flinders 
University, Australia, preference weights were since derived from best-worst scaling DCE 
interviews of 590 Australian adolescents aged 11-17.311 This means that the CHU9D can 
be valued using adult and adolescent preference weights. 
At the time of writing, there were over 150 research studies currently applying the 
CHU9D in clinical trials, observational, and cohort studies across the world and there were 
Chinese, Spanish, Welsh, Danish, Italian, and Dutch versions available in addition to the 
original British English version.316 It is a self-complete measure with a proxy completion 
available for younger children, and the recall period is today/last night. It is the only 
paediatric generic preference-based measure of HRQoL exclusively developed with 
children and for children (i.e. it did not start out as an adult measure that was adapted for 
use with children). Current research collaboration between the London School of Hygiene 
and Tropical Medicine, Great Ormond Street Hospital and the Royal College of Art is 
developing an app for iPad to collect CHU9D health state data from children through use 
of animation.317 The five levels of each dimension are represented through animation and 
children pick which animation is most like them today. The three-stage project, 
CHILDSPLA, is still ongoing. In stage one the app was developed with primary school 
children and children in hospital. In stage two, the app was tested in multiple schools with 
multiple age groups ranging from 4-14 years. The research is currently in stage three 
which involves the development and testing of a method to elicit health state preferences 
from children.317 This would mean that preference weights from younger children may 
soon be available in addition to the preference weights from adolescents and adults. 
4.2.1.4 Social emotional wellbeing and condition specific measures of 
outcome 
Mental wellbeing in children and adolescents in the UK has been declining over the past 
30 years.318 There have been increases in the number of young people reporting frequent 
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feelings of depression or anxiety,319 in parent-reported behaviour problems, and in 
conduct disorders.320 The frequent use of social media by young people as well as the 
increase in cyber bullying is often purported as a potential cause of this recent trend.  
Impacts of emotional and behavioural or mental health problems in childhood can impact 
adult outcomes including educational failure, unemployment, unhealthy lifestyles, and 
problems with interpersonal relationships.321 SEW encompasses all of these problems (or 
lack thereof), however problems arise when attempting to meaningfully measure SEW. 
“[…] not everything that can be counted counts and not everything that 
counts can be counted” – William Bruce Cameron (1963) 
A NICE guidance report on SEW in education5 highlights the lack of valid methods for 
measuring SEW of primary school children and monitoring those changes over time. A 
suggested measure that has gained popularity among clinicians is the SDQ. 
The SDQ 322, 323 is a widely used and validated behavioural screening questionnaire which 
can be used for children aged 4 to 17.324-326 An additional early-years SDQ can be 
completed by parents or educators for ages 2-4.326 There are three versions of the 
questionnaire that can be completed by the teacher (ages 4-17), parents (ages 2-4 and 4-
17) and self-completed by the pupils (ages 11-17).326 The use of all three informants 
(teacher, parent, and child) is considered ideal so that the results can be triangulated. 
Using just one informant can be problematic because parents tend to be good at 
identifying externalising and conduct problems, but less so at identifying emotional 
problems. Children are better at reporting emotional symptoms accurately, but under-
report conduct problems, and teachers are somewhere in between (Minnis H 2016, oral 
communication, 14th October).  
The SDQ consists of five symptom scales (emotional, conduct problems, hyperactivity, 
peer problems and prosocial) with five items each. Four of the scales represent negative 
attributes of the child’s behaviour (total difficulties), while the fifth (prosocial scale) 
represents a positive attribute of the child’s behaviour. The total difficulties score is the 
sum of the four negative attribute symptom scales.  The 25 item behavioural and 
emotional assessment tool is much shorter and less cumbersome than other instruments 
such as the Child Behaviour Checklist.327 The SDQ is also less dated with a focus on 
identifying children’s strengths rather than solely focusing on their deficits as with the 
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traditional yet well-established Rutter Questionnaire.328 The SDQ was developed by 
Robert Goodman who worked closely with Michael Rutter as many of the questions are 
similar and the two measure are highly correlated; the main difference of course being 
the addition of prosocial behaviours.322 
SDQ Scoring algorithms converted into Stata (StataCorp LP, College Station, Texas, USA) 
syntax are available on the SDQinfo website.326 They involve assigning a score from 0-2 
(0=not difficulties, 2=many difficulties) for each item of the questionnaire and summing 
the total for each scale. The total difficulties and prosocial scores can be assigned to one 
of three general clinical thresholds; ‘normal,’ ‘borderline’ and ‘abnormal.’ These are 
general bandings and may be adjusted depending on the population which may vary by 
country, age and gender.326 Table 7 gives the banding for interpretation of the teacher 
completed SDQ scores. 
Table 7: Bandings for interpretation of Teacher Completed SDQ     
     Normal Borderline Abnormal  
Emotional Symptoms Score  0-4  5  6-10 
Conduct Problems Score  0-2  3  4-10 
Hyperactivity Score   0-5  6  7-10 
Peer Problems Score   0-3  4  5-10 
Prosocial Behaviour Score  6-10  5  0-4 
Total Difficulties Score  0-11  12-15  16-40 
 
The bandings are not considered a diagnostic threshold, rather they tend to be used as a 
screening tool to refer children who score in the ‘borderline’ and/or ‘abnormal’ ranges to 
Child and Adolescent Mental Health Services (CAMHS) for further examination (Minnis H 
2016, oral communication, 14th October). The SDQ is also used as a clinical outcome 
measure to examine change over treatment. However, some experts in child and 
adolescent psychology are unsure how sensitive the SDQ is to change (Minnis H 2016, 
oral communication, 14th October). This could have important consequences when using 
the SDQ as a primary outcome measure of effectiveness in a RCT. Because the bandings 
are not considered diagnostic, changes in scores cannot be compared to any clinically 
meaningful differences when using the SDQ as an outcome measure in an RCT. This poses 
challenges when interpreting effectiveness as no consensus has been reached on what a 
clinically meaningful change in the SDQ represents (Minnis H 2016, oral communication, 
14th October). More discussion on this topic is given in section 5.7. The SDQ is certainly 
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popular; it is freely available, has been translated into over 80 languages, and there have 
been over 4,000 published articles from over 100 countries that use the SDQ.326 In the UK, 
it is being routinely collected in the Millennium Cohort Study as well as by CAMHS. 
However, as the NICE guidance alluded to earlier, there is a lack of valid measures for 
measuring primary school children’s SEW.  
Given the points brought up above (bandings cannot be used as a diagnostic threshold, it 
may not be sensitive to change, and few valid measures exist to measure SEW), the SDQ 
may not be appropriate to measure something that is very difficult to quantify. SEW is an 
abstract and subjective concept. The five SDQ subscales certainly do cover most of the 
major aspects of child and adolescent mental health, but SEW is not simply the absence 
of mental health problems, i.e. SEW involves a child flourishing and is not equivalent to 
mental health. In the absence of specific and validated measures of SEW, the SDQ is 
appropriate in attempting to quantify and measure this difficult area. In a randomised 
controlled trial and economic evaluation context, it is important to include both a generic 
preference-base quality of life measure, as well as a condition specific measure of 
outcome. This is because of the difficulties that arise when trying to quantify changes in a 
non-generic preference-based outcome, such as the SDQ, in terms of other education 
outcomes covered under the same budget, e.g. increases in test scores. This is where a 
generic ‘yardstick’ measure can be quite useful, and to address the limitations of a 
generic outcome, condition-specific outcomes can be included which may be able to 
measure the intervention’s effectiveness more accurately. However, when using a 
condition specific outcome measure in CEA, there may be difficulties in interpretation of 
unit changes in scores and what values should be attributed to such changes (i.e. cost per 
unit increase/decrease in SDQ).  CEA ICERS are more difficult to interpret because unit 
changes in condition specific measures have rarely been valued. This places more burden 
on the decision-maker to determine these values and can lead to less transparency and 
consistency in decision-making. 
Mapping algorithms have been published that allow SDQ scores to be converted into 
CHU9D utility values,329 but more information including primary analysis will follow in 
Chapter 6. The base-case analysis, detailed later, uses the CHU9D to measure QALYs (to 
be compliant with NICE guidance), while a sensitivity analysis CEA, uses the SDQ to 
115 
 
examine the cost-effectiveness of the primary outcome measure of the RoE trial. The 
following section describes the main trail of RoE. 
4.3 Roots of Empathy 
The economic evaluation was conducted alongside: A cluster randomised controlled trial 
evaluation and cost-effectiveness analysis of the Roots of Empathy school-based 
programme for improving social and emotional wellbeing outcomes among 8-9 year olds 
in Northern Ireland; which was funded by the National Institute of Health Research 
Programme (Project Reference: 10/3006/02).55 The funder did not have any role in the 
identification, design, conduct, and reporting of the analysis. Professor McIntosh reports 
that she is a member of the funding board of the NIHR PHR programme and all other co-
authors have nothing to disclose and no conflicts of interest.  
RoE is a universal school-based SEL programme that was developed in Canada over two 
decades ago by Mary Gordon.53 It is one of the few SEL programmes that has an existing 
evidence base regarding its effectiveness.40, 43, 45 A recap of the RoE programme is 
provided here for clarity. The programme is delivered on a whole-class basis over one 
academic year (October to June) and consists of 27 lessons, which are all based around a 
monthly classroom visit from an infant and parent, usually recruited from the local 
community. During these monthly visits, children learn about the baby’s growth and 
development through interaction and observation of the baby and parent over the course 
of the year. The intervention is highly structured and any adaptation or tailoring of either 
the content or method of delivery is discouraged by the RoE organisation. 
Each month a trained RoE instructor, who is not the class teacher, visits the classroom 
three times for: a pre-family visit; the visit of the parent and infant; and a post-family 
visit. Instructors undergo a total of four days intensive training that is delivered directly by 
a specialist RoE trainer from Canada. The specialist trainer also provides on-going 
mentoring support via regular telephone calls to all instructors. In addition, on-going 
support is also available to each instructor through each Health and Social Care Trust’s 
lead RoE coordinator. Each RoE lesson takes place in the classroom with the teacher 
present but not actively involved in delivery. The programme provides opportunities to 
discuss and learn about the different dimensions of empathy, namely: emotion 
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identification and explanation; perspective-taking; and emotional sensitivity. The parent-
infant visit serves as a springboard for discussions about understanding feelings and 
infant development and effective parenting practices.  
At the heart of the programme is the development of empathy in young children. The 
psychological definition of empathy is ambiguous330 with few coming to a consensus,331 
but it is largely agreed to consist of three processes: 1.) an emotional simulation process; 
2.) a conceptual, perspective-taking process; and 3.) an emotion-regulation process.332 
The Oxford Concise Medical Dictionary provides a clear, simple, and easy to understand 
definition as, ‘the ability to imagine and understand the thoughts, perspective, and 
emotions of another person.’333 It is through the development of empathy that RoE seeks 
to improve children’s social and emotional understanding, promote prosocial behaviours, 
and decrease aggressive behaviours. Because the baby cannot verbally communicate 
his/her needs, wants, and emotions, children must learn to identify these through 
observations of the baby’s behaviour. This allows children to not only become better at 
identifying emotions of their peers, but within themselves as well. If and when children 
learn empathy, they have the foundation for developing positive and prosocial 
interactions. This social and emotional development has potential implications for a 
child’s future and longer-term outcomes.  
4.3.1 The RoE trial 
The RoE programme’s reach is now worldwide, but it has only recently been introduced 
to the UK, thus the RoE trial aimed to evaluate the immediate and longer-term impacts of 
the programme on SEW outcomes and its cost-effectiveness. The trial was conducted in 
primary schools in four of the five Health and Social Care Trust areas in Northern Ireland 
and given to Year 5 pupils (8-9 years old). The trial was led by Professor Paul Connolly, 
Head of the School of Education and Interim Dean of Research at Queen’s University 
Belfast. The economic evaluation was led by Professor Emma McIntosh, Deputy Director 
of the Health Economics and Health Technology Assessment research group at the 
University of Glasgow. Information given in this section (pertaining to the main trail) was 
completed by the main trial research team and reported elsewhere in the end of study 
report currently in press for peer reviewed publication by the NIHR Journals Library (Ref: 
10/3006/02).55 
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The research team identified and synthesised data from seven eligible evaluations of RoE 
that had been conducted to date (synthesis led by Dr Sarah Miller, August 2016). A 
summary of the synthesis is given. Of the seven eligible studies, only one was a (cluster) 
randomized controlled trial. The pooled data from these studies suggests that Roots of 
Empathy is effective in leading to small improvements in prosocial behaviour 
(standardised mean difference (SMD) = +0.13) and reductions in aggressive behaviour 
(SMD = -0.18). There is no evidence to suggest it is effective in improving other SEL 
outcomes amongst children, in this case empathy and emotional regulation. Only one 
evaluation studied the longer-term impact of the programme and it suggests that after 
three years the intervention group had poorer prosocial behaviour compared to the 
control group (SMD=-0.12, 95% CI [-0.17, -0.07]). With respect to aggressive behaviour 
three years post intervention, the intervention group were displaying only slightly less 
aggressive behaviour compared to the control group (SMD=-0.06, 95% [-0.09, -0.03]) and 
although statistically significant, this effect was much reduced compared to the effect 
observed at immediate post-test (SMD=-0.25). There were no evaluations to examine the 
potential cost-effectiveness of RoE so the following economic evaluation is highly original 
and a significant contribution to the RoE evidence base. 
4.3.2 RoE trial aims 
Given the limited existing evidence base for RoE, particularly economic evidence, the aims 
of the overall trial evaluations were to:55 
A. Evaluate the immediate and longer-term impact of the RoE programme on social 
and emotional wellbeing outcomes among 8-9-year-old pupils. 
B. Evaluate the cost-effectiveness of the programme from a public sector perspective 
over trial time horizon of 45 months (3.75 years or 3 years follow-up after 
intervention completion). 
The trial aimed to answer the following research questions:55 
1. What is the impact of the programme at post-test and up to three years following 
the end of the programme on a number of specific social and emotional wellbeing 
outcomes for participating children? 
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2. Does the programme have a differential impact on children depending on: their 
gender; the number of siblings they have; and their socio-economic status and/or 
the socio-economic profile of the school? 
3. Does the impact of the programme differ significantly according to variations in 
implementation fidelity found? 
4. What is the cost-effectiveness of the programme in reducing cases of aggressive 
behaviour and increasing prosocial behaviour among school-aged children? 
The final aim (B) and research question (4) for the RoE trial were the focus of this 
economic evaluation and the following methods reported in this chapter. Addressing the 
fourth research question is not only relevant to decisions on school policy, but health 
policy as well. The other aim and research questions were tackled by the main trial team 
whose findings are available elsewhere, currently in press with the NIHR Journals 
Library.55 As research question 2 is relevant to PHIs in terms of reducing inequalities, the 
findings from the report are summarised here briefly. Pre-specified subgroup analyses 
were undertaken to explore whether the programmed worked better according to the 
socio-economic background of the child’s family which was measured using multiple 
deprivation rankings for the child’s home address. Given that there were 27 tests in total 
and only two interaction terms were found to be significant, the findings may have 
occurred by chance and should be considered with caution. SDQ total difficulties or 
prosocial scores were not found to be significantly impacted by deprivation level in the 
multilevel model analyses.55 
4.3.3 Data Collection 
The data collection for the RoE trail was led by the RoE trial team and full methods 
detailing data collection are available elsewhere.55 Seventy-four primary schools were 
recruited to the trial between March and June 2011. Schools were randomly allocated to 
receive the RoE intervention (n=37), or to the waitlist control group (n=37), which did not 
receive RoE and continued with their regular curriculum and usual classroom activity. This 
comparator was selected because in the absence of RoE, usual classroom activity would 
be what would take place normally. Schools allocated to the intervention group, received 
the RoE programme in their selected year 5 class for one academic year (2011/2012). 
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Schools placed on the waitlist received the programme in 2012/2013, but on the 
understanding that RoE would not be delivered to their current Year 5 cohort (control 
group) as they progressed through the remainder of the trial follow-ups. 
Pre-test (or baseline) data collection from the children, parents and teachers took place in  
October 2011 across all participating schools prior to the first sessions of RoE being 
delivered in the intervention schools. Consent forms were sent home with children prior 
to baseline data collection. Post-test (or immediately after intervention completion) data 
were collected in June 2012. Follow-up data collection took place annually at 12 months 
(June 2013), 24 months (June 2014), and 36 months (June 2015). At the final sweep of 
data collection, children were 11-12 years of age and at the end of their first year in 
secondary school. Outcomes  collected for the RoE trial but not included in the economic 
evaluation included the: Child Behaviour Scale, Infant Facial Expression of Emotions Scale, 
Emotion Recognition Questionnaire, Interpersonal Reactivity Index, Child Anger 
Management Scale, and the Revised Olweus Bully/Victim Scale. 
Teachers were asked to complete a questionnaire for each participating child at each time 
point, which included the SDQ and the Child Behaviour Scale. Parents were contacted via 
post and asked to complete a questionnaire and return it to the research team in a 
freepost envelope. The questionnaire included the SDQ and asked parents about 
background information on family composition, parental education, and employment. 
Fieldworkers administered questionnaires to the children on a whole-class basis. 
Fieldworkers were fully trained and coordinated by the research team. Included in the 
children’s questionnaire was the CHU9D as well as other secondary outcome measures: 
emotion regulation, empathy, recognition of emotions, understanding of infant crying, 
and bullying. Children were asked not to confer, and this was ensured by the teacher and 
RoE fieldwork present. Each question was read aloud to the class and any words or 
phrases that were difficult were explained. If a child was absent, efforts were made to 
return to the school at a later date.  
4.3.3.1 Economic evaluation outcome measures 
The primary outcomes for use within the economic evaluation were the SDQ and CHU9D, 
which were collected at each data collection time point as described above. Due to a low 
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response rate from parents, the teacher complete version of the SDQ was used in the 
analysis. As teachers completed the SDQ, they acted as a proxy for child behaviour 
outcome, as the self-complete version was only available for older children aged 11-17. 
Other outcomes that were incorporated within the economic evaluation included age (as 
measured by year in school), gender, deprivation level, and number of siblings. These 
were all collected from the trial and  deprivation was measured by the Northern Ireland 
Multiple Deprivation Measure 2010 (NIMDM) which is a relative measure of 
deprivation.334 Additionally, in order to try to capture broader outcomes of the 
programme, parent’s quality of life was measured via EQ-5D. Unfortunately, it was only 
available at 24 and 36-month follow-up due to issues with the trial design (see section 
below and section 4.4.2.2). Response rates were low and it was subsequently dropped 
from analysis. 
4.3.3.2 Resource use 
Resource use and costs of the intervention were also collected from the trial. Due to 
issues with the trial design, resource use was only collected and available from 24 and 36-
month follow-up. As cost and outcome data should be consistent over the relevant time 
horizon, the 24-month resource use questionnaire asked parents to recall resource use 
for their child since the beginning of the trial period. The long recall is a recognised 
limitation and more detail about the resource use and cost data collection is given in 
section 4.4.2.2 and 4.4 which details the within trial economic evaluation of the RoE 
programme. 
4.4 RoE main within-trial analysis methods 
The last section (4.3) gave background to the RoE trial, aims, and data collection. This final 
section details the full economic evaluation methods using all data from the three years 
of follow-up from the RoE trial. The first section (4.4.1) gives a brief overview of the 
methods that were employed, followed by a detailed description of the costs, outcomes, 
missing data, analyses, and sensitivity analyses performed. 
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4.4.1 Overview 
The base-case analysis of the RoE economic evaluation took the form of a CUA, which was 
based on the incremental cost per QALY gained. Various sensitivity analyses were 
performed including a CEA, which was based on the incremental cost per one-unit 
decrease of the total difficulties score and incremental cost per one-unit increase of the 
prosocial behaviour subscale of the SDQ. Health economics data were collected at five 
time points: 
1. Pre-test (baseline)  
2. Post-test (after intervention completion)  
3. 1-year follow-up from post-test  
4. 2nd year follow-up form post-test, and  
5. 3rd year follow-up from post-test.  
The analysis had a time horizon of 3.75 years (45 months) which equates to three years 
follow-up after intervention completion. This time horizon is appropriate within the limits 
of resource constraints, as it is one of the longest cluster RCT follow-ups of RoE to be 
performed. The study took a public sector perspective with NHS, PSS, local government 
authority, and family costs included.  Costs were derived from resource use 
questionnaires that were developed by the author and supervisor specifically for this trial, 
which were sent home to parents.  Costs were also derived from the actual cost to deliver 
the RoE intervention. Costs and QALYs were discounted using NICE’s public health 
guidance discount rate of 1.5%.79 QALYs were determined from the CHU9D which was 
completed by children in their classroom. Missing data on costs and QALYs were handled 
using MI with chained equations.335 Regression methods were used to obtain incremental 
cost and effect estimates. Multiple regression methods that ignore clustering (e.g. the 
within school clusters as in this trial) can lead to biased coefficients and especially biased 
standard errors.336 Multilevel models have been proposed as a method to address issues 
surrounding clustering in economic evaluation337 and their use was explored. Upon 
recognition of the model being a poor fit for costs in this particular dataset, regression 
with robust standard errors was conducted to adjust standard errors by indicating that 
observations within schools may be correlated, but are independent between schools.  
122 
 
ICERS were estimated by dividing the difference in mean costs between groups by the 
difference in mean effects between groups. The uncertainty surrounding the ICER was 
investigated by use of a nonparametric bootstrap of 1,000 iterations. This uncertainty was 
then presented on the cost-effectiveness plane and summarised on the cost-effectiveness 
acceptability curve (CEAC).These estimates of ICERs were considered with respect to the 
£20,000 to £30,000 per QALY threshold generally accepted by NICE to determine cost-
effectiveness in the UK. To allow for uncertainty a series of sensitivity analyse were 
performed. All analyses were conducted as intention-to-treat analyses and in Stata/SE 
14.1 (StataCorp, College Station, TX, USA). Table 8 below gives an overview of the data 
collected for use in the economic evaluation. A completed CHEERS checklist for the RoE 
economic evaluation can be found in Appendix 6. 
Table 8: Data from the RoE trial collected for the economic evaluation 
Data Type Description of Data Time Points 
Costs of Intervention Fees, training, personnel, and materials to run RoE Pre-test 
NHS/PSS Resource 
use 
NHS/PSS Service use including staff time and parent 
self-report children’s medications 
F2, F3 
Cost to Society Time off work to care for child and police visits F2, F3 
HRQoL Child Health Utility 9D (CHU9D) questionnaire Pre-test, post-
test, F1, F2, F3 
Trial Primary 
Outcome 
Strengths and Difficulties Questionnaire (SDQ) Pre-test, post-
test, F1, F2, F3 
Demographics for 
Subgroup Analysis 
Gender, school, Multiple Deprivation Measure 
2010, number of siblings 
Pre-test 
 
4.4.2 Costs  
Costs of the RoE programme were made up of the following: 
Equation 8:Total cost of RoE programme 
𝑪𝑻 = 𝑪𝑰𝒏𝒕 +  𝑪𝑵𝑯𝑺 + 𝑪𝑺𝒐𝒄 
 
Where 𝐶𝑇 is the total cost made up of: 𝐶𝐼𝑛𝑡, the cost of the intervention including 
personnel, training, materials, fees and other cost; 𝐶𝑁𝐻𝑆, NHS resources used including 
service use, staff time, and medications; and 𝐶𝑆𝑜𝑐, societal costs such as parental time off 
work, charity, and police costs. 
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4.4.2.1 Costs of the Intervention 
All costs were reported in price year 2014 British Pounds (GBP). A number of costs were 
incurred in 2011 when the intervention ran. Where required, costs were inflated to the 
base year 2014 using the Hospital and Community Health Services (HCHS) price index (see 
Table 9).338 The HCHS is a weighted average of two separate inflation indices: the pay cost 
index and the health service cost index.338 The total cost of the intervention was made up 
of the following cost categories: key point people, administrative support, instructor time, 
instructor training materials, instructor materials, instructor fee, and other costs. 
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Table 9: Hospital and Community Health Services Index  
Year Pay and Prices index 
(1987/88=100) 
1995/96 166 
1996/97 170.6 
1997/98 173.5 
1998/99 180.4 
1999/00 188.6 
2000/01 196.5 
2001/02 206.5 
2002/03 213.7 
2003/04 224.8 
2004/05 232.3 
2005/06 240.9 
2006/07 249.8 
2007/08 257.0 
2008/09 267 
2009/10 268.6 
2010/11 276.7 
2011/12 282.5 
2012/13 287.3 
2013/14 290.5 
*2014/15 286.8 
 * Estimate only, an average of the three previous years 
Personnel costs (salary costs) were classified by NHS Band and were taken from the 2011 
Health Service pay scale.339 Personnel costs included: four key point people (Band 7) who 
are Health Trust employees who co-ordinate RoE in each of the four participating Trusts, 
four administrative support part-time workers (Band 3), and a RoE instructor for each 
school (Band 6). Salaries were based on mid-spine points for each respective band range 
(including 25% oncosts) and adjusted for time spent on RoE activities (see footnotes in 
Table 11). Key point people underwent 28 hours of self-directed learning as training over 
three to five days and spent an average of 13 hours a week on RoE related activities. 
Administrative support salaries were 50% full time equivalent, or 18.75 hours per week. 
RoE instructor costs were split into training, time spent preparing for the 27 sessions and 
time spent delivering each session. Each instructor received 30 hours of training. Time 
spent preparing and delivering the sessions varied; the average time spent preparing and 
delivering all 27 sessions was 24 hours for preparation and 24 hours for delivery. 
Additionally, there were instructor training materials, instructor materials for delivering 
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the programme, and an instructor fee paid to each instructor. This fee would become an 
annual fee if the programme were to be continued along with all other personnel costs 
described previously.  
Fees paid to the RoE programme in Canada for use of the programme in the UK are 
reported in a cost category referred to as ‘other costs’ in Table 11. These included 
programme support costs, materials shipping, training and mentoring expenses, and 
ongoing mentoring. The programme fees were originally purchased in 2011 Canadian 
dollars and converted to GBP price year 2011 using purchasing power parities (PPP) 
reported by the OECD340 (see Table 10)  and inflated to the current price year (2014) using 
the HCHS index. The RoE intervention was given to 33 schools with 764 pupils receiving 
the intervention. Please see Table 11 for a list of component costs that make up the total 
cost of providing the RoE programme in a Northern Ireland context. 
Table 10: OECD Purchasing Power Parities (PPP) 
OECD PPP 
  2011 2014 
Canada 1.2399 1.2612 
United Kingdom 0.6997 0.7081 
 
Table 11: Component costs of the RoE programme 
   
Cost Item Unit cost per 
hour 
(personnel)/Item 
cost 
Quantity 
Key point person a  £18.26  Varies 
Administrative support b  £6.61  18.75 per week 
Instructor time c  £15.29  Varies 
*Instructor training materials  £1,027.97  1 
*Instructor materials  £456.88  1 
Instructor fee d  £171.33  1 
*Other costs 
Programme support costs  £5,710.94  1 
Materials Shipping  £2,569.92  1 
Trainers/mentoring expenses  £3,426.57  1 
Mentoring  £5,139.85  1 
 
*Annuitized cost 
a One key point person per Trust at mid-point Band 7 salary range £35,600 
b One part-time support worker per Trust at mid-point Band 3 salary range £12,900 
c One instructor per school at mid-point Band 6 salary range £29,800 
d 300 CAN$ 
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Annuitization was carried out to spread fixed costs of the intervention over the 
anticipated five-year life span of the RoE intervention. Annuitization is typically 
performed for capital costs such as buildings and equipment, however other costs such as 
training and materials may also be annuitised if they are incurred at the start of the 
programme, yet have a useful life longer than the initial period.341 Training and 
development incur costs at the beginning of a programme, but the effects of training 
often last much longer than the initial period. Training, materials and other programme 
costs were one-time costs that were annuitised over the expected life of the 
intervention.341 The base-case assumption of the expected life of the intervention was 
assumed to be five years, at which point training would need to be repeated and 
materials replaced. Therefore, costs were annuitised over five years at a discount rate of 
1.5%. The equivalent annual cost was estimated using the annuitisation formula given in 
Equation 9. 
Equation 9: Annuitization formula 
𝐾 = 𝐸 ∗ [
1 − (1 + 𝑟)−𝑛
𝑟
] 
    where   K= the initial outlay 
     E=the equivalent annual sum 
     n= the expected life of the asset 
     r = the rate of interest or discount rate 
 A number of sensitivity analyses were conducted around this assumption such as use of 
varying discount rates (3.5% and 5%) and the useful life of the training and materials (3 
years). Table 12 is the discount table used to calculate the equivalent annual sum for the 
annuitized costs. A scenario with no annuitization or discounting was also performed.  
Table 12: Discount table for Annuitization 
n 1.5% 3.50% 5% 
1 0.985221675 0.966183575 0.952380952 
2 1.955883424 1.899694275 1.859410431 
3 2.912200417 2.801636981 2.723248029 
4 3.854384648 3.673079209 3.545950504 
5 4.782644973 4.515052375 4.329476671 
6 5.697187165 5.32855302 5.075692067 
7 6.598213956 6.11454398 5.786373397 
8 7.48592508 6.873955537 6.463212759 
9 8.36051732 7.607686509 7.107821676 
10 9.222184552 8.316605323 7.721734929 
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4.4.2.2 Resource Use 
Resource use was identified through early discussions with the trial managers and their 
contacts with the school to identify likely resource use. Resource use was then measured 
over the length of the trial and was made up of the following data collection: i.) NHS 
resource use including service use and staff time, and parent self-report children’s 
medications; and ii.) societal costs such as social worker, school nurse, parent’s time and 
potential contacts with the police. These broad ranging costs were considered from a 
public sector perspective as per NICE public health guidance.79 
Resource use that was expected to differ between groups was collected at the second 
and third year follow-ups (24 and 36 months). A series of complications arose due to 
changes in co-investigators during the trial, and thus resource use (and parental EQ-5D) 
were not collected at pre-test, post-test, or at the 12-month follow-up. To account for 
resource use over the entirety of the trial period, resource use questionnaires at the 24-
month follow-up asked parents to recall health and social care resource use from ‘when 
their child started Primary 5,’ which relates to the beginning of the study. At the final 
follow-up (36 months), resource use questionnaires asked parents to recall their child’s 
resource use from the past 12 months. While the long recall periods are not ideal, it was 
decided that some data on resource use was better than none. Resources were valued 
using UK national unit costs.338 
Specifically, health and social care resource use collected included the number of contacts 
with various NHS services, children’s medications, time off work or daily activities parents 
needed to take due to their child being off school, and any contacts children had with the 
police. The time off work or other leisure activities was collected in order to approximate 
the opportunity cost of how parents choose to spend their time. As not all parents may 
need to take off work, the average British wage was applied as a unit cost to represent 
parent’s time equally. The NHS services that were collected were visits to: general 
practitioner (GP), school nurse, accident and emergency (A&E), social worker, speech 
therapist, occupational therapist, physiotherapist, educational psychologist, education 
welfare officer, psychiatrist, counselling/therapy, dentist, optician, hospital inpatient and 
outpatient stays, and any other services that were not included could be written in. See 
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Figure 12, which shows the initial health and social care services questionnaire sent home 
to parents at the 24-month follow-up. 
Unit costs were assigned to resource use using the PSSRU Unit Costs of Health and Social 
Care 2014,338 NHS Reference Costs 2013/14,342 and Office for National Statistics (ONS) 
median weekly earnings.343 See  
 
 
Table 13 for unit cost and source information for RoE resource use. Up to four 
medications could have been self-reported and unit costs for those were obtained from 
the British National Formulary (BNF) for children.344 Occasionally parents reported over-
the-counter medications which were considered societal costs. These were assigned unit 
costs using a market value from a national pharmacy, Boots. Up to two ‘other service 
uses’ could have been self-reported by parents; these were assigned unit costs in the 
same manner as described above. Occasionally parents listed contacts with charitable 
services so these were considered societal costs. Once all resource use had been assigned 
a unit cost, two sample t-tests with equal variances were performed to test for significant 
differences in resource use between groups. Finally, total cost was calculated for each 
group and discounted by 1.5% in the base case. Sensitivity analyses were performed 
varying the discount rate to the traditional 3.5% rate recommended by NICE.64 
Additionally, t-tests were performed on each service use to determine if the intervention 
had any impact on resource use between the groups.  
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Figure 12: Resource use questionnaire 
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Table 13: RoE resource use, unit costs, and sources for unit costs  
    
Variable Unit 
Cost 
Source 
GP  £46.00 PSSRU 2014 pg. 195. Per patient contact lasting 11.7 minutes, with qualifications 
School Nurse £63.00 PSSRU 2014 pg. 85. Nursing average cost per contact. School-based children's health care services- group. 
Education Welfare Officer £27.00 PSSRU 2014 pg. 155. TAC meeting attended by education welfare officer 
A&E £72.00 NHS Reference costs 2013/14. Type 1 admitted, emergency medicine any investigation with category 5 treatment 
Social Worker £41.00 PSSRU 2014 pg. 99 
Speech therapist £89.00 PSSRU 2014 pg. 85. Average cost per group session 
Occupational Therapist £113.00 PSSRU 2014 pg. 85. Average cost per group session 
Physiotherapist £81.00 PSSRU 2014 pg. 85. Average cost per group session 
Educational psychologist £41.00 PSSRU 2014 pg. 156 
Psychiatrist £228.00 NHS Reference costs 2013/14. CAMHS, Children and adolescents, national average unit cost 
Counselling/therapy £81.00 PSSRU 2014 pg. 85. Average cost per group session 
Dentist £65.00 PSSRU 2014 pg. 197. Unit cost/hour 
Optician £21.10 Northern Ireland sight test fee (children don't pay) MOS/294 
*Police £325.00 PSSRU 2014 pg. 149. Police cost for criminal offence (statement and interview), cost to others 
Hospital Stay (no. nights) £326.00 PSSRU 2014 pg. 111. Inpatient specialist palliative care, average cost per bed day  
Hospital Outpatient visit £189.00 PSSRU 2014 pg. 85. Paediatrics average cost per attendance 
Other Service use (x2) varied Varied: PSSRU or NHS Reference costs 
Medication (x4) varied Varied: BNF or *Boots market prices for over the counter drugs 
*Time off work (days) £104.00 £518 median weekly earnings April 2014 http://www.ons.gov.uk/ons/rel/ashe/annual-survey-of-hours-and-
earnings/2014-provisional-results/stb-ashe-statistical-bulletin-2014.html 
*Indicates societal cost
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4.4.3 Outcomes 
The primary child outcomes for the trial were increases in prosocial behaviour and 
decreases in difficult behaviour as measured by the teacher rated version of the SDQ. Given 
the primary outcomes of the trial, the SDQ was a logical choice for measuring those 
outcomes. Thus, the cost-effectiveness analysis (a sensitivity analysis) was based on 
incremental changes in both total difficulties and prosocial behaviour scores of the SDQ.  
In order to gain further understanding and background context of the SDQ, an informal 
expert interview was conducted with Professor Helen Minnis of Child and Adolescent 
Psychiatry. The questions focused of gaining a clearer understanding of how the SDQ was 
currently being used in practice, if it was a reliable measure of SEW, and what the changes 
in scores meant from a clinical standpoint. The interview was recorded and transcribed by 
the author; however, no formal qualitative analysis was conducted. The transcript was used 
for general background information and to add to the discussion of the SDQ as an outcome 
for SEW in CEA.  
The trial was a large cluster-randomised controlled trial with over 1,000 pupils taking part in 
the study. The size and rigour of a large randomised controlled trial provided a sufficient 
source of effectiveness data as both clinical effectiveness (SDQ) and HRQoL (CHU9D) were 
collected and available for analysis. Because the two main benefits collected in this trial 
were health benefits, a CUA was conducted and inclusion of a further CCA or CBA was not 
required.79 Other secondary outcomes collected for the main trial were all related to 
measuring SEW, and thus non-health benefits were not collected. Because RoE is a school-
based PHI, broader non-health benefits could be expected to arise such as improved 
education outcomes. This is a limitation from the perspective of the education decision 
maker as they may be interested in RoE’s potential effect on education outcomes. However, 
this trial was funded for and focused on analysing the potential health benefits arising from 
the programme. 
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4.4.3.1 Quality Adjusted Life Years (QALYs) 
In the RoE trial, HRQoL was measured using the CHU9D which is the first generic preference 
based measure specifically designed for use with children to estimate QALYs for economic 
evaluation of programmes/interventions for young people.345 All other generic HRQoL 
measures for children were originally developed for adults and adapted for children, or 
developed for children, but require use of a mapping or crosswalk function to adult values 
to estimate health utility. The CHU9D was designed with children, specifically for children, 
and has been valued by adolescents and adults without requiring the use of a mapping 
function to estimate child health utility. 
Because the CHU9D is the only HRQoL measure developed specifically for children and 
valued by children, the adolescent values tariff was deemed the more appropriate tariff to 
apply to health state profiles in the base-case analysis as it incorporates adolescent values 
into the decision making process.  Sensitivity analysis was performed which applied the 
adult values tariff. Utilities were converted to QALYs using the AUC method described by 
Matthews et al102 and given in Equation 5. In this context, QALYs should be interpreted in 
the same way as the outcome of any PHI. RoE QALYs reflect the quality of life gains achieved 
from the intervention’s aim to increase social and emotional understanding, empathy, 
promote prosocial behaviours, and decrease aggressive behaviours. 
4.4.4 Missing Data 
Health and resource use costs for children were measured using parental self-report. Health 
and resource use questionnaires (Figure 12) were posted home to parents who were asked 
to return the completed questionnaire in a freepost envelope. Health and resource use data 
was available for the second and third year follow-ups only as mentioned previously. A 
descriptive analysis of missing data was first undertaken to identify an appropriate analysis 
method to deal with the missing data. The missing data analysis follows recommendations 
set out by Faria and colleagues346 for handling missing data in CEA. Missing data 
mechanisms are often categorised using Rubin’s framework for missing data:347 
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• Data missing completely at random (MCAR) assumes missing data do not 
depend on the observed and unobserved data values, the missing data is 
independent. The observed data is a representative sample of the overall 
population. 
• Data missing at random (MAR) is a less restrictive assumption than MCAR. 
Missing data depend only on the observed data and not the unobserved missing 
data. Any systematic differences between observed and unobserved data can be 
explained by differences in observed data. 
• Data are not missing at random (NMAR) when the probability that data are 
missing depends on unobserved values. For example, individuals with worse 
outcomes may be more likely to be missing. There is no way to identify with 
certainty if data are NMAR because it depends on the unobserved data that are 
missing.  
If data are MCAR a complete-case analysis is valid. In complete-case analysis, only 
individuals with complete data at each follow-up are included in the analysis. This is an 
inefficient use of the data because any individuals with missing follow-up data are dropped 
from the analysis.346 Available-case analysis makes more efficient use of data by calculating 
costs and QALYs by treatment group at each follow-up point. They are then summed by 
treatment group over the whole time horizon of the study. A limitation is that different 
samples of costs and QALYs may be used which can lead to non-comparability and affect the 
covariance structure.348 The MAR assumption is a less restrictive assumption as missing data 
depend only on the observed data and not the unobserved missing data. MI is an 
appropriate analysis strategy for dealing with MAR data. Data are unlikely to be MCAR if the 
proportion of missing data varies widely by group. Therefore, descriptive analysis of 
percentage of missing values by group and in total was undertaken along with range, mean, 
and standard deviation of the observed data. If a variable was found to have over 80% of its 
values missing at any one time point, the variable would be dropped from further analysis 
and MI on those variable would not be performed. 
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4.4.4.1 Missing Data Patterns 
Patterns of missing data were explored using the Stata/SE 14.1 (StataCorp, College Station, 
TX, USA) ‘misspattern’ command on total costs and QALYs at each time point. Data follow a 
non-monotonic pattern when data may be missing for an individual in one follow-up but 
then they return in subsequent follow-ups. Here the MCAR assumption would be inefficient 
because data from subsequent follow-ups would not be utilised and all non-complete cases 
would be dropped. 
4.4.4.2 Association between missing and baseline variables/observed 
outcomes 
Logistic regression was undertaken to explore if baseline covariates were associated with 
the probability of data being missing. A dummy variable indicating missing data was created 
for overall costs and QALYs. Logistic regression was conducted with baseline covariates 
including gender, year group, multiple deprivation, and number of siblings.   A significant 
association between a baseline covariate and missing data indicates that data are not 
MCAR.  
Dummy variables were also created for costs and QALYs at each time point to explore 
association between missing data and observed outcomes. Each indicator variable was then 
regressed on all other costs and QALYS observed in each year (i.e. missing baseline QALYs 
were regressed on costs and QALYs in each subsequent follow-up). Data were assumed to 
be MAR in which MI is an appropriate method of analysis to deal with MAR data. 
4.4.4.3 Multiple Imputation 
MI first arose in the early 1970s to address the problem of survey nonresponse in 
educational testing (Rubin, 1976).349 Since then it has gained popularity as a flexible 
statistical technique for handling missing data. Missing data within CEA poses particular 
analytical challenges due to complex data structures such as correlated cost and effect 
endpoints and right skewed cost distributions; MI has been proposed by several authors as 
an appropriate method to deal with missing data specifically in CEA.133, 346, 348, 350, 351 
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MI consists of three steps: 
1. Imputation step: an imputation model is used to predict plausible values for missing 
observations from the observed values. M imputations are generated allowing uncertainty 
to be reflected in both the imputation model and missing data (m=number of completed 
datasets generated). Originally, Rubin352 recommended five imputations to achieve 
sufficient, valid inference. Shafer353 proposes little to no value of using more than 5 to 10 
imputation unless the percentage of missing information is unusually high.  However, due to 
advances in computational feasibility a rule of thumb has been proposed that ‘the number 
of imputations should be similar to the percentage of cases that are incomplete.’335 
2. Completed data analysis step (estimation): each completed data set is analysed 
separately using the desired analysis method. This is performed after data have been 
imputed. 
3. Pooling step: estimates obtained from each completed dataset are combined using 
Rubin’s rules352 to generate a single mean estimate of the quantity of interest with its 
standard error. 
MI was employed using chained equations to handle missing cost and QALY data. Costs 
were imputed at the total cost level and QALYs imputed at the index score level for each 
time point. Missing data on resource use costs was particularly high so 75 imputations 
(m=75) were performed as it was computationally feasible to do so in Stata. Predictive mean 
matching (PMM) was used for continuous, restricted range, and skewed cost and QALY 
variables. PMM is useful as it avoids predictions that lie outside the bounds of each 
variable,335 however it can produce predictions that closely match observed values. The 
uncertainty in these values is incorporated into the mean costs and QALY estimates using 
Rubin’s rules.  
MI was implemented separately by allocation (intervention and control) as recommended 
as good practice.346 Covariates included in the imputation model were the same as those 
used during the estimation step and included: gender, year in school, intervention 
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allocation, number of siblings, school, trust, and deprivation level.  After imputation, three 
passive variables were created in Stata to allow total costs, total QALYs, and QALY 
decrements to be classified as imputed variables to be analysed during the estimation stage. 
The total costs and QALYs variables generated were the sum of the imputed costs and 
QALYs at each time point. The QALY decrement was defined as the maximum QALYs that 
could possibly be accrued within the timeframe minus the actual QALYs gained. 
4.4.5 Analyses 
Regression methods were used to estimate the incremental difference in cost and QALYs 
while simultaneously adjusting for baseline characteristics which were the same covariates 
used in the imputation model. Generalised linear models (GLMs) were selected due to their 
advantage over ordinal least squares and log models in that they model both mean and 
variance functions on the original scale of cost.91 They also take into account the typically 
skewed nature of cost and QALY data.354 As cost data are typically right-skewed, a right-
skewed gamma distribution is appropriate. As QALYs are typically left-skewed, the QALY 
decrement (described above) was analysed with a gamma distribution. Thus, both costs and 
QALYs were analysed with a GLM model specifying a gamma family and identity link. Cost 
and QALY decrements were adjusted for the following covariates: gender, year in school, 
intervention allocation, number of siblings, school, trust, and deprivation level. Baseline 
HRQoL was also included to adjust for any imbalance of HRQoL between groups.355 
Mean costs and QALYs for each group were presented using the method of recycled 
predictions.91 Incremental costs and QALYs along with their respective robust standard 
errors were reported from results of the GLM model. The ICER was estimated and 
uncertainty surrounding the estimates of cost and effects for RoE and usual classroom 
activity were investigated through the use of a nonparametric bootstrap of the cost and 
effect pairs for 1,000 iterations.356 This approach employs re-sampling techniques to 
generate a distribution of estimates; in this case the distribution of mean costs and mean 
outcomes for each group. This provided an estimate of the extent of the uncertainty 
surrounding the costs and effects individually.  
137 
 
 
This uncertainty was then presented graphically on the cost-effectiveness plane and a 95% 
confidence interval (CI) of the bootstrapped ICER was calculated. Results were summarised 
using a CEAC to reflect the probability of RoE being cost-effective at various WTP thresholds.  
CEACs are an alternative to confidence intervals around ICERs and were originally developed 
in the context of a decision problem involving two interventions.357 They provide a graphical 
representation of a range of values (WTP thresholds) where the probability of the 
intervention is at optimal cost-effectiveness.358 The thresholds varied from £0 to £50,000 
per QALY reflecting the range generally accepted to be considered cost-effective by NICE 
(£20,000 to £30,000/QALY). 
4.4.5.1 Clustering within Economic Evaluation 
RoE was a cluster randomised controlled trial, so randomisation took place at the cluster 
(school) level versus at the individual level. It is therefore important take the effects of 
clustering into account in the economic analysis.336 Cluster randomisation tends to reduce 
statistical power and precision359 because in the case of RoE, individual pupils from the 
same school will be more similar than pupils from other schools. This non-independence is 
referred to as the intracluster (or intraclass) correlation coefficient (ICC).360 The ICC could be 
thought of as the proportion of variance due to between-cluster variation; or the correlation 
between members of the same cluster.336 For sample size calculation in the trial, an ICC of 
0.05 was assumed. 
 Clustering was accounted for by use of a multilevel model (MLM)337 and the true ICC was 
estimated. It was anticipated that use of a MLM may not actually be the best fitting model 
for this analysis (due to only having collected cost at two time points) to which the ICC was 
examined to determine if clustering had a design effect on the economic outcomes. If the 
ICC was lower than 0.01, then a more practical approach to reflect clustering would be 
employed by reporting robust standard errors361 for the GLM regressions. 
A simple MLM of cost was fit, but due to issues with the design of the trial (i.e. resource use 
was only collected at second and third year follow-up), the data did not fit this type of 
model as there were only two time points for cost. The ICC was estimated for cost and it 
was low at 0.0055. The low ICC was assumed to have a minimal design effect for this 
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outcome so robust standard errors were reported within the GLM regressions to account for 
clustering in the uncertainty estimates. 
4.4.6 Sensitivity Analyses 
A series of one-way sensitivity analyses were undertaken to allow for, explore, and assess 
the uncertainty around the cost-effectiveness results. Thorough exploration through 
sensitivity analysis strengthens the external validity and generalisability of the results. All 
sensitivity analyses were derived from the base-case analysis described above and a 
description of each variation is provided in Table 15. To answer the fourth research question 
for the main trial (section 4.3.2), outcomes were varied by conducting CEA on the primary 
outcome, the SDQ. The SDQ was scored using the predictive algorithm converted into Stata 
syntax available on the SDQinfo website326 (and in Appendix 7) in StataSE 14 (StataCorp LP, 
College Station, Texas, USA). This involved assigning a score from 0-2 (0= ‘Not True’ or no 
difficulties; 1= ‘Somewhat True’ or some difficulties; and 2= ‘Certainly True’ or many 
difficulties) for each item of the questionnaire and summing the total for each scale. Totals 
from all scales (excluding prosocial behaviour) were then summed to generate the total 
difficulties score. As the SDQ comprises two components, the total difficulties score and the 
prosocial behaviour score; CEA was conducted on both. For the CEAs, differences in effect 
were measured as the difference in scores from year 3 to baseline by group, see Table 14. 
There is no established WTP threshold for changes in the SDQ outcome measure, therefore 
the probability of the SDQ being cost-effective within a £20,000 to £30,000 threshold will 
not be reported. 
Table 14: ICER for cost-effectiveness analyses on SDQ 
 Total 
Cost 
(mean) 
Baseline 
Score 
(mean) 
Score at 
final follow-
up (mean) 
Difference in 
Score 
ICER  
RoE a c e (e-c)  
Control b d f (f-d) (a-b)/((e-c)-(f-d)) 
Difference (a-b)   (e-c)–(f-d)  
 
There is currently a mapping algorithm available to map SDQ scores to CHU9D utilities.329 In 
order to explore the validity of the mapping algorithm, a sensitivity analysis CUA was 
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performed using utility scores mapped from the SDQ. The final outcomes related sensitivity 
analysis involved a CUA using the values from the adult values tariff to estimate utilities. 
The cost of the intervention was a main cost driver so annuitisation assumptions around the 
useful life of the intervention were varied to account for no annuitisation and annuitisation 
over a shorter useful life of three years versus five in separate sensitivity analyses. The 
discount rate was also varied to reflect a more traditional discount rate of 3.5% versus the 
1.5% public health discount rate. Missing resource use and HRQoL data from the trial was 
particularly high, thus sensitivity analysis was conducted to explore the uncertainty 
surrounding the MAR assumption and use of MI. An available-case analysis was conducted 
assuming data were MCAR to assess the impact MI had on the incremental costs and QALYs. 
A limitation of available-case analysis is that different samples of costs and QALYs may be 
used which can lead to non-comparability and affect the covariance structure, therefore the 
results of this sensitivity analysis should be interpreted with caution. 
Finally, to further explore whose values in health should be considered,288 the base-case 
assumption using the adolescent values tariff to value child health utility was switched to 
the adult values and all sensitivity analyses were re-run with the updated base-case 
assumptions. This second set of sensitivity analyses are referred to as adult values (AV). SA4 
which reported adult values is the base-case in this set of results (AV0). A simple ‘scaling up’ 
exercise was performed to demonstrate the prevention paradox. The effects from the trial 
were scaled up to represent the total QALY gain that might be expected over the population 
if RoE were rolled out throughout Northern Ireland. The incremental QALY gain from the 
base case was multiplied the total number of children aged 5-9 in Northern Ireland. This 
estimate was taken from census estimates from 2014.362 
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Table 15: List of sensitivity analyses 
 
Sensitivity 
Analysis (SA) 
Element Description of Variation 
0 Base-case Multivariate analysis of cost and QALY Public Sector 
perspective, 1.5% discount rate, child health utility adolescent 
values, MAR assumption, and multiple imputation 
1 SDQ Total Difficulties (CEA) 
2 SDQ Prosocial Behaviour (CEA) 
3 CHU9D mapped from SDQ  
4 CHU9D estimated from adult values tariff (UK) 
5 Costs Training and material costs not annuitised 
6  Training and material costs annuitised over 3 years 
7 Discount 
Rate 
Use of more traditional 3.5% discount rate for costs and 
outcomes 
8 Missing Data Available case analysis assuming MCAR 
Adult Values 
(AV) 
  
0 Base-case Multivariate analysis of cost and QALY Public Sector 
perspective, 1.5% discount rate, child health utility adult 
values, MAR assumption, and multiple imputation 
1 Outcomes SDQ Total Difficulties (CEA) 
2  SDQ Prosocial Behaviour (CEA) 
3  CHU9D mapped from SDQ  
4  CHU9D estimated from adolescent values tariff (UK) 
5 Costs Training and material costs not annuitised 
6  Training and material costs annuitised over 3 years 
7 Discount 
Rate 
Use of more traditional 3.5% discount rate for costs and 
outcomes 
8 Missing Data Available case analysis assuming MCAR 
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4.4.7 Summary 
Currently there is a paucity of evidence in the literature of high quality school-based 
economic evaluations that include outcomes designed specifically for children and 
incorporate their preferences. This methods chapter described the first economic evaluation 
of school-based PHI, RoE, to address the evidence gaps in the literature. The chapter started 
by describing the differences between economic evaluation of child and adult interventions, 
and how there is a need to develop outcome measures specifically for children. The CHU9D 
is the only preference-based HRQoL measure that was developed specifically for children, 
which was also valued by adolescents (with the elicitation of younger children’s values 
currently ongoing). Another child specific measure, the SDQ, was also described, in detail as 
it was used in CEA.  
The next section (4.3) provided background and contextual information to the main cluster 
randomised controlled trial of RoE. A review of the existing evidence of RoE’s effectiveness 
found that only one evaluation was a cluster RCT design, with follow-up at three years. This 
evaluation took place in a different contextual setting to Northern Ireland and none of the 
existing evidence included an economic evaluation. The main trial aims and research 
questions were stated and data collection detailed. The final section described in detail, the 
methods of the economic evaluation of the RoE programmed. The section started with an 
overview, followed by detailed descriptions of the costs, outcomes, how missing data was 
handled, analyses, and sensitivity analyses performed. The next chapter reports the results 
of this novel economic evaluation. 
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5 RoE Main Trial Results: a Case Study 
5.1 Introduction 
The previous chapter outlined economic evaluation in child health including paediatric 
outcome measurement, the RoE trail, and the methods for conducting the economic 
evaluation. This chapter reports the results of the economic evaluation of RoE. The next 
section (5.2) provides descriptive results from the main trial which has been replicated from 
the original end-of-study report.55 Sections 5.3 through 5.6 report the results under the 
same headings which were described in the methods; costs, outcomes, missing data, and 
cost-effectiveness which describes the results of the base-case analysis and sensitivity 
analyses. The discussion of these results, the limitations of this study, and the conclusion 
follows. 
5.2 RoE Main Trial Descriptive Results 
This section provides a description of the data collected from the main trial. This section was 
originally described elsewhere55 and replicated here for clarity. Data collection is presented 
in Figure 13, which is a flow diagram of teacher, pupil, and parent responses through the 
trial. Seven schools withdrew before the start of the trial. Of the 1,182 pupils tested at pre-
test, 902 remained in the study at the final third-year follow-up (76.3% retained). Fewer 
parents returned data about their child; 686 returned data at pre-test (58.0% of the sample 
of children tested) which reduced to 373 at the end of the study (31.6% of the sample of 
children tested). 
In total 1,278 pupils aged between eight and nine years were recruited into the study, 
n=583 in the control group and n=695 in the intervention group. Table 16 describes the 
sample characteristics at baseline, showing a breakdown by gender, Health and Social Care 
Trust, geographic area (urban vs. rural) and primary school type (controlled, Catholic 
maintained, integrated, or other).  
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Figure 13: Flow diagram of recruitment and testing of children 
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Table 16: Baseline sample characteristics 
 Control 
N (%) 
Intervention 
N (%) 
Total 
N (%) 
Gender 
Male 310 (24.3) 347 (27.2) 657 (51.4) 
Female 273 (21.4) 348 (27.2) 621 (48.6) 
Class 
P4 43   (3.4) 38   (2.9) 81   (6.3) 
P5 528 (41.3) 611 (47.8) 1139 (89.1) 
P6 12   (.94) 46   (3.6) 58   (4.5) 
Trust 
Belfast 145 (11.4) 201 (15.7) 346 (27.1) 
South Eastern 150 (11.7) 222 (17.4) 372 (29.1) 
Southern 181 (14.2) 171 (13.4) 352 (27.5) 
Western 107 (8.4) 101 (7.9) 208 (16.3) 
Area 
Urban 330 (25.8) 363 (28.4) 693 (54.2) 
Rural 253 (19.8) 332 (26.0) 585 (45.8) 
School type 
Controlled 189 (14.8) 242 (18.9) 431 (33.7) 
Catholic Maintained 286 (22.4) 360 (28.2) 646 (50.6) 
Integrated 85 (6.7) 77 (6.0) 162 (12.7) 
Other 23   (1.7) 16   (1.3) 39   (3.1) 
Total 583 (45.6) 695 (54.4) 1278 (100) 
 
The main trial analysis found initial positive effects on prosocial (effect size, g=+0.20, 
p=.045) and difficult behaviour (g=-.16, p=.06) at the post-test time point. These initial 
positive effects disappeared at all subsequent follow-ups. For all other secondary outcomes, 
there was no statistically significant difference between scores in the intervention and 
control at any subsequent follow-up point. The next section reports the resource use and 
costs of the RoE main trial economic evaluation. 
5.3 Costs   
All costs reported in this section are subject to the base-case assumptions i.e. they were 
discounted by a rate of 1.5% and fixed costs were annuitized over 5 years. 
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5.3.1 RoE intervention costs 
A summary of intervention costs can be found in Table 17. A detailed further breakdown of 
costs including unit costs is available in  
Table 18. The total instructor time cost was £37,200. Per instructor: training materials were 
£1,030, materials for delivering RoE were £457, and fees were £172.  
Table 17: Summarised cost of the Roots of Empathy Intervention 
 
Total Costs Annuitized 5 years 1.5% Per School 
Key Point People £51,419.28 £4,056.54 
Admin Support £25,793.46   
Instructor Time £37,231.17   
Instructor Training Materials £7,092.94 Per Pupil 
Instructor Materials £3,152.42   
Instructor Fee £5,653.83 £175.22 
Other Costs £3,522.59   
Total Cost £133,865.69   
 
Table 18: Detailed cost breakdown of intervention costs 
Cost Item  Unit Cost 
(2014) 
Quantity  Total*  
Number of pupils  -  764 764 
Salaries 
   
Key point person  £35,600  4  -  
Administrative support FTE  £12,900  4  -  
RoE instructor  £29,800  33  -  
                            RoE activities 
   
Key point person training  £18.26  112  £2,045  
Key point person time spent on RoE  £18.26  2704  £49,374  
Administrative support  £6.61  3900  £25,793  
Instructor training  £15.29  30 hours  £15,137  
Instructor preparation time  £15.29  varied  £11,982  
Instructor delivery time  £15.29  varied  £10,112  
Instructor fees  £171.33  33  £5,654  
Materials 
   
Instructor training  £1,027.97  33  £33,923  
RoE    £456.88  33  £15,077  
Other costs 
   
Programme support  £5,710.94  1  £5,711  
Materials shipping  £2,569.92  1  £2,570  
Training and mentoring expenses  £3,426.57  1  £3,427  
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Mentoring  £5,139.85  1  £5,140  
* Exact figures not shown, totals were rounded 
5.3.2 Resource Use 
Overall, resource use did not differ significantly between groups. One item did demonstrate 
a significant difference; average dentist costs in the control was £24 more than the 
intervention group. Some resource use items had a large amount of missing data and were 
subsequently dropped from the analysis. These dropped resource use items included days 
off work due to a child being home from school, other resource use, and medications. More 
information on missing data is given in section 5.5. Mean resource use before MI is given in  
Table 19. 
MI and regression of the mean total cost (including intervention and resource use costs) for 
RoE was £1,190 and the mean cost for the control group which was £1,030 ( 
 
Table 24). The incremental cost was £160 (95% CI: £14-£307) significantly higher for RoE (p-
value = 0.032). The additional cost of the intervention is the main cost driver in this 
incremental cost. 
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Table 19: Mean resource use costs by group and differences between groups  
 RoE  Control Difference between groups* 
Resource Use Item  Mean 
cost (£)  
Std. 
Err. 
95% CI  Mean 
cost (£)  
Std. 
Err. 
95% CI  Mean 
cost (£)  
Std. 
Err. 
95% CI 
GP  £    49.83  4.09 41.80 to 57.87  £    56.12  4.43 47.42 to 64.81  £    6.28  6.03 -5.54 to 18.10 
School Nurse  £    13.41  1.91 9.65 to 17.17  £    18.94  3.52 12.03 to 25.85  £    5.54  3.87 -2.05 to 13.12 
A&E Visit  £    15.54  1.71 12.17 to 18.90  £    18.31  2.07 14.25 to 22.37  £    2.77  2.66 -2.45 to 8.00 
Social Worker  £      3.48  2.94 -2.29 to 9.25  £       1.27  0.58 0.13 to 2.40 -£   2.21  3.20 -8.50 to 4.08 
Speech therapist  £      2.52  1.73 -0.88 to 5.91  £       1.68  0.76 0.19 to 3.18 -£   0.83  1.99 -4.74 to 3.07 
Occupational therapist  £      1.01  0.47 0.08 to 1.94  £       0.97  0.51 -0.04 to 1.98 -£   0.04  0.70 -1.41 to 1.33 
Physiotherapist  £      8.44  5.03 -1.44 to 18.31  £    12.80  4.69 3.60 to 22.00  £    4.37  6.94 -9.26 to 17.99 
Educational Psychologist  £      2.93  0.84 1.27 to 4.58  £       3.31  1.06 1.22 to 5.40  £    0.38  1.34 -2.25 to 3.01 
Psychiatrist  £      3.05  2.17 -1.21 to 7.32  £    10.97  9.53 -7.75 to 29.68  £    7.92  9.17 -10.07 to 25.90 
Counselling/therapy  £    10.13  2.88 4.46 to 15.79  £    16.77  6.55 3.91 to 29.63  £    6.65  6.84 -6.76 to 20.06 
Dentist  £ 125.94  7.35 111.50 to 140.37  £  149.99  8.69 132.92 to 167.06  £  24.05  11.30 1.86 to 46.23 
Optician  £    14.26  1.20 11.89 to 16.62  £    16.02  1.34 13.39 to 18.67  £    1.77  1.80 -1.75 to 5.29 
Police  £      3.87  1.52 0.89 to 6.86  £       2.79  1.47 -0.10 to 5.69 -£   1.08  2.14 -5.27 to 3.11 
Hospital stay  £    17.94  8.91 0.45 to 35.44  £    17.92  4.70 8.70 to 27.15 -£   0.03  10.53 -20.68 to 20.63 
Hospital outpatient  £    48.09  8.42 31.56 to 64.63  £    56.51  10.20 36.48 to 76.53  £    8.41  13.11 -17.31 to 34.14 
*Two-sample t-test with equal variances 
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5.4 Outcomes 
The mean QALY gain in the RoE group was 2.97 versus 2.95 for the control. The incremental 
QALY gain of 0.0146 (95% CI: -0.023 to 0.0522) was not statistically significant (p-value = 
0.448). The results of the base-case CUA as well as sensitivity analysis are reported in  
 
Table 24. 
5.5 Missing Data 
38% of resource use questionnaires were returned for the second year follow-up and 29% 
were returned at the final third year follow-up, see Table 20. Variables that were dropped 
due to having over 80% of their values missing were other resource use (97%), medications 
(86%), and days off work due to a child being home from school (88%).The dropped 
variables were all self-report free-form text variables (questions 1, 2, and 3 in Figure 12: 
Resource use questionnaire). See Table 20 for the descriptive missing data analysis which 
details percentage of missing values by group and in total, range, mean, and standard 
deviation of the observed data. 
Missing data followed a non-monotonic pattern (see Figure 14) because cost or QALY data 
may be missing for an individual in one follow-up, but then they return in subsequent 
follow-ups. The grey shading represents observed data, while the black represents missing 
data for one or more individuals along the horizontal axis. The cost (a) and QALY (b) 
variables at each time point lie along the vertical axis. The chequered pattern demonstrates 
how data for an individual may be missing at one time point, but then observed at a 
subsequent time point.
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Table 20: Variable descriptions and missing data percentages 
Variable Description Missing values, % Range Mean SD  
Total (n=1,254) RoE (n=672) 
Control (n=582) 
Total RoE  Control  
  
  Baseline variables             
Gender Male or Female 0% 0% 0% 0,1 51.45% 
Male 
 
YearGroup Year in School at trial entry 0% 0% 0% 4,5,6 89% P5 
 
MD-rank Northern Ireland Multiple 
Deprivation Measure 
2% 3% 0% 1 to 889 414.13 245.9 
Siblings_PT0 Number of siblings at 
baseline 
1% 1% 0% 0 to 7 1.01 1.26 
Table 20 continued: Outcome variable descriptions and missing data percentages 
  Outcome variables for health related quality of life 
utility0 CHU9D at pre-test 13% 10% 16% 0.3261 to 1 0.84 0.12 
utility1 CHU9D at post-test 12% 11% 13% 0.3261 to 1 0.85 0.11 
utility2 CHU9D at 1 year follow-up 14% 12% 16% 0.4582 to 1 0.84 0.1 
utility3 CHU9D at 2 year follow-up 14% 15% 13% 0.3261 to 1 0.85 0.1 
utility4 CHU9D at 3 year follow-up 31% 31% 31% 0.3929 to 1 0.87 0.1 
  Outcomes for cost-effectiveness 
total_QALYs Total QALYs over 3.75 yearsa 45% 43% 48%  1.70 to 3.61  3.09 0.26 
total_costs Total costs over 3.75 yearsa 76% 78% 75%  77 to 10580   £899.04   £841.93  
 
a* Total QALY and costs refers to the sum of QALYs and costs over the 3.75 year trial period discounted at a 1.5% annual rate.
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Table 20 continued: Resource use variables for cost 
Variable Missing values, % Range Mean SD  
Total RoE Control 
   
Intervention cost 0% 0% 0%  £175.22  £175.22 
 
GP_3 62% 66% 57%  0 to 706   £ 96.07   102.56  
School Nurse_3 62% 66% 57%  0 to 1209   £9.65   £64.75  
A&E_3 62% 66% 57%  0 to 345   £29.26   £ 53.22  
Social Worker_3 62% 66% 57%  0 to 1416   £4.43   £65.43  
Speech therapist_3 62% 66% 57%  0 to 1025   £4.89   £52.51  
Occupational Therapist_3 62% 66% 57%  0 to 261   £2.44   £18.86  
Physiotherapist_3 62% 66% 57%  0 to 1555  £12.89  £107.42  
Educational psychologist_3 62% 66% 57%  0 to 393   £ 6.52   £33.31  
Psychiatrist_3 62% 66% 57%  0 to 5252   £10.74  £237.53  
Counselling/therapy_3 62% 66% 57%  0 to 2332   £20.35  £137.51  
Dentist_3 62% 66% 57%  0 to 1247  £253.53  £138.02  
Optician_3 62% 66% 57%  0 to 202   £27.00   £32.96  
Police_3 62% 66% 57%  0 to 623   £4.47   £46.62  
Hospital Stay_3 62% 66% 57%  0 to 1564   £21.12  £127.31  
Hospital Outpatient visit_3 62% 66% 57%  0 to 2902   £88.30  £277.06  
GP_4 71% 72% 70%  0 to 652   £44.09   £74.42  
School Nurse_4 71% 72% 70%  0 to 595   £39.07   £67.80  
Education Welfare Officer_4 71% 72% 70% 0 to 102 £0.48 £5.78 
A&E_4 71% 72% 70%  0 to 204   £15.83   £35.80  
Social Worker_4 71% 72% 70%  0 to 465   £2.10   £25.48  
Speech therapist_4 71% 72% 70%  0 to 84   £0.46   £6.19  
Physiotherapist_4 71% 72% 70%  0 to 3064   £16.77  £175.15  
Educational psychologist_4 71% 72% 70%  0 to 155   £1.48   £10.61  
Psychiatrist_4 71% 72% 70%  0 to 1293   £7.58   £84.40  
Counselling/therapy_4 71% 72% 70%  0 to 919   £15.88   £88.97  
Dentist_4 71% 72% 70%  0 to 614  £110.88   £75.35  
Optician_4 71% 72% 70%  0 to 79   £13.46   £14.06  
Police_4† 71% 72% 70%  0 to 307   £4.98   £38.87  
Hospital Stay_4 71% 72% 70%  0 to 5241   £30.00  £289.11  
Hospital Outpatient visit_4 71% 72% 70%  0 to 1787   £51.83  £191.40  
a b  
Figure 14: Pattern of missing data in a. costs and b. QALYs. Black shading represents missing 
data grey represents observed data. 
582 individuals
costs_year4
costs_year3
Observed Missing
582 individuals
qaly_3
qaly_0
qaly_1
qaly_2
Observed Missing
151 
 
 
5.5.1 Logistic Regression 
Deprivation level and number of siblings at baseline were found to be significant predictors 
of missing cost (Table 21). Gender, age, deprivation, and number of siblings were all 
significant predictors of missing QALYs which can rule out the MCAR assumption (Table 22). 
For regressions that explored the association between missing data and observed 
outcomes, at least one covariate produced statistically significant results (Table 23) 
indicating the data are unlikely to be MCAR and thus assumed to be MAR. As the results 
from the missing data patterns and logistic regression both indicated data to be MAR, MI 
was performed as a method to address the missing data in the dataset. 
Table 21: Association between missing cost and baseline variables 
 
Table 22: Association between missing QALY and baseline variables 
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Table 23: Example of regression output for association between missing and observed values 
 
 
5.6 Cost-effectiveness 
The ICER was £11,000 per QALY gained (CI: -£95,500 to £147,000), see  
 
Table 24, SA0. This is below that standard £20,000 to £30,000 threshold that is generally 
accepted as cost-effective in the UK. Uncertainty around this estimate was explored through 
bootstrapping. The CE plane is presented in Figure 15. The majority of the bootstrap estimates 
lie within the NE quadrant demonstrating that RoE is a more costly, but more effective 
intervention. However, because there are a few bootstrap estimates in the NW quadrant, there 
is some uncertainty about whether RoE is more effective than usual classroom activities. This 
uncertainty is also demonstrated in the non-significant incremental mean QALY gain of 
0.0146 (CI: -0.0230 to 0.0522) and overall ICER uncertainty of £11,000 per QALY gained (CI: -
£95,500 to £147,000  reported in  
 
Table 24.  There is little uncertainty surrounding the difference in costs, as demonstrated on 
the CE plane where all points lie above the x-axis, indicating RoE is more costly than usual 
classroom activities. The CEAC is presented in Figure 16, which demonstrates that at a cost-
effectiveness threshold of £20,000, RoE had an 84.6% probability of being cost-effective. 
This probability rises to 89.9% at a threshold of £30,000. 
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Table 24: Cost-effectiveness results (adolescent values)  
Mean Costs Mean Effects 
   
Analysis RoE Control Incremental cost 
(95% CI) 
Robust 
Std. 
Err.a 
RoE Control Incremental Effects (95% CI) Robust 
Std. Err. 
a 
ICER (£ 
per QALY) 
95% CI of 
bootstrapped ICER 
Probability 
of being 
cost-
effectiveb 
(%) 
SAc0 £1,190  £1,030  £160 (£14 to £307) 74.6 2.97 2.95 0.0146 (-0.0230 to 0.0522) 0.0192  £11,000  -£95,500 to £147,000 84.6 (89.9) 
SA1 £1,170  £1,060  £107 (-£38 to £252) 73.7 1.17 0.627 0.541 (0.0718 to 1.01) 0.239  £197d  £77 to £471 e 
SA2 £1,190  £1,040  £154 (£12 to £297) 72.4 -0.547 -0.574 0.0274 (-0.349 to 0.403) 0.192  £5,630f -£23,400 to £29,100 
 
SA3 £1,180  £1,040  £143 (-£21 to £306) 82.9 3.04 3.02 0.0150 (-0.00398 to 0.0339) 0.0967  £9,540  £4,160 to £30,300 93.1 (97.4) 
SA4 £1,180  £1,030  £153 (£14 to £292) 70.9 3.09 3.07 0.0160 (-0.0143 to 0.0462) 0.0154  £9,570  -£87,800 to £107,000 83.1 (90.1) 
SA5 £1,260 £1,030 £230 (£83 to £380) 74.5 2.97 2.95 0.0146 (-0.0230 to 0.0522) 0.0192 £15,800 -£137,000 to £202,000 76.4 (85.4) 
SA6 £1,200 £1,030 £172 (£26 to £319) 74.6 2.97 2.95 0.0146 (-0.0230 to 0.0522) 0.0192 £11,800 -£103,000 to £156,000 82.6 (89.5) 
SA7 £1,130 £968 £161 (£22 to £301) 70.8 2.85 2.83 0.0134 (-0.0229 to 0.0497) 0.0185 £12,100 -£103,000 to £137,000 83 (89.4) 
SA8 £1,130 £895 £236 (£54 to £417) 92.6 2.96 2.96 0.00587 (-0.0429 to 0.0546) 0.0249 £40,200 -£218,000 to £157,000 78.6 (86.7) 
 
a Adjusted for 66 clusters in school 
b At £20,000 per QALY (£30,000 per QALY) 
c Sensitivity Analysis (SA) (see Table 15 for description), results reported to 3 significant figures 
d ICER per unit decrease in SDQ total difficulties score 
e No cost-effectiveness threshold for change in SDQ defined 
f ICER per unit increase in SDQ prosocial behaviour score
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Figure 15: Cost-effectiveness plane representing 1000 bootstrapped cost and QALY pairs 
  
Figure 16: CEAC showing probability of RoE being cost-effective compared to usual 
classroom activities. The dashed lines indicate the probability of RoE being cost-effective at 
the defined threshold. 
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5.6.1 Sensitivity Analysis 
The planned sensitivity analyses described in Table 15 are replicated here for clarity. 
 
Sensitivity 
Analysis (SA) 
Element Description of Variation 
0 Base-case Multivariate analysis of cost and QALY Public Sector 
perspective, 1.5% discount rate, child health utility adolescent 
values, MAR assumption, and multiple imputation 
1 SDQ Total Difficulties (CEA) 
2 SDQ Prosocial Behaviour (CEA) 
3 CHU9D mapped from SDQ  
4 CHU9D estimated from adult values tariff (UK) 
5 Costs Training and material costs not annuitised 
6  Training and material costs annuitised over 3 years 
7 Discount 
Rate 
Use of more traditional 3.5% discount rate for costs and 
outcomes 
8 Missing Data Available case analysis assuming MCAR 
Adult Values 
(AV) 
  
0 Base-case Multivariate analysis of cost and QALY Public Sector 
perspective, 1.5% discount rate, child health utility adult 
values, MAR assumption, and multiple imputation 
1 Outcomes SDQ Total Difficulties (CEA) 
2  SDQ Prosocial Behaviour (CEA) 
3  CHU9D mapped from SDQ  
4  CHU9D estimated from adolescent values tariff (UK) 
5 Costs Training and material costs not annuitised 
6  Training and material costs annuitised over 3 years 
7 Discount 
Rate 
Use of more traditional 3.5% discount rate for costs and 
outcomes 
8 Missing Data Available case analysis assuming MCAR 
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SA refers to ‘Sensitivity Analysis’ which used adolescent values and AV refers to ‘Adult 
Values.’ The CEA of the main trial outcome measure, the SDQ total difficulties score (SA1), 
resulted in an ICER of £197 per one-unit decrease in the total difficulties score (CI: £77 to 
£471). In this sensitivity analysis, the cost difference of £107 between arms was not 
significantly different (CI: -£38 to £252).  For the incremental effects, the difference 
between the arms was a significant decrease in total difficulties score of 0.541 (CI: 0.0718 to 
1.01). SA2 was a CEA of the SDQ prosocial behaviour score. The ICER was £5,630 per unit 
increase in SDQ prosocial behaviour score (CI: -£23,400 to £29,100). For SA2, costs were 
significantly higher in the RoE group, but the difference in effect was not significant. SA3 
used a mapping algorithm to map from the SDQ to the CHU9. Neither the incremental costs 
or effects were statistically significantly different resulting in an ICER of £9,540 per QALY 
gained (CI: £4,160 to £30,300). The final sensitivity analysis that varied outcomes was SA4, 
which used adult values to estimate child health utilities; this sensitivity analysis resulted in 
an ICER of £9,570 per QALY gained (CI: -£87,800 to £107,000). 
SA5 and SA6 varied how costs were annuitised. SA5 did not annuitize any costs which 
resulted in an ICER of £15,800 per QALY gained (CI: -£137,000 to £202,000). SA6 annuitised 
training and material costs over a shorter three-year period compared to the five years in 
the base-case. The resulting ICER was £11,800 per QALY gained (CI: -£103,000 to £156,000). 
SA7 varied the discount rate to a more traditional 3.5% and the available-case analysis (SA8) 
explored the uncertainty around the MAR assumption by only analysing the available data 
and not performing MI. The ICER for SA7 was £12,100 per QALY gained (CI: -£103,000 to 
£137,000) and SA8 was £40,200 per QALY (-£218,000 to £157,000). All results of the 
adolescent values are reported in  
 
Table 24.  All resulting ICERs fell within the considered ‘cost-effective’ range except SA8, the 
available-case analysis. In all analyses RoE had significantly higher costs except in SA1 and 
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SA3, likewise there was a lack of statistically significant difference in effects in all analyses 
except SA1. 
 
 
Table 26 reports the results of the sensitivity analyses re-run with adult values. AV0, the 
base-case using adult values to estimate child health utility, is same as SA4, ICER £9,570 per 
QALY gained (CI:-£87,800 to £107,000). Additionally, the results of AV1 and AV2 have not 
changed from SA1 or SA2 because the outcome measure of effect was the SDQ, ICER £197 
per unit decrease in total difficulties score (CI: £77 to £471 and £5,630 per unit increase in 
prosocial behaviour score (CI: -£23,400 to £29,100) respectively. Neither the incremental 
costs nor effects were significantly different in AV3, which mapped SDQ scores to utility 
values resulting in an ICER of £9,700 per QALY gained (CI: £4,210 to £30,800). AV4 is the 
same as SA0, ICER £11,000 per QALY gained (CI: -£95,500 to £147,000). AV5 did not 
annuitise any costs resulting in an ICER of £13,900 per QALY gained (CI: -£125,000 to 
£151,000).  AV6 annuitised costs over 3 years resulting in an ICER of £10,300 per QALY 
gained (CI: -£93,700 to £114,000). AV7, where costs and outcomes were discounted at 3.5% 
had an ICER of £9,660 per QALY gained (CI:-£94,500 to £113,000). Finally, AV8 the available-
case analysis, had the highest ICER estimate of £19,600 (CI: -£149,000 to £145,000). Cost-
effectiveness planes and CEACs for all sensitivity analyses are detailed in Appendix 8. 
Finally, to demonstrate the prevention paradox, the total potential QALY gains that could be 
expected if RoE reached all children in Northern Ireland aged 5-9 are presented in Table 25. 
The results of the simple scaling up exercise indicate that nearly 1,800 additional QALYs 
could be gained if RoE reached this entire population of children in Northern Ireland. 
Table 25: QALY gain over population demonstrating the prevention paradox   
Source 
Incremental QALY estimate from trial 0.0146 RoE economic evaluation 
Population estimate of children 5-9 in Northern 
Ireland 2014 
121850 Office for National Statistics published 29 
October 2015 
QALY estimate for population 1779.01 RoE economic evaluation 
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Table 26: Cost-effectiveness results (adult values)  
Mean Costs Mean Effects 
   
Analysis RoE Control Incremental cost 
(95% CI) 
Robust 
Std. 
Err.a 
RoE Control Incremental Effects (95% CI) Robust 
Std. Err. 
a 
ICER (£ 
per QALY) 
95% CI of 
bootstrapped ICER 
Probability of 
being cost-
effectiveb (%) 
AVc0 £1,180  £1,030  £153 (£14 to £292) 70.9 3.09 3.07 0.0160 (-0.0143 to 0.0462) 0.0154  £9,570  -£87,800 to £107,000 83.1 (90.1) 
AV1 £1,170  £1,060  £107 (-£38 to £252) 73.7 1.17 0.627 0.541 (0.0718 to 1.01) 0.239  £197d  £77 to £471 e 
AV2 £1,190  £1,040  £154 (£12 to £297) 72.4 -0.547 -0.574 0.0274 (-0.349 to 0.403) 0.192  £5,630f -£23,400 to £29,100 
 
AV3 £1,180  £1,040  £143 (-£20 to £306) 82.9 3.04 3.02 0.0147 (-0.00404 to 0.0335) 0.00957  £9,700  £4,210 to £30,800 92.7 (97.4) 
AV4 £1,190  £1,030  £160 (£14 to £307) 74.6 2.97 2.95 0.0146 (-0.0230 to 0.0522) 0.0192  £11,000  -£95,500 to £147,000 84.6 (89.9) 
AV5 £1,250 £1,030 £222 (£83 to £362) 70.9 3.09 3.07 0.0160 (-0.0143 to 0.0462) 0.0154 £13,900 -£125,000 to £151,000 75.2 (84.2) 
AV6 £1,190 £1,030 £165 (£25 to £304) 70.9 3.09 3.07 0.0160 (-0.0143 to 0.0462) 0.0154 £10,300 -£93,700 to £114,000 82.1 (88.6) 
AV7 £1,120 £965 £154 (£17 to £290) 69.5 2.96 2.95 0.0160 (-0.0128 to 0.0446) 0.0146 £9,660 -£94,500 to £113,000 82.5 (89.8) 
AV8 £1,130 £894 £238 (£58 to £419) 92.2 3.09 3.08 0.0121 (-0.0271 to 0.0514) 0.0200 £19,600 -£149,000 to £145,000 77.3 (86.3) 
 
a Adjusted for 66 clusters in school 
b At £20,000 per QALY (£30,000 per QALY) 
c Sensitivity Analysis (SA) (see Table 15 for description), results reported to 3 significant figures 
d ICER per unit decrease in SDQ total difficulties score 
e No cost-effectiveness threshold for change in SDQ defined 
f ICER per unit increase in SDQ prosocial behaviour score
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5.7 Discussion 
Over the trial period, the base-case analysis indicated that the RoE intervention incurred a 
mean additional cost of £160 (95% CI: £14 to £307) per pupil. Utility, as measured by the 
CHU9D and combined with duration to calculate QALYs showed no significant QALY 
difference between groups (incremental effect 0.0146 (CI: -0.0230 to 0.0522) over the three 
year follow-up post-intervention completion. Although the use of directly measured child 
health utility in a CUA framework is infrequent, QALY gains in other areas of child health 
research are often small and insignificant.363, 364 However, economic evaluation methods still 
use such estimates to explore the probability of cost-effectiveness when combined with the 
cost of achieving these gains. When applied across a population even small QALY gains can 
be highly cost-effective. The simple scaling up exercise presented in Table 25 demonstrated 
small QALY gains to the individual could potentially result in nearly 1,800 QALYs gained over 
the population of children in Northern Ireland.  A recent study looking at a family-based 
childhood obesity treatment used the EQ-5D youth version to measure QALYs.363 They 
reported a non-significant QALY gain of 0.03 (95%CI: -0.04 to 0.10). Another recent study for 
an asthma intervention in children used adult EQ-5D QALY estimates.364 They found a 
difference in mean QALYs of -0.00017 (95% CI: -0.00051 to 0.00018). These non-significant 
results are reported here to demonstrate that non-significant QALY gains are not unusual in 
paediatric PHIs and additionally demonstrate that the evidence produced from the RoE trail 
economic evaluation is the first of its kind in a SEW context. 
This research adds to the current evidence available for the effectiveness and cost-
effectiveness of RoE. Compared to the evidence currently available, this study used other 
outcome measures such as mental health, empathy, perspective taking, and SDQ showing 
that RoE is effective immediately post intervention.40, 43-45 However, most evaluations of RoE 
had no follow-up after post-test and the only published study that did follow-up pupils 
(three year after post-test), similarly found no significant differences in effect after three 
years of follow-up.40 Two interpretations of these results are possible: 1.) RoE, like other 
child PHIs, are not effective at follow-ups post-test, or 2.) RoE is effective at follow-ups post-
test, however we have not been able to accurately measure and evidence its effectiveness. 
The latter point may be due to measures not being sensitive to change, incorrectly 
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identifying appropriate outcomes to measure, or its effectiveness is not quantifiable in the 
mid-term  with future outcomes demonstrating meaningful differences (i.e. a sleeper effect 
detailed in section 7.3.1). Although QALY differences between the arms of this RCT were not 
statistically significantly different, the majority of the incremental points lie in the northeast 
quadrant (Figure 15) indicating a more costly, yet more effective intervention. This leads to 
a high probability of RoE being cost effective within the £20,000 to £30,000 per QALY 
threshold. 
 
Because of the uncertainty demonstrated in the 95% CIs around costs, effects, and cost-
effectiveness, sensitivity analyses were performed to explore this uncertainty further. The 
CEA of the SDQ total difficulties score (SA1) was the only effect that was statistically 
significantly different at the final follow-up between groups. This perhaps reflects that the 
SDQ is the most sensitive for detecting changes in SEW, the main outcome RoE intends to 
improve. The CHU9D is appropriate for a QALY framework, however many of the 
dimensions would not have been affected by RoE, e.g. pain and daily routine. Therefore, its 
appropriateness for detecting change in SEW is questioned. It does however capture a 
generic health improvement. Its nine dimensions worried, sad, pain, tired, annoyed, school 
work/homework, sleep, daily routine, and ability to join in activities, capture an overall 
improvement in functioning. One of the hypothesized health outcomes of RoE is to decrease 
aggressive and bullying behaviour, so if fewer children are being bullied that may be 
evidenced in the worried, sad, pain, annoyed, sleep, and ability to join in activities 
dimensions of the CHU9D. The CHU9D is the only HRQoL instrument designed for children 
and valued by adolescents, which was a main reason for selecting this outcome to measure 
QALYs in children. Other HRQoL measures for children exist however, they are usually either 
adapted from an existing adult measure (16D),302 they are valued using adult values (EQ-5D-
Y304 and HUI-2305), or they have not been valued at all but mapped to an adult measure 
(PedsQL309). This is partly because it has typically been very difficult elicit children’s health 
preferences due to ethical and cognitive difficulties. Time-trade off would involve asking 
children about death and the ethics of such an activity is questioned. It is also a cognitively 
challenging task the may not be appropriate for children. The base-case analysis used 
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adolescent values to value health state utilities as they were thought to be more the 
appropriate values to apply to our population of children (section 4.2.1.2). However, as can 
be seen in  
 
Table 24 and  
 
Table 26, differences do exist and they do impact on ICERs. The adolescent values result in 
mean health state utilities that are consistently lower than those of the adult values; in the 
base-case analysis the adult values resulted in an ICER £1,400 less than the adolescent 
values tariff. As was demonstrated in Ratcliffe, et al.,288 these differences could impact on 
policy decisions and it is important to consider whose values in health matter in decision 
making. In this study, the differences between the two value tariffs would not be enough to 
impact on a decision of whether or not RoE would be deemed cost-effective, except in the 
available-case analysis where the minor difference of 0.01 QALY impacts the ICER massively 
(£19,600 versus £40,200). Interestingly, the comparison of the probabilities of SA8 and AV8 
being cost-effective are indeed very similar. So depending on what criteria are being used, 
the differences between the adult and adolescent values may not impact on the decision in 
this instance. It is important to note the £20,000 to £30,000 per QALY gain threshold is from 
an NHS and PSS perspective.  
If RoE were to be rolled out to schools across Northern Ireland, it is likely the cost of 
providing the programme will largely fall on schools or local education authorities and their 
WTP for the programme may be very different from current threshold supported by NICE. In 
fact, recent Education Endowment Foundation (EEF) guidance states that all EEF funded 
evaluations must now include a cost evaluation where schools are assumed to be paying all 
costs to provide the intervention, even if the EEF provides funding for the intervention 
during the evaluation phase.365 This guidance provides an important finding in itself as it 
answers the question ‘Who should pay for funding preventive PHIs that may generate 
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multisectoral benefits (e.g. health, education, economic, and social)?’ The guidance makes 
an explicit assumption that schools should pay for school programmes even if it seems 
appropriate theoretically for the other sectors that stand to benefit from the intervention to 
contribute to the funding. Schools should be aware of this and not depend on funding from 
other sectors; however, calls should be made to redistribute the burden of funding from 
one sector to multiple sectors if multiple sectors stand to gain from the intervention.  
 
Remme and colleagues35 suggest a cofinancing approach in which multiple sectors dedicate 
parts of their budgets, based on their current marginal productivity, to jointly finance 
interventions (such as PHIs) that generate multisector benefits including health and non-
health benefits. While the article puts forward a stylised example of how cofinancing could 
work in theory, there are still many practical issues identified that make this approach an 
area for further research. For example, each sector may not have a single payer to make 
allocation decisions about funding other sectors; rather there may be multiple payers with 
differing budget constraints.35 There is no established cost per QALY threshold from the 
education sector perspective, so while RoE is arguably cost-effective from an NHS 
perspective, the same cannot be said from an education sector perspective, and education 
decision-makers may ultimately need to decide whether or not to continue funding RoE 
from their own budgets. There are two methods for estimating a cost-effectiveness 
threshold that have been explored in health that could potentially be used in other sectors 
to help determine their WTP for sector-specific outcomes and/or the proportion they would 
be willing to cofinance. The first, mentioned previously in section 2.1.8, involves estimating 
marginal productivity through econometric analyses of routinely available health 
expenditure and outcome data.118 The second uses a ‘bookshelf’ analogy to demonstrate 
how a cost-effectiveness threshold could be estimated from cost-effectiveness evidence 
available in the literature.366 Imagine a bookshelf with the tallest books lined up from the 
left, representing an intervention’s effectiveness. The width of the books represent their 
costs, so the length of the bookshelf represents an exhausted budget as the tallest books 
will be included starting from the left and shorter books added until funding runs out. To 
estimate the threshold would be to identify the least cost-effective intervention included on 
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the bookshelf.366 These approaches to estimate non-health-sector cost-effectiveness 
thresholds are promising in theory; however, they rely on substantial data that may not be 
available.35 Also, they rely on a generic sector-specific outcome (such as the QALY) being 
available to make cost-effectiveness comparisons within each sector. From the work of this 
thesis, a generic, education-specific outcome measure has not been identified in economic 
evaluation of school-based interventions (see Chapter 3). Identifying an appropriate 
education-specific generic outcome measure; estimating the education sector’s potential 
cost-effectiveness threshold; and exploring potential cofinancing options are thus areas for 
further research. 
Mapping utility scores from the SDQ (SA3 and AV3) may underestimate the uncertainty 
around the ICER estimate. While ICER point estimates were similar to base-case point 
estimates, SA3 and AV3 had the tightest confidence intervals and highest probabilities of 
being cost-effective despite neither cost nor effect coefficients being statistically significant. 
The use of this mapping algorithm will be explored further in Chapter 6. The use of 
annuitisation and the assumptions around the useful life of the intervention do impact on 
the cost-effectiveness results. SA5, where there was no annuitisation, resulted in an ICER of 
£15,800 versus £11,000 in the base-case SA0. There is less of a difference between the base-
case and when costs are annuitised over three years, ICER £11,800. In this study, the choice 
between a 1.5% and 3.5% discount rate minimally affects the cost-effectiveness results 
when using the adult values (£90 difference in ICERs) and adolescent values (£1,100 
difference in ICERs). The available-case analysis (SA8) demonstrated the most conservative 
estimate; with greater incremental costs and lower incremental QALYs resulting in the 
highest ICER estimate and lowest probability of cost-effectiveness for RoE. As was described 
earlier in the methods for the missing data analysis (section 4.4.4), a limitation of available-
case analysis is that different samples of costs and QALYs may end up being used which can 
lead to non-comparability and affect the covariance structure.348  Thus, the results from the 
available case analysis should be interpreted with caution. 
Because a threshold for cost-effectiveness does not currently exist for units of effectiveness 
outside of the QALY used in healthcare, it makes it difficult to determine if costs and 
benefits accruing outside of the QALY framework are cost-effective (e.g. the value of 
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changes in SDQ scores or increases in educational attainment).367 To complicate matters 
further, there is still no consensus among clinicians as to what constitutes a meaningful 
change in SDQ. In order to value changes in the SDQ, it first must be established what these 
changes represent, and if they follow a linear pattern. When decision-makers are presented 
with an ICER from a CEA, they will have to rely on their own experience of the CEA 
effectiveness outcome and value judgements to decide on an appropriate cost-effectiveness 
threshold. The interpretation of the cost-effectiveness of RoE is dependent on a number of 
factors because a.) an attempt was made to capture wider societal benefits of which no 
current threshold for cost-effectiveness exists; b.) there are few other school-based 
economic evaluations of similar aims to compare to; and c.) RoE is delivered at the school 
and if local authorities are making funding decisions they may be more interested in non-
health related benefits (i.e. educational attainment) versus quality of life. Ultimately, 
whoever is making the funding decision about RoE will need to decide which threshold will 
guide their decision-making and what other factors to consider. From the analyses 
presented, RoE has demonstrated its cost-effectiveness across many assumptions and 
values of the threshold. The research question asked what the cost-effectiveness was of the 
programme in reducing aggressive behaviour and increasing prosocial behaviour. SA1, SA2, 
AV1, and AV2 were conducted to answer this question and cost-effectiveness ICERs were 
presented. However, the interpretation of the results are dependent on the decision-
maker’s WTP for unit improvements on each of the scales. 
Even within the realms of a stated cost-effectiveness threshold per QALY gained, there is 
contention. The lack of a theoretical and empirical basis for the estimation of the current 
threshold is still debated116 as mentioned in section 2.1.8. Claxton and colleagues118 suggest 
the current threshold is too high and it should be much lower because £13,000 of NHS 
resources adds one QALY to the lives of NHS patients. This new lower threshold (£12,936 to 
be exact) was estimated from use of routinely collected NHS data. The research found the 
NHS spends too much on approving new drugs and the consequence of these decisions is 
the opportunity cost forgone which relates to actual NHS patients who bear these costs.118 
This was contested in a critique by Barnsley and colleagues,121 but perhaps the current 
threshold is too high. If a new lower threshold were applied to all new HTAs, the effect 
would be to prioritise less costly public health programmes and interventions in current 
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health and social care decision making. RoE was evaluated in relation to the currently 
accepted thresholds, if the new lower threshold was applied, a majority of the sensitivity 
analyses would meet this new criterion including both base-case analyses using both 
adolescent and adult values.  
The CEA of the SDQ total difficulties score (SA1) was the only effect that was statistically 
significantly different at the final follow-up, with the RoE group demonstrating lower 
difficulties. This perhaps reflects that the SDQ is the more sensitive for detecting changes in 
SEW, as it was selected as the primary outcome in a similar classroom based CEA of a 
teacher management programme to increase child and teacher mental health and 
wellbeing.213 The ICER for the SDQ was based on a one-unit decrease/increase in scores 
(total difficulties and prosocial behaviour), but there is still uncertainty around the meaning, 
or the value of a one-unit decrease/increase in scores. As reported previously, there are 
bandings in place to help with interpretation of SDQ results. However, those bandings are 
not based on any diagnostic thresholds and are instead meant be used to recommend 
referral for further examination.368 Because the SDQ has not been valued by the preferences 
of the public, it is difficult to assess the opportunity cost of other programmes covered 
under the same budget that do not use the SDQ as a measure of outcome, in other words it 
is like comparing apples to oranges. Additionally, there is not a consensus upon a minimally 
important difference in the SDQ. In personal communication with an expert colleague from 
Child and Adolescent Psychiatry (Minnis H 2016, oral communication, 14th October), 
Professor Minnis noted a typical change you might see in the SDQ total difficulties score is 
0.3 to 0.35 in an RCT. This would reduce the score from “borderline” to “normal,” however, 
this estimate unfortunately is not based on a lot of data, further demonstrating this lack of 
agreement. Essentially, the incremental unit decrease/increase in scores that were used to 
calculate the SDQ ICERS were arbitrary as no consensus has yet been reached as to what 
incremental should be used for the SDQ. Despite this apparent arbitrariness, this method for 
calculating SDQ ICERs has been employed elsewhere in the literature.369 This issue cannot 
be ignored as future interest in using the SDQ as a primary outcome measure is likely to 
increase, and this is particularly relevant for economic evaluation using the SDQ. Further 
research into determining a clinically meaningful difference in scores is warranted.  
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There are three forms of the SDQ, parent-complete, teacher-complete, and self-complete by 
the child.326 The perfect study would have information from all three informants as parents 
are good at identifying externalising problems (such as Attention Deficit and Hyperactivity 
Disorder and conduct problems) but less so at identifying emotional problems (Minnis H 
2016, oral communication, 14th October). Children are more likely to record depression and 
anxiety symptoms accurately, but under-report conduct problems (Minnis H 2016, oral 
communication, 14th October). And teachers are somewhere in between; some will argue 
they are less biased with identifying behavioural type problems (Minnis H 2016, oral 
communication, 14th October). The economic evaluation used the SDQ teacher complete 
form, thus being exposed to a potential risk of bias for this particular outcome. The parent 
informant version had been sent home to parents during the trial, however due to low 
response rates the data had been dropped from the analysis. Self-report is recommended 
for children aged 11-17, therefore it would not have been appropriate to include this 
measure, as children were too young to fill it in on their own. Even though the base-case 
analysis was a CUA, thorough discussion of the CEA using the SDQ was provided as the SDQ 
as an outcome in economic evaluation is novel and it was the primary outcome in the main 
trail for detecting changes in SEW. 
The health and medical fields have long used CUAs to aid policy decision making. Without 
such analyses, decisions are at risk of being made based on emotional appeal, absolute 
intervention cost, and political pressure.370 This CUA and accompanying sensitivity analyses 
provide initial evidence that school-based PHIs are feasible, are likely to be cost-effective 
according to current thresholds, and can be employed to aid decision making.  
5.8 Limitations 
Data on resource use would have ideally been collected at each data collection time point. It 
was recognised that recall bias was likely with the long recall periods for estimating resource 
use expenditure; however, the alternative was to completely forego collecting any resource 
use for the trail. The lack of resource use being consistently collected was the main 
limitation within this CUA, which also had a limiting effect on the choice of analytical 
methods employed.  
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The available resource use data was also limited by large percentages of missing data. 
Variables with the highest percentages of missing data may have been impacted by a survey 
design effect as they were all questions that were self-reported using free form text. 
Therefore, a detailed descriptive analysis was employed to determine the appropriate 
assumptions around the missing data and missing data were subsequently handled using 
MI. Future evaluation work of school-based PHIs should be mindful of potentially large 
amounts of missing data, particularly data that is collected from parents by post. 
Wider non-health benefits such as educational outcomes and spillover effects such as 
increases in quality of life at home were not captured in this study, but they would have 
added further understanding of the cost-effectiveness of RoE. Until 2012, CUA was NICE’s 
main method for determining cost-effectiveness of public health interventions.23 It wasn’t 
until the 3rd edition of the NICE public health guidance’79 that more emphasis was placed on 
CCA and CBA to ensure all relevant benefits (health, non-health, and community) were 
taken into account and aid local authorities or other organisations to judge whether or not 
an intervention is value for money. The attempt to collect wider societal costs and benefits 
was also hindered by the high percentage of missing data. The only method for capturing 
wider outcomes available was through contact of the children’s parents by post. In this trial, 
this method proved difficult and was prone to producing missing data. Other more routine 
data sources might have provided more reliable societal costs and benefits and these should 
be considered for future research. 
Cost estimates in this trial may not be generalizable to contexts that differ from that of the 
current trial (e.g. resource use implications, RoE fees, and healthcare organisation). The 
costs estimated in this evaluation were specific to the costs incurred during the trail and 
information was not available about how implementation throughout Northern Ireland 
might impact on these costs. Estimating the cost of rolling out RoE across Northern Ireland 
may not be a simple ‘scaling up’ exercise (such as multiplying the intervention cost per child 
by the population of school children) because it is unknown how the fee structure (those 
paid to the RoE organisation in Canada) might change depending on scale. This however, 
does not seem to apply to the effectiveness of RoE as evaluations conducted in multiple 
countries have found RoE to be effective.40, 43, 44 
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Educational outcomes such as attainment would have benefited this analysis because local 
authorities will most likely end up making and funding the decision to implement RoE. They 
will need to decide whether RoE represents value for money, and they are more likely to be 
interested in comparing costs in terms of educational outcomes in addition to health 
outcomes. The thresholds stated are what NICE considers to be cost-effective from an NHS 
perspective. Cost-effectiveness thresholds do not exist outside the health sector,367 nor has 
a method been devised to apportion costs (who should bear them) when more than one 
government department or sector is involved.30 This is particularly an issue when one sector 
benefits from a public health intervention while the other is required to fund it. NICE does 
not make any recommendations for how costs should be apportioned, rather the methods 
chosen should be transparent and justified.30 This trial was funded by the NIHR and 
delivered through the Public Health Trusts in Northern Ireland. In the event that the funding 
decision about RoE is transferred to local authorities, the collection of educational outcomes 
would have aided the decision-making process. Additionally, there is overwhelming 
evidence that education is linked to health and other outcomes371 so the presence would 
have provided further information to aid a decision. 
It would have been useful to explore the longer-term impacts of ROE by modelling potential 
impacts over the child’s lifetime. However, there is a paucity of longer-term evidence using 
the main outcomes of our analysis, the SDQ and CHU9D, especially the CHU9D which is a 
relatively new generic HRQoL measure. Additionally, the lack of statistically significant 
difference in effects (in terms of any other outcome measured in the trial) at the third year 
follow-up meant that any potential longer-term benefits would have significant assumptions 
and uncertainty attached. The RoE trial did provide one of the longest follow-ups of any RoE 
evaluation identified, so the single trial was a sufficient source of immediate and mid-term 
data. 
5.9 Conclusion 
This study shows that, within current commonly accepted thresholds for the value of a 
QALY, RoE is likely to be a cost-effective school-based population health intervention. Even 
when considering a much lower QALY threshold of £13,000, over 80% of the sensitivity 
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analyses would still be cost-effective. To my knowledge, this was the first school-based 
economic evaluation to incorporate children’s preferences through use of the CHU9D. It 
also adds to the growing body of cost-effectiveness evidence incorporating the SDQ. A 
growing pool of incremental costs per change in SDQ may help with the estimation or 
valuation of those incremental changes, which is an area for further research. There is a 
plethora of SEL classroom programmes available, but none of them have been rigorously 
analysed in terms of cost-effectiveness as RoE has. Furthermore, no other evaluations of 
RoE have been fully costed within a formal economic evaluation so this work represents the 
first cost-effectiveness evidence of a full-scale cluster randomised controlled trial of the 
programme. These findings are novel in this context; however, this novelty presents 
difficulties for allocative decision-making as there are few other school-based programmes 
that have been evaluated in a cost per QALY framework to act as comparators, much less in 
a SEL context. 
From an NHS perspective, RoE is likely to be cost-effective immediately after intervention 
and for up to three years post-intervention. However, important additional analyses relating 
to the total budgetary impact of rolling out this intervention, assumptions about RoE 
intervention life span, and longer-term quality of life benefits are required to draw definitive 
conclusions relating to its longer-term cost-effectiveness. In addition, future studies are 
needed to compare RoE interventions with alternative interventions aiming to achieve the 
same SEW gains.  
The following chapter describes a methodological work that examines the use of mapping or 
‘crosswalking’ from a behavioural screening tool, the SDQ, to a generic preference-based 
HRQoL measure, the CHU9D. There is interest in such algorithms as they allow for the 
calculation of QALYs when no utility measure is available or collected. The methods research 
that follows applies two previously developed  mapping algorithms using RoE data. 
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6 Appropriate Outcome Measurement: a Mapping 
Validation Study 
The importance of looking after children’s SEW is clearly a priority as highlighted in chapter 
1. The school setting is an ideal place to reach children and offer intervention to improve 
SEW. However, measuring SEW in a school environment is highly challenging as it is 
recognised that a lack of valid methods exist for primary schoolchildren.5  A recent review of 
eleven mental health outcome measures found none to have sufficient psychometric 
evidence to reliably measure severity and change over time in key groups.372 Despite this, 
the use of the SDQ322 has been viewed positively by staff in pre-school establishments373 
and is currently being used in school-based settings to assess SEW.213, 374-376 It is also widely 
used in CAMHS throughout the United Kingdom377 providing a source of routinely collected 
SDQ data. 
The SDQ is a favoured primary outcome measure of SEW in school-based interventions 
however, due to its measurement properties, i.e. lack of a value-based outcome, its 
applicability in economic evaluation (i.e. CUA) is limited. The significance of the SDQ’s 
inclusion in school-based economic evaluation was detailed in section 4.2.1.4). Briefly, the 
SDQ is widely used behavioural screening tool whose use in SEW is gaining popularity.368, 373, 
378 It’s specific properties may make it more sensitive to change as compared to a generic 
measure. As was discussed in section 5.7, interpretation of incremental changes in SDQ in 
terms of the incremental costs places more burden on decision-makers because there is no 
explicitly stated threshold with which to compare. One potential solution is to apply 
mapping or ‘crosswalk’ algorithms to convert data from a non-preference-based generic or 
condition-specific measure, e.g. SDQ, to a generic preference-based measure. This would 
allow evaluations of school-based interventions that collected the SDQ to estimate health 
state utility values. Mapping is an option recommended by NICE for estimating EQ-5D utility 
values when EQ-5D data are unavailable.379 However, as stated in 2011 technical support 
guidance, ‘in most cases, mapping should be considered at best a second-best solution to 
directly collected EQ-5D values, as the use of mapping will lead to increased uncertainty and 
error around the estimates of health-related utility.’291 There is now a large body of 
literature that have used functions to map between non-preference based and generic 
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preference-based measures for the purposes of estimating health utilities for use in 
economic evaluation.380 
Currently there are two mapping algorithms available to convert SDQ data into preference-
based utility values. The first uses all five SDQ subscales to map from the SDQ to CHU9D.329 
This algorithm was used in SA3 and AV3 in Chapters 4 and 5. The second uses only three of 
the SDQ subscales to estimate CHU9D child health utility. For studies that only have SDQ 
data available, these mapping algorithms provide an additional tool for the facilitation of 
CUA; however, its use and applicability for economic evaluations within a school-based 
context is under-researched. In particular, how SEW is valued within CUA of school-based 
interventions and which tools are best placed to do this valuing. 
Use of non-traditional economic outcomes such as the SDQ may provide a useful starting 
point for health economists to determine long-term health impacts of PHIs as the SDQ is 
now established in long-term cohort studies381, 382 as well as being recently mandated for 
use in Australia’s specialised CAMH services as a consumer-oriented outcome assessment 
tool. Furber et al.329 outlines that national and international data coordination efforts 
(e.g.383, 384 ) have led to the creation of large SDQ data sets, which represent thousands of 
episodes of care in CAMH services across Australia and the United Kingdom. Transforming 
SDQ scores to utility values would facilitate CUA of routine CAMHS data, open up school-
based SDQ data to this possibility, as well as provide the opportunity to estimate longer-
term QoL impacts from long-term cohorts which include the SDQ.  
This chapter details a methodological mapping validation study that was conducted while 
the RoE trail was ongoing.385 This work is the final of the three empirical studies conducted 
to help answer the overarching research question, ‘How should the cost-effectiveness of 
school-based, population health interventions aimed at children be determined?’ As 
discussed earlier, the different types of economic evaluation rely on appropriate and valid 
outcome measurement to determine effectiveness. With the research in child outcomes 
lagging behind adult outcomes,37 outcomes research as related to economic evaluation 
outcomes is necessary to contribute to the limited evidence-base. This early stage 
methodological work was planned using non-randomised baseline data available during the 
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interim of the trial. Outcome data from pre-test, post-test, and the first follow-up of the RoE 
trial were analysed to examine the suitability of mapping the SDQ to the CHU9D within a 
CUA framework using previously published mapping algorithms.329   
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6.1 Study aims 
This study aims to contribute to the outcomes evidence base for economic evaluation of 
school-based PHIs by testing and validating previously published mapping algorithms329 to 
translate SDQ scores to utility values. Given this aim, the research question asks: 
1. Can SDQ scores elicited within an educational context be mapped using published 
algorithms to preference-based CHU9D utilities with a view to incorporating such 
utilities within an economic evaluation framework?  
Utility mapping methods have been conducted to transform SDQ scores into CHU9D 
values;329 beyond that, there are no completed economic evaluations using these two 
measures together or indeed externally validating the algorithms. This empirical sub-study 
within the RoE economic evaluation was planned to explore the relationship between these 
two measures, as well as externally validate the SDQ mapping algorithm developed by 
Furber et al329 against the self-completed CHU9D utility scores from the RoE trial. 
6.2 Methods 
This section describes the outcomes and methods used to address the research question 
above by describing the analyses undertaken. Data incorporated into this analysis were non-
randomised and those collected at pre-test (baseline October 2011), post-test (after 
intervention completion June 2012), and at 12-month follow-up (June 2013). Data collection 
methods from the full trial given in Chapter 4. 
6.2.1 Strengths and Difficulties Questionnaire 
There are three forms of the SDQ questionnaire available as described in section 4.2.1.4; 
this study utilised the teacher complete proxy version. The SDQ was scored using the 
predictive algorithm converted into Stata syntax available on the SDQinfo website326 
(Appendix 7) in Stata 11.2 (StataCorp LP, College Station, Texas, USA). This involved 
assigning a score from 0-2 (0= ‘Not True’ or no difficulties; 1= ‘Somewhat True’ or some 
difficulties; and 2= ‘Certainly True’ or many difficulties) for each item of the questionnaire 
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and summing the total for each scale. Totals from all scales (excluding prosocial behaviour) 
were then summed to generate the total difficulties score. 
SDQ scores can be classified into four provisional bands that reflect the distribution of the 
general population’s scores; these bandings were based on a large UK community sample 
provided elsewhere.386 The provisional bandings categorise SDQ scores into four groups: 
‘close to average’ (80% of the population), ‘slightly raised’ (10%), ‘high’ (5%) and ‘very high’ 
(5%). The teacher complete four-band categorisation for SDQ scores is given below in Table 
27. Previous versions of these cut-points included a three-band categorisation which 
combines the highest two categories (High and Very High) shown in Table 27. 
Table 27: SDQ domain score four band categorisation* 
Teacher Complete Close to 
Average 
Slightly Raised High Very High 
Total Difficulties Score 0-11 12-15 16-18 19-40 
Emotional Problems Score 0-3 4 5 6-10 
Conduct Problems Score 0-2 3 4 5-10 
Hyperactivity Score 0-5 6-7 8 9-10 
Peer Problems Score 0-2 3-4 5 6-10 
Prosocial Behaviour Score± 6-10 5 4 0-3 
*From http://www.sdqinfo.org/py/sdqinfo/b3.py?language=Englishqz(UK) ‘scoring instructions 
for SDQs for 4-17 year olds 
±Higher values preferred in this subscale. Column titles for this subscale are as follows: Close 
to Average, Slightly Low, Low, Very Low. 
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6.2.2 Child Health Utility 9D 
There are currently two tariffs available to value the CHU9D as described in section 4.2.1.3. 
The adult values tariff was developed using preferences of 300 members of the UK adult 
population using a standard gamble technique.96 To incorporate adolescent values in 
decision making, an adolescent values tariff has also been developed using preferences from 
590 Australian adolescents aged 11-17.311 A best-worst scaling discrete choice experiment 
was used to derive preferences from this population.  For this study each tariff was applied 
to CHU9D scores to calculate utility values, for comparative purposes. For the adult values 
tariff, coefficients from the ordinary least squares (OLS) parsimonious model (model 5)96 
were used as decrements to calculate utility. For the adolescent values tariff, rescaled 
conditional logit estimates were used.311  
The two OLS regression based algorithms developed by Furber et al.329 were applied to 
transform SDQ scores into utility values. The dataset used to develop the mapping 
algorithms assessed CHU9D by parent proxy, an important difference to this current study in 
which children self-completed the CHU9D. The CHU9D was developed and intended to be 
completed by children. Both algorithms using three and five SDQ subscales are replicated in 
Equation 10 and Equation 11 below from Furber et al.329  
Equation 10: Algorithm using five SDQ subscales329 
 
𝑈𝑡𝑖𝑙𝑖𝑡𝑦 = 0.880 + (−0.019 × 𝑒𝑚𝑜𝑡𝑖𝑜𝑛) + (−0.009 × 𝑐𝑜𝑛𝑑𝑢𝑐𝑡)
+ (−0.001 × ℎ𝑦𝑝𝑒𝑟) ± (0.008 × 𝑝𝑒𝑒𝑟) + (0.005 × 𝑝𝑟𝑜𝑠𝑜𝑐𝑖𝑎𝑙) 
Equation 11: Algorithm using three SDQ subscales329 
 
𝑈𝑡𝑖𝑙𝑖𝑡𝑦 = 0.918 + (−0.018 × 𝑒𝑚𝑜𝑡𝑖𝑜𝑛) + (−0.12 × 𝑐𝑜𝑛𝑑𝑢𝑐𝑡) + (−0.009 × 𝑝𝑒𝑒𝑟) 
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6.2.3 Analysis 
All analyses performed were on the entire non-randomised sample which included data 
from pre-test, post-test and 12-month follow-up from post-test. A descriptive analysis 
(mean, standard deviation (SD)) was performed to describe the sample in terms of gender, 
grade, deprivation rank (measured by the Northern Ireland multiple deprivation measure 
2010), and mean scores from the SDQ and its subscales as well as the CHU9D estimated 
from both tariffs and both mapping algorithms. Missing data were modelled through MI via 
chained equations as recommended by good research practice guidelines.133, 348, 353, 387 
Tables of frequency were graphed for CHU9D and SDQ level responses for a visual 
representation of the spread and nature of the data. When assessing the agreement 
between prosocial behaviour, total difficulties and utility measures, variables were plotted 
in pairs to check for approximate linearity, outliers, and subgroups. Pearson’s correlation 
coefficient was used to assess the strength of relationship between utility (adult values 
tariff), total difficulties and prosocial behaviour. T-tests were performed to test for pairwise 
differences in utility values created from the adult values tariff,96 the adolescent values 
tariff,311 and both mapping algorithms.329  
6.3 Results  
Questionnaires were returned by teachers in 67 schools at baseline, 65 schools after 
intervention and 64 schools at 12-month follow up. After data cleaning and MI, a total of 
1,254 child participants were included in the analysis making up 3,762 observations. At 
baseline, a majority of the pupils (88.9%) were recruited in Primary 5 (approximately 9 years 
old); however, some Primary 4 (6.5%) and Primary 6 (4.6%) pupils were also included. Table 
28 presents the characteristics of these participants. The sample was made up of 51.5% 
boys, and median deprivation rank was 430 which is comparable to median population rank 
of 445. As the sample deprivation rank is less than the median rank it can be said the sample 
median is more deprived than the population median rank, but the extent to which the 
sample is more deprived cannot be inferred from the rankings.  
The mean (SD) for SDQ total difficulties and prosocial behaviour scores were 12 (3.2) and 8.3 
(2.1) respectively, which are classified as ‘slightly raised’ and ‘close to average.’ Please refer 
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to Table 27 which provides the four bands to aid interpretation of the SDQ scores. The mean 
(SD) for SDQ subscales emotion, conduct, hyperactivity and peer problems was 1.5 (2.0), 2.3 
(1.0), 4.1 (1.3) and 4.1 (0.9). Emotion and hyperactivity subscales were classified as ‘close to 
average’ and conduct and peer problems were ‘slightly raised.’ The frequency of responses 
for each symptom scale is reported in Figure 17.  
The mean (SD) utility scores were 0.84 (0.11) and 0.80 (0.13) based on the adult and 
adolescent values tariffs respectively. With both scoring algorithms, approximately 5.72% of 
participants were classified in full health (i.e. utility = 1). In all dimensions of the CHU9D 
except ‘tired,’ no problems were most commonly reported. Figure 18 reports the frequency 
of responses to all levels. 
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Figure 17: SDQ response frequency 
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Figure 18: CHU9D response frequency by level
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Table 28: Characteristics of participants 
Characteristics Participants‡ 
(n = 1254) 
British 
Community 
Sample† 
 
Gender    
   Boys, n (%) 646 (51.5)   
   Girls, n (%) 608 (48.5)   
Grade level    
   P4 (≈8 years old), n (%) 81 (6.5)   
   P5 (≈9 years old), n (%) 1115 (88.9)   
   P6 (≈10 years old), n (%) 58 (4.6)   
NIMDM deprivation rank,* median (SD) 430 (245.9)   
SDQ Total Difficulties, mean (SD) 12 (3.2) 6.6 (6.0)  
SDQ Prosocial subscale, mean (SD) 8.3 (2.1) 7.2 (2.4)  
SDQ Emotion subscale, mean (SD) 1.5 (2.0) 1.4 (1.9)  
SDQ Conduct subscale, mean (SD) 2.3 (1.0) 0.9 (1.6)  
SDQ Hyperactivity subscale, mean (SD) 4.1 (1.3) 2.9 (2.8)  
SDQ Peer Problems subscale, mean (SD) 4.1 (0.9)   
CHU9D Original tariff, mean (SD) 0.84 (0.11)   
CHU9D Alternative tariff, mean(SD) 0.80 (0.13)   
CHU9D Algorithm using five SDQ subscales, 
mean(SD) 
0.84 (0.05)   
CHU9D Algorithm using three SDQ subscales, 
mean(SD) 
0.83 (0.04)   
‡Participants had responses at 3 time points for a total of 3,762 observations  
*Lower rank=higher deprivation 
†From British sample 8,208 teachers of children aged 5-15 
http://www.sdqinfo.org/norms/UKNorm1.pdf 
 
The mean (SD) utility values for the mapping algorithms using five and three of the SDQ 
subscales were 0.84 (0.05) and 0.83 (0.04). Table 29 reports the t-tests results from the 
pairwise comparisons. Each method for estimating utility produced statistically 
significantly different results except the adult values tariff and mapping algorithm using 
five SDQ subscales in which no statistically significant difference was detected (p=0.69) 
(95% CI: -0.003, 0.004).  
There were weak but statistically significant correlations between all combinations of 
CHU9D (adult values tariff), total difficulties, and prosocial behaviour. Pearson’s rank 
correlation coefficient showed significant correlations between: total difficulties and 
CHU9D (r = -0.08, p<0.01); total difficulties and prosocial behaviour (r= -0.27, p<0.01); and 
prosocial behaviour and CHU9D (r= 0.04, p=0.02).  
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Table 29: Differences in utility values 
Difference in pair n Mean SD t df p 95% CI 
Adult vs Adolescent 3762 0.036 0.051 43.926 3761 0.000 0.035 to 0.038 
Adult vs 5 SDQ 
subscales 
3762 0.001 0.116 0.402 3761 0.688 -0.003 to 0.004 
Adult vs 3 SDQ 
subscales 
3762 0.010 0.115 5.360 3761 0.000 0.006 to 0.014 
Adolescent vs 5 SDQ 
subscales 
3762 -0.036 0.136 -16.10 3761 0.000 -0.040 to -0.031 
Adolescent vs 3 SDQ 
subscales 
3762 -0.026 0.135 -12.022 3761 0.000 -0.031 to -0.022 
5 SDQ vs 3 SDQ 
subscales 
3762 0.009 0.011 53.209 3761 0.000 0.009 to 0.010 
 
6.4 Discussion 
According to the bandings set out in Table 27, the prosocial behaviour, emotional, and 
hyperactivity SDQ subscales were considered ‘close to average’ in comparison to a large 
UK sample.386 Using that same sample as a comparison, total difficulties, conduct, and 
peer problems subscales were classified as ‘slightly raised.’ This is somewhat unexpected 
as the sample comprises a general school population in Northern Ireland, and all 
subscales would be expected to fall within the ‘close to average’ band. In terms of 
economic evaluation, this outcome on its own is less useful because the ‘value’ associated 
with unit changes in SDQ scores is unknown as discussed in section 5.7. For the CHU9D, 
all dimensions had most respondents classified in the ‘no problems’ category, with the 
exception of ‘tired’ (see Figure 18). The SDQ total difficulties scores is ‘slightly raised’ in 
this sample compared to a generally healthy ‘no problems’ quality of life scores; these 
differences demonstrate that the two descriptive systems do not overlap entirely.  This is 
due to differences on a conceptual basis; the SDQ is a behavioural screening tool 
designed to assess emotional and behavioural function, while the CHU9D assesses the 
child’s broader functioning and HRQoL. Mapping functions rely on statistical association 
and this is less strong when the descriptive systems of the two measures are not 
measuring the same thing.173 However, when comparing single dimensions of the two 
measures in terms of frequency of responses (Figure 17 and Figure 18), there is some 
overlap. Worried and Sad dimensions of the CHU9D overlap the Emotional symptom scale 
of the SDQ well indicating some overlap in the two descriptive systems. Furber and 
Segal388 conducted a recent study to assess the suitability of the CHU9D as a routine 
outcomes measure in a CAMHS setting. They also found the CHU9D and SDQ correlated 
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moderately, with significant correlations between the CHU9D worried item and three 
SDQ items: many worries, low confidence, and many fears. The CHU9D sad item was also 
significantly correlated to the SDQ often unhappy item.388 In terms of overlap between 
the two measures, the authors found that linear regression of the nine items of the 
CHU9D explained 31.5% of the variance in the SDQ total difficulties score.388 Their results 
are in line with this current study which does not demonstrate large overlap between the 
two measures’ descriptive systems. A key difference to note was that their study was 
conducted in a CAMHS setting while this current study was conducted in a school setting 
which indicates the relationship between the two measures is consistent across both 
settings.  
It is important to note that despite all of the correlations between the SDQ and CHU9D 
being significant, they were not very strong. Using a rule of thumb whereby correlations 
of 0.70 to 1.0 represent strong correlation and 0.30 and below represent weak 
correlations, all of the current correlations were considered weak and thus the statistical 
significance of the correlation may simply be a result of the large sample size.  
The mean utility generated for adult values CHU9D was 0.84, which compares with the 
range of mean values reported in previous studies (0.803-0.86).388-390 The studies varied 
in context, setting, and age groups, but were included for comparison as so few studies 
have published CHU9D outcomes. The mean utility from adolescent values CHU9D was 
lower than the adult values tariff which is consistent with recent Chinese and Australian 
studies that applied both tariffs to their samples.288, 389 Ratcliffe and colleagues288 have 
compared the adult and adolescent value tariffs using the responses to a web-based 
survey of 500 Australian adolescents, aged 11-17. They found differences in adult and 
adolescent values for identical health states may have enough significance to impact on 
health care policy decision making.288 Differences between the instruments may be due 
to differences in descriptive systems, size and nature of the samples, and the valuation 
methods used to develop each scoring algorithm.288 Nevertheless, the Chinese version 
CHU9D found utilities generally discriminated well in relation to self-reported health 
status, regardless of which tariff was employed.389 As noted throughout this thesis, the 
author proposes the use of adolescent values in decision-making that ultimately affect 
them. 
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The SDQ alone cannot provide insight into resource allocation decision making, i.e. 
whether the programme is a worthwhile use of educational resources (or indeed an 
argument for investing health care resources). As discussed previously, there are issues 
around the understanding of clinically meaningful differences in SDQ scores; the value of 
those differences; and whether or not there should be a pre-specified threshold to 
determine cost-effectiveness. The use of the SDQ alone in a CEA context places more 
burden on the decision maker in terms of determining cost-effectiveness (as outlined in 
section 5.7) and for these reasons, it is less useful in economic evaluation. Yet, the SDQ is 
a common primary outcome measure in many paediatric PHIs. For economic evaluation, 
the CHU9D is useful because it has value associated with incremental change. The 
advantage the CHU9D brings to the evaluation of paediatric interventions is that they can 
now be assessed using a preference-based measure combined with costs, and 
judgements can made in relation to their relative cost-effectiveness. It is now possible to 
compare paediatric programmes from a range of areas that aim to improve different 
aspects of children’s health and wellbeing by including a generic HRQoL measure such as 
the CHU9D. Changes in effectiveness as measured using the SDQ and mapped to CHU9D, 
can now be compared in terms of their costs required to achieve those changes in 
outcomes. For example, a cost per three-point change in the SDQ could not readily be 
compared to a cost per three-point increase on a national exam. Having a uniform 
measure of QoL that has been valued by the population, allows comparison of 
programmes in terms of both cost and effects because they have been measured on the 
same generic scale. 
To my knowledge, this is the first study to apply the preliminary mapping algorithms329 to 
an external dataset, contributing to the sparse evidence base of an appropriate and 
validated alternative for conducting CUA using the SDQ. The caregiver version of the SDQ 
was used in development of these algorithms as opposed the teacher-rated version used 
in the current study. Additionally, parent completed proxy report CHU9D was used,329 as 
opposed to child completed CHU9D in the current study. The validity of applying the 
mapping algorithms to different versions of SDQ and CHU9D is questioned (i.e. the 
validity of mapping from teacher complete SDQ to child complete CHU9D when the 
algorithms were developed using parent complete SDQ and CHU9D). However, the 
CHU9D was intended to be completed by children and there are multiple valid versions of 
the SDQ. Recently, due to the increased use of mapping methods to generate generic 
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preference-based health utilities, guidance on a set of preferred reporting items for 
mapping studies has been published. The MAPS (Mapping onto Preference-based 
measures reporting Standards) Statement is a set of 23 items deemed essential in order 
to increase clarity and promote complete and transparent reporting of mapping 
studies.391 The original study that developed the mapping algorithms was published 
before these guidelines became available, however it would have benefited from 
reporting to a uniform standard. 
Utilities derived from the four different approaches were all significantly different, the 
only pair that was not was the adult values tariff and five SDQ subscale algorithm. This is 
an interesting finding because the population from which the algorithm was developed 
was sampled from a CAMHS setting. These children would be expected to have lower QoL 
than a general school-aged population. Also, these algorithms were developed using the 
adolescent values tariff and it is of note that in our results, the five SDQ subscale 
algorithm better predicts the adult values utilities. Nonetheless, this study adds to the 
evidence and generalisability of the mapping algorithm using all five of the SDQ subscales. 
By applying the mapping algorithms to an external dataset, this research contributes to 
the existing evidence base around the suitability of the use of the five SDQ subscale 
mapping algorithm for eliciting utilities which was the aim of this study. To answer the 
research question, economic evaluation is now feasible in studies where SDQ data (but 
not preference-based utility data) have been collected and our results suggest the 
algorithm containing all five SDQ subscales to be superior. This is in line with 
recommendations;329 however, future studies should be conducted replicating use of 
these algorithms to confirm these results.  
These findings have practical implications as they may make conducting CUA in school-
based settings more efficient, as fewer resources would be needed for data collection, 
speeding up the evaluation process. Additionally, it now may be possible to conduct CUA 
retrospectively if cost and SDQ data for school programmes are available. This provides 
an opportunity for a wide range of activities that could now be subject to economic 
evaluation with low additional resource input. There is also the potential of converting 
SDQ data from longitudinal datasets into utilities, which could be useful in establishing 
links between short-term surrogate outcomes and long-term established outcomes. As 
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the CHU9D is a relatively new measure, longer-term child health utility data does not yet 
exist to establish links between immediate and long-term child health utilities. As the SDQ 
has been established for longer, using this measure to estimate longer-term child health 
utilities, is a promising area for further research. In the future, researchers interested in 
mapping from the SDQ to CHU9D should use the mapping algorithm, which contains all 
five SDQ subscales. 
6.4.1 Reflection of the overall aims and research question 
As Chapter 6 concludes the final of the three empirical works making up this thesis, the 
overall aim and research question can now be reflected upon. The overall aims were to: 
(i) determine what evaluation methods (economic and non-economic) are 
currently being used to evaluate school-based population health interventions;  
(ii) illustrate a good practice example of a thorough cost-utility and cost-
effectiveness analysis of a school-based intervention (the RoE programme) to 
reflect on the advantages of such practice and disadvantages that remain, such 
as decision-making in multisectoral settings; and  
(iii) explore which outcomes are appropriate for children in the SEW and economic 
evaluation context to support future evaluation work in this context.   
 Chapter 3 addressed the first aim, finding that the methods currently being utilised to 
evaluate school programmes are varied and widespread with poor quality reporting of 
economic evaluations being noted. Of the CUAs identified, none had directly measured 
HRQoL using a child appropriate measure and values. For the second aim, RoE was found 
to be cost-effective with a base-case analysis ICER of £11,000 per QALY. There was 
considerable uncertainty around this estimate (CI: -£95,500 to £147,000) due to a lack of 
finding any statistically significant effect that lasted up to the 36 month follow-up. 
However, the probability of the RoE being cost-effective was high, at 85% at a WTP of 
£20,000/QALY from an NHS perspective. CEA using the SDQ resulted in an ICER of £197 
per unit decrease in total difficulties score (CI: £77 to £471). It is unknown how this result 
would be interpreted in a health or education decision-making context, however this 
study has contributed to the growing pool of incremental costs per SDQ improvement, 
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which will aid the valuation of those incremental changes if at first, consensus can be 
reached on the clinical significance of those incremental changes. For the final aim, the 
SDQ is appropriate for measuring SEW (see section 4.2.1.4), but is less effective for cost-
effectiveness decision-making. Converting the SDQ into child health utility, provides an 
option of valuing incremental changes in QoL against a generally accepted cost-
effectiveness threshold. Chapter 6 validated a mapping algorithm to convert SDQ into 
child health utility, which can be compared to a generally accepted cost-effectiveness 
threshold. 
The overarching research question asked, ‘How should the cost-effectiveness of school-
based, population health interventions aimed at children be determined?’ Based on the 
findings from the literature review, and the empirical works on the economic evaluation 
and mapping validation studies, the author presents four options to be considered; CBA, 
CCA, CUA (first introduced in section 2.1), and MCDA (section 2.2.1.2). The first and most 
appropriate method theoretically is CBA. Because of the challenges identified involving 
multisector outcomes which are broader by nature, it makes sense that the most 
comprehensive form of economic evaluation is most appropriate, as it allows monetary 
valuation of these multisector outcomes in a final cost to benefits ratio or net benefit/loss 
making for clear, consistent, decision-making criteria. Practical limitations of CBA include 
a lack of standardisation in elicitations methods, stated-preference biases, and the 
considerable measurement burden which requires increased time and resources resulting 
in a more costly evaluation. New Economy (introduced in section 2.2.1.1) developed in-
depth guidance on how to conduct CBA in a local public services context where analytical 
and research resources may be limited.149 It’s also supported by an example excel-based 
CBA model and unit cost database with more than 600 unit cost estimates; providing a 
resource to revive CBA in a community context where it is more appropriate than 
CEA/CUA. For example, in local public services there may be limited analytic and research 
resources; this guide and excel-based example may help facilitate the formal evaluation 
of programmes delivered in the community. 
CCA can also take into account the varied multi-sector benefits, but places more burden 
on decision-makers to make trade-offs between costs and effects and does not rank 
alternatives. This hinders consistency in decision-making with no clear decision rules. 
However, disaggregated costs and benefits may be preferred by the decision-maker, so is 
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still worth considering. CCA requires less research burden, so the author recommends 
completing CCA in addition to another form of economic evaluation. If the school-based 
programme being evaluated gives rise to primarily health outcomes, CUA is good option 
because it benefits from having clear decision rules in place in terms of cost-effectiveness. 
However, the applicability of those decision rules to an educational setting is less clear 
and the current QALY framework does not take into account any non-health outcomes. In 
the latest NICE social care guidance manual,151 NICE specifically states an openness to 
consider ‘social care QALYs’ if validated. The Adult Social Care Outcome Toolkit (ASCOT) 
used by the Department of health would be considered as a parallel evaluation as well as 
undertaking a capability and wellbeing approach using the Investigating Choice 
Experiments for the Preferences of Older people – CAPability (ICECAP). This new 
openness to consider other non-health QALYs demonstrates a potential openness to 
consider a generic education utility as a parallel evaluation when there are health and 
non-health benefits of school-based intervention.  
The recommendation of including an ‘impact inventory’ from the Second US Panel on 
cost-effectiveness128 could be useful in this respect as well. The impact inventory would 
lists all health and non-health consequences of an intervention to ensure those that occur 
outside of the health sector are considered regularly. If a CUA framework is to be adopted 
for education, further research is needed to understand what generic education utility 
outcome is appropriate in this setting, how it should be valued, and how the threshold for 
cost-effectiveness should be determined (section 5.7). A limitation to adopting this 
framework, is that multi-sector benefits such as health and labour market outcomes 
would not be captured in a generic education outcome, and thus parallel evaluations 
using sector-specific generic outcomes (e.g. QALY, social care QALY, and ICECAP) would 
be needed. Finally, MCDA is an option to improve transparency in decision-making 
involving multiple criteria. It does place more cognitive burden on decision-makers as 
they will be responsible for determining weights and scoring for the multiple criteria. 
There also has not been any published examples identified in the school-based literature, 
so methods and standardisation are still being developed. 
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6.4.2 Limitations 
The use of mapping to derive generic preference-based indices from disease specific 
measures raises a fundamental concern as mapping methods assume overlap in each 
measure’s descriptive systems.380 One method for assessing mapping functions is to 
evaluate the difference between predicted and observed values by calculating the root 
mean squared error (RMSE).380 The RMSE gives an indication of the size of the prediction 
errors between predicted and observed values.  With the mapping algorithms,329 RMSE 
indicated large differences between predicted and observed values at the individual level. 
However, the purpose of mapping is to predict differences across groups or between trial 
arms, not at the individual level. As was evidenced in Chapter 5, the sensitivity analysis 
which used the mapping algorithm to estimate utilities resulted in unusually narrow 
confidence intervals indicating more certainty around the results and higher probability of 
being cost-effective. This was an unusual result as the confidence intervals around every 
other sensitivity analysis were wider, indicating that the algorithm may underestimate 
uncertainty. A recent study by Madan and colleagues392 found mapping algorithms that 
were based on raw scores overestimated QALY gains as condition specific measures may 
improve the condition without impacting on any other generic domains of health, which 
can lead to over-estimating health utility benefits. The authors conclude, that mapping 
algorithms should reflect within person changes and be estimated from datasets that 
contain repeated measures in order to avoid overestimating health utility.392 The Furber 
et al.329 study did not contain repeated measures and did not estimate the algorithms 
with this type of approach, so this might partly explain the over-estimation of certainty in 
the confidence intervals. Due to the lacking overlap between the SDQ and CHU9D 
descriptive systems and the potential underestimation of uncertainty, the use of the 
mapping algorithm is a second best option to the use of preference-based HRQoL 
measures, but it may be necessary in population health programmes for pragmatic 
reasons.  
This study has demonstrated initial evidence for the justification of the SDQ in economic 
evaluation of school-based interventions with a view to it being mapped to a broader, 
more generic QALY. In settings outside of the adult healthcare sector (i.e. education, 
paediatric, and population health), condition-specific primary outcome measures such as 
the SDQ, may be the only measure of effect collected. In these instances, this study 
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indicates the five SDQ subscale algorithm is a useful instrument, affording health 
economists’ the opportunity to conduct CUA. This allows decision-makers a uniform 
‘yardstick’ measure to compare across interventions and determine cost-effectiveness.  
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6.5 Conclusion 
The SDQ and CHU9D are able to measure outcomes in children aged 8–13 years within an 
educational setting, and this study has validated use of the five SDQ subscale mapping 
algorithm for estimating child health utility at a group level. This study adds to the 
currently sparse evidence base, providing an appropriate and validated alternative to 
conducting CUA in contexts involving children. It is now possible for researchers to 
perform economic evaluation of population-based interventions where traditional utility 
measurement methods are missing, but the SDQ is available. This allows analysts the 
opportunity to conduct CUA retrospectively in paediatric or school-based programmes 
where previously this would have been impossible due to unavailability of preference-
based outcome measures. This can be achieved with few additional resources allowing 
decision-makers access to cost-effectiveness evidence that was previously absent, and 
therefore improving the decision-making process.  To my knowledge, the SDQ and CHU9D 
have not yet been used to predict longer-term outcomes within an economic evaluation 
context, as the CHU9D has only become recently available. This is an important avenue 
for further research because issues remain as to how these childhood measures 
extrapolate into adulthood, and how school-based and/or preventive PHIs can 
demonstrate longer-term cost-effectiveness.  
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7 Chapter summary and discussion 
7.1 Introduction 
The overall aims of this thesis was to:  
(i) determine what evaluation methods (economic and non-economic) are 
currently being used to evaluate school-based population health interventions;  
(ii) illustrate a good practice example of a thorough cost-utility and cost-
effectiveness analysis of a school-based intervention (the RoE programme) to 
reflect on the advantages of such practice and disadvantages that remain, such 
as decision-making in multisectoral settings; and  
(iii) explore which outcomes are appropriate for children in the SEW and economic 
evaluation context to support future evaluation work in this context.   
This thesis addressed these aims, through three separate, but interlinking empirical 
works: the systematic literature review and narrative synthesis of school-based 
evaluation methodologies; the economic evaluation of the RoE trial; and the mapping 
validation study which explored the appropriateness of applying previously published 
algorithms to predict child health utility from the SDQ. Each chapter is summarised in turn 
followed by a critique of the strengths and limitations of these three major works. 
7.2 Chapter Summaries 
7.2.1 Chapter 1 
SEW, as was set out early on, has been linked to better health, wellbeing, and education 
outcomes in children. This is because SEW enables children to build and maintain healthy 
relationships and handle interpersonal situations constructively; also helping to prevent 
mental health problems from developing which can predict future academic, social, and 
labour market outcomes. Because promoting and maintaining children’s SEW is gaining 
increased attention from academics and policy-makers, a variety of school-based SEL 
programmes have been developed18 as a means to improve children’s SEW as well as 
their success in school and life. Schools have been recognised as an ideal setting for 
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health promotion activities as they have the ability to reach most children efficiently. The 
importance of determining the effectiveness as well as cost-effectiveness of SEL 
programmes is justified as the need to demonstrate value for money is required when 
schools face increased financial pressures. This is especially important when decision-
makers in education are faced with a plethora of SEL programmes to choose from. 
Economic evaluation in healthcare settings has been established for some time, however 
applying those methods to an education setting has been limited.185 With few economic 
evaluations of school programmes being conducted, decision-makers are left without 
cost-effectiveness evidence when making decisions about implementing or continuing 
school based programmes. Another important question raised was regarding, ‘Who 
should pay for implementing PHIs when multiple sectors stand to benefit from the 
intervention?’ NICE has not issued guidance on this matter as, ‘no standard method has 
yet been devised to apportion costs - and who should bear them - when more than one 
government department (or, indeed, local authority) is involved’ (p 5).30 Further reflection 
on this key issue follows in the Chapter 5 summary (section 7.2.5). 
RoE, a SEL and PHI, was introduced briefly in Chapter 1. The overall aim and research 
question was put forward given the lack of established economic evaluation methods in 
school settings and the need for cost-effectiveness evidence to aid decision-makers in 
school based interventions. The overall aim was to determine: what evaluation methods 
are currently being used to evaluate school-based population health interventions 
through systematic review; the cost-effectiveness of the RoE programme through 
economic evaluation; and which outcomes are appropriate for children in the SEW 
context specifically aimed at paediatric populations in a school setting.  The overall 
research question asked, ‘How should the cost-effectiveness of school-based, population 
health interventions aimed at children be determined?’ Chapter 1 concluded by providing 
a chapter outline for the rest of the thesis. 
7.2.2 Chapter 2 
Chapter 1 introduced key concepts of this thesis; the need to promote and maintain 
children’s SEW, and the need to establish the cost-effectiveness of school-based SEL 
programmes. Chapter 2 delved deeper into these and related fundamental concepts of 
economics such as scarcity and opportunity cost. Important definitions of key concepts 
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were defined such as economics, health economics, HTA, and economic evaluation. The 
field of health economics developed due to market failures and the use of economic 
evaluation has increased to aid decision makers in determining what health services 
should be offered to maximise the health of the population within the financial 
constraints of the healthcare system. Additionally, a brief history introduced some of the 
earliest works in economic evaluation, before the disciple had been formally recognised. 
One of the earliest forms of economic evaluation was a cost-benefit type analysis of 
England’s Public Health Act 1875 where estimates of life years gained from the 
improvement were compared to the cost enacting the Act. In 1917, the appropriately 
named Charles ‘Value’ Chaplin, recognised that institutions have a hard time breaking 
away from traditions of the past, creating inefficiencies in the health care system and this 
was a theme repeated throughout this chapter. In 1917, he hypothesised that if 
healthcare institutions were to start over with a new health care budget, they would 
probably end up with a different allocation of resources based on current knowledge of 
costs and effectiveness. However, starting over is difficult to do, and examples of this 
notion are the reluctance of NICE to consider a lower cost-effectiveness threshold, as well 
as a reluctance to break away from the standardised method of economic evaluation, the 
CUA. CUA is efficient and useful when the context is limited to health and health 
outcomes; however, PHIs cover a broader context and sometimes give rise to non-health 
outcomes that are not captured by the QALY. Selma Mushkin was one of the first to 
define health economics in 1958 before Kenneth Arrow, who is often credited with the 
recognition of health economics as a discipline in 1963. Herbert Klarman wrote the first 
health economics textbook, and was the first make a quality adjustment to life years 
gained from a kidney transplant.  
From the 1970s onward, methods for modern economic evaluation were developed. A 
number of recommendation guidelines, documents, and texts have emerged since the 
1990s on the design and conduct of health economic evaluation enabling the 
standardisation of the basic elements of economic evaluation and analytic techniques.37 
Many countries have their own country specific HTA guidance in place for conducting 
economic evaluation and an updated list can be found on the ISPOR website: 
https://www.ispor.org/PEguidelines/index.asp.  
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Sections 2.1.3 to 2.1.7 described the different types of economic evaluation 
methodologies and gave examples of outcomes that distinguish the different types and 
situations where certain methods may be more appropriate. CUA, a form of CEA, is the 
most commonly used type of economic evaluation in the UK due to NICE guidance 
specifically calling for this type of evaluation in the reference case. CBA is the most 
comprehensive form of economic evaluation, but due to various challenges, 
comprehensive CBAs are still rarely published. CBAs require more time and are more 
costly to design and implement, as there are a broader spectrum of outcomes to identify, 
measure, and value which will be unique to each CBA. Valuing these broader outcomes 
faces challenges as well because there is a lack of standardisation and biases present in 
stated preference methods.  CMA has been criticised for failing to investigate uncertainty 
in determining equivalence between two different treatment options. It has been found 
to bias measures of uncertainty; therefore, data on costs and effects should still be 
collected and analysed to assess this bias. Recommendations are that CMA should no 
longer be used due to these problems and biases that present from attempting to 
determine total equivalence in effectiveness of two or more alternatives. Finally, CCA is 
not always considered a full economic evaluation, however it provides decision makers 
the option of deciding themselves the appropriate trade-offs that need to be made in 
terms of costs and benefits.  
The final subsection of section 2.1 detailed the role of economic evaluation in decision 
making in the UK and internationally. This was described in terms of cost-effectiveness 
thresholds and trial-based, model-based, and mixed economic evaluation methodologies. 
The UK specifically adopts a £20,000 to £30,000 per QALY threshold to aid decision 
making. The WHO uses a multiple of the average per capita income to determine cost-
effectiveness in low and middle-income countries. The US chooses not to set a threshold, 
instead preferring a range of thresholds being explored. The scepticism of the 
appropriateness of the use of a QALY threshold in decision-making was critiqued, as the 
current threshold used by NICE is not based on theory or empirical evidence. The UK is 
the only country to specifically state a value for the threshold. Other countries support 
the use of a threshold, while some, such as the USA outright disagree with a threshold.128-
130 There are differing views as to what the threshold should represent: 1.) the society’s 
monetary valuation of health gains; or 2.) the opportunity cost resulting from 
disinvestment required to adopt a new health technology. This thesis proposes both 
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perspectives are valid as the value of the threshold should be based on collective values 
of society. At the same time, the public needs to be aware that valuing the threshold 
equates to an opportunity cost or disinvestment elsewhere in the healthcare system, 
often times those affected by the disinvestment are less visible, such as cuts to mental 
health services. Stating a cost-effectiveness threshold essentially places a value on human 
life, so debate and scepticism around this issue will continue. Finally this subsection, 
concluded by describing the various vehicles for economic evaluation. They can be 
conducted alongside trails, in a decision analytic framework, or a mix of both 
methodologies and the advantages and disadvantages of each were described. 
The first half of the chapter summarised above, introduced the general methods of 
economic evaluation in a typical clinical trial hospital-based economic evaluation. The 
second half focused on PHIs and how those traditional methods could be applied to deal 
with broader perspectives, inclusion of non-health outcomes, other challenges, and 
economic evaluation in school settings. The second half introduced key concepts of 
economic evaluation of PHIs, which was the focus for this thesis as RoE is considered a 
PHI that is delivered in schools. The economics of prevention assumes health behaviours 
function much like goods consumption functions in market places. Many external 
influences impact on individual choices such as cost, opportunity, incentives, and 
constraints. When markets fail, such as the healthcare market, government intervention 
is acceptable to correct the failure (e.g. taxes on tobacco, alcohol, and sugary drinks).  As 
unhealthy behaviours are the cause for many preventable diseases and deaths, this 
market is failing, and intervention to prevent disease and death are warranted. This sets 
up the economic case for investing resources to prevent disease and ill health versus 
spending those resources later on in treatment. These approaches are sometimes 
referred to as upstream methods of prevention.  
The prevention paradox has the potential to impact population outcomes on a large scale. 
If the entire population is exposed to a safe intervention, then the entire distribution of 
risk in that population can be shifted placing more people in low and moderate risk than 
would be the case if only the high-risk group was targeted.  
However, the prevention paradox states the individual benefits may be insignificant or 
non-existent, but those small benefits added up over the population could result in 
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significant community or population benefits. This is particularly relevant for RCTs of PHIs 
or public health interventions as measures are collected at the individual level. Often 
effect sizes are small and/or diminishing, and this could partly be explained by the 
prevention paradox. PHIs evaluated in a cluster RCT framework typically only include a 
subset of the whole population, and therefore the sum of the combined effect may not 
reach significance, as the entire population was not included in the study. However, 
simple projections can be performed to estimate the population effect by multiplying the 
effectiveness results of an RCT, by the total relevant population, as demonstrated in 
Chapter 5. While this does not produce a robust estimate, it certainly can provide and 
idea of the potential of PHIs. 
Investing in preventive and effective measures of the population have the potential to 
bring large community benefits, as well as being cost-effective. However, as economic 
evaluation moves from a narrow NHS setting to a broader public sector/societal 
perspective, challenges start to emerge when conducting economic evaluation of 
population and public health interventions. These challenges include those previously 
defined by Weatherly and colleagues36 such as attribution of effects; measuring and 
valuing effects; identifying intersectoral costs and consequences; and incorporating 
equity considerations.  
Broader perspectives represent an increased research burden in terms of identifying, 
measuring and valuing additional health and often-times non-health outcomes. Non-
health outcomes are particularly problematic in health economic evaluation as they fall 
outside the remit of the preferred QALY measure in the UK. NICE has recognised this by 
considering other forms of economic evaluation which may be more appropriate for PHIs 
such as CBA and CCA. There are considerable research burdens associated with CBA such 
increased time and resources to develop and implement a CBA. Preference elicitation is 
time consuming, often produces biased results, and is lacking in standardisation. Even if 
standardisation improved, CBA would still be time consuming because each stated 
preference design would need to be unique to the problem at hand. There is the in depth 
guidance developed by New Economy149 (section 2.2.1) which provides resources on how 
to conduct CBA in a local public services context where analytical and research resources 
may be limited.149 The guidance also provides an example of an excel-based CBA model 
and unit cost database with more than 600 unit cost estimates. This is a useful resource 
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to encourage CBA in the public services and population health contexts, although analysts 
may still be limited by the unit cost estimates that are available in the database. The 
methodology, CBA guidance, and Excel spreadsheet model are freely available for 
download from their website (http://www.neweconomymanchester.com/our-
work/research-evaluation-cost-benefit-analysis/cost-benefit-analysis/cost-benefit-
analysis-guidance-and-model), and the methodology has been included in supplementary 
guidance to the HM Treasury Green Book.393 A development such as this is a promising 
attempt to ‘revitalise’ CBA methods for modern day economic evaluation of PHIs. CCA is 
less time consuming, but places more cognitive burden on decision-makers as there is no 
single combined outcome of cost-effectiveness presented.  
 Emerging methodologies such as MCDA may become more prominent in the future, once 
researchers have a chance to digest and implement the recent methods guidance 
released by ISPOR.160, 161 The main advantages to adopting MCDA is that it gives analysts a 
transparent and systematic method for incorporating multiple criteria in decision-making. 
If a generic approach were to be adopted by NICE, evaluations could incorporate pre-
specified multiple criteria that already have generic weights attached, therefore 
increasing comparability amongst different clinical areas. However, a generic approach 
may eventually face similar challenges as the QALY, in that the pre-specified criteria are 
too narrow to capture broader societal benefits that might arise from PHIs. Economic 
evaluation alongside natural experiments are also a promising alternative for evaluating 
national policy PHIs. However, in the UK, there is still a major focus on CUA as there are 
justifiable reasons for keeping the established decision-making process, which is based on 
an established cost per QALY threshold. Knowing the limitations of CUA for PHIs (in 
examples where many outcomes are non-health outcomes), health economists should 
not continue following the status quo, as they are not helping the growth and 
development of this area. This thesis proposes that instead, researchers and health 
economists should be pushing for funding to develop alternative methods such as CBA 
and MCDA and utilise them in research projects. If funders are still going to require a 
CUA, more time could be written into grant applications to allow completion of multiple 
forms of evaluation, such as CBA, CUA, and CCA together. Each method has its limitations 
on its own, but this approach to research alongside trials would allow a more complete 
picture of evidence to be presented to decision makers, as well as help advance the area 
198 
 
 
methodologically as to which use of multiple methods are suitable and appropriate in 
practice. 
Finally, even more challenging is establishing a transparent and consistent decision-
making process in the education sector by introducing economic evaluation to school-
based PHIs. The education economics literature has produced some examples of 
economic evaluation, but it has been limited. No consensus has been reached if a 
decision-making threshold should be established for the education sector and what the 
generic outcome should be to allow consistency in decision-making. Education is not 
unlike health, in that resources are under constant financial pressure, so there is an 
opportunity to learn from the health sector. Namely, alternative methods to CUA should 
be considered to take account of intersectoral benefits that are likely to arise from 
school-based PHIs. This chapter concluded that arguably, we may be coming full circle in 
reconsidering CBA for PHIs, as one of the first records of economic evaluation was a CBA 
of England’s Public Health Act in 1875. 
7.2.3 Chapter 3 
Because of the limited development of economic evaluation in school settings, there was 
a need to understand what evaluation methodologies were currently in place to evaluate 
school programmes to aid decision-making. In addition to the challenges relating to 
economic evaluation of PHIs, there is a lack of research into child preference-based 
measures, which are necessary when evaluating child health outcomes in a CUA 
framework. Together, these resulted in a novel, ‘uncharted area’ for economic evaluation 
methodology of school-based PHIs. To explore this area further, the following research 
question was posed, ‘What evidence currently exists around economic and other 
evaluation methodologies of school-based interventions and/or programmes?’ Because 
the economic evaluation of RoE was one of the first of its kind (both in terms of context 
and outcome measurement), a systematic literature review was conducted to identify 
evidence of economic and other evaluation methodologies that currently exist for the 
evaluation of school-based programmes. The purpose of the review was to gain an 
understanding of how economic evaluation (and other evaluation methodologies) of 
school-based programmes are currently being conducted and the types of preference-
based child utility measures that are currently being utilised. There was an implicit 
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assumption that HRQoL would be an appropriate measure of outcome in school-settings 
as the majority of the economic evaluations that were identified were for programmes 
and interventions that aimed to improve child health in some way. Additionally, RoE aims 
to improve children’s SEW, so because health was the focus of the economic evaluation in 
Chapter 4 and 5, emphasis was placed on identifying appropriate child preference-based 
HRQoL measures for CUA. The review revealed relatively few high quality existing studies 
and zero published studies that incorporated children’s preferences in CUA. 
Only four published studies were identified that directly measured HRQoL. Two used the 
EQ-5D,243, 267 one used the PedsQL,282 and the final a disease specific caregiver’s quality of 
life instrument.281 It was noted that the only studies to incorporated child-specific HRQoL 
were non-economic evaluation studies, clearly in CUA it would be preferable to collect 
utility directly versus relying on estimation, mapping or a crosswalk function. There is a 
paucity of evidence in the published literature of CUA of school-based interventions that 
directly measure HRQoL using appropriate, child-specific measures. Twenty-five of the 76 
studies included for review were identified as CUAs; of those 25, only one directly 
measured HRQoL using the Shona-language version of the EQ-5D. The review identified 
zero published studies that directly measured HRQoL in children (using a measure 
designed specifically for children) and which used children’s preferences; the only 
measure to fulfil both of these conditions is the CHU9D. The use of the CHU9D in this 
context is an important and novel contribution to the literature as RoE would be the first 
school-based economic evaluation to incorporate the CHU9D with adolescent values, as 
currently there are no values from younger children available.  
The review found the evidence of evaluation methodologies of school-based programmes 
are varied and widespread. Economic evaluation is still a relatively novel concept in the 
school setting185 despite efficient resource allocation being a high priority for budget 
constrained education boards. The review also revealed that alternative methods for 
incorporating multisector benefits such as MCDA and SROI were not being utilised in the 
education evaluation literature. Reasons for this might include publication time lags, or 
the need for further guidance and/or standardisation in these alternative methods. Few 
studies report follow-up longer than six months18 and there is little evidence of cost-
effectiveness and long-term effectiveness. Budget cuts to publically funded education has 
resulted in scarce resources needing to be maximised to their full potential. Economic 
200 
 
 
evaluation can help education decision-makers make more informed decisions about how 
to allocate limited funds.  The lack of cost-effectiveness evidence in the area of SEW 
identifies a gap in the current knowledge leaving decision-makers less informed about the 
cost-effectiveness of new SEL programmes they might choose to implement.  
The quality of reporting and methods used in the identified economic evaluations were 
not quite up to the standards that might be expected in the clinical trials-based medical 
literature. Few studies directly measured HRQoL in children leading to uncertainty in the 
programmes’ effectiveness estimates. Improvements can be made in the quality of 
reporting of economic evaluations of school-based programmes as low quality of 
reporting was prevalent. As a minimum, economic evaluation focused on health 
outcomes should report each of the applicable CHEERS checklist items and this review did 
not identify any studies that reported on each item. As was touched upon in chapter two, 
economic evaluation of school-based programmes will not always have a health focus. 
They may give rise to benefits that span multiple sectors, and if education is the focus, 
more development of the methods as appropriate for an education setting should be 
researched further. This is because the downside of the QALY framework is that it does 
not take into account non-health benefits and it is not as flexible at incorporating multi-
sector benefits. The chapter concluded that as the methods for school-based economic 
evaluation develop, the quality of reporting should improve as well. 
7.2.4 Chapter 4 
In order to address some of the shortcomings of economic evaluation of school-based 
PHIs identified in Chapter 3, Chapter 4 presented the methods of a thorough economic 
evaluation of the RoE programme. The chapter described in detail, the methods used for 
the main trial economic evaluation of the RoE programme which was  the first economic 
evaluation of school-based PHI, RoE, to address the evidence gaps in the literature such 
as low-quality reporting and a lack of evidence that directly measures children’s quality of 
life using their preferences. The evaluation was thoroughly reported to address the lack 
of quality reporting available in the current literature, and set an example of a 
standardised method (CUA) for conducting and reporting economic evaluation of a 
school-base PHI. The chapter started by describing the differences between economic 
evaluation of child and adult interventions, and how there is a need to develop outcome 
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measures specifically for children. The CHU9D is the only preference-based HRQoL 
measure that was developed specifically for children, which can also be valued by 
adolescents (with the elicitation of younger children’s values currently ongoing). Another 
child specific measure, the SDQ, was also described in detail as it was used in CEA. There 
was discussion around appropriate measures for SEW as a lack of valid measures 
currently exist; the SDQ may not be entirely appropriate to measure something that is 
very difficult to quantify in the first place. However, in the absence of specific and 
validated measures of SEW the SDQ is the best available option. The importance of 
including both a generic preference-base quality of life measure, as well as a condition 
specific measure of outcome was discussed as difficulties arise when trying to quantify 
changes in a non-generic, non-preference-based outcome, such as the SDQ, in terms of 
other education outcomes covered under the same budget, e.g. increases in test scores. A 
generic ‘yardstick’ measure can be useful in this context and to address the limitations of 
a generic outcome, condition-specific outcomes can be included which may be able to 
measure the intervention’s effectiveness more accurately.  
Background and contextual information to the main cluster randomised controlled trial of 
RoE was provided. A review of the existing evidence of RoE’s effectiveness found that 
only one evaluation was a cluster RCT design, with follow-up at three years. This 
evaluation took place in a different contextual setting to Northern Ireland and none of 
the existing evidence of RoE effectiveness included a cost component or economic 
evaluation. The main trial aims and research questions were stated and data collection 
detailed. For the economic evaluation, the aim was to evaluate the cost-effectiveness of 
the programme from a public sector perspective over trial time horizon of 45 months 
(3.75 years or 3 years follow-up after intervention completion). The research question 
asked, ‘What is the cost-effectiveness of the programme in reducing cases of aggressive 
behaviour and increasing prosocial behaviour among school-aged children?’ The final 
section described in detail, the methods of the economic evaluation of the RoE 
programme. The section started with an overview, followed by detailed descriptions of 
the costs, outcomes, how missing data was handled, analyses, and sensitivity analyses 
performed.  
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7.2.5 Chapter 5 
This chapter reported the results of the economic evaluation of RoE. The evaluation 
found that, within current commonly accepted thresholds for the value of a QALY, RoE is 
likely to be a cost-effective school-based population health intervention, with an ICER of 
£11,000 per QALY gained (CI: -£95,500 to £147,000). The value of the threshold had been 
discussed and critiqued in previous chapters, with Claxton and colleagues118 re-valuing 
the threshold using routinely available data. Their estimate based on technical fact versus 
informal judgement was closer to £13,000 per QALY. Even when considering this lower 
QALY threshold of £13,000, over 80% of the RoE sensitivity analyses would still be cost-
effective, including the base-case analysis. This evaluation is novel for two reasons: 1.) it 
was the first economic evaluation of the RoE programme, and 2.) it was the first school-
based economic evaluation to incorporate children’s preferences through use of the 
CHU9D as well as adding to the growing body of cost-effectiveness evidence 
incorporating the SDQ. The CHU9D is appropriate for a QALY framework, because it 
provides a uniform ‘yardstick’ measure that can be compared to other programmes and 
interventions across education and health sectors. The CHU9D is appropriate in school-
settings when the programme being evaluated generates primarily health outcomes, and 
it has been used in school settings previously,389, 390 just not in a formal economic 
evaluation. This is particularly useful for transparent and consistent decision-making 
because the monetary value of a QALY has generally been accepted by British society. 
However, many of the dimensions of the CHU9D would not have been affected by RoE, 
e.g. pain and daily routine. Therefore, its appropriateness for detecting change in SEW is 
questioned.  
The CEA using the SDQ as an effectiveness measure was more appropriate for measuring 
SEW. The CEA also answered the economic evaluation research question of determining 
the cost-effectiveness of reducing aggressive behaviour and increasing prosocial 
behaviour. The ICER for SDQ total difficulties score was £197 per one-unit decrease (CI: 
£77 to £471) and the ICER for prosocial behaviour was £5,630 per unit increase (CI: -
£23,400 to £29,100). There are bandings in place to help with interpretation of SDQ 
results, however, these bandings are not based on any diagnostic thresholds and are 
instead meant be used to recommend referral for further diagnostic examination. 
Consequently, there is no clinical consensus for the interpretation of a one-point 
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decrease or increase in total difficulties or prosocial scores. The results of the CEA are 
undermined by this lack of clinical relevance especially when these results cannot be 
readily transferred to other relevant health outcomes or education attainment. This also 
makes valuing incremental changes in the SDQ a challenge. As more CEAs using the SDQ 
are undertaken and the resulting cost-effectiveness decisions documented, values for 
incremental changes will be revealed. There are a plethora of SEL classroom programmes 
available however, none of them were analysed rigorously in terms of cost-effectiveness 
as has been the case with this RoE economic evaluation. Because few other SEL 
programmes have been evaluated for cost-effectiveness, the findings from the RoE 
economic evaluation were novel in this context. At the same time, this novelty presented 
difficulties for allocative decision-making as there are few other school-based 
programmes that have been evaluated in a cost per QALY framework to compare the RoE 
results to. There are even fewer economic evaluations of SEL programmes to compare.  
The probability of cost-effectiveness was high, however when considering quality of life 
differences at three-year follow-up, no significant differences were observed. This effect 
is potentially that of the prevention paradox introduced in Chapter 2. If the effects 
observed in the RoE trial were scaled up to reach the entire population of children aged 
5-9 in Northern Ireland, then nearly 1,800 additional QALYs could be gained, thus 
demonstrating how small individual benefits could add up over the population. The 
chapter concluded that additional analyses relating to the total budgetary impact of 
rolling out this intervention, assumptions about RoE intervention life span, and longer-
term quality of life benefits were required to draw definitive conclusions relating to its 
longer-term cost-effectiveness. In addition, future studies will be needed to compare the 
RoE intervention with alternative interventions aiming to achieve the same SEW gains.  
More research is needed to determine the longer-term cost-effectiveness of RoE and 
other SEL programmes like it. If investment decisions are based on assumptions that the 
programme will be beneficial to the children in the long-run, then better links to long-
term outcomes need to be established. If/when these long-term benefits are established, 
the author believes that funding for these types of programmes should come from the 
sectors that stand to benefit. This is not only the case for long-term benefits but 
established short-term benefits as well. It is difficult to expect the onus of investment in 
SEL programmes to rely solely on the education sector. EEF guidance (section 5.7) states 
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that all EEF funded evaluations must now include a cost evaluation where schools are 
expected to pay all costs of providing the intervention,365 implicitly assuming schools 
should be responsible for funding all costs related to school-based programmes even if it 
will end up benefiting sectors outside of education. Remme et al.35 (section 5.7) have 
suggested a cofinancing approach to jointly fund PHIs with multisector benefits based on 
other sectors’ current marginal productivity or cost-effectiveness thresholds, however 
estimating these proportions that each sector should be responsible for is difficult to do 
in practice. Reasons include there being multiple payers per sector with differing financial 
constraints and a paucity of suitable cost-effectiveness data to estimate sector-specific 
cost-effectiveness thresholds in areas outside the health sector. Upon reflection of EEF 
guidance and difficulties estimating equitable cofinancing options, schools should be 
aware of that they might need to fund these types of programmes entirely themselves 
and not depend on funding from other sectors. However, the author considers that calls 
should be made to redistribute the burden of funding more equitably and more research 
into equitable cofinancing options should be prioritised. 
7.2.6 Chapter 6 
SEW is an important component of child health and wellbeing, but as was seen in Chapter 
5, decision-making resulting from cost-effectiveness results of a CEA using a SEW 
outcome can be a challenge, due to a lack of consensus for interpretation of incremental 
changes in SDQ and a lack of monetary valuation for those changes. As Chapter 3 
highlighted, there is also a lack of directly measured child utility measures being used in 
school-based economic evaluation. Chapter 6 aimed to explore a possible solution to 
these problems by answering the research question, ‘Can SDQ scores elicited within an 
educational context be mapped using published algorithms to preference-based CHU9D 
utilities with a view to incorporating such utilities within an economic evaluation 
framework?’ Additionally, Chapter 6 aimed to address the challenge of interpreting SDQ 
cost-effectiveness results by converting the SDQ into a generic HRQoL measure for which 
interpretation of the value of a cost per QALY is much more straightforward. Addressing 
this research question is not only beneficial for economic evaluation in school-settings, 
but more broadly in paediatric settings as the SDQ is commonly collected in clinical 
settings. The study found the mapping algorithm using five SDQ subscales optimal for 
predicting mean utility and could be used when conducting CUA where there is an 
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absence of a child health utility measure. This study provided validation of these mapping 
algorithms and contributed to the limited evidence surround the use of these two 
measures together in economic evaluation. The study also assessed the differences 
between the adult and adolescent utility values and found the adolescent values 
produced lower mean utilities, which is consistent with what has been found elsewhere in 
the literature. Adolescent values were chosen as the base-case in the economic 
evaluation (in Chapters 4 and 5) because the author believes adolescent values should be 
used when decisions are being made that ultimately affect this younger population. 
Because they are consistently lower than what is produced by the adult values, they also 
ensure a more conservative estimate, which instils more confidence in a cost-effective 
ICER result. 
The use of mapping is a second best option compared to directly measuring health utility, 
because the descriptive systems of each measure do not overlap entirely; essentially, 
they are measuring two different outcomes. There is some evidence of overlap, e.g. in the 
worried and sad dimensions of the CHU9D overlap the Emotional subscale of the SDQ. 
This has implications on how well the mapping algorithms can perform as they rely on 
statistical association between the two measures. Additionally, the unusually narrow 95% 
CIs observed in Chapter 5, resulted in bias in the uncertainty estimates of the probability 
of RoE being cost-effective. However, for practical reasons, the use of mapping may be 
the only option to enable economic evaluation. Transforming SDQ scores to utility values 
(through use of the mapping algorithm suggested) would facilitate CUA of routine CAMHS 
data, open up school-based SDQ data to CUA, as well as provide the opportunity to 
estimate longer-term QoL impacts from long-term cohorts which include the SDQ. This is 
an important avenue for further research because issues remain as to how these 
childhood measures extrapolate into adulthood. 
To answer the overarching research question of, ‘How should the cost-effectiveness of 
school-based, population health interventions aimed at children be determined?’ four 
alternative methods were suggested with CBA being the strongest theoretically. CBA 
addresses the issue of multi-sector benefits that may arise from school-based PHIs and 
provides decision-makers with a clear decision rule. There are practical limitations such as 
increased research burden, inconsistent stated preference elicitation methods, and 
resulting biases; however, guidance from New Economy intends to revive CBA in the 
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public services sector providing detailed guidance, an example excel-based CBA model, 
and cost database. The other three methods (CCA, CUA, and MCDA) put forward all have 
their strengths and weaknesses and their use for determining cost-effectiveness in 
school-based PHIs should be based on context-specific factors. CCA requires less research 
burden, so should be presented alongside with another of the three remaining methods 
recommended. CUA should be considered if benefits are primarily health benefits, 
however more work needs to be done to determine an appropriate cost-effectiveness 
threshold for education, and if a generic education utility measure should be developed. 
This would also progress aims of the cofinancing approach to determine a more equitable 
contribution to funding interventions with multisector benefits, as cofinancing is 
entrenched in the extrawelfarist framework.35 MCDA should be considered if decision-
makers are willing and able to weight multiple decision criteria and the research team is 
comfortable taking on newer, less standardised method of evaluation. 
7.3 Limitations and Strengths 
7.3.1 Critique of methods 
The work of this thesis was split into three main empirical parts: the systematic literature 
review and narrative synthesis in Chapter 3; the case study of the RoE economic 
evaluation described in Chapters 4 and 5; and the outcomes validation study in Chapter 6. 
The following is a thorough discussion and critique of the methods used in this thesis as 
well as those used by others who have published similar work. 
7.3.1.1 Systematic literature review 
The main critique for this systematic review is that the review question chosen was quite 
broad which meant a wide range of evaluation methodologies were included. The broad 
nature of the question was justified as little was known of the types of evaluation 
methodologies that were currently being practiced in the school setting. Nevertheless, 
this posed difficulty with evaluating quality as a single, yet comprehensive tool such as 
the CHEERS checklist would not be appropriate for all methodologies included such as the 
costing studies and non-economic evaluations. It also meant that synthesising the 
evidence through meta-analysis would not be appropriate. However, even if the focus of 
the review was restricted to include only economic evaluation, meta-analysis still would 
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not be possible because the nature of the review question intends to explore 
methodology used in current practice, not to identify and synthesise an effect size from a 
single type of intervention. Heterogeneity in the review was dealt with through narrative 
synthesis and followed a systematic process that included preliminary synthesis, exploring 
relationships within and between groups, and assessing the robustness of the synthesis. 
To my knowledge, there is no existing systematic review which attempts to review 
methods of school-based evaluation methodologies. As was revealed from the review, 
obesity prevention interventions were the most common type of school-based 
intervention evaluated in the published and grey literature. Systematic reviews of these 
types of interventions do exist, however outcomes are still too heterogeneous to 
combine in formal meta-analysis.394, 395 This further provides justification for use of 
narrative synthesis as the previous two studies cited did not provide any formal method 
of synthesis, rather they reported their results descriptively. An example of a systematic 
review which employed narrative synthesis is a study that aimed to synthesise current 
knowledge of shared decision making in palliative care by Bélanger et al.396 The aim of 
this systematic review is similar in that it sought to gather evidence from different types 
of methods and approaches and thus a narrative synthesis would be appropriate for the 
heterogeneous outcomes and methods included in review. The authors similarly follow 
the same guidance for conducting a narrative synthesis by Popay et al.190 The guidance 
followed involved three steps: developing a preliminary synthesis of findings of included 
studies; exploring relationships within and between studies; and assessing the robustness 
of the synthesis. This formal method for synthesising the data collected from the review 
instils further confidence of the robustness of the review as data synthesis is 
recommended for systematic review, but is often ignored when meta-analysis is not 
appropriate. 
Initially, the scoping review conducted was much more focused; the inclusion criteria was 
narrower, only focusing on economic evaluation of school-based interventions. The 
scoping review identified few studies, so a broader approach was taken to make sure a 
comprehensive review of all available evidence was conducted. Economic evaluation of 
school-based programmes is a novel area, so the current literature may have used other, 
broader methodologies outside of economic evaluation such as MCDA, SROI, SIA, or HIA. 
As the review found, this was not the case, however, this is a finding in itself.  
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The other main critique of the methods for this systematic review was that only one 
author reviewed all studies and performed the data extraction and synthesis. The CRD 
guidance used to conduct the review specifically advises that a minimum of two authors 
should be involved in the review to minimise bias and error resulting from the conduct of 
the review. As only the author conducted each of the major stages, this is a potential 
source of bias. The review attempted to mitigate any bias with two authors (members of 
the supervisory team) conducting validity checks during the evidence gathering stages.  
The validity checks ensured that the decisions the author took screening papers to 
include for review, were replicated by the two supervisory team authors. The results of 
both validity checks found all authors coming to the same conclusions, which ensured a 
systematic process for deciding which articles to include for review.   
7.3.1.2 RoE economic evaluation 
The base-case CUA of RoE is the first school-based CUA to incorporate directly measured 
utility values from children using their preferences. As identified in the systematic review, 
only four published studies of school-based CUA directly measured health utility, the 
remaining 21 CUAs identified estimated or modelled health utility indirectly. Of the four 
that directly measured health utility, two used the adult measure EQ-5D and were 
published after the availability of the CHU9D, which would now be considered 
inappropriate.397 Prior to the availability of the CHU9D, poor approximation through use 
of adult measures was considered better than no approximation of health utlities.397 
However, the main critique for the RoE economic evaluation is that CUA may not capture 
the full range of costs and outcomes of PHIs such as RoE. Wider non-health benefits such 
as educational outcomes and spillover effects such as increases in quality of life at home 
were not captured, but they would have added further understanding of the cost-
effectiveness of RoE. Until 2012, CUA was NICE’s main method for determining cost-
effectiveness of public health interventions.23 It wasn’t until the 3rd edition of the NICE 
public health guidance’79 that more emphasis was placed on CCA and CBA to ensure all 
relevant benefits (health, non-health, and community) were taken into account to aid 
local authorities or other organisations to judge whether or not an intervention is value 
for money. Since 2012 when this new guidance came out, there have still been relatively 
few CCAs and CBAs of PHIs to appear in the literature.68 This could again be attributable 
to a reoccurring theme in this thesis that institutions have a hard time evolving from the 
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status quo. CUA was planned for the RoE economic evaluation because having that 
generic ‘yardstick’ measure to make comparisons to other competing sources of funding 
is still the main requirement set out in NICE guidance, with CCA and CBA being considered 
as secondary analyses.150 Also, the outcomes collected from the RoE trial were all 
primarily health outcomes, and thus a QALY framework was appropriate. CBA is a 
resource intense evaluation method and less attractive to analysists who already have to 
provide a cost per QALY analysis as a requirement of many British funding bodies. 
However, it is a superior method theoretically in terms of capturing broader, multi-sector 
benefits. Researchers could consider the practical limitations of CBA and apply for 
additional funds to push the CBA agenda forward in order to more appropriately address 
economic questions in population health and education settings. 
The attempt to collect wider societal costs and benefits was also hindered by a high 
percentage of missing data. The only method for capturing wider outcomes available was 
through contact of the children’s parents by post. In this trial, this method proved difficult 
and was prone to producing missing data. In addition, the long recall period is prone to  
inaccuracies as there is a tendency to underreport community service utilisation with 
longer recall periods.398 Even if the planned CUA is rigorous and well reported there are 
still unforeseen issues to be dealt with in terms of missing data. Typically, in a healthcare 
setting self-reported outcomes come directly from the patient/participant. In a school-
setting there is the added element of complexity in that self-reported outcomes will not 
come directly from the participant (the child) and will instead be reliant on their 
caregivers who may not have much contact with the intervention/school, or be as 
motivated to contribute to the research.  
Other more routine data sources might have provided more reliable societal costs and 
benefits and these should be considered for future research.399 Data linkage to routinely 
collected sources of health and social care data may contribute to a more efficient 
research design by reducing: measurement issues, such as patient recall; time and 
resources used to design individual resource use questionnaires for each trial; and patient 
burden, or in this particular case, caregiver burden.400 Linkage to routinely collected 
health service resource use may have reduced the amount of missing data in the RoE 
trial; the burden on caregivers; and the time and resources required to develop the 
questionnaire and post them out. It also could have addressed the issue of resource use 
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only being collected at the second and third-year follow-ups. This lack of consistency was 
a limitation of this CUA which then also had a limiting effect on the choice of analytical 
methods employed (MLMs could not be fit). The time and resources needed to extract 
and link data may outweigh the potential efficiency gains, but data linkage to routine 
resource use is something that should have been considered in the design of the 
economic evaluation. It is still an option to be considered for future research if necessary 
funding can be obtained with a small supplemental grant, because if proven to be more 
efficient and less prone to producing missing data, this data linkage to routine service use 
should be adopted more widely in economic evaluation of PHIs.  
It is now possible to design RCTs using an efficient trial design relying entirely on routinely 
collected data.401 The Pleasant trial used Clinical Practice Research Datalink (CPRD) to 
examine cost-effectiveness of an asthma intervention for children. Benefits of the 
efficient study design were that there was no primary data collection, and no consent 
needed as the data was anonymised and routinely collected. The intervention intended to 
optimise usual care so did not require consent for participation. Additionally, funding 
required to conduct the research was less than that of a typical grant funded RCT.401 The 
main limitation was that utility values were not available and to ask CPRD to collect this 
information would nullify any cost savings to the efficiency of the trial design. Therefore, 
utility decrement was modelled using adult estimates. Estimating or modelling utility 
from adult measures adds a considerable amount of uncertainty to the effectiveness 
results. Consensus among health economists is still yet to be reached on the best way 
measure resource use; 400 there are advantages and disadvantages to traditional and 
efficient measurement methods. 
Another methods point from this analysis that should be critiqued is the use of the SDQ in 
CEA. The advantage of using a condition-specific measure alongside a generic preference-
based HRQoL measure is that they may be more sensitive to change. The disadvantage is 
that these changes along with the cost of achieving such gains produce difficulties for 
decision makers trying to determine cost-effectiveness. As there is no clinical consensus 
on clinically meaningful changes in the SDQ, placing a monetary value on these changes is 
even less straightforward as there is no link to an immediate health or education gain. 
From a local authority perspective, decision makers would need to decide how much they 
are willing to pay for a one-point decrease in SDQ total difficulties score. WTP could be 
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elicited from decision-makers assumes this is their best estimate of the opportunity 
cost.35 This payer threshold may be arbitrary; however, consensus of the threshold value 
may be reached by determining the ranges that previous decision-makers were willing to 
accept as cost-effective, much like was the case with the QALY. The Incredible Years 
programme is a PHI which also quantified outcomes using the SDQ in CEA.369 They report 
a one-point improvement in the SDQ on a 40-point scale (decrease in total difficulties) 
over the wait-list control to cost £1,295 (95%CI -£9,150 to £593). However, the 
uncertainty estimates reported are questioned as the point estimate does not fall within 
the 95% CI. Other analyses determined the cost per child to move out of the ‘high risk’ 
group for the SDQ ranged from £1,612 to £2,418 per child.369 The funder in this study 
accepted these costs per improvement in SDQ, so this is an important case for 
determining the appropriate cost-threshold for point improvements in the SDQ. Moving 
out of the high-risk group has more meaning than a one-point improvement in the SDQ, 
as in a clinical setting those at ‘high risk’ would be assessed further for clinical diagnosis. 
The RoE CEA reported one-point improvements in SDQ (decreases in total difficulties 
score) costing £197 (95% CI: £77 to £471) which depending on contextual circumstances 
may or may not be acceptable to the decision-makers who will decide if RoE should be 
rolled-out more extensively. Publishing these costs per SDQ improvements will contribute 
to defining a socially acceptable threshold. This is of course assuming a one-point 
improvement in SDQ scores can be linked to verifiable and useful outcomes in this 
context. If consensus were reached to determine that a one-point improvement is 
actually meaningless, then any cost per unit improvement is not a worthwhile investment 
and could arguably be better spent somewhere else in the education system, such as 
hiring more teachers or providing more class options.  
Educational outcomes such as attainment would have benefited the RoE economic 
evaluation because local authorities will most likely end up making the funding decision 
for RoE. They will need to decide whether RoE represents value for money, and they are 
more likely to be interested in comparing costs in terms of educational outcomes in 
addition to health outcomes. The thresholds stated are what NICE considers to be cost-
effective from an NHS perspective. Cost-effectiveness thresholds do not exist outside the 
health sector,367 nor has a method been devised to apportion costs (who should bear 
them) when more than one government department or sector is involved.30 This is 
particularly an issue when one sector benefits from a public health intervention while the 
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other is required to fund it. NICE does not make any recommendations for how costs 
should be apportioned, rather the methods chosen should be transparent and justified.30 
This trial was funded by the NIHR and delivered through the Public Health Trusts in 
Northern Ireland. In the event that the funding decision about RoE is transferred to local 
authorities, the collection of educational outcomes would have aided the decision-making 
process. Additionally, there is overwhelming evidence that education is linked to health 
and other outcomes371 so collection of education outcomes would have provided further 
information to aid a decision. 
A critique of the traditional gold standard RCT design with economic evaluation alongside, 
is that they often fail to compare all relevant options.135 Trials are expensive to conduct 
and often times only compare two alternatives head to head, but economic evaluation 
seeks to compare all relevant options. Practically, this is where modelling can be more 
effective at incorporating more than two relevant alternatives. The systematic literature 
review did identify potential CUAs that could have been synthesised and modelled over 
the short-term to act as comparators to RoE. Assumptions would have to be made about 
the comparability of the different measures used for utilities and the differing contexts in 
each study. Modelling over the short-term with the existing data available on cost-
effectiveness in the literature could assist decision-makers as they would have a more 
complete information of different options. However, as few SEL programmes were 
identified, programmes presented would have very different aims, from obesity 
prevention, to vaccination. This evaluation did not address the potential longer-term 
impacts of RoE through use of extrapolation or modelling of potential impacts over the 
child’s lifetime. There is a paucity of longer-term evidence using the main outcomes of 
our analysis, the SDQ and CHU9D, especially the CHU9D which is a relatively new generic 
HRQoL measure. The main reason long-term modelling was not conducted was because 
there was no statistically significant difference in any effect measured in the trial at the 
third year follow-up. If any parameters remained statistically significant, these could have 
been extrapolated into the longer-term; however, this was not the case. The RoE trial did 
provide one of the longest follow-ups of any RoE evaluation identified, so the single trial 
was a sufficient source of immediate and mid-term data.  
An immediate post-intervention significant difference in outcomes that wane over time is 
common in PHIs particularly those that involve behaviour change. A lack of statistical 
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significance in a child outcome in the mid-term does not necessarily mean the 
intervention will not have significant impacts on other adult outcomes. A prime example 
of this is the Perry Preschool Program.28, 246, 402 The Perry Preschool Program is a highly 
cited example of early intervention having long-term impacts on adult outcomes such as 
education, employment, earnings and crime. It is one of few intervention studies to 
follow the 123 participants up to age 40. It also had low attrition with over 90% of the 
original sample participating in age 40 interviews.27 During preschool years, the 
experimental group showed significant gains in IQ over the control, however those gaps 
narrowed when pupils entered school and differences in IQ eventually disappeared when 
pupils reached the age of 8 years.403 By age 40 however, the experimental group 
significantly outperformed the control group on: highest level of schooling completed, 
being in employment, and having fewer lifetime arrests.402 There were methodological 
issues with the randomisation of this study, and unfortunately there are few other 
experimental study designs that have as long a follow-up to replicate these findings. 
However, it does provide an example of potential ‘sleeper effects’ of early intervention. 
The idea that if significant differences in child outcomes wane over time, there is the 
potential for other important adult outcomes to ‘wake up’ when the child matures. This is 
a possibility for RoE, but such long-term follow-up will be costly and likely unfeasible. 
‘Sleeper effects’ provide justification for preventive childhood intervention and offer 
explanation for the prevention paradox and for the small and often waning effects 
observed in PHIs over time during one to three-year follow-ups. Establishing their validity 
is key for this area of prevention and further research is required exploiting the use of 
long-term prospective cohort studies that follow children over their lifetime. 
7.3.1.3 Mapping validation study 
Mapping from a condition specific outcome to a generic preference-based HRQoL 
outcome is a second best option to directly measuring HRQoL, but it may be necessary in 
population health programmes for pragmatic reasons. The fundamental concern is that 
mapping methods assume overlap in each measure’s descriptive systems380 and that can 
be a difficult assumption to make when comparing a specific to a generic measure such as 
the SDQ and CHU9D. The RMSE of the mapping algorithms used in this outcomes piece 
indicated large differences between predicted and observed values at the individual 
level.329 However, the purpose of using mapping methods in economic evaluation is to 
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predict differences across groups or between trial arms, not at the individual level. 
Additionally, the sensitivity analysis that used the mapping algorithm to estimate utilities 
in Chapter 5 resulted in unusually narrow confidence intervals indicating more certainty 
around the results and higher probability of being cost-effective. This indicates that the 
algorithm underestimates uncertainty. The lack of overlap between descriptive systems 
and the algorithms’ potential to underestimate uncertainty requires careful 
consideration.  
There are other mapping algorithms available to estimate child health utility, Khan and 
colleagues309 generated mapping algorithms to predict EQ-5D-Y utility scores from the 
PedsQL. The authors similarly conclude the use of directly measured HRQoL is preferable 
to mapping, but when those measures are not available mapping can produce reasonable 
predictions. A critique of predicting and using EQ-5D-Y utility scores in CUA is that it is not 
structurally different to the adult EQ-5D (the only difference is the language which is 
more appropriate for children) and there are still no preference weights from children 
available to value the resulting utility scores that have been predicted from the PedsQL. 
Chen et al.404 have developed a mapping algorithm to map from non-preference-based 
generic HRQoL KIDSCREEN-10 index to preference-based CHU9D. Two of the original 
developers of the CHU9D (Stevens, K) and corresponding adolescent preferences 
(Ratcliffe, J) were involved in this study. There is also ongoing research by Stavros and 
colleagues310 to develop a preference-based index for the PedsQL. This would provide 
another child specific HRQoL measure much like the CHU9D. Depending on the 
preference elicitation methods used, it may even provide some of the first child values for 
children younger than adolescence (as is currently the case with the CHU9D). More 
recently, a mapping study has been published to map from the CHU9D to the PedsQL to 
estimate QALYs in studies where only PedsQL data is available.405 This algorithm may be 
useful in specific contexts where only PedsQL data is available, however when planning a 
child health economic evaluation, the use of directly measured HRQoL and corresponding 
values (the CHU9D) is preferable to estimating child health utility using a mapping 
algorithm. 
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7.3.2 Strengths of study 
Having critiqued the methods used throughout this thesis, this section now highlights the 
strengths of this body of work. Starting with the systematic review, the novelty and 
breadth of the review are two key strengths. No other review (from my knowledge) 
attempted to collect and synthesis current evidence around evaluation methods 
(economic and non-economic) of school-based health interventions. This was necessary 
to inform methods for future economic evaluations of school-based PHIs (as well as those 
used in this current body of work). The breadth of the review was critiqued in the last 
section, however there were merits for selecting a wide scope and from a purely 
theoretical perspective, the comprehensive review increases confidence in relevant 
evidence being identified. This also minimises potential selection bias as broad selection 
criteria were implemented. In a recent systematic review, a majority of existing 
systematic reviews of economic evaluations found that searches were not extensive 
enough to meet minimum requirements,406 providing further justification for the 
comprehensive approach taken. Other biases and errors were mitigated by implementing 
a novel technique of validity checks performed by the entire review team. As is often the 
case with doctoral candidates, limited time and resources prevent the recruitment of a 
second researcher to be involved in each step of the systematic review process. To 
address this limitation and mitigate any potential bias and error, two validity checks were 
performed at two key stages of the review, a third strength of systematic review. A fourth 
and final strength of the systematic review was the inclusion of a narrative synthesis to 
formally synthesise the evidence gathered. Where meta-analysis is not possible, many 
authors of systematic reviews simply describe the results of the evidence gathered. This 
work took the descriptive analysis a step further by formally synthesising the evidence, a 
final key strength of the review.  
A major methodological component of this thesis was the economic evaluation of RoE. 
The key strength of this work was the novelty of the context for which the economic 
evaluation was performed. It was the first comprehensive CUA which employed a 
paediatric preference-based HRQoL measure within a school-based context. Other 
elements of novelty include the intervention being a PHI and relevant implications for 
CUA, use of child-specific outcomes developed for children, and the application of adult 
and adolescent tariffs in economic evaluation to compare and assess differences between 
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the value sets. The adolescent values are supported as they are the closest to child values 
available and support the notion that decision-making affecting children should 
incorporate their values. The adolescent tariff also produces lower utility values than the 
adult tariff, so it provides a more conservative cost-effectiveness result, which instils 
more confidence in a cost-effective result. This is the opinion of the author, and whose 
values should be considered in economic evaluation is an important theoretical and policy 
question that will continue to be debated. This research not only adds to the available 
effectiveness evidence of RoE, but it also provides the first cost-effectiveness evidence of 
the programme, despite it being around for over 20 years. As it is particularly novel in this 
context, education decision makers may not be entirely sure how to interpret the 
evidence in comparison to other competing budget constraints. The key point is that this 
work acts as a catalyst to start the conversation of cost-effectiveness and economic 
evaluation within the school context. This work acts as a first step to attempt to influence 
decision-making in an education setting. Dissemination will take place primarily through 
publication in the academic literature. This work did not investigate how decision-making 
in education is actually conducted in real life, and further qualitative work would aid this 
understanding.  Previously, decisions were at risk of being made based on emotional 
appeal, absolute intervention cost, and the political landscape.370 A key example of this 
found in the literature is the D.A.R.E (Drug Abuse Resistance Education) programme in 
the USA. It was a large nationwide school-based drug abuse prevention programme that 
averaged three quarters of a billion dollars of federal expenditure annually.407 Numerous 
studies called into question the programme’s effectiveness and a systematic review and 
meta-analysis confirmed the programme to be ineffective.408 This example illustrates the 
need to determine cost-effectiveness of school-based interventions before wider 
implementation, which in this example was across the USA. 
Another strength of this study was the inclusion of the SDQ in CEA. The SDQ is becoming 
more widely used in child and adolescent mental wellbeing. The CEA provided some of 
the first cost-per-improvement in SDQ results to allow the pool of acceptable thresholds 
to accumulate as well as offer a direct comparison to a known threshold of cost per 
QALYs gained. This work will contribute to a growing pool of evidence to aid decision 
makers in interpreting their own cost-effectiveness results using the SDQ. The final 
strength of the economic evaluation was the extensive exploration of uncertainty in the 
base-case estimates of cost-effectiveness, through sensitivity analysis. Sixteen sensitivity 
217 
 
 
analyses were performed to address uncertainty as well as the overarching research 
question of which methods are best to determine cost-effectiveness within this unique 
context. CUA and CEA both have their merits, and while CCA and CBA are worth 
exploring, within the current British context, CUA will be preferred. In terms of addressing 
uncertainty, even when a lower threshold of £13,000 per QALY was adopted, over 80% 
(10/12) of the applicable sensitivity analyses demonstrated cost-effectiveness. This 
increases the certainty of RoE’s cost-effectiveness in a within the trial context. However, 
what is still uncertain is its long-term impacts on cost-effectiveness. 
A key finding from the outcomes study can address this issue of estimating longer-term 
impacts of interventions, given they have collected the SDQ. Strengths of this work mainly 
relate to the implications of the findings. The mapping algorithm which incorporates all 
five subscales of the SDQ predicts the adult values of the CHU9D well. This finding has 
two key implications: 1.) analysts are now afforded the opportunity to conduct CUA in 
paediatric or school-based programmes in the absence of a preference-based HRQoL 
measure, and 2.) the opportunity now exists to estimate longer-term child health utility 
as the SDQ is currently being routinely collected in CAMHS and long-term cohort studies 
such as the Millennium Cohort Study and the Copenhagen County Child Cohort. The 
former impacts economic evaluation in a within trial context and the latter a longer-term, 
modelling context. However, it was found that the mapping algorithms may 
underestimate uncertainty, so this should be carefully considered in a modelling context 
where uncertainty compounds over the longer lifetime horizons of children. 
This work of this thesis will contribute to the sparse literature currently available on 
economic evaluation in a school-based context. It also illustrates the need for a more 
formal decision-making process with regards to incorporating evidence-based education 
programming. While contributing important and novel findings in the area, this thesis also 
gives rise to important questions about how decision-making in education should be 
addressed:  
 How are real life decisions made in education settings? 
 Should CBA, the most comprehensive approach be adopted as standard?  
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 Should the education sector learn from the health sector and adopt a generic 
education outcome to provide a common ‘yardstick’ measure for which all 
programmes can be compared?  
 Are there other more appropriate emerging methodologies? 
 Who should pay for the initial investment of interventions that have multi-sector 
benefits? 
 How should potential long-term outcomes of preventive interventions be 
accounted for? 
The final chapter will address these and additional questions raised throughout by 
providing recommendations, areas for further research, and overall conclusions.  
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8 Recommendations and Conclusion 
8.1 Implications for policy and practice 
The systematic literature review revealed that while there are school-based economic 
evaluations currently available in the literature, the quality of reporting leaves a 
considerable amount to be desired. As a minimum, a health economic evaluation should 
report each of the applicable CHEERS checklist items. Granted the majority of studies 
identified were published prior to the publication of the CHEERS checklist. With 
publication time lags, authors of studies published after 2013 may not have been aware 
of CHEERS because of its focus on health economic evaluation, which might not be on the 
radar of education economists. Still no relevant reporting guidance was found for 
conducting an education economic evaluation.  If/when economic evaluation in school 
settings becomes more standardised, either the CHEERS or other relevant reporting 
guidance could be adopted to improve the quality of reporting. 
From an NHS perspective, RoE is cost-effective based on QALY outcomes, and therefore 
on that basis alone, would be recommended for implementation. However, as it is a 
school-based intervention, cost-effectiveness from the education perspective needs to be 
established. Development of a generic education outcome may be warranted and 
estimation of a cost-effectiveness threshold based on this generic education outcome (or 
other relevant outcome in CEA) could be estimated three different ways. These include: 
estimating marginal productivity through econometric analyses of routinely available 
cost-effectiveness data (requires routinely collected established ‘education outcome’); 
using the ‘bookshelf analogy’ mentioned in section 5.7; or by eliciting WTP from decision-
makers. There may be an obligation for schools to fund the entirety of these programmes 
for future implementation as this is assumed to be the case in Education Endowment 
Foundation draft guidance.365 Given that a number of government departments 
(education and health) could potentially benefit from the outcomes of RoE, there may be 
a case for joint contribution from both sectors to fund its future implementation. 
However, as there is no standard method to apportion these costs,30 this may have 
implications on the future implementation of the programme if schools are required to 
fund the entirety of the intervention.  
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Additionally, less is known about the competing resource constraints in schools or the 
cost-effectiveness of other related SEL programmes that might actually represent better 
value for money. There were high RoE programme costs related to maintaining fidelity to 
Canadian model, and the effectiveness of the programme diminished over the three-year 
follow-up. Other SEL programmes may provide similar effectiveness results with fewer 
costs, but currently this is unknown because the economic evaluation of RoE was the first 
school-based CUA of a SEL programme. The relative novelty of this work in this context 
means that few other school-based programmes have been evaluated in a cost per QALY 
or cost per SDQ improvement framework, meaning that few alternatives are available to 
compare cost-effectiveness results from a RCT study design. It is possible other study 
designs evaluated the SDQ, however comparability may then be compromised as other 
non-randomised study designs are more prone to bias. 
This work has paved the way for economic evaluation in school settings by providing an 
example of a thorough CEA and CUA using child specific outcome measures. However, 
this work has also highlighted the lack of clear funding decision rules for new and existing 
school programmes in terms of a cost per QALY, SDQ, or other relevant education 
outcomes. Allocation decisions in an education setting could potentially be made more 
explicit when economic evaluation of school programmes is performed. Monetary 
analysis using CBA is a starting point as theoretically it is the most comprehensive form of 
economic evaluation enabling multisector benefits to be accounted for in monetary 
terms. If an extrawelfarist framework is to be adopted (in terms of maximising education 
benefits, i.e. a generic education utility), important implications for policy and practice 
will be to determine an appropriate generic education outcome (utility) and  thresholds 
for cost-effectiveness from the school’s perspective as mentioned previously. With an 
established threshold, the cofinancing approach could actually be considered in practice 
as the education sector would have a value per unit of education utility they would be 
willing to pay to help fund an intervention. This would enable the development of 
transparent, consistent decision-making in education as well as a more equitable method 
for funding cost-effective programmes in education. The work of this thesis demonstrates 
the importance of thoroughly evaluating new programmes or interventions for cost-
effectiveness before school-wide or nationwide implementation. It is currently unknown 
if decision-making in education follows a clear and consistent process. In light of this, 
education policy could pose a requirement for all new school-based programmes to be 
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evaluated for effectiveness and cost-effectiveness before school-wide or nationwide 
implementation. This could potentially save billions in wasted resource as would have 
been the case with the D.A.R.E. programme (see Section 7.3.2). 
8.2 Recommendations 
Considering the findings, the following recommendations are made regarding the 
economic evaluation of school-based population health interventions. 
 Economic evaluation of future school-based PHIs could clearly and consistently 
report a set of standardised and appropriate items relevant for an economic 
evaluation. If the economic evaluation is primarily concerned with health 
outcomes, it could as a minimum report all applicable CHEERS checklist items. If 
the PHI is primarily concerned with multi-sector or education benefits, then new 
guidance could be developed which could borrow applicable elements from 
CHEERS.  
 Schools and/or education authorities could consider requiring economic 
evaluation of new programmes before wider implementation. This is especially 
important if substantial investment is required. Key elements of education 
economic evaluations are reported in the following two recommendations below. 
 This thesis recommends CBA as the type of economic evaluation for school-based 
programmes or interventions due to it being the most comprehensive form of 
economic evaluation. CBA can take into account multi-sector outcomes (a key 
challenge for economic evaluation in this setting) as it allows monetary valuation 
of these outcomes in a final cost to benefits ratio or net benefit/loss. This type of 
analysis is feasible given appropriate time and funding, and provides results that 
enable clear, consistent, decision-making criteria. 
 If CBA is not feasible (due to some of the limitations associated with this method 
as previously mentioned), then a mix of CCA, CUA, and MCDA are recommended 
as alternative methods to evaluate cost-effectiveness of school-based PHIs. 
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o CCA is recommended alongside another evaluation method, as it requires 
less resource input and does not present a single combined result in terms 
of costs and effects (therefore enabling clear and consistent decision-
making criteria).  
o CUA is recommended when the PHI is primarily concerned with health 
benefits. However, currently accepted decision rules for cost-effectiveness 
from an NHS perspective may not be acceptable in an education setting. 
Therefore, development of an appropriate generic education utility 
measure, its values, and cost-effectiveness threshold is recommended. 
o MCDA is recommended for PHIs where emphasis for the evaluation is not 
based on a primary outcome but places more emphasis on incorporating 
multiple criteria to improve transparency in decision-making. Methods and 
standardisation are still in a developmental stage; however, this is an area 
worthy of further advancement. 
 When conducting CUA on a child-focussed health intervention, utility could be 
directly measured using the CHU9D and valued with adolescent values. 
Development of preference weights for younger children is currently ongoing, and 
more age appropriate values could be considered for younger children in the 
future. However, use of the adolescent values is currently recommended for all 
child-focussed interventions as values of young people should be considered in 
decision-making that will ultimately affect them. 
 Direct measurement of utility should be the gold standard, where and if this is 
unavailable the SDQ could be used to estimate child health utility as it can be 
reliably mapped to the CHU9D. 
 Further investigation is needed to understand the ‘real life’ decision-making 
context in education. Decision-making could be made more transparent and 
consistent by adopting a set of criteria by which all funding and allocation 
decisions will be made. The criteria could be based on the results of one or 
multiple methods for economic evaluation as recommended above.  
223 
 
 
 It is difficult to expect the onus of funding school-based programmes to rely 
entirely on the education sector when the particular programme generates 
multisector benefits. Development of an equitable method for distributing the 
costs of funding preventive PHIs, such as cofinancing, amongst the sectors that 
stand to benefit, should be explored further. 
 Further work is needed to establish links from short-term trials whose effects may 
wane over time to potential long-term adult outcomes such as ‘sleeper effects.’ 
Lifetime follow-up of an early intervention RCT would provide the strongest 
evidence. If this is not feasible, data linkage and long-term birth cohort studies 
could provide insight into these potential ‘sleeper effects.’ 
8.3 Areas for further research 
8.3.1 Practical application of appropriate methodology to evaluate 
PHIs 
Four different methodologies have been recommended for the economic evaluation of 
school-based PHIs: CBA, CCA, CUA, and MCDA. CBA has been recommended as the gold 
standard, most comprehensive evaluation method as it has the ability to account for 
multi-sector benefits while providing a single combined cost-effectiveness result. 
However, CBA requires more time and resources in the designing and implementation of 
the analysis as more outcomes need to be identified, measured, and valued 
appropriately. Valuation takes more time as the broader outcomes are likely to be unique 
to each evaluation. To take this recommendation forward, researchers need to be aware 
of additional time and resource implications, and build this into funding applications. 
Funders and decision-making bodies should also encourage the use and advancement of 
CBA in PHI contexts.   
NICE currently suggests the use of CUA in the evaluation of PHIs due to it providing a 
common ‘yardstick’ measure to compare the health outcome components of PHIs. NICE 
does consider that CBA and CCA might be a more appropriate way to measure non-health 
outcomes, but still requires a cost per QALY. In recent social care guidance, NICE has 
stated it will consider outcomes other than the QALY such as the ‘social care QALY’ or the 
ASCOT if validated. NICE would also consider parallel analyses incorporating capabilities 
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such as the ICECAP.151 This openness to consider additional outcomes other than the 
QALY could signify an openness to consider CBA on its own without an accompanying 
CUA. CUA is not as useful in an education decision-making context if health is not the 
primary outcome, even if the programme is primarily concerned with health, such as RoE, 
decisions about cost-effectiveness and currently accepted thresholds cannot be expected 
to be the same in education settings. Therefore, if a CUA approach is to be adopted in the 
education sector further research is required to determine an appropriate generic 
education utility, its values, and cost-effectiveness threshold. 
MCDA is an emerging methodology that holds promise for this context, as ISPOR has 
issued several recent guidance documents.160, 161 A disadvantage is that it requires 
considerable cognitive burden on decision makers to provide weights for each individual 
criterion. There is the option to standardise weights, but then the multiple criteria start to 
become restricted and MCDA starts to act a lot like CUA where the disadvantage is that 
broader outcomes cannot be incorporated. The systematic literature review revealed no 
school-based evaluation methodologies employing MCDA suggesting a potential research 
time-lag in the use of MCDA, or the existing guidance may not be sufficient for 
researchers new to the method to confidently conduct MCDA. More research to further 
the development and standardisation of MCDA is needed.  
Economic evaluation alongside a natural experiment design offers the advantage that no 
new data is required to be collected if routine sources are available. The disadvantage is 
that randomisation is not possible and researchers have no input into group allocation or 
the data that is collected. Practical application of this study design will be challenging and 
exploratory as there is no current guidance for the conduct of economic evaluation of 
natural experiments available. Development of methodological guidance for this area is 
justified. 
A final practical issue that could be explored in further research is the utilisation of 
routine data sources to provide more reliable societal costs and benefits of PHIs. In the 
RoE trial, the attempt to collect wider societal costs and benefits was hindered by high 
percentages of missing data. The only method available to capture wider outcomes was 
through contact of the children’s parents by post. This method proved difficult and was 
prone to producing missing and potentially inaccurate data. Further research could 
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explore potential cost-effectiveness of utilising routinely collected data to estimate 
societal costs and benefits. Currently, issues of access to routine data have hindered 
exploitation of this resource. Extracting the data can be time consuming and costly, and 
there are always concerns over patient confidentiality and data breeches. However if 
these issues are addressed and incorporated into the research process, benefits might 
include more accurate and complete data on resource use. 
8.3.2 Defining resource allocation decision criteria in education 
This thesis did not thoroughly investigate how the decision-making process is conducted 
in ‘real life’ education contexts and further research is required. What is lacking in the 
literature is reference to consistent and transparent resource allocation criteria. Clear 
decision criteria could be defined for educational settings to promote consistency and 
prevent any misuse of limited resources. Defining these criteria will depend on the 
economic evaluation method selected as most appropriate for school-based PHIs and 
other school programmes. If CBA is selected, decision criteria could be as simple as only 
considering programmes whose net benefit is positive. If CUA is selected, decision makers 
need to decide if they are willing to accept currently accepted cost-effectiveness 
thresholds for QALYS which don’t currently take into account non-heath benefits. If they 
are not willing to accept this, or would like to incorporate non-health benefits, then 
further work is needed to develop an appropriate generic education utility, values for this 
utility, and an acceptable cost-effectiveness threshold. It is more difficult to define 
decision rules for CCA as decision-makers need to weigh up cost and benefits based on 
their specific needs. Therefore, to promote consistency in the decision making process, it 
is recommended CCA be incorporated as an additional analysis.  
Decision-making in terms of SEW could be standardised if consensus were to be reached 
in terms of the clinical significance of incremental changes in SDQ. The economic 
evaluation of RoE has contributed to a small but growing pool of incremental costs per 
unit change in SDQ and these results will contribute to the estimation or valuation of 
those incremental changes, in addition to eliciting WTP directly from decision-makers. 
The SDQ has been mentioned over 4,000 times in the published literature, if any of those 
studies included or were concerned with cost-effectiveness, then valuation of this SEW 
outcome is warranted.  
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8.3.3 Determining long-term cost-effectiveness of SEL 
programmes 
The potential long-term cost-effectiveness of RoE is still unknown. The short-term 
effectiveness results at 12 months and beyond were not sustained and were insignificant 
at the 36-month follow-up. Therefore, because all outcomes observed in the trial were 
not statistically significantly different at the final follow-up, extrapolation beyond this 
time period was not warranted. Viable extrapolation would be based on multiple 
uncertain assumptions, and the extrapolation time horizon is longer over a child’s lifetime 
creating more uncertainty. The potential validation of ‘sleeper effects’ could mean that 
initial effectiveness results could be linked to long-term adult outcomes such as education 
attainment, health behaviours, unemployment, and crime. However, reliable long-term 
evidence either from a RCT or birth cohort study is needed to establish if any sleeper 
effects are likely. 
An obstacle is the lack of sources containing long-term effects of the childhood measures 
used in the RoE economic evaluation.  The CHU9D was only validated in 2012, which 
means there would only be potentially five years of CHU9D data. The SDQ however, has 
been routinely collected in the Millennium Cohort Study, in which participants will be 
reaching adulthood shortly. With the validation of the SDQ to CHU9D mapping algorithm, 
it may be possible estimate long-term child health utility from cohort studies that have 
collected SDQ scores. This is an exciting area for further research into the estimation of 
long-term child health utility. 
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8.4 Conclusion 
The overarching research question asked, ‘How should the cost-effectiveness of school-
based, population health interventions aimed at children be determined?’  The work of 
this thesis determined CBA to be the most comprehensive method for determining cost-
effectiveness of school-based PHIs. The overall aims of this thesis were to:  
(i) determine what evaluation methods (economic and non-economic) are 
currently being used to evaluate school-based population health interventions;  
(ii) illustrate a good practice example of a thorough cost-utility and cost-
effectiveness analysis of a school-based intervention (the RoE programme) to 
reflect on the advantages of such practice and disadvantages that remain, such 
as decision-making in multisectoral settings; and  
(iii) explore which outcomes are appropriate for children in the SEW and economic 
evaluation context to support future evaluation work in this context.   
This thesis was split into three empirical works to address each part of the aim. The 
systematic literature review revealed that current evaluation methodologies of school-
base PHIs were varied, quality of reporting of health economic evaluation was poor, and 
no emergent methodologies such as MCDA were identified.  
The case study economic evaluation provided an example of the practical application of a 
CUA and CEA in line with current NICE recommendations for determining cost-
effectiveness using child specific outcome measures. From a health services perspective, 
RoE is cost-effective at £11,000 per QALY (CI: -£95,500 to £147,000). It is unknown if this 
result would be acceptable from an education perspective as no consensus has been 
reached if a decision-making threshold should be established for the education sector and 
what generic outcome should be used. Further research is required to understand how 
funding allocation decisions are made in education and how this process could be made 
more transparent. CEA using the SDQ resulted in an ICER of £197 per unit decrease in 
total difficulties score (CI: £77 to £471). It is unknown how this result would be 
interpreted in a health or education decision-making context, however this study has 
contributed to the growing pool of incremental costs per SDQ improvement, which will 
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aid the valuation of those incremental changes if at first, consensus can be reached on 
the clinical significance of those incremental changes.  
Directly measuring child health utility using the CHU9D is preferable as it is the only 
measure to have been developed specifically for children and valued by adolescents 
(eliciting younger children’s values is currently ongoing). However, when traditional utility 
measurement methods are missing, mean utility can be predicted by mapping from the 
SDQ as the final empirical study validated this mapping algorithm. When applying this 
mapping algorithm in economic evaluation, analysts should be cautious of overly narrow 
confidence intervals from resulting ICERS as the algorithm has a tendency to 
underestimate uncertainty. The validated mapping algorithm allows analysts the 
opportunity to conduct CUA in paediatric or school-based programmes where previously 
this would have been challenging due to a lack of preference-based outcome measures. 
This also affords the opportunity to estimate longer-term utility by utilising long-term 
cohort data that routinely collects SDQ outcomes. The school plays an important role in 
shaping our young people’s futures. Economic evaluation of school-based PHIs is justified, 
as schools need to maximise their existing resources in order to give children the best 
start in life. 
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Appendices 
Appendix 1: Description of Electronic Database Searches 
CINAHL was searched using the EBSCOhost interface on 16/07/15, no date restriction was 
applied (1981) 
S1 (MH "Psychological Well-Being") OR (MH "Well-Being (Iowa NOC)") OR (MH 
"Psychological Well-Being (Iowa NOC) (Non-Cinahl)+") OR (MH "Family Member Well-
Being Index") OR "(emotion* OR social*) AND (learn* OR wellbeing OR “well being”)" OR 
(MH "Wellness") (11,047) 
S2 (MH "Program Development/EC/ED/EV") OR (MH "International Classification of 
Functioning, Disability, and Health/EC/ED/EV") OR "2. (improve OR develop) AND (health 
OR academ* OR mental* OR physical*)" OR (MH "Student Health Services/EC/ED/EV") OR 
(MH "Community Health Centers/EC/ED/EV") OR (MH "Health Resource 
Utilization/EC/ED/EV") OR (MH "Child Development Disorders, Pervasive/EC/ED") OR (MH 
"Child Development Disorders+") OR (MH "Child Health/ED/EV") (2,966) 
S3 S1 OR S2 (13,995) 
S4 (MH "Schools, Middle") OR (MH "Students, High School") OR (MH "Students, Middle 
School") OR (MH "High School Graduates") OR (MH "Schools, Secondary") OR "(primary 
OR secondary OR elementary OR junior OR middle OR high) AND (school*)" OR (MH 
"Schools, Elementary") OR (MH "Students, Elementary") OR (MH "Child Development: 
Middle Childhood (6-11 Years) (Iowa NOC)") OR (MH "Unsafe Sex") OR (MH "Risk for 
Violence, Self-Directed or Directed at Others (NANDA)") (13,306) 
S5 (MH "Schools") OR "school* OR educat* OR academ*" (4,775) 
S6 (MH "Child Psychology") OR (MH "Child Psychiatry") OR (MH "Adolescent Nutritional 
Physiology") OR "child* OR adolescent OR p?ediat*" OR (MH "Adolescent Psychology") 
OR (MH "Adolescent Psychiatry") OR (MH "Pediatric Obesity") OR (MH "Physical Therapy 
Practice, Research-Based") OR (MH "Child Nutritional Physiology") (10,746) 
S7 (MH "Course Evaluation") OR (MH "Early Childhood Intervention") OR (MH "Course 
Content") OR (MH "Early Intervention") OR (MH "Curriculum Development") OR (MH 
"Integrated Curriculum") OR (MH "Curriculum") OR "program* OR intervention OR 
curriculum OR course" OR (MH "Intervention Scheme (Omaha)") OR (MH "Crisis 
Intervention") OR (MH "Intervention Trials") (38,282) 
S8 S3 AND S4 AND S5 AND S6 AND S7 (51,449) 
S9 (MH "Cost Benefit Analysis") OR (MH "Costs and Cost Analysis") OR (MH "Health Care 
Costs") OR (MH "Cost Control") OR (MH "Cost Savings") OR (MH "Economic Aspects of 
Illness") OR "(economic*AND eval*) OR (“cost effective*”) OR (“cost benefit”) OR (“cost 
utility”) OR (“cost consequence”)" OR (MH "Health Resource Utilization") OR (MH 
"Substance Addiction Consequences (Iowa NOC)") OR (MH "Therapy, Computer Assisted") 
OR (MH "Sports Science") OR (MH "Outcomes of Education") OR (MH "Health Resource 
Allocation") (77,829) 
S10 (MH "Health and Life Quality (Iowa NOC) (Non-Cinahl)") OR (MH "Quality-Adjusted 
Life Years") OR (MH "Quality of Life") OR (MH "Quality of Life (Iowa NOC)") OR (MH 
"Ferrans and Powers Quality of Life Index") OR (MH "Quality of Health Care") OR (MH 
"Quality of Care Research") OR "model* OR utility* OR (“quality of life”) OR (“health 
related quality of life”) OR ( “return on investment”) OR (“social return on investment”)" 
OR (MH "Quality Assessment") OR (MH "Economic Value of Life") OR (MH "Evaluation and 
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Quality Improvement Program") OR (MH "Life Cycle") OR (MH "Lifelong Learning") 
(88,989) 
S11 S9 AND S10 (7,994) 
S12 S8 AND S11 (120)  
S13 (MM "Health Impact Assessment") OR "(economic*AND eval*) OR (“cost effective*”) 
OR (“cost benefit”) OR (“cost utility”) OR (“cost consequence”) OR model* OR (“decision 
tree”) OR (“decision analytic model”) OR (“return on investment”) OR (“social return on 
investment”) OR (“budget impact analysis”) OR (social impact assessment”) OR (“health 
impact assessment”) OR (“discrete choice”) OR (“stated preference”) OR (“multi-criteria 
decision analysis”)" OR (MM "Cost Benefit Analysis") OR (MM "Costs and Cost Analysis") 
OR (MM "Decision Support Techniques") OR (MH "Health Care Costs") OR (MM "Decision 
Trees") OR (MH "Social Network Analysis (Saba CCC)") OR (MH "Decision Making") (501) 
S14 "utility* OR (“quality of life”) OR (“health related quality of life”) OR (“quality 
adjusted life year”) OR (“disability adjusted life year”) OR (“net benefit*”) OR (“net 
present value”) OR cost* OR (“resource use”) OR fund* OR benefit* OR effect* OR 
“contingent valuation” OR “willingness to pay” OR “human capital”" OR (MM "Quality-
Adjusted Life Years") OR (MM "Health and Life Quality (Iowa NOC)") OR (MM "Economic 
Value of Life") OR (MM "Quality of Life") OR (MH "Adolescent-Family Inventory of Life 
Events and Changes") (21,303) 
S15 S9 OR S13 (78,268) 
S16 S10 OR S14 (88,996) 
S17 S15 AND S16 (8,027) 
S18 S8 AND S17 (16) Exported to Endnote 
 
The Cochrane Library was searched on 22/05/15, no date restriction was applied  
#1 MeSH descriptor: [Psychology, Social] explode all trees (15257) 
#2 (emotion* or social*) and (learn* or wellbeing or "well being") (5018) 
#3 (improve or develop) and (health or academ* or mental* or physical*) (28403) 
#4 #1 or #2 or #3 (44611) 
#5 school* or educat* or academ* (128706) 
#6 (primary or secondary or elementary or junior or middle or high) and (school*) (43117) 
#7 child* or adolescent or p?ediat* (157987) 
#8 program* or intervention or curriculum or course (154614) 
#9 #4 and #5 and #6 and #7 and #8 (3001) 
#10 (economic*AND eval*) or ("cost effective*") or ("cost benefit") or ("cost utility") or 
("cost consequence") (31104) 
#11 model* or utility* or ("quality of life") or ("health related quality of life") or ("return 
on investment") or ("social return on investment") (108172) 
#12 #10 and #11 (15714) 
#13 #9 and #12 (419) Exported to Endnote 
 
ERIC was searched using the EBSCOhost interface on 16/07/15, no date restriction was 
applied 
S1 (emotion* OR social*) AND (learn* OR wellbeing OR “well being”) (85,454) 
S2 (improve OR develop) AND (health OR academ* OR mental* OR physical*) (41,581) 
S3 school* OR educat* OR academ* (1,272,403) 
S4 (primary OR secondary OR elementary OR junior OR middle OR high) AND (school*) 
(444,603) 
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S5 child* OR adolescent OR p?ediat* (1,523,815) 
S6 program* OR intervention OR curriculum OR course (704,690) 
S7 crim* OR (“criminal justice”) OR famil* (140,888) 
S8 S1 OR S2 OR S7 (245,788) 
S9 S3 AND S4 AND S5 AND S6 AND S8 (49,319) 
S10 (economic*AND eval*) OR (“cost effective*”) OR (“cost benefit”) OR (“cost utility”) 
OR (“cost consequence”) OR model* OR (“decision tree”) OR (“decision analytic model”) 
OR (“return on investment”) OR (“social return on investment”) OR (“budget impact 
analysis”) OR (social impact assessment”) OR (“health impact assessment”) OR (“discrete 
choice”) OR (“stated preference”) OR (“multi-criteria decision analysis”) (202,536) 
S11 utility* OR (“quality of life”) OR (“health related quality of life”) OR (“quality adjusted 
life year”) OR (“disability adjusted life year”) OR (“net benefit*”) OR (“net present value”) 
OR cost* OR (“resource use”) OR fund* OR benefit* OR effect* OR “contingent valuation” 
OR “willingness to pay” OR “human capital” (485,700) 
S12 S10 AND S11 (86,710) 
S13 S9 AND S12 (264) Exported to Endnote 
 
MEDLINE was searched using the Ovid interface on 16/07/15, no date restriction was applied 
(1946 to February Week 2 2015) 
1. (emotion* or social*).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier] (456,271) 
2. (learn* or well?being).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier] (238,234) 
3. 1 and 2 (30,284) 
4. (improve or develop).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier] (716,326) 
5. (health or academ* or mental* or physical*).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier] (2,031,573) 
6. 4 and 5 (195,757) 
7. (crim* or criminal justice or famil*).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol supplementary 
concept word, rare disease supplementary concept word, unique identifier] (723,064) 
8. 3 or 6 or 7 (919,578) 
9. (school* or educat* or academ*).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol supplementary 
concept word, rare disease supplementary concept word, unique identifier] (601,969) 
10. (primary or secondary or elementary or junior or middle or high).mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, keyword heading 
word, protocol supplementary concept word, rare disease supplementary concept word, 
unique identifier] (4,623,768) 
11. school*.mp. (149,259) 
12. 10 and 11 (68,859) 
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13. (child* or adolescent or p?ediat*).mp. [mp=title, abstract, original title, name of 
substance word, subject heading word, keyword heading word, protocol supplementary 
concept word, rare disease supplementary concept word, unique identifier] (1,634,123) 
14. (program* or intervention or curriculum or course).mp. [mp=title, abstract, original 
title, name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier] (1,066,300) 
15. 8 and 9 and 12 and 13 and 14 (5,336) 
16(economic*AND eval* or cost effective* or cost benefit or cost utility or cost 
consequence or model* or decision tree or decision analytic model or return on 
investment or social return on investment or budget impact analysis or social impact 
assessment or health impact assessment or discrete choice or stated preference or multi-
criteria decision analysis).mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept word, 
rare disease supplementary concept word, unique identifier] (2,247,848) 
17. (utilit* or cost* or fund* or benefit* or effect*).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary concept word, unique 
identifier] (3,947,557) 
18. (<quality of life> or <health related quality of life> or <quality adjusted life year> or 
<disability adjusted life year> or <net benefit*> or <net present value> or <resource use> 
or <contingent valuation> or <willingness to pay> or <human capital>).mp. [mp=title, 
abstract, original title, name of substance word, subject heading word, keyword heading 
word, protocol supplementary concept word, rare disease supplementary concept word, 
unique identifier] (205,812) 
19. 17 or 18 (4,046,146) 
20. 16 and 19 (976,895)  
21. limit 20 to (english language and full text and humans and "all child (0 to 18 years)" 
and "economics (best balance of sensitivity and specificity)") (10,087) 
22. 15 and 21 (99) 
 
PsychINFO was searched using the EBSCOhost interface on 22/05/15, no date restriction 
was applied (Journal coverage from 1800s to present) 
S1 DE "Well Being" OR DE "Early Intervention" OR DE "Social Support" OR DE "Anxiety 
Disorders" (76841) 
S2 DE "Health Promotion" OR DE "Health Knowledge" OR DE "Health Education" OR DE 
"Health Behavior" OR DE "Conduct Disorder" OR DE "Early Intervention" OR DE 
"Psychological Development" OR DE "Delayed Development" OR DE "Mental Health 
Program Evaluation" OR DE "Child Guidance" OR DE "Community Mental Health" OR DE 
"Child Care Workers" (66390) 
S3 S1 OR S2 (131937) 
S4 DE "Social Approval" OR DE "Help Seeking Behavior" OR DE "School Psychologists" OR 
DE "School Based Intervention" (20066) 
S5 DE "Middle School Students" OR DE "Secondary Education" OR DE "Primary Mental 
Health Prevention" OR DE "Intermediate School Students" OR DE "School Psychologists" 
OR DE "Primary School Students" OR DE "Boarding Schools" OR DE "Multicultural 
Education" OR DE "Social Studies Education" OR DE "Junior High School Students" OR DE 
"Performance" OR DE "Course Evaluation" OR DE "Junior High Schools" OR DE "Junior 
High School Teachers" OR DE "Juvenile Delinquency" (67602) 
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S6 DE "Adolescent Psychopathology" OR DE "Juvenile Justice" OR DE "Juvenile 
Delinquency" OR DE "Adolescent Psychology" OR DE "Adolescent Pregnancy" OR DE 
"Adolescent Development" OR DE "Adolescent Psychotherapy" OR DE "Adolescent 
Psychiatry" OR DE "At Risk Populations" OR DE "Course Evaluation" OR DE "Educational 
Program Evaluation" OR DE "School Psychologists" OR DE "Child Psychopathology" 
(101035) 
S7 DE "Course Evaluation" OR DE "School Based Intervention" OR DE "Early Intervention" 
OR DE "Family Intervention" OR DE "Curriculum Development" OR DE "Educational 
Objectives" OR DE "Intervention" OR DE "Group Intervention" OR DE "Curriculum" OR DE 
"Educational Counseling" OR DE "Behavior Change" OR DE "Health Promotion" OR DE 
"Psychotherapeutic Outcomes" OR DE "Psychological Assessment" (126761) 
S8 S3 AND S4 AND S5 AND S6 AND S7 (70) 
S9 DE "Costs and Cost Analysis" OR DE "Cost Containment" OR DE "Health Care Costs" OR 
DE "Health Care Economics" OR DE "Early Intervention" (economic*AND eval*) OR (“cost 
effective*”) OR (“cost benefit”) OR (“cost utility”) OR (“cost consequence”) OR DE "School 
Based Intervention" (62257) 
S10 DE "Time Perspective" OR DE "Psychological Assessment" OR DE "Quality of Care" OR 
DE "Quality of Life" OR DE "Mental Health Program Evaluation" OR DE "Relationship 
Quality" (54239) 
S11 S9 AND S10 (2785) 
S12 DE "School Based Intervention" (10612) 
S13 S9 AND S15 (28) Exported to Endnote 
 
Web of Science was searched using the Core Collection interface on 22/05/15, no date 
restriction was applied  
#1 TOPIC: (emotion* OR social*) Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, 
BKCI-S, BKCI-SSH, CCR-EXPANDED, IC Timespan=All years (1046458) 
#2 TOPIC: (learn* OR well?being) Indexes=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, 
BKCI-S, BKCI-SSH, CCR-EXPANDED, IC Timespan=All years (621095) 
#3 TOPIC: (crim* OR (“criminal justice”) OR famil*) DocType=All document types; 
Language=All languages; (58970) 
#4 #3 OR #2 OR #1 DocType=All document types; Language=All languages; (4939163) 
#5 TOPIC: (school* OR educat* OR academ*) DocType=All document types; Language=All 
languages; (2646697) 
#6 TOPIC: ((primary OR secondary OR elementary OR junior OR middle OR high) AND 
(school*)) DocType=All document types; Language=All languages; (552141) 
#7 TOPIC: (child* OR adolescent OR p?ediat*) DocType=All document types; Language=All 
languages; (605619) 
#8 TOPIC: (program* OR intervention OR curriculum OR course) DocType=All document 
types; Language=All languages; (1292500) 
#9 #8 AND #7 AND #6 AND #5 AND #4 DocType=All document types; Language=All 
languages; (8975696) 
#10 TOPIC: ((economic*AND eval*) OR (“cost effective*”) OR (“cost benefit”) OR (“cost 
utility”) OR (“cost consequence”) OR model* OR (“decision tree”) OR (“decision analytic 
model”) OR (“return on investment”) OR (“social return on investment”) OR (“budget 
impact analysis”) OR (“social impact assessment”) OR (“health impact assessment”) OR 
(“discrete choice”) OR (“stated preference”) OR (“multi-criteria decision analysis”)) 
DocType=All document types; Language=All languages; (394642) 
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#11 TOPIC: (utilit* OR (“quality of life”) OR (“health related quality of life”) OR (“quality 
adjusted life year”) OR (“disability adjusted life year”) OR (“net benefit*”) OR (“net 
present value”) OR cost* OR (“resource use”) OR fund* OR benefit* OR effect* OR 
“contingent valuation” OR “willingness to pay” OR “human capital”) DocType=All 
document types; Language=All languages; (170748) 
#12 #11 AND #10 DocType=All document types; Language=All languages; (1421934) 
#13 #12 AND #9 DocType=All document types; Language=All languages; (223993) 
#14 #12 AND #9Refined by: RESEARCH AREAS: (PEDIATRICS OR EDUCATION 
EDUCATIONAL RESEARCH) DocType=All document types; Language=All languages; (5700) 
#15 #12 AND #9Refined by: RESEARCH AREAS: (PEDIATRICS OR EDUCATION 
EDUCATIONAL RESEARCH) AND DOCUMENT TYPES: (ARTICLE OR CLINICAL TRIAL OR 
REVIEW) DocType=All document types; Language=All languages; (229585) 
#16 #12 AND #9Refined by: RESEARCH AREAS: (PEDIATRICS OR EDUCATION 
EDUCATIONAL RESEARCH) AND DOCUMENT TYPES: (ARTICLE OR CLINICAL TRIAL OR 
REVIEW) AND LANGUAGES: (ENGLISH) DocType=All document types; Language=All 
languages; (200) Exported to Endnote 
 
Health Technology Assessment Database, DARE AND NHS EED were searched using the 
University of York Centre for Reviews and Dissemination interface on 22/05/15, no date 
restriction was applied 
1 MeSH DESCRIPTOR Population EXPLODE ALL TREES (140) 
2 MeSH DESCRIPTOR Schools EXPLODE ALL TREES (180) 
3 MeSH DESCRIPTOR Child EXPLODE ALL TREES (4567) 
4 MeSH DESCRIPTOR Early Intervention (Education) EXPLODE ALL TREES (36) 
5 MeSH DESCRIPTOR Health Promotion EXPLODE ALL TREES (823) 
6 MeSH DESCRIPTOR Curriculum EXPLODE ALL TREES (38) 
7 #1 OR #2 OR #3 OR #4 OR #5 OR #6 (5384) 
8 MeSH DESCRIPTOR Cost-Benefit Analysis EXPLODE ALL TREES (12838) 
9 MeSH DESCRIPTOR Quality of Life EXPLODE ALL TREES (2248) 
10 #8 AND #9 (1041) 
11 #7 AND #10 (166) Exported to Endnote 
 
EconLit was searched using the EBSCOhost interface on 17/07/15, no date restriction was 
applied (Journal coverage from 1800s to present) 
#S1 (emotion* OR social*) AND (learn* OR wellbeing OR “well being”) (18,341) 
#S2 (improve OR develop) AND (health OR academ* OR mental* OR physical*) (8,097) 
#S3 crim* OR (“criminal justice”) OR famil* (51,628) 
#S4 S1 OR S2 OR S3 (74,251) 
#S5 school* OR educat* OR academ* (170,695) 
#S6 (primary OR secondary OR elementary OR junior OR middle OR high) AND (school*) 
(12,661) 
#S7 child* OR adolescent OR p?ediat* (1,291,718) 
#S8 program* OR intervention OR curriculum OR course (96,305) 
#S9 S4 AND S5 AND S6 AND S7 AND S8 (735) 
#S10 (economic*AND eval*) OR (“cost effective*”) OR (“cost benefit”) OR (“cost utility”) 
OR (“cost consequence”) OR model* OR (“decision tree”) OR (“decision analytic model”) 
OR (“return on investment”) OR (“social return on investment”) OR (“budget impact 
235 
 
 
analysis”) OR (“social impact assessment”) OR (“health impact assessment”) OR (“discrete 
choice”) OR (“stated preference”) OR (“multi-criteria decision analysis”) (345,972 
#S11 utilit* OR (“quality of life”) OR (“health related quality of life”) OR (“quality adjusted 
life year”) OR (“disability adjusted life year”) OR (“net benefit*”) OR (“net present value”) 
OR cost* OR (“resource use”) OR fund* OR benefit* OR effect* OR “contingent valuation” 
OR “willingness to pay” OR “human capital” (502,451) 
#S12 S10 AND S11 (177,671) 
#S13 S9 AND S12 (149) Results Exported to Endnote 
  
Appendix 2: Systematic literature review validity checks 
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Authors
Year of 
Publication
Country of 
Origin
Title
Journal
Aims/Objectives Study Design Age
Setting
Intervention Description
CEA
Ansell, J.; 
Guyatt, H. L.
2002
Tanzania
Comparative cost-effectiveness of 
diagnostic tests for urinary 
schistosomiasis and the implications 
for school health programmes
Annals of Tropical Medicine and 
Parasitology
To compare the costs and cost-effectiveness of self-
diagnosis, use of reagent strips and parasitological 
examination in identifying infected individuals or 'high 
risk' schools for S. haematobium.
Descriptive, diagnostic testing School-aged children
15 schools (n=2370) in 
Muheza district, 
Tanzania
Four diagnostic tests considered: 1) self-reporting of 
schistosomiasis during interview with public-health 
nurse, 2) the reagent-strip testing of urine for presence of 
blood, 3) the examination of urine for visible blood, and 
4) filtration of a 10-ml urine sample and microscopical 
examination of the filter for S. haematobium eggs.
Bertrand, 
Elise; et al
2011
Canada
Cost-effectiveness simulation of a 
universal publicly funded sealants 
application program
Journal of Public Health Dentistry
To simulate a publicly funded program of pit and fissure 
administration, either in the public or private sectors, 
and compare these hypothetical situations with the 
current one, i.e., a publicly funded, school-based 
selective program.
Markov model developed using a 
virtual population of 8-year-old 
children monitored over a time span of 
10 years.
8-year-old children
Children in Quebec
3 options of sealant delivery: the mixed, private, and 
school situation.
Crowley, D. 
Max; et al
2014
USA
Can we build an efficient response to 
the prescription drug abuse epidemic? 
Assessing the cost effectiveness of 
universal prevention in the PROSPER 
trial
Preventive Medicine
Evaluate the cost effectiveness of universal evidence-
based-preventive-interventions (EBPIs) to reduce 
nonmedical prescription opioid use.
Rural schools from Iowa and 
Pennsylvania randomised to control or 
intervention groups
Grade 6 children 
approx. 11-12 years
US schools/ 
communities
Four programmes evaluated: Strengthen families 
program (n=827), All Stars (n=1936), Life Skills Training 
(n=1166), and Project Alert (n=1924)
Foster, E. M.; 
et al
2006
USA
Can a costly intervention be cost-
effective?: An analysis of violence 
prevention
Archives of general psychiatry
Examine the cost-effectiveness of the Fast Track 
intervention designed to reduce violence among at-risk 
children.
Costs estimated using program budgets 
of this cluster randomised controlled 
trial. ICERS computed to determine 
cost per unit improvement in the 3 
outcomes measured in the 10th year of 
study (CEA).
School-aged children 
grade 1-10
US schools
High risk children identified in schools and those scoring 
in the top 40% were selected to receive the intervention, 
91% agreed (n=3,274). Intervention delivered from grades 
1 though 10. Parents offered parent training and home 
visiting, academic tutoring, and social skill training. 
Parent and child groups offered 2-hour enrichment 
program. Group meetings held weekly, biweekly, then 
monthly each year on. Social emotional learning program 
PATH adapted in school curriculum.
Foster, John 
M.; et al
2013
USA
Does Teacher Professional 
Development Improve Math and 
Science Outcomes and Is It Cost 
Effective?
Journal of Education Finance
Examine in-service professional development program 
targets at chronically low-achieving schools and examine 
whether it improve student learning at those schools 
while considering cost of providing program compared to 
other types  of school improvement interventions.
38 school districts participated and 
evaluated outcome data pre and post 
intervention
School-aged children 
grade 4 to 12
Appalachian Kentucky 
school districts
Ultimate goal is to improve student outcomes in the STEM 
subject areas. Training delivered for K-12 tears of math 
and science covering content training in algebra, 
geometry, physics, and biology.
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Authors
Year of 
Publication
Country of 
Origin
Primary Outcome
Follow-up
Results (OR, RR, risk ratio, CI, p-value, mean diff) Conclusions Type of evaluation
Viewpoint/perspective
Time horizon
Costs
CEA
Ansell, J.; 
Guyatt, H. L.
2002
Tanzania
1) number of children who were 
correctly identified by the test, 
and 2) number of infected 
children who were identified by 
the test (i.e. true positives)
none
Using self report to identify high risk schools and 
then reagent strips to id individuals in low-risk 
schools was more 'cost-effective' than the gold 
standard urine test, but would result in 8% of cases 
being missed.
A cost-consequence type of analysis with 
various scenarios was presented for 
health care planners to decide which 
approach to take considering local 
resource constraints.
CEA
none stated
none stated
Cost per infected child: Urine filtration: $2.30; Self-
reported: $1.33; and self-reported to identify high risk 
schools and reagent strips to identify individuals: $1.43. 
Cost/correct diagnosis: Urine filtration: $1.00, Reagent 
strips: $0.5, Visible blood $0.56, see Table 1 and 2 
provide fixed and variable costs of the screening tests. 
Bertrand, 
Elise; et al
2011
Canada
No. of children without decay 
on the surface of the first 
permanent molar.
modelled over 10 years
School is most cost-effective strategy at $172 per 
child without decay as compared to the mixed 
situation. It is $868 in private compared to mixed.
Implementing a universal, school-based 
program of pit and fissure sealant 
application would improve access to 
preventive dental care and provide more 
social equity in Quebec's healthcare 
system. But it is ultimately a political 
decision.
Markov Model
Health care system and parents' 
perspective
10 years, due to estimated 
efficacy of sealants.
Screening in schools, examinations in private clinics, 
sealant application and restoration in private clinics. 
Cost of staff, materials, travel by patients and their 
parents, and productivity loss for parents. Fees from a 
Fee Guide and Description used as proxy for costs of 
examinations, sealant application and restoration in 
private clinics. See table 3 for more details
Crowley, D. 
Max; et al
2014
USA
Cases of opioid use averted
Mentions 6 year follow-up of 
one of the trials (PROSPER).
Authors report universal school-based EBPIs can 
efficiently reduce nonmedical prescription opioid 
use, and family programs may enhance the school-
based programs.
Universal EBPIs can effectively and 
efficiently reduce nonmedical 
prescription opioid use and should be 
considered when developing responses 
to the growing national crisis.
Cost-effectiveness analysis with 
decision tree, classified as CEA
societal
not explicitly stated 
Program costs estimated from previous analysis, 
opportunities costs estimated expenditures and any 
inputs from outside sources.
Foster, E. M.; 
et al
2006
USA
Three key long-term outcomes 
first is diagnosis of conduct 
disorder i.e. cost per case of 
conduct disorder averted 
10 years
The intervention was not cost-effective at likely 
levels of policymakers' willingness to pay for key 
outcomes. Subgroup analysis of those most at risk 
showed intervention was likely to be cost-effective 
given specified willingness-to-pay criteria.
Intervention is cost-effective for children 
at the highest risk. Practical issues still 
remain such as the ability to effectively 
identify and recruit such high-risk 
children.
CEA
Payer such as a state department 
of mental health.
10 years
Estimated from Fall 1991 to Summer 2003 from annual 
budget record or program costs from early years of the 
intervention. Cost of intervention estimated 
retrospectively.
Foster, John 
M.; et al
2013
USA
AMSP professional 
development activities' effect 
on student outcomes
None, before and after study
AMSP professional development program appears to 
provide a rout to improving the quality of current 
teachers therefore improving student outcomes.
Replication of this type of cost-
effectiveness analysis on middle school 
mathematics training should be carried 
out and if results replicated, content-
focused professional development 
targeted to middle school teachers looks 
promising as a means of enhancing 
teacher quality of the current work force.
CEA
none stated
None, before and after
Table 6 from expenditure reports of the AMSP grant. 
Includes: admin compensations and travel, trainee 
stipends and meals, wages and fees, materials, supplies 
and overheads. Average cost per student $44.33
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Authors
Year of 
Publication
Country of 
Origin
Alternatives described?
Important costs and consequences 
of each alternative identified?
Resource use
Effectiveness data
Type of preference 
measure
Measure of benefit (QALY, 
DALY)
Use of discounting?
Rate used
Currency
ICER Analysis of uncertainty
Model Parameters
CEA
Ansell, J.; 
Guyatt, H. L.
2002
Tanzania
yes
Costs identified seem sufficient 
for each alternative. Mainly costs 
of delivering screening were 
identified with less resource use 
being identified.
Second visit for treatment and drug costs were 
considered, but only drug cost would effect an 
incremental if one had been calculated.
Correct diagnosis, infection identified, and no. of 
infected children treated were the measures of 
effect
none
none
No, assume not 
needed because 
screening under a 
year
none
USD 1995
Calculated based on cost of each scenario and effect as 
the proportion of number of infected children treated. 
Urine filtration compared to self-report: $12.13. Self 
report to id schools compared to self report alone: $2
none
none
Bertrand, 
Elise; et al
2011
Canada
yes
Yes, data integrated in models are 
specific to each option.
Staff costs, sealant, productivity loss, travel and 
meals.
Children without decay at first molar
none
Decay on first permanent 
molar.
yes
3% base case and 0 
and 5% for 
sensitivity analysis
CAD, no year 
specified
C/E ratios from health care perspective: $179/child 
without decay in mixed, $220 in private, $179 in school. 
C/E ratios for parents: $125, $68 and $84 respectively. 
ICER $868 per child in private compared to mixed and 
$172 in school compared to mixed.
Sensitivity analysis varying retention, resealing, 
re-restoration, decay incidence, high-risk 
children proportion and discounting.
Yes, they are listed in table 2
Crowley, D. 
Max; et al
2014
USA
Yes, but mean costs and effects 
for each not reported
no
Lumped into societal costs and estimated from 
previous studies
Probability of youth misusing prescription opioids
none
none, not CUA
yes 
3%
USD assumed, not 
explicitly stated
All are compared to controls  not the next most 
costly/effective intervention. Life Skills: 
$613/prevention of one youth misusing prescription 
opioids, All Stars + school family program (SFP): $4,923, 
Life Skills + SFP: $3,959, no ICER reported for Project 
Alert?
Bootstrapping to construct 95% CI around each 
ICER (using 1,000 replications)
not stated
Foster, E. M.; 
et al
2006
USA
No, just described as control 
group.
No, just reported ICER
Did not detail
Three outcomes, conduct disorder averted, index 
criminal act avoided and personal act of violence 
avoided.
n/a
none
yes
5%
USD 2004
Entire sample: CD: $3,481,433, Crime: $423,480, 
Violence: 736,010. Low-risk group: CD: $-2,059828, 
Crime: $-1,786,032, Violence: $-9,046,977. High-risk 
group: CD: $752,103, Crime: $150,738, Violence: 
$283,542.
Yes, generated 1000 bootstrapped samples
n/a
Foster, John 
M.; et al
2013
USA
Not really, but costs and effects of 
alternative interventions are 
provided in table 7
yes
None collected, just intervention costs
Reported effect size of comparators, intervention 
effect reported effect size of 0.03 on middle school 
math achievement.
none
none
no
none
USD, no price year 
stated
They report effectiveness/cost of 0.000677. I 
recalculated at $1477.66. Comparators range from 
$48.19 for rapid assessment to $8,086,300 for charter 
schools. Outcomes are reported effect sizes, but 
outcome for each is unknown and assumed to be 
different for different studies.
no
n/a
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Year of 
Publication
Country of 
Origin
Title
Journal
Aims/Objectives Study Design Age
Setting
Intervention Description
CEA
Hollingworth, 
W.; et al
2012
UK
Reducing smoking in adolescents: cost-
effectiveness results from the cluster 
randomized ASSIST (A Stop Smoking In 
Schools Trial)
Nicotine & tobacco research : official 
journal of the Society for Research on 
Nicotine and Tobacco
Conduct a cost-effectiveness analysis of a school-based 
'peer-led' intervention.
Cluster randomised controlled trial of 
59 secondary schools in England and 
Wales.
12-13 year-old 
students
Secondary schools in 
England and Wales
The ASSIST programmed trained students to act as peer 
supporters during informal interactions to encouraged 
their peers not to smoke.
Kesztyus, D; 
et al
2013
Germany
Economic evaluation of URMEL-ICE, a 
school-based overweight prevention 
programme comprising metabolism, 
exercise and lifestyle intervention in 
children
European Journal of Health Economics
Measuring the impact of the URMEL-ICE school-based 
overweight prevention programme on anthropometric 
measures in primary-school children, computing 
incremental cost-effectiveness relation?(ICER) and net 
monetary benefit.
Intervention study with historical 
control. School-based cluster 
randomised intervention trail w/o 
control.
Second grade primary 
school children
Ulm, Germany,  for 
control. Bavarian 
country of Gunzberg 
for intervention.
Lecture material integrated into usual curriculum so 
didn't require additional lessons. Three risk factors 
address: physical activity, consumption of sweetened 
beverages, and media use. 28 teaching units over 36 
weeks with 6 family homework assignments.
Levaux, HP; 
et al
2001
USA
Economic evaluation of a 2-dose 
hepatitis B vaccination regimen for 
adolescents
Pediatrics
Investigate the economic implications of a 2-dose hep B 
vaccine compared to 3 does for adolescents in 3 settings: 
public schools, public health clinics, and private sector 
settings in US.
Model based on primary data collection 
(CEA).
Adolescents 11-15
Private, public health 
clinics and public 
schools across USA
Comparing 2-dose regimen to 3-dose regimen given in 
three different settings: private, public health clinic and 
public schools
Noyes, K; et 
al
2012
USA
Cost-effectiveness of the school-based 
asthma therapy (SBAT) program
Pediatrics
Examine the cost-effectiveness of school-based asthma 
therapy (SBAT) compared with usual care.
School-based randomised controlled 
trial with stratification based on smoke 
exposure (OTHER
Children aged 3-10
Urban school, 
Rochester City School 
District, NY
Each child received 1 dose of medication from school 
nurse once each school day, dose varied depending on 
severity. In control caregivers encouraged to contact their 
PCP to discuss asthma symptoms.
Simon, E; et 
al
2013
Netherlands
An explorative cost-effectiveness 
analysis of school-based screening for 
child anxiety using a decision analytic 
model
European Jouranl of Adolescent 
Psychiatry
Determine CE of 1) one-time school-based screening 
child focused intervention 2)screening and parent 
intervention 3)screening and parent or child 
intervention 4) do nothing for child anxiety.
Model based on real-world data, 
mainly based on econ evaluation of 
RCT of this screening programme, 
followed-up for 2 years (CEA).
8 to 12
The Netherlands, 
screens take place at 
primary schools.
Evaluating effectiveness of three types of interventions 
to a do nothing approach.
Wang, LY; et 
al
2008
USA
Cost-Effectiveness of a School-Based 
Obesity Prevention Program
Journal of School Health
Evaluate the cost-effectiveness of the Medical College of 
George FitKid Project, a 3-year, afterschool program 
designed to prevent obesity among elementary school 
students
CEA of a randomised, controlled trial of 
18 elementary schools in Georgia were 
randomly assigned. Total of 601 
students with retention of 88% and 
96% intervention/control in first year. 
CEA
Third graders
Elementary schools in 
Augusta, GA
2-hour after-school session offered 5 days a week which 
encouraged youth to make PA a regular part of their 
schedules. Sessions included 40 mines of academics and 
snack and 80 minutes of MVPA. Average attendance 49%.
Beets, M. W.
2014
USA
Making healthy eating and physical 
activity policy practice: The design and 
overview of a group randomized 
controlled trial in afterschool programs
Contemporary clinical trials
To evaluate the effectiveness of healthy eating and 
physical activity (HEPA) strategies, which consist of a 
multi-step, adaptive intervention approach, that 
addresses price barriers to serving more healthful snacks 
and professional development training to develop core 
competencies to promote physical activity.
RCT will be reported to CONSORT 
guidelines for cluster RCTs. Repeated 
cross-sectional group randomized 
controlled trial with delayed treatment 
group.
Elementary school-
aged children (6-12)
After school programs 
(ASP) in the state of 
California
ASP that serve on a daily basis a fruit or vegetable, 
eliminate foods and beverages high in added sugar, avoid 
artificial ingredients and provide at least 30 to 60 minutes 
of moderate to vigorous physical activity.
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Year of 
Publication
Country of 
Origin
Primary Outcome
Follow-up
Results (OR, RR, risk ratio, CI, p-value, mean diff) Conclusions Type of evaluation
Viewpoint/perspective
Time horizon
Costs
CEA
Hollingworth, 
W.; et al
2012
UK
Odds ratio for being a smoker 
2 years
Programme cost £32/student, incremental 
cost/student not smoking at 2 years was £1,500 
(95%CI £669-£9947). Students in intervention were 
less likely to believe they would be a smoker at age 
16.
The ASSIST programme reduced smoking 
among adolescents at a modest cost. 
Extending intervention to year 8 students 
would cost approx. £38 million and result 
in potentially 20,400 fewer adolescent 
smokers.
Cost-effectiveness analysis
Public sector including cost to 
Local Authority and NHS
1 school year, not discounted but 
followed up for 2 years
Staff costs, intervention costs and personnel costs.
Kesztyus, D; 
et al
2013
Germany
Waist circumference
1 year
WC gain was 1.61 and WHtR gain 0.014 significantly 
less in intervention. Cost €24.09 per child. ICER €11.11 
(95CI 8.78:15.02) per cm WC and €18.55(95CI 
14.04:26.86) per unit WHtR gain prevented.
New info about cost-effectiveness of 
structured health promotion embedded 
in daily routine at primary schools. At 
WTP of €35 this intervention is cost-
effective and this result may help 
decision makers in implementing 
programmes to prevent childhood 
overweight in school settings.
CEA stated
societal
1 year
Cost of developing programme, time spent prepping 
lessons, materials, training. Costs of programme 
delivery all summed to get a cost per pupil. No health 
resource use collected.
Levaux, HP; 
et al
2001
USA
Cost per LY gained Compliance rose with 2 does which resulted in lower 
infection rate and greater CE in all settings. In public 
health clinic, 2 dose dominated 3 dose in LT. ST costs 
higher for 2 dose, without LT cost offsets of reduced 
infection.
Improved compliance with 2 doses 
contribute to a higher probability of 
adolescents achieving HBV protection, 
when LT consequences of HBV  included, 
2 dose is CE in all settings.
Decision analytic model, decision 
tree for ST
societal
lifetime
Preparation work for vaccine dose, admin and disposal 
of vaccine, follow-up of patient who may have missed 
scheduled dose.
Noyes, K; et 
al
2012
USA
mean number of symptom free 
days
$10 per one extra day symptom free. 158 SFD gained 
per 30-day period per 100 children. Extra $4822 per 
100 children per month, net savings $3240.
SBAT was effective and cost-effective in 
reducing symptoms in urban children 
with asthma compared with usual care.
CEA
Main analysis: Medicaid 
perspective (payer) also used 
societal perspective for ICER
1 school year (7-9 months)
4 categories: programmatic costs, health care costs, 
school attendance fees losses, and parents' productivity 
losses.
Simon, E; et 
al
2013
Netherlands
ICER based on ADIS improved 
child
Strategies 1 and 2 were dominated by 3 and 4, 
strategy 3 requires additional investment of 107 for 
each additional ADIS improved child.
Screening followed by child/parent 
intervention depending on parent 
anxiety had high increment effects and 
low costs compared to do nothing 
approach. Differences between groups 
small, explorative and first evidence of 
CE for this screening intervention.
DAM, decision tree, CEA
societal
2 years inferred, not directly 
stated.
Healthcare, direct non-healthcare, indirect and out-of-
pocket costs
Wang, LY; et 
al
2008
USA
Reduction in percent body fat 
(%BF)
1 year
Intervention cost $174070, $558/student or 
$956/student who attended >40% of sessions. Usual 
after-school care costs estimated at $639/student. 
Students who attend >40% reduced %BF by 0.76% (CI -
1.42, -0.09) at an additional cost of $317/student
Students who attended >40% of sessions 
achieved a sig reduction in  %BF at 
relatively low cost. School-based obesity 
prevention programs of this type are 
likely to be a CE use of public funds and 
warrant careful consideration by policy 
makers and planners.
CEA  
states societal
1 year, doesn't give adequate 
justification for not including the 
2 additional years follow-up that 
is available.
Two types of costs considered: cost of delivering FitKid 
program after-school and usual cost of after-school care 
when no intervention is provided.
Beets, M. W.
2014
USA
Children's accelerometer-
derived MVPA and time spent 
sedentary at ASP, HEPA 
promoting and inhibiting 
behaviours, types of snacks 
served and consumed.
3 years, one year baseline 2 
years intervention
protocol protocol Protocol, stated CEA will be 
performed.
Societal
none stated
Costs of snacks and cost of intervention/standard 
practice.
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Hollingworth, 
W.; et al
2012
UK
Smoking prevention 
education/standard practice.
No health service costs identified.
Staff time including travel time, training materials, 
venue costs, bus hire, peer support vouchers.
OR of being a smoker and smoker prevalence.
none
Reduction in smoking 
prevalence
No, one year 
programme, but 
followed up over 2 
years
none
GBP 2008
£1500 per student not smoking. (£32/0.021) CI's 
calculated using bootstrap sampling of 10,000 
iterations.
Sensitivity analysis around privately contracted 
trainers increased cost £38/student and if 
employed ASSIST trainers average cost/student 
falls by £6.
none
Kesztyus, D; 
et al
2013
Germany
Not enough detail, very confusing, 
poor quality reporting
No, control had 'null costs' so 
missing costs of control
Teacher time, scientific coordinator for training and 
teacher support.
Relative risk for overweight at follow-up and RR for 
incident WHtR.
none, CEA
none
no, one year
none
2008 Euro
Cost €24.09 per child. ICER €11.11 (95CI 8.78:15.02) per 
cm WC and €18.55(95CI 14.04:26.86) per unit WHtR gain 
prevented. ICER calculation in text does not match 
mean values reported in Table 2.
Sensitivity analysis varying effectiveness by 10, 
20 and 30%, but said it 'shall be tested' as if they 
haven't done it yet? State all costs were precisely 
collected during trial so only vary effects at 10, 20 
and 30% lower values. 
no model
Levaux, HP; 
et al
2001
USA
Yes, 2 and 3-dose regimens
yes
Advertising and promo material, equipment in set-
up, vaccine/materials, staff time required to 
administer/ clinical duties
Compliance of 3-dose regimens from 
questionnaires. As no 2-dose data available, 
compliance derived from 3 doses.
LYs gained
yes 
5%
2001 USD CPI
Private sector 2-dose: $964/LY, $1517/infection 
prevented; public school 2-dose: $1246/LY 
$1960/infection prevented
One-way and multivariate sensitivity analyses 
performed, varied from 50% to 150% of base-case 
values. Varied compliance as well.
Probability of vaccine, protection, preventing 
infection, cost/person/infection prevented/LY.
Noyes, K; et 
al
2012
USA
yes
yes
see costs above
SFD
none
Cost per SFD
no
USD 2009
see results Bootstrapped and varied unit costs to lower and 
upper bounds of 95% CI
Probability of high anxious or not high anxious.
Simon, E; et 
al
2013
Netherlands
yes Resources used for care of the child (anxiety, other 
psych problems, physical problems) through use of 2 
week cost diaries.
ADIS (diagnostic interview) 'improved' or 'not 
improved'
yes
4%
2012 Euro Dutch 
indexes
€107 per ADIS improved between strategy 3 and 4. Scenario performed with 1) screening organised 
during annual visit of school physician 2) optimal 
participation rates 3) with only direct health care 
costs (i.e. healthcare perspective). One-way 
sensitivity Analyses on costs and probabilities 
increasing/decreasing by 25%.
Wang, LY; et 
al
2008
USA
Yes, estimated cost of after-school 
care
Only considered two types of 
costs and barely considered 
consequences
Personnel, training, transportation and materials to 
deliver the intervention
%BF reduction
none
No, stated this was a 
limitation
No, one year time 
horizon
2003 USD
see results Simple sensitivity analysis varying per capita 
usual after-school care costs in plausible range 
from $5 to $10.
Beets, M. W.
2014
USA
Briefly as standard practice, no 
HEPA strategies
no
none mentioned
Didn't specify from outcomes which would be the 
main measure of effect they would use in the ICER 
calculation. Refer to it simply as 'effect.'
None
'Effect' not specified
no
USD, no year stated
Refer to calculation of CER, but definition given is an 
ICER.
none
none
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Brooker, 
Simon; et al
2010
Kenya
Improving educational achievement 
and anaemia of school children: design 
of a cluster randomised trial of school-
based malaria prevention and 
enhanced literacy instruction in Kenya
Trials
To evaluate the impact of school-based malaria 
prevention and enhanced literacy instruction on the 
health and educational achievement of school children 
in Kenya.
A factorial, cluster randomised trial Primary school classes 
1 to 5
Being implemented in 
101 government 
primary schools on 
the coast of Kenya
i) Intermittent screening and treatment of malaria in 
schools by public health workers, ii)training workshops 
and support for teachers to promote explicit and 
systematic literacy instruction. Schools randomised to 
one of four groups receiving either i) the malaria 
intervention alone, ii) the literacy intervention alone, iii) 
both combined, or iv) control
Ford, Tamsin; 
et al
2012
UK
Supporting teachers and children in 
schools: the effectiveness and cost-
effectiveness of the incredible years 
teacher classroom management 
programme in primary school children: 
a cluster randomised controlled trial, 
with parallel economic and process 
evaluations
Bmc Public Health
To evaluate whether teacher classroom management 
improves socio-emotional well-being among children as 
measured by the SDQ and cross-validated with direct 
observation, parental SDQ and child report on How I Feel 
About My School where available. Many more, see page 
2.
Cluster randomised controlled trial of 
the Incredible Years teacher classroom 
management (TCM) course with 
combined economic and process 
evaluations.
Children aged 4-9
Primary schools 
within Devon, Torbay 
and Plymouth
TCM draws on cognitive social learning theory, about how 
coercive cycles of interaction between adults and 
children reinforce unwanted behaviour patterns. It also 
incorporates strategies for challenging angry, negative, 
and depressive internal dialogue in adults whilst 
interacting with children, drawn from cognitive 
behavioural approaches.
Carabin, H.; 
et al
2000
Egypt
A population dynamic approach to 
evaluating the impact of school 
attendance on the unit cost and 
effectiveness of school-based 
schistosomiasis chemotherapy 
programmes
Parasitology
Model the possible costs and effectiveness of reaching 
non-enrolled children through school-based 
programmes using empirical data from Egypt. 
Population dynamic model School-aged children
Egypt
Four strategies compared: school-based coverage of 85% 
and school-aged targeted coverage of 25, 50 and 85%. No 
actual trial, modelled strategies based on previously 
collected data.
Nishiura, H; 
et al
2014
Japan
Cost-effective length and timing of 
school closure during an influenza 
pandemic depend on the severity
Theoretical Biology and Medical 
Modelling
Optimize the timing and length of school closure during 
influenza pandemic for cost-effectiveness.
Modelling study with ICER of Yen/LY 
(OTHER)
Age groups 
proportional to that of 
Japan
Japanese schools
Modelled effect of different lengths of school closures to 
'reactive school closings' closing when many people are 
infected. Closure was varied from 7, 14 and 21 days.
Muennig, PA; 
et al
2014
USA
The Cost-effectiveness of New York 
City's Safe Routes to school program
American Journal of Public Health
Evaluate CE of a package of roadway modification in NYC 
funded under the Safe Routes to School program for 
both school age and adult users.
Markov model (OTHER) School age and adults
New York City
Federally funded $612M program to build new sidewalks, 
bicycle lanes, and improve safety at crossings, upgrade 
signage. Intended to encouraged children to walk/bike to 
school.
Barrett, 
Jessica; et al
2015
USA
Cost Effectiveness of an Elementary 
School Active Physical Education Policy
American Journal of Preventive 
Medicine
The purpose of this study is to estimate the cost 
effectiveness of a state “active PE” policy implemented 
nationally requiring that at least 50% of elementary 
school PE time is spent in moderate to vigorous physical 
activity (MVPA).
A previously developed cohort model 
(ACE from Australia) was used to 
simulate the impact of an active PE 
policy on physical activity, BMI, and 
healthcare costs over 10 years for a 
simulated cohort of the 2015 U.S. 
population aged 6–11 years. Data were 
analysed in 2014.
Aged 6-11 years
US population of 
children attending 
public elementary 
schools
An "active PE" policy implementing state policy directing 
state boards of education to include PE curriculum a 
requirement that 50% of PE time be devoted to MVPA.
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CEA
Brooker, 
Simon; et al
2010
Kenya
Educational achievement and 
anaemia, the hypothesised 
mediating variables through 
which education is affected.
24 months
protocol protocol Protocol, CEA
Assessed from both provider 
(government) and societal 
perspective
none stated
Assessed using an ingredient approach, based on 
interviews with individuals involved in delivering the 
interventions and by consultation of the programme 
accounting system. The aim is to estimate the cost of 
scaling-up the interventions in Kenya.
Ford, Tamsin; 
et al
2012
UK
Total difficulties score from the 
SDQ completed by class teacher, 
supplemented by parent SDQs.
30 months, with data collection 
at baseline, 9, and 18 months
protocol protocol Protocol, CEA
Broad public sector perspective, 
including use of all health, 
education and social care 
services, plus criminal justice 
sector resources and criminal 
activity.
Primary economic evaluation will 
look at T3, 30 month follow-up. 
Will explore 'longer-term 
implications.'
A brief questionnaire to parents to capture high 
cost/high use resource items. The full interview will be 
used with a random sample of 50 parents to validate 
the supplement. Educational service use collected from 
schools. TCM costs will use a micro costing (bottom-up 
approach.
Carabin, H.; 
et al
2000
Egypt
Cases of disease prevented
Wasn't an intervention study so 
no follow-up
No. treated, infection and early disease of both 
bacterium presented in Table 4. The school based 
strategy which only covered 85% still prevented 77% 
of cases of disease. Would cost USD $0.06-1.03 to 
reach non-enrolled children.
Treating non-enrolled children is an 
important consideration in maximizing 
the effectiveness of treatment 
programmes while mainlining a cost-
effectiveness comparable to school-
based delivery.
Population dynamic model
none stated
15 years modelled, 5 for 
intervention 10 years follow-up
Nishiura, H; 
et al
2014
Japan
Not cost-effective. If risk of death three times greater 
than that of H1N1, the school closure could be 
regarded as cost-effective.
No fixed timing and duration of school 
closure that can be recommended as 
universal guideline. The effectiveness of 
school closure depends on the 
transmission dynamics of a particular 
strain especially the infection fatality 
risk.
model
none stated
1 year, inferred
Annual leave due to needing to stay home with 
children, and cost to save a single year of life?
Muennig, PA; 
et al
2014
USA
SRTS associated with net societal benefit of $230M 
and 2055 QALYs gain in NYC
SRTS reduces injuries and saves money in 
the long run.
Markov model
societal
50 years
Cost of pedestrian injury, transport cost to school, 
death, program cost
Barrett, 
Jessica; et al
2015
USA
cohort model simulated over 10 
years
: An elementary school active PE policy would 
increase MVPA per 30-minute PE class by 1.87 
minutes (95% uncertainty interval [UI]¼1.23, 2.51) 
and cost $70.7 million (95% UI¼$51.1, $95.9 million) in 
the first year to implement nationally. Physical 
activity gains would cost $0.34 per MET-hour/day 
(95% UI¼$0.15, $2.15), and BMI could be reduced 
after 2 years at a cost of $401 per BMI unit (95% 
UI¼$148, $3,100). From 2015 to 2025, the policy would 
cost $235 million (95% UI¼ $170 million, $319 million) 
and reduce healthcare costs by $60.5 million (95% 
UI¼$7.93 million, $153 million).
: Implementing an active PE policy at the 
elementary school level could have a 
small impact on physical activity levels in 
the population and potentially lead to 
reductions in BMI and obesity-related 
healthcare expenditures over 10 years.
CEA
Modified societal perspective
10 years
1) training PE teachers; 2) training school principals; 3) 
replacement of equipment and materials; 4)state PE 
coordinator time for oversight, implementation and 
monitoring.
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Brooker, 
Simon; et al
2010
Kenya
Yes, see intervention description
not mentioned
none mentioned
Improvements in test scores and educational 
achievement, assessed in terms of differences in 
standard deviation units.
None
See effectiveness
No
not stated
ICER will be calculated for each outcome in relation to 
the status quo, the other health intervention packages 
tested in the present study, and current interventions.
A comparison with alternative education 
interventions, especially those conducted in 
Kenya, will also be undertaken.
None
Ford, Tamsin; 
et al
2012
UK
Briefly as no classroom 
management
not mentioned
Will be collected mainly via Child and adolescent 
service Use schedule (CA-SUS). 
Total difficulties score SDQ.
Not a preference measure
SDQ
none stated
Not stated, GBP 
assumed
CE will be assessed using the net benefits approach. Will use non-parametric bootstrapping to explore 
the probability that each of the treatments is the 
optimal choice, subject to a range of possible 
maximum values (ceiling ratio) that a decision-
makers might be willing to pay for an additional 
unit of outcome gained.
Didn't mention specifics, just that data from the 
trial supplemented by data from the literature 
will be used in decision analytic modelling 
techniques.
Carabin, H.; 
et al
2000
Egypt
yes
unclear
Unit cost of treatment
Reduction in the number of infection or in the 
number of early disease cases over 15 years.
none
Number of disease cases 
prevented
yes
5%
USD no price year 
stated
None presented, gave unit cost per child of $0.60 for 
school-based and an additional $1.03 per child treated 
to reach non-school enrolled children
Performed on unit costs
Yes, given in Appendix 2
Nishiura, H; 
et al
2014
Japan
no
not clear
not clear
Life years, infections, absolute difference b/t two 
scenarios.
ICER in Japanese Yen per 
LY
LY
no
Japanese Yen
Provided graphically, didn't state ICER, because was 
never below their threshold.
none stated
Age groups, susceptibility of contracting flu, 
2ndary transmission, reduction of cases due to 
closure, risk of death.
Muennig, PA; 
et al
2014
USA
no
not clear
Not described outside of costs listed
QALE, questionable methods to obtain QALE. 
EQ5D5L given to two 
senior Pediatric 
orthopaedic surgeons
QALE
Yes, only over 50 
years
3%
2013 USD
None reported, supposedly cost saving, QoL .95 too 
high for injured people.
Found it to be cost saving so didn't run, so only 
did it on the annual model? A series of 1-way 
sensitivity along with MC sim including 'plausible 
boundaries' for values.
No. of people at risk, risk ratio of injury, 
probability of hospitalisation, case fatality ratio, 
QALE. Costs: total program costs, injury costs, 
death and transportation costs to school.
Barrett, 
Jessica; et al
2015
USA
yes, current practice
yes
see costs
MVPA converted to MET-hours assuming average 
MET level of 4.5. MET hour increase and BMI unit 
change
none
MET-hour increase per day 
after 1 year and cost per 
BMI unit change after 2 
years
yes 
3%
2014 USD
$0.34 per MET-hour gained (95% UI$0.15 to $2.51) $401 
per BMI unit reduced (95% UI $148 to $3,100). Over a 10 
year period $1,720 per BMI unit reduced. ($272 to 
$5,710).
PSA using Monte Carlo simulations in @RISK over 
10,000 and 1,000,000 iterations.
yes, given in Table 1
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Blakely, 
Tony;et al
2014
New Zealand
Cost-effectiveness and equity impacts 
of three HPV vaccination programmes 
for school-aged girls in New Zealand
Vaccine
Estimate the health gains, net-cost and cost-
effectiveness of the currently implemented HPV 
national vaccination programme of vaccination dispersed 
across schools and primary care, and two alternatives: 
school-based only, and mandatory school-based 
vaccination but the opt-out permitted.
Markov macro-simulation model 12-year-old girls and 
boys
New Zealand schools 
and primary care
1) as currently implemented HPV national vaccination 
programme for girls only across schools and primary care 
for 2) school-based only 3) mandatory school-based with 
active opt out.
Cooper, K.; et 
al
2012
UK
An economic model of school-based 
behavioural interventions to prevent 
sexually transmitted infections
International Journal of Technology 
Assessment in Health Care
Assess the cost-effectiveness of behavioural 
interventions in school, for the prevention of sexually 
transmitted infections, in young people.
Economic model 13-15 years
UK, school/ 
community care
Three interventions: teacher led (20 sessions over two 
years), peer led (three sessions of one hour over one 
school term), and standard sexual health education. 
Frick, K. D.; et 
al
2004
USA
Modelled cost-effectiveness of the 
experience corps Baltimore based on a 
pilot randomized trial
Journal of Urban Health-Bulletin of the 
New York Academy of Medicine
1) Model the cost-effectiveness of the Experience Corps 
Baltimore using data from a pilot randomized trial, 
including costs, older adults' health status, and quality of 
life and cost data from the medical expenditure panel 
survey and 2) describe the relationship between 
children experience increased expected lifetime earning 
through improve educational attainment resulting from 
exposure to the Experience Corps Baltimore volunteers  
and the program's cost-effectiveness.
Pilot randomised controlled trial of 6 
schools
Older adults and 
children
Baltimore schools
Designed to provide opportunities for older adults to give 
back to their communities by involving volunteers in high-
impact generative activities to provide help for public 
elementary schools with attendant moderate physical, 
social, and cognitive engagement of the volunteers. 
Volunteers provided literacy support, behaviour 
management, violence prevention, community outreach 
and library support.
Gerald, JK; et 
al
2010
USA
Cost-effectiveness of school-based 
asthma screening in an urban setting
Journal of Allergy Clinical Immunology
To conduct a cost-effectiveness analysis of school-based 
asthma screening strategies.
5 health state Markov model used to 
evaluating school-based screening in 
simulated population of urban 
elementary school children (CUA)
Elementary school-
aged children
Urban school setting, 
in Birmingham, 
Alabama; 95% black, 
80% eligible for 
subsidized lunches
Simulated four mutually excluding screening strategies 
compared to no screening over 1 year. Four strategies: 1) 
the Narrow Questionnaire, 2) The Broad Questionnaire, 
3)Multi-Stage with Spirometry, and 4) Multi-stage with 
Exercise testing.
Konig, HH 
and Barry, JC
2004
Germany
Cost-Utility analysis of orthoptic 
screening in Kindergarten: a Markov 
model based on data from Germany
Pediatrics
To estimate the long-term cost-effectiveness of a 
hypothetical screening program for untreated amblyopia 
in 3-year-old children conducted by orthoptists in all 
German kindergartens in the year 2000.
CUA with decision tree combined with 
Markov model.
3-year-old children
All German 
kindergartens
Orthoptic screening for children age 3 in all German 
kindergartens in the year 2000.
Kowada, A
2012
Japan
Cost effectiveness of Interferon-
Gamma Release Assay for School-
based tuberculosis screening
Molecular Diagnosis & Therapy
To assess the cost effectiveness of school-based 
tuberculosis (TB) screening using QunatiFEROn TB Gold 
In-Tube (QFT) versus the tuberculin skin test (TST) and 
chest x-ray examination (CXR).
Markov models 1st year high school 
and university 
students
Hypothetical cohort 
modelled. 
QFT vs. TST vs. CXR
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Blakely, 
Tony;et al
2014
New Zealand
State cost/QALY, but actually 
Years of life lived in disability
Not intervention study so no 
follow-up
Current programme $18800/QALY; school only 
$33000/QALY;  mandatory $117000/QALY. All 
interventions generated more QALYs for indigenous 
and deprived people
A more intensive school-only vaccination 
programme seems warranted. Reducing 
in vaccine price will greatly improve CE 
possibly making mandatory vaccine 
optimal from a HC perspective
Markov macro-simulation model 
with 2,000 Monte Carlo iterations
Health care system  
Lifetime, or until participants 
reach 110.
Vaccine costs $113 , delivery and administration $141 or 
$126, and cost of enacting new law for third 
intervention and delivery admin cost of $19 per dose
Cooper, K.; et 
al
2012
UK
Condom use estimated using 
meta-analysis of studies 
identified
Not an intervention study so no 
follow-up. No information of 
time horizon of model
See summary outcomes and ICER results. School-based behavioural interventions 
which provide information and teach 
young people sexual health skill can 
bring about improvements in knowledge 
and increased self-efficacy through these 
may be limited in terms of impact on 
sexual behaviour. Some uncertainty 
around these results.
Cost-utility analysis
NHS and PSS 
Not explicitly stated so unclear if 
discounting required
Direct costs were treatment of infection and provision 
of the interventions and taken form published UK 
sources. All updated using NHS multiplier and reported 
in Euros. Assume no difference in costs and outcomes 
of standard education.
Frick, K. D.; et 
al
2004
USA
Cost/QALY, QALYs not 
measured, estimated from 
other sources
2 years
$205,000/QALY older adults, with 12-15 additional 
students graduation because $49,000/QALY and cost-
effective. WTP threshold not defined.
Using conservative modelling 
assumptions and excluding benefits to 
teachers, principals and the surrounding 
community, the Experience Corps 
Baltimore appears expensive for older 
adults' health improvements, but 
requires only small long-term benefits to 
the target children to make the program 
cost-effective.
Markov model, with random 
transitions
none stated
2 years
Salaries of supervisory staff, recruitment/training, 
volunteer stipends, and other operating costs.
Gerald, JK; et 
al
2010
USA
Cost/QALY, obtained from 
secondary sources
1 year modelled
Most efficient strategy identified children with 
previously diagnosed but poorly controlled asthma at 
a cost of $15000/QALY. 
Population-based (school) asthma 
screening is not cost-effective at 
$50,000/QALY and has only a 20% chance 
of being cost-effective at $100,000/QALY. 
Population-based asthma screening not 
cost-effective.
Decision tree with Markov model
societal
1 year, Markov model has 365 
daily cycles
Daily cost included: ASFD, symptom day and 
exacerbation recover day, medicines, and routine 
physician visits. Screening costs, health resource use, 
indirect costs, medication and acute care. 
Konig, HH 
and Barry, JC
2004
Germany
Incremental costs and effects, 
the ICER
Lifetime modelled
Orthoptic screening was €7,397/QALY. Probability of 
ICER <€25,000/QALY was 84%.
The ICER of orthoptic screening seems to 
fall within a range that warrants careful 
consideration by decision-makers. Much 
of the uncertainty in the results stems 
from the effect of amblyopia on quality 
of life.
CUA with decision tree and 
Markov model
Third-party payer perspective
Lifetime
Costs of organisation screening exam, fixed costs, 
variable costs, ophthalmologic exam, and cost of 
treatment.
Kowada, A
2012
Japan
QALYs gained
Lifetime modelled
QFT strategy yielded the greatest benefits at the 
lowest cost: 16-years-olds $627.89, 29.69835 QALYs; 19-
year-olds $646.04, 29.15361 QALYs. TST 16 $943.50, 
29.69767 QALYs; 19 $998.62, 29.15288 QALYs. CXR 16 
$7,286.24, 29.69767QALYs; 19 $7,305.19, 29.14911 
QALYs
The QFT strategy provided the greatest 
benefits at the lowest cost for school-
based TB screening. There appears to be 
little role for TST or CXR in screening of 
school populations. Current practices 
using either TST or CXR screening should 
be reconsidered on the basis of cost 
effectiveness.
Markov model
Societal
Lifetime (up to 80 years)
Direct costs, such as inpatient and outpatient costs and 
indirect costs arising from loss of productivity. Costs of 
screening included the labour cost for two physician 
visits and TST kits. QFT included screening kits, on 
physician visit and labour cost for lab technicians. CXR 
material, on physician visit and labour of radiologic 
technetium, etc.
249 
 
 
 
Authors
Year of 
Publication
Country of 
Origin
Alternatives described?
Important costs and consequences 
of each alternative identified?
Resource use
Effectiveness data
Type of preference 
measure
Measure of benefit (QALY, 
DALY)
Use of discounting?
Rate used
Currency
ICER Analysis of uncertainty
Model Parameters
CUA
Blakely, 
Tony;et al
2014
New Zealand
yes
yes
Delivery and administration for each scenario, cost 
of enacting new immunization law. Health systems 
cost based on sex and age group and cancer stage of 
care.
Vaccine coverage and subsequent reduction in HPV
Used disability weights
Referred to as QALY, but 
used disability weights 
applied to non-fatal states 
to calculate years life lived 
in disability.
yes
3% base case and 0 
and 6% in scenario 
analyses
NZ dollars 2011
School based program vs current program 
$34,700/'QALY.' For mandatory law vs school-based 
$122,500/'QALY'
Univariate sensitivity analysis using 2.5 and 97.5 
percentile values from the uncertainty 
distribution for each input parameter showed 
large variation in ICER. Scenario analyses to 
change costs, excluding unrelated health care 
costs, and herd immunity estimates.
Sex, age, ethnicity, mortality due to cancer and 
incidence
Cooper, K.; et 
al
2012
UK
yes
No, did not identify costs and 
outcomes of the standard sexual 
health programme. Also appears 
they assume the same effect for 
both teacher and peer lead 
intervention.
For teacher and peer led interventions based on 
results of two UK trials and valued using UK primary 
and secondary sources.
From published studies and UK reports, condom use
Utility data from studies of 
groups of patients who 
had developed 
complications from STIs. 
Methods for eliciting 
preferences not reported.
QALY  
State that they 
updated the analysis 
to reflect changes in 
discount rates.
none stated
EUR, no price year 
stated
€24,268/QALY for teacher led and €96,938 with the peer-
led intervention. Probably of less than €36,000=16%
One-way sensitivity analyses undertaken by 
varying all the model parameters across plausible 
ranges. A PSA carried out with input values 
sample from probability distribution using 1,000 
Monte Carlo simulations. Presented as CEAC.
Yes, detailed in table 4
Frick, K. D.; et 
al
2004
USA
no
not detailed 
Volunteer commitment of 15 hours a week (not 
costed specifically but given a stipend to cover 
expenses)
Self-report health status.
Didn't use one, so used 
self-reported health status 
of project older adults' 
outcomes.
QALY (projected from self-
report health status)
yes
3%
USD 2003
$205,000/QALY for adults. If 12 additional students 
graduated (0.3%) ICER would be $50,000/QALY and if 15 
additional graduate, the program would be cost-saving.
5,000 iterations to obtain a distribution of cost-
effectiveness results
Health states of older adults
Gerald, JK; et 
al
2010
USA
In previous paper
yes
Screening costs, questionnaire, spirometry, 
administration, dry visit, diagnostic procedure, 
medication, MD visit, hospital stay, ED visit
QALY, not entirely sure how they got their QALY 
weights. Symptom days, asthma severity, ED visits, 
hospitalisations.
Each health state was 
associated with a 'quality 
adjusted life day' and used 
paediatric health outcome 
measure to calculate 
QALYs.
QALY stated. Reference is 
given in a table.
No, 1 year time 
horizon
none
USD 2006
Not sure how calculated, report Narrow Questionnaire: 
$151,000/QALY; Broad Questionnaire: $312,000/QALY; 
in text and NQ: $127,020 and BQ: $251, 850 and MSwSP 
and MSwET as dominated in table E3.
One way deterministic sensitivity analysis 
between NQ and status quo repeated with 
individual cost elements. Sensitivity analysis 
demonstrated 3 variables accounted for 90% of 
uncertainty: symptom day preference weight, 
prevalence, and baseline rate of symptom days.
Asthma, diagnosis, controlled, prevalence, and 
disease severity, see table 1 for model inputs.
Konig, HH 
and Barry, JC
2004
Germany
Briefly as usual care
yes
modelled costs
Modelled from estimates from literature.
QALY
QALY
Yes
5%
EUR 2000
€7,397/QALY Univariate and Monte Carlo simulation. 90% 
uncertainty interval of the ICER of €3,452 to 
€72,637/QALY
Screening population, test characteristics, 
Effectiveness, utilities, costs, mortality, 
treatment success, discount rate
Kowada, A
2012
Japan
yes
yes
Just the costs mentioned were include in a 
hypothetical cohort.
QALYs as identified in the literature.
QALY
QALY
yes
3%
USD 2009
See Table 4, all ICERs are dominated by the QFT 
strategy.
One-way and two-way sensitivity analyses, 
comparing all strategies simultaneously. Each 
model variable was assigned a distribution based 
on the values in literature or assumptions. PSA 
with Monte Carlo simulation also performed.
Age, probability of having TB, LTBI, developing TB 
fromLTBI, mortality rate from TB, all cause 
mortality.
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Miller, T.; et 
al
2013
Zimbabwe
Cost-effectiveness of school support 
for orphan girls to prevent HIV 
infection in Zimbabwe
Prev Sci
Analyse cost per QALY gained in school support as a 
structural intervention to prevent HIV risk factors among 
Zimbabwe orphan girls adolescents.
RCT Adolescent orphan 
girls grade 6
A rural province in 
Zimbabwe
Based on Social Development Model, includes school 
support (fees, uniforms and school supplies) and a helper 
which is a trained teacher (approx. 1 per 10 participants). 
Helpers monitored attendance and intervened with 
absenteeism with access to a small emergency fund.
Moodie, M;et 
al
2009
Australia
Cost-effectiveness of active transport 
for primary school children-Walking 
school bus program
International Journal of Behavioural 
Nutrition and Physical Activity
To assess from a societal perspective the incremental CE 
of the Walking School Bus (WSB) program for Australian 
primary school children as an obesity prevention 
measure.
Modelled effects on BMI and DALYs of 
he WSB program applied throughout 
Australia. (CUA)
5 to 7
Australia
Children are accompanied by 2 volunteer adult 
"conductors" (ratio 1 adult to 8 children) and travel along 
a set route through a neighbourhood picking up children 
along the way at designated stops and delivering them to 
school.
Moodie, M; 
et al
2013
Australia
The Cost-effectiveness of a successful 
community-based obesity prevention 
program: the be active eat well 
program
Pediatric Obesity
Examine the CE of Be Active Eat Well (BAEW), a large, 
multifaceted, community-based capacity-building 
demonstration program that promoted healthy eating 
and PA for Australian children.
CEA/CUA (CUA) 4 to 12
Australia 2003-2006, 
conducted in rural 
town of Colac, 
population 11000
Particular focus on primary school setting. 6 primary 
schools and 4 preschools participated. Targeted reduced 
to viewing, consumption of sugar drinks, increased water, 
fruit and veg and active play after school
Moodie, ML; 
et al
2010
Australia
The Cost-effectiveness of Australia's 
Active After-school Communities 
Program
Obesity
Assess from a societal perspective the cost-effectiveness 
of the Active After-school communities (AASC) program, 
a key plank of the former Australian Government's 
obesity prevention program.
Simulation model (CUA). Retrospective 
policy review, didn't actually have 
control, but assumed no intervention 
as a comparator
Prep to grade 6 aged 5-
14
Australian schools/ 
communities from 3-
5pm time slot
Funding provided by small grants to participating schools.  
PA coordinators were appointed to develop and deliver 
physical activity program specific to the needs of the 
school over 2-3 session per week for 8 weeks of each of 
the four school terms per year.
Muennig, P; 
Woolf, S
2007
USA
Health and Economic Benefits of 
reducing the number of students per 
classroom in US primary schools
American Journal of Public Health
Estimate the costs associated with reducing class sizes in 
kindergarten through grade 3 as well as the effects of 
small class sizes on selected outcomes such as QALYs and 
future earnings.
Markov model using multiple datasets, 
but mainly trial data of STAR Project 
(CUA)
Hypothetical cohort 
aged 5 to 65
Elementary schools in 
US
Project STAR was a randomised trial of 12000 students in 
schools in Tennessee. Randomised to 22-25 student 
classrooms or 13-17 students. Health economic outcomes 
not collected, so used regression for estimates of 
educational attainment and earnings.
Philipsson, 
A.; et al
2013
Sweden
Cost-utility analysis of a dance 
intervention for adolescent girls with 
internalizing problems
Cost Eff Resour Alloc
To assess the cost-effectiveness of a dance intervention 
in addition to usual school health services for adolescent 
girls with internalizing problems, compared with usual 
school health services alone.
Prospective, RCT. Adolescent girls aged 
13-18
City in central 
Sweden, and their 
schools
Dance twice weekly during 8 months in addition to usual 
school health services. Participants followed-up 5 times 
during study.
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Miller, T.; et 
al
2013
Zimbabwe
Cost per unit of improvement in 
outcome. State cost/QALY but 
EQ-5D only taken in 2010.
None, but lasted 3.33 years
Intervention yielded an estimated US$1472 in 
societal benefits and .36 QALY gain, costing $6/QALY.
For non-boarders financial benefits 
exceeded it's costs, boarding was not 
cost-effective as it did not have any 
effect on outcome measures relative to 
girls in treatment group who did not 
board.
CUA
societal
3 years plus one term in the 
fourth year.
Intervention program costs: supplies, helper fee, 
boarding charges if boarded.
Moodie, M;et 
al
2009
Australia
Benefit assessment estimate of 
health gain using DALY. 
Increased PA, converted to BMI 
change and cost-offsets and 
DALYs over lifetime
Modelled interventions cost $AUD22.8M and resulted 
in incremental saving of 30 DALYs at a net cost per 
DALY saved of $AUD0.76M. Evidence base judged 
'weak' as no data available documenting an increase 
in  number of children walking due to  intervention.
Under current modelling assumptions, 
the WSB is not an effective or CE 
measure to reduce childhood obesity. 
The attribution of some costs to non-
obesity objectives (reducing 
traffic/pollution) is justified for other 
possible benefits.
CUA/ CEA
societal
Lifetime, modelled until reached 
100 years of age or died.
Unit costs, resource use and assumptions included in 
additional file 1.  Adjusted to reference year using CPI. 
Cost to participants and families and all sectors 
involved in delivery of intervention.
Moodie, M; 
et al
2013
Australia
BMI units saved and DALYs 
averted over predicted cohort 
lifetime.
Cost AUD .34M annually, and saved 547 BMI units and 
10.2 DALYs. Net cost per DALY saved AUD 29798.
BAEW was affordable and CE, and 
generated substantial spin-offs in terms 
of activity beyond funding levels. 
Elements fundamental to its success and 
potential CE associated with scaling up 
require identification.
CUA/CEA
societal
Lifetime of predicted cohort, 
takes current cohort 5-19 and 
follows in five-year groups for 
remaining life or 100 years.
See table 1, many costs included, very thorough
Moodie, ML; 
et al
2010
Australia
Cost/DALY saved
Lifetime simulated
No. of new children receiving intervention benefit 
69,300. One year intervention costs $40.3 M and 
saved 450 DALYs, cost-offsets $3.7M and cost/DALY 
$82,000.
Although the program has intuitive 
appeal,  it was not CE under base-case 
modelling assumption. To improve CE as 
an obesity prevention measure, a 
reduction in costs needs to be coupled 
with increases in no. of participants and 
PA undertaken.
Simulation model
societal
Lifetime or age 100
Intervention costs 40.3 million, unit costs and sources, 
and assumptions in Supplementary table not available. 
Adjusted to 2001 using relevant consumer price index. 
Costs to health sector, participants and families, and 
other sectors involved in the delivery of the 
intervention.
Muennig, P; 
Woolf, S
2007
USA
Costs, cost savings and cost per 
QALY, QALY and future earnings
To age 65 simulated
From societal perspective, reducing class size 
generates $168,000 in cost savings and gain of 1.7 
QALYs per graduate. From government perspective 
costs saving to $15,000/QALY gained.
Reducing class size would be cost saving 
from a societal perspective. Reducing 
class size may be more cost-effective 
than most public health and medical 
interventions.
Markov model
Societal and governmental
Up to age 65
Medicare/Medicaid, salary costs, additional schooling 
costs, higher education costs, include crime costs in 
sensitivity analyses to make 'conservative.'
Philipsson, 
A.; et al
2013
Sweden
Cost per QALY
20 months
$25 per dance session. Cost was $670 per participant. 
Visit to nurse $58, mean number of visits to school 
nurse decreased by 10.75 in intervention group 
compared to 6.89. Increased QoL by 0.08 units more 
than those in the control group. 
Intervention with dance twice weekly in 
addition to usual school health service 
may be considered cost-effective 
compared with usual school health 
services alone, for adolescents with 
internalizing problems.
CUA
societal
20 months
1.) cost of the dance classes, (fraction of costs of dance 
teacher, rent, equipment and overhead) 2.) cost of 
using selected healthcare resources, i.e. visits to the 
school nurses. 
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Miller, T.; et 
al
2013
Zimbabwe
No, control not formally 
described, but there are effects 
presented in Table 4.
EQ-5D not distributed to most 
married girls because they either 
dropped out of school or were lost 
to follow-up.
Education resources used to support the girls. 
Staying in school, marrying early, and QALY gained 
from preventing HIV.
Shona-language version of 
EQ-5D
QALY (range 0.985-0.094)
yes
3%
USD 2010
Stated as $6/QALY. When I calculate myself using 
total/pupil cost $1565 given in table two and QALYs 
given in table 4 (0.807-0.752)= $28454 and Thai scoring 
(.678-.612)=$23712. When use QALY gain stated in 
abstract and table 5 (probabilistic estimate .36)=$4347
Sensitivity analysis applying Thai scoring system 
for EQ-5D (as only other value set available for 
developing country), range 0.798:-0.454. Also 
used excel add-in to estimate uncertainty around 
costs and QALYs through 1 million simulations.
Yes, gave uncertainty ranges in Table 1
Moodie, M;et 
al
2009
Australia
Current practice, 'do nothing' as 
there's no organised program in 
place
yes
see figure 2
Reduction in BMI, DALYs, increased METS DALY
yes
3%
AUD 2001
Incremental effect reduction of 0.03 BMI units per 
child. Incremental costs were $22.8M. $0.76M/DALY 
which exceeds $50,000/DALY
atRisk software conducted Monte Carlo 
simulations (4000). Optimistic and very optimistic 
scenarios modelled.
See table 2, height weight, BMI, estimated 
energy expend. METS, etc.
Moodie, M; 
et al
2013
Australia
Yes, current practice in 12 primary 
schools across Victoria, where no 
specific intervention offered.
Yes, pathway analysis to id costs
Who did what, to whom, when where and how 
often. Opportunity cost of time expended.
Reduction in BMI, DALYs averted, 
DALY
yes
3%
AUD 2006
Gross cost per BMI unit saved $399. Net cost per DALY 
saved of $20,227.
Same as before with atRisk software. Uncertainty 
distribution not attached to intervention costs 
since based on detailed evaluation data. 
Conducted scenario of 50% receiving benefit.
See table 2, BMI, cost-offsets, triangular and 
uniform distributions
Moodie, ML; 
et al
2010
Australia
Briefly describe current practice as 
no intervention
Can't tell from the description of 
costs in the article.
Should be reported in supplementary table S1 which 
is no longer available. Coordinator time, program 
delivery planning and operation
A range of available data used to model BMI change 
from increase in PA. Change in BMI then converted 
to DALYs saved.
DALY
DALY
yes
3%
AUD 2001
AUD$82,000/DALY saved (95%CI $40,000-$165,000) Monte Carlo simulations to present 95% 
uncertainty range around costs, benefits and 
ICER. Univariate sensitivity analysis i) reduction 
in the ratio of sites per regional co-ordinator, ii) 
reduction in the number of state level co-
ordinators, iii) application of the same wage rate 
to all site co-ordinators. Iv) combination of 
scenarios, v) all participants receive full 
intervention benefit.
Height, weight, % of schools interested, no. of 
children, METs, extra minutes on PA, etc. (Table 
2)
Muennig, P; 
Woolf, S
2007
USA
No, only description was the 
number of children in the 
classrooms of the control group.
not clear
Additional school and staff costs of small class size, 
additional schooling achieved and higher education. 
Additional teaching resource, educational resources, 
Medicaid. *did not include potential construction to 
build bigger schools to accommodate smaller class 
sizes.
High school and college graduation, life expectancy, 
QALY (assumed to be applied to additional life 
expectancy) came from adult study.
EQ5D taken from MEPS 
participants age 25-65
QALY
Yes, but only for 12.5 
because benefits 
wouldn't be realised 
until graduated, 
unclear
3%
not stated
From governmental perspective, intervention was 
$15,415/QALY (CI $19000-$33000). In all other scenarios, 
the intervention dominates control. How is this 
possible? Some grand assumptions.
1-way uncertainty to isolate most influential 
variables, and Monte Carlo simulation to 
generate CI around estimates.
Classroom size, deprivation(free lunch), high 
school grads, college attendants, earnings, 
Medicare/Medicaid, general costs, see Table 2
Philipsson, 
A.; et al
2013
Sweden
Described as control
Just resource use
Dance classes, usual school health services of 
prevention and care provided by the school nurse.
QALY gained as measured by HUI3, translated by a 
professional translator into Swedish.
Health Utility Index Mark 3
QALY
yes 
3%
Converted from 
Swedish krona to 
USD 2011
US $ 3830/QALY, 95% probability of CE with WTP 
$50,000/QALY
5,000 bootstrapped ICERS, sensitivity analyses of 
50% higher costs and 50% lower effect.  ICER 
$7,660 and $7,180 respectively.
no model
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Rein, D. B.; et 
al
2012
USA
The potential cost-effectiveness of 
amblyopia screening programs
J Pediatric Ophthalmol Strabismus
Estimate incremental cost-effectiveness of amblyopia 
screening at preschool and kindergarten. 
Individual microsimulation model 
using natural history data of amblyopia
3-100
US general population
Compared costs and benefits of 3 amblyopia screening 
scenarios: 1) acuity/stereopsis (A/S) screening at 
kindergarten, 2) A/S screening at preschool and 
kindergarten, and 3) photo screening at preschool and 
A/S screening at kindergarten.
Rush, E; et al
2014
New Zealand
Lifetime cost effectiveness of a 
through-school nutrition and physical 
programme: Project Energize
Obesity Research & Clinical Practice
Project energize aims to improve the overall health and 
reduce the rate of weight gain of all Waikato primary 
school children. An existing model used to extrapolated 
effects of general and Maori child pop of NZ.
Modelling study (CUA) 6 to 8 and 8 to 12
Waikato district is 
where the trial took 
place, model assumes 
NZ pop.
Program to increase physical activity and encourage 
healthy eating. Multicomponent program delivered to 
two age groups.
Shepherd, J; 
et al
2010
UK
The effectiveness and cost-
effectiveness of behavioural 
interventions for the prevention of 
sexually transmitted infections in 
young people aged 13-19: a systematic 
review and economic evaluation
Health Technology Assessment
Assess the effectiveness and CE of schools-based skills 
building behavioural interventions to encourage young 
people to adapt and maintain safer sexual behaviour and 
to prevent them from acquiring sexually transmitted 
infections.
Systematic review of effectiveness and 
econ evaluation model (CUA)
13-19 Behavioural interventions defined as any activity to 
encourage your people to adopt sexual behaviours that 
would protect them from acquiring STIs for which 
reported sexual behavioural outcome.
te Velde, 
Saskia J.; et al
2011
Netherlands
Modelling the Long Term Health 
Outcomes and Cost-Effectiveness of 
Two Interventions Promoting Fruit and 
Vegetable Intake among 
Schoolchildren
Economics and Human Biology
To date, future health effects and cost-effectiveness at 
the longer term have not been estimated for existing 
school-based fruit and vegetable interventions. The 
current study aimed to provide an example of how these 
calculation can be done, by using data of two existing 
Dutch intervention programs, and to estimate cost-
effectiveness for these two interventions.
Retrospective economic evaluation 
using cluster randomised controlled 
trial data and epidemiological 
modelling.
10-12 year-olds
Primary schools in the 
Netherlands.
Detailed descriptions of the two fruit and vegetable 
interventions published previously, both aimed to 
improve intake of fruits and vegetables. Pro children 
provided fruit and veg twice a week, with worksheets and 
online feedback tool, and parent component. The 
Schoolgruiten included a free fruit and vegetable scheme 
and curriculum to increase knowledge and skills related 
to fruit and veg consumption.
Tengs, TO; et 
al
2001
USA
The cost-effectiveness of intensive 
national school-based anti-tobacco 
education: results from the tobacco 
policy model
Preventive Medicine
Evaluate the CE of enhanced nationwide school-based 
anti-tobacco education relative to the status quo.
System dynamic simulation modelling 
study (CUA)
12-13 years
US schools nationwide
Intensive school-based tobacco use prevention program 
given to every 7th and 8th grader in US.
Vijgen, SMC; 
et al
2008
Netherlands
Cost-effectiveness analyses of health 
promotion programs: a case study of 
smoking prevention and cessation 
among Dutch students
Health Education Research
Determine Cost-effectiveness of a Dutch school-based 
smoking education program.
CUA adolescents
Health promotion in 
school , Netherlands 
(model based)
Based on another study of a peer led 45 minute smoking 
cessation school programme. Social influence group vs 
control
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Rein, D. B.; et 
al
2012
USA
Cost per QALY and cost per case 
avoided
Simulated to age 100
No screening most CE with WTP of less than 
$16,000/QALY. A/S at kindergarten WTP of $17,000 
and $21,000. A/S screening at preschool and 
kindergarten WTP between $22,000 and $75,000. 
Photo screening WTP over $75,000. All scenarios CE 
when assuming WTP of $10,500 per case of amblyopia 
cured.
All three likely to be considered cost-
effective relative to may other public 
health programs. Choice of program 
depends on budgetary resources and 
value placed on monocular vision loss 
prevention.
CUA/CEA
Societal perspective excluding 
cost of informal care and lost 
productivity from adult visual 
impairment.
3-100 simulated
Screening costs, German cost estimates of amblyopia 
treatment by age: $2,102 age 3 and $775 age 10 and 
older.
Rush, E; et al
2014
New Zealand
Cost per QALY
Extrapolated lifetime model
$44.96/child/year to deliver programme. ICER for 
younger, $30,438, older $24,690. For Maori $28,241 
and $22,151 respectively. For middle socioeconomic 
status schools $23,211, $17,891. Cost effective in a 
number of scenarios of general, Maori and different 
age groups.
Project Energize would improve quality 
and length of life and when compared 
with other obesity prevention programs 
previously assessed with this model, it 
would be relatively CE from the health 
payer's perspective.
Previously developed model 
applied
funder's/payer's
lifetime
Ongoing cost of the intervention estimated from 
project budget. Healthcare costs of chronic conditions 
same as in existing model.
Shepherd, J; 
et al
2010
UK
STIs averted Few significant differences between interventions 
and comparators in changes in sexual behaviour 
outcomes. Some significant differences in knowledge 
and self-efficacy. Quality of intervention provider 
influence young people's perceptions. Cost £4.30 and 
£15/ pupil for teacher and peer led interventions and 
£20,223 and £80,782/QALY. OR 1.03 not significant.
School-based behavioural intervention 
can bring about improvements in 
knowledge, but didn't significantly 
influence sexual risk-taking behaviour or 
infection rates.
CUA, systematic review of 
economic evaluations for 
prevention of STIs in young 
people and Bernoulli model for 
probability of STI infection
NHS PSS 
Lifetime, intervention effects last 
1 year
NHS national and local unit costs
te Velde, 
Saskia J.; et al
2011
Netherlands
Fruit and vegetable intake. 
Epidemiological modelling 
estimated the number of DALYs 
gained over the lifetime of all 10 
year olds in the Netherlands.
2 years
Pro Children ICER €5,728/DALY. Schoolgruiten was 
€10,674/DALY. Probability of being CE 80% and 68% 
respectively. Pro Children has 70% chance of 
dominating Schoolgruiten.
Well-designed fruits and vegetable-
promoting interventions targeting 
primary school-age children may be a 
good investment, but trials with a follow-
up of a decade or more are required to 
enable more rigorous analyses.
CUA 
Health services perspective
lifetime
Costs from the two programmes were used to estimate 
nationwide implementation costs in the model. Health 
care costs related to diseases were incorporated into 
the epidemiological model.
Tengs, TO; et 
al
2001
USA
Never actually stated
None, computer simulation 
model that relied on secondary 
data
Over 50 years, CE estimated $4900 and $340000/QALY. 
Assuming 30% effectiveness that dissipates over 4 
years CE is $20000/QALY.
Although not cost saving, a much more 
intensive school-based anti-tobacco 
education effort would be an 
economically efficient investment for 
the nation.
Simulation modelling study using 
Marconian system dynamic 
model, The Tobacco Policy 
Model. CUA, but no preference 
measure taken directly. 
societal
50 years
Used costs from TNT program, estimated average direct 
medical costs incurred by adults from previous study. 
To estimate annual cost for each age, gender and 
smoking status, performed multiple regression model 
using Hodgson's data.
Vijgen, SMC; 
et al
2008
Netherlands
Cost per QALY
18 months, mentions 
insufficient follow-up.
ICER 19900 per QALY. Several assumptions had to be 
made, lack of effectiveness data on smoking in 
adolescents.
CE of health promotion programs is 
lacking. For policy makers, CE is very 
important because investment now may 
return gains/savings in the future.
Model based CUA using the 
Chronic Disease model (CDM)
didn't state
100 years, lifetime
Estimated intervention costs, model include health care 
costs of various smoking related diseases.
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Rein, D. B.; et 
al
2012
USA
Yes, person-level simulation of 
amblyopia incidence, detection 
with and without screening at 
preschool and kindergarten.
Estimates from literature
Rates of referral and follow-up care QALY
QALY, decrements 
assumed by estimates 
from the literature.
yes
3%
2002 Euros 
converted to USD 
and inflated to 2005 
using consumer 
price index medial 
care component.
For no screening cost was less than $16,000/QALY, 
screening at kindergarten $17 to $21,000 per QALY. 
Screening at preschool and kindergarten $22 to 
$75,000. Photo screening at preschool and kindergarten 
at $75,000 and greater.
PSA, Sensitivity analysis of A/S screening on rates 
observed in VIP study.
A/S screening sensitivity in preschool and 
kindergarten, photo screening sensitivity in pre-
schoolers and kindergarten
Rush, E; et al
2014
New Zealand
status quo
Described elsewhere
Used the same resource use costs as was already 
built into model.
BMI reductions, effect assumed to decay at 1% each 
year for first 5 years.
QALY
QALY
yes
3.5%
2011 NZ$
Younger: $30438/QALY Older: $24690 Maori Y: $28241 
Maori O: $22151 Middle SES: $23211, $17891
Varied conditions such as cost of intervention +-
10%, discount rate 0-5%, decay of effect which 
had biggest impact on ICER 5-10% $100K to $500K.
Model described elsewhere
Shepherd, J; 
et al
2010
UK
Yes, teacher 20 sessions, peer led 
3 sessions
Costs associated with each STI 
case such as complications, PID 
and infertility and HRQoL loss.
Medical treatment of STIs, cost of behavioural 
interventions.
Condom use, from systematic review of 
effectiveness.
HRQoL taken from 
previous utility studies of 
patients with condition of 
interest.
QALY, STI cases averted, 
medical costs saved.
yes 
3.5%
GBP
£20,223 and £80,782/QALY Uncertain in clinical effect, HRQoL and resource 
use. Deterministic and probabilistic sensitivity 
analysis. One-way deterministic of individual 
parameters.
STI prevalence, single-act transmission 
probabilistic, condom effectiveness and condom 
use, number of sexual episodes and number of 
sexual partners.
te Velde, 
Saskia J.; et al
2011
Netherlands
yes 
 Not clear what all went into the 
epidemiological model.
Hospitalization, care, and care by a family physician 
related to diseases in the epidemiological model.
Effects at 2 years for each intervention were input 
into their model even though they were not 
statistically significant.
DALY
DALY
yes
3%
2003 Euro
Net intervention costs + difference in health care 
costs/DALYs averted by intervention
PSA, bootstrap of 10,000 iterations, used Ersatz 
program to simultaneously vary key parameters.
Effect in Pro Children and Schoolgruiten and 
lasting life long, costs of Pro Children and 
Schoolgruiten, relative risks of diseases, 
discounting, value of a DALY.
Tengs, TO; et 
al
2001
USA
'Current average education 
practice nationwide'
Yes, but mostly assumed
Estimated costs included in model
Used Quality of Well being scale (QWB) to assess 
QoL. Based effectiveness on seven sources.
QWB, not sure if 
preference based
QALY
yes
3%
1999 USD using MCPI
Cost/QALY from $24000-$600000. Cost/LY$3.8M and 
$170M
3 way Monte Carlo sensitivity analysis to assess 
impact on medical costs, QoL and mortality. 
Distributions placed on difference  costs, QoL, 
and mortality. Performed many scenarios.
Age, gender, smoking status, exposure to 
nicotine in utero and year, see Table 2.
Vijgen, SMC; 
et al
2008
Netherlands
control
not identified
not identified
States effectiveness data is lacking, LYG and QALYs
QALY
QALY
yes
4%
Euro 2004
1990 Euros /QALY Sensitivity analysis on key parameters, varied 
effectiveness in daily and experimental smokers, 
intervention costs, discount rate and time 
horizon.
Smoking prevalence, incidence mortality and 
costs of 14 smoking related diseases
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Wang, LY; et 
al
2001
USA
Cost-effectiveness of a school-based 
tobacco-use prevention program
Arch Pediatr Adolesc Med
Determine he CE of a school-based tobacco-use 
prevention program.
Using data from the 2 year efficacy 
study of the Project Toward No Tobacco 
Use (TNT), conducted decision analysis. 
Benefits were Lys saved, and QALYs, 
costs saved. (CUA) Model with base 
case, worst and best case scenarios 
using data from previous sources.
12-15 (7-9th grades)
Based TNT, school-
based in Southern 
California
10 lessons to counteract social influences and 
misconceptions that lead to tobacco use, delivered by 
trained health educators in 8 junior high schools. 2 less 
booster delivered in 8th grade and followed up o 9th 
grade
Wang, Li Yan; 
et al
2011
USA
The Economic Effect of Planet Health 
on Preventing Bulimia Nervosa
Archives of Pediatrics & Adolescent 
Medicine
To assess the economic effect of the school-based 
obesity prevention program Planet Health on preventing 
disordered weight control behaviours and to determine 
the cost-effectiveness of the intervention in terms of its 
combined effect on prevention of obesity and 
disordered weight control behaviours.
Modelling study using previous RCT 
and economic evaluation evidence.
RCT data on girls 10-
14, present study 
projected up to age 17
Middle schools
The Planet Health program was implemented from 1995 
to 1997 and designed to promote healthful nutrition and 
physical activity among youth. Interdisciplinary, school-
based obesity prevention program. Eating disorders 
positively associated with overweight and obesity in 
adolescence, there is an interest in integrating 
prevention of both disorders.
Barber, Sally 
E.; et al
2013
UK
Pre-schoolers in the playground an 
outdoor physical activity intervention 
for children aged 18 months to 4 years 
old: study protocol for a pilot cluster 
randomised controlled trial
Trials
To undertake a pilot cluster randomised controlled trial 
of an outdoor playground-based physical activity 
intervention for parents and their children aged 18 
months to 4 years old and to assess the feasibility of 
conducting a full scale cluster RCT.
Study protocol for cluster RCT and 
economic evaluation.
18 months to 4 years
Bradford, West 
Yorkshire, UK which 
includes some of the 
most deprived areas 
in UK
Pre-schoolers in the Playground (PiP) comprises a 10-
week initiation phase (one school term) followed by a 20-
wekk maintenance phase (two school terms).
Quach, J.; et 
al
2013
Australia
Sleep well - Be well study: Improving 
school transition by improving child 
sleep: A translational randomised trial
BMJ Open
To determine whether using school-based screening 
followed by a brief behavioural intervention is cost-
effective when delivered by an existing school-based 
health workforce.
RCT nested in a population-based, 
cross-sectional survey.
No age specified, just 
children with sleep 
problems
Primary schools in the 
southern region of 
Melbourne, Australia
School nurse arranges a 45 minute session to provide the 
intervention to the parent at the child's school, covering 
education about normal sleep requirements and the 
importance of good sleep hygiene practices, then select 
acceptable strategies. Two weeks later a follow-up 15 min 
phone call, and then final 30 face-to-face appointment if 
needed.
Chestnutt, IG; 
et al
2012
UK
Protocol for "Seal or Varnish?" (SoV) 
trial: a randomised controlled trial to 
measure the relative cost and 
effectiveness of pit and fissure 
sealants and fluoride varnish in 
preventing dental decay
Bmc Oral Health
To compare the clinical effectiveness of pit and fissure 
sealants (PFS) and fluoride varnish (FV) in preventing 
dental caries in first permanent molars in 6-7 year-olds. 
Secondary aims: examining the impact of PFS and FV on 
children and their parents/carers in terms of quality of 
life/treatment acceptability measures, and 
implementation in a community setting
Randomised, assessor-blinded, two-
arm, parallel group trail 
6-7 year old 
schoolchildren
Primary schools in 
deprived areas of 
South Wales
Treatment delivered via mobile dental clinic. PFS and FV 
will be applied by trained dental hygienists. FV will be 
applied at baseline, 6, 12, 18, 24 and 30 months. PFS will 
be applied at baseline and re-examined at all follow-ups 
and reapplied if detached/insufficient.
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Wang, LY; et 
al
2001
USA
Not specifically mentioned
2 years 
Cost $16403, prevented estimated 34.9 students from 
becoming smokers. Savings of $13316/LY and 
$8482/QALY. TNT was cost savings over a reasonable 
range of model parameter estimates.
TNT is highly CE compared with other 
widely accepted prevention 
interventions. School-based prevention 
programs of this type warrant careful 
consideration by policy makers and 
program planners.
CUA/CEA without preference 
measures collected. Decision 
model to model lifetime, based 
on decision tree up to age 26.
societal
Lifetime, from estimated 
established smokers at 26 and 
over lifetime.
Training, teaching and material costs. 
Wang, Li Yan; 
et al
2011
USA
Intervention costs, medical 
costs saved, quality-adjusted 
life years gained, and cost-
effectiveness ratio.
RCT 2 years, present study 
modelled to age 17.
An estimated 1 case of bulimia nervosa would have 
been prevented. As a result, an estimated $33,999 in 
medical costs and 0.7 QALYs would be saved. At an 
intervention cost of $46,803, the combined 
prevention of obesity and disordered weight control 
behaviours would yield a net savings of $14,238 and a 
gained of 4.8 QALYs.
Primary prevention programs, such as 
Planet Health, warrant careful 
consideration by policy makers and 
program planners. The findings provide 
additional argument for integrated 
prevention of obesity and eating 
disorders.
Modelling study/CUA
societal
10 years
Used medical costs for bulimia nervosa previously 
reported in the literature. Estimated 10-year 
cumulative costs based on two studies. Chose cost of 
CBT and inpatient and outpatient treatment costs. 
Incorporated 10 year costs of patient returning to 
treatment. Estimated cumulative costs over 10 years, 
then calculated average which was used in base-case 
and sensitivity analyses.
Barber, Sally 
E.; et al
2013
UK
To assess the feasibility of a full-
scale cluster RCT, the pilot will 
examine recruitment rates, 
attendance and attrition, see 
right
52 weeks with follow-ups at 10 
and 30 weeks.
protocol protocol Protocol, CUA planned
none stated
Within-trail analysis and if 
possible modelled costs and 
benefits over a more appropriate 
time horizon.
Will explore possibility of using routine databases to 
capture relevant resource use. Will collect costs of the 
intervention
Quach, J.; et 
al
2013
Australia
Child psychosocial functioning 
at 6 months.
12 months, with 6 months
protocol protocol Protocol, two step, CCA, then CEA 
using PedsQL as main analysis. 
Secondary analysis presenting 
combined child and parent QALY 
CUA. Classified as CUA
Health and education and 
broader societal perspective.
12 months
Costs of intervention and resource use
Chestnutt, IG; 
et al
2012
UK
The presence or absence of 
dental caries and caries 
treatment on all surfaces of all 
teeth will be recorded using the 
ICDAS system.
36 months
protocol protocol Protocol, type of eval not stated, 
assumed CUA
societal
none stated
Costs for each trial participant including number and 
frequency of service use, travel costs to families, 
assessment of total cost of PFS and FV including 
potential costs of treatment avoided.
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Wang, LY; et 
al
2001
USA
no
no
Just costs mentioned above
Estimated Lys and QALY gains, based on 2 year 
dataset on TNT.
QALYs assumed from 
literature.
QALY, not directly 
measured
yes
3%
1990 USD
none Multivariate sensitivity analysis, varied values of 
each of 10 key parameters assuming estimates 
normally distributed.
see tables 2-4
Wang, Li Yan; 
et al
2011
USA
No, only modelled project costs of 
bulimia.
No, no costs or consequences 
identified for control group that 
didn't receive the Planet Health 
intervention.
None collected specifically. Took medical costs of 
bulimia from the literature.
Taken from the RCT in terms of prevented from 
developing bulimia. Took HRQoL from one study 
using a preference-weighted 15D.
Preference-weighted 15D, 
a generic, comprehensive, 
self-administered 
instrument for measuring 
and assessing HRQoL 
among BN patients. A set 
of utility preference 
weights were elicited 
from the general public.
QALY
yes
3%
2010 USD
$2,966/QALY, to be interpreted with caution. This was a 
modelling study that assumed the effectiveness of the 
intervention would prevent one person from 
developing BN. It also assumed cost savings (instead of 
taking the difference in cost between interventions) 
and assumed QALY gains from the literature (instead of 
directly measuring for each intervention).
Sensitivity analyses were performed to test the 
assumptions made. Univariate and multivariate 
sensitivity analyses on 5 parameters: percentage 
of girls with disordered weight control 
behaviours who had eating disorders, 
progression probability, medical treatment costs, 
HRQoL of BN patients, and time to recovery. 
Multivariate, 10000 Monte Carlo simulation using 
@RISK.
Many, see above. This model is based on many 
assumptions.
Barber, Sally 
E.; et al
2013
UK
usual care
trial protocol
Number and type of injuries sustained during 
intervention period and service use reported by 
parents at each assessment point using previously 
developed questionnaires.
PedsQL for child HRQoL and EQ5D for parental HRQoL
Not specified
QALY planned, did not give 
preference details
none stated
GBP
Will be generated PSA will be conducted
Plan for longer term model
Quach, J.; et 
al
2013
Australia
briefly
assumed
Parents will retrospectively recall resource use for 
child's sleep.
Child psychosocial functioning at 6 months, PedsQL
CHU9D, PedsQL, child, EQ-
5D parent
QALY
yes
5%
None stated, GBP 
assumed
Will present a CUA on the combined parent-child 
QALYs as a secondary analysis.
Will perform extensive sensitivity analysis
none
Chestnutt, IG; 
et al
2012
UK
Yes, but didn't include a do 
nothing approach
yes 
Staff resources, treatment/appointment duration, 
equipment and materials used. Costs to families 
collected from parental resource utilisation 
questionnaire. Will also capture school resource use.
HRQoL as measured by the CHU9D being sent home 
to parents asking children to complete with 
assistance if necessary.
CHU9D
QALY
none stated
Not stated, GBP 
assumed
Did not state if will calculate an ICER none stated
none
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Pearson, 
Amber; et al
2014
New Zealand
Is expanding HPV vaccination programs 
to include school-aged boys likely to 
be value-for-money: a cost-utility 
analysis in a country with an existing 
school-girl program
BMC Infectious Diseases
The goal of this research was to examine the cost-
effectiveness
of adding boys to a girls-only program in New
Zealand. We modelled the incremental health gain and 
costs for extending the current girls-only program to 
boys, intensifying the current girls-only program to 
achieve 73% coverage, and extension of the intensive 
program to boys.
: A Markov macro-simulation model, 
which accounted for herd immunity, 
was developed for an annual cohort of 
12-year-olds in 2011 and included the 
future health states of: cervical cancer, 
pre-cancer (CIN I to III), genital warts, 
and three other HPV-related cancers
cohort of 12 year-old 
boys
New Zealand schools 
and primary care
Methods followed the Burden of disease epidemiology, 
equity and cost-effectiveness program protocol. They 
adapted a previous Markov model on the cost-utility of 
girls only HPV vaccination to estimate QALYs gain and net 
health system costs for girls only and girls and boys 
vaccination.
CBA
Barnett, 
Steven
1985
USA
Benefit-Cost Analysis of the Perry 
Preschool Program and Its Policy 
Implications
Educational Evaluation and Policy 
Analysis
Benefit-Cost Analysis of the Perry Preschool Program 
and its long-term effects and examine the analysis as a 
basis for US public policy decisions regarding early 
childhood education.
Benefit-cost analysis, of two year 
program with follow-up at 15 and 19 
(CBA)
3 and 4-year-old black 
children with no 
discernible physical 
handicaps
Original study 
conducted in 
Ypsilanti, MI with 
children born b/t 1958 
and 1962. 
Operated from October to May with 3 elements: 1. centre-
based for 2.5 hours each morning, evolving from 
traditional nursery school to cognitively oriented 
Piagetian approach. 2. Home visiting, teachers visit once a 
week for 1.5 hours. 3. Group parent meetings.
Belfield, CR; 
et al
2005
USA
The High/Scope Perry Preschool 
Program: Cost-Benefit Analysis Using 
data from the Age-40 follow-up
Journal of Human Resources
Perform cost-benefit analysis of the High/Scope Perry 
Preschool Program using new data on the careers and 
livelihoods of the participants and control group up to 
age 40.
123 at risk children in Michigan in 1960. 
58 randomly assigned to receive the 
program and 65 to be in the control. 
They have been surveyed periodically 
since the program.
3 and 4-year-old black 
children with no 
discernible physical 
handicaps
Ypsilanti, MI
Operated from October to May with 3 elements: 1. centre-
based for 2.5 hours each morning, evolving from 
traditional nursery school to cognitively oriented 
Piagetian approach. 2. Home visiting, teachers visit once a 
week for 1.5 hours. 3. Group parent meetings.
Glewwe, 
Paul; et al
2001
Philippines
Early Childhood Nutrition and 
Academic Achievement: A Longitudinal 
Analysis
Journal of Public Economics
Investigate the nutrition-learning nexus using a unique 
longitudinal data set that follows a large sample of 
Filipino children from birth until the end of their primary 
education. Also to perform a cost-benefit analysis of 
return on investment of early childhood nutrition 
programs.
Statistical and economic analysis of 
longitudinal data, non-experimental.
Birth to end of 
primary school
Cebu, Philippines 
1983-1994
No intervention, analysis focused on the achievement 
production function, which relates to early nutritional 
and other academic inputs to a child's scholastic output as 
measured by achievement test scores.
Reynolds, 
Arthur J.; et 
al
2011
USA
Age 26 Cost-Benefit Analysis of the 
Child-Parent Centre Early Education 
Program
Child Development
Conduct a CBA of the Child Parent Centre (CPC) 
Education program using outcome data at age 26. 1) Does 
participation in the CPC continue to demonstrate high 
economic benefits relative to costs? 2) Do the estimated 
economic benefits in 2007 USD differ across preschool, 
school-age, and extended-program participation? 3) Do 
economic benefits differ by child and family subgroups, 
including gender, parent education, family risk status, 
neighbourhood poverty, and length of participation?
Prospective cohort study, quasi 
experimental design, Title 1 
Elementary and Secondary Education 
Act of 1965 is after Head Start the US's 
oldest federally funded preschool 
program. 989 CPC and 550 comparison 
children followed up to age 26 
(approximately 90% of each group). 
Comparison group matched to 
intervention on age, eligibility, 
neighbourhood and family poverty.
Intervention given 
from age 3 to 9, 
followed-up to 26.
US schools (Chicago 
area)
Child parent centre early education program (CPC) 
provide preschool and school-age services up to age 9 for 
economically disadvantaged children in the Chicago 
Public schools system. Data for the study was collected 
from the Chicago Longitudinal Study (CLS) which has 
follow-up to age 26. Intervention described previously.
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Pearson, 
Amber; et al
2014
New Zealand
QALYs gained
simulation over lifetime
At an assumed local willingness-to-pay threshold of 
US$29,600, vaccination of 12-year-old boys to achieve
the current coverage for girls would not be cost-
effective, at US$61,400/QALY gained (95% UI $29,700 
to $112,000; OECD purchasing power parities) 
compared to the current girls-only program, with an 
assumed vaccine cost of US $59 (NZ$113). This was 
dominated though by the intensified girls-only 
program; US$17,400/QALY gained (95% UI: dominant 
These results suggest that adding boys to 
the girls-only HPV vaccination program in 
New Zealand is highly unlikely to be cost-
effective. In order for vaccination of 
males to become cost-effective in New 
Zealand, vaccine would need to be 
supplied at very low prices and 
administration costs would need to be 
minimised.
CUA Markov macro-simulation 
model
none stated, but may be 
described elsewhere
Stated 12 year-olds over their 
whole lives.
Used routine, linked admin health data for entire NZ 
population. Assigned health system costs by sex, and 
age to healthy state. Added costs for cancer patients, 
and other disease states from regression and averages 
respectively. Intervention costs included cost of vaccine 
(NZ$113) and delivery/admin of $141 in schools and 
primary care or $126 in schools only.
CBA
Barnett, 
Steven
1985
USA
cost/benefit Significantly better outcomes for intervention in IQ, 
test scores, graduation, higher education, arrests, 
employment and welfare. Good evidence it's a good 
investment for society for one year, relatively good 
for 2 years.
While study is old, authors argue (in 
1985) that structure of school and society 
hasn't changes enough to threaten 
generalisability, may be more effective 
for deprived populations. More 
evaluations should be planned because 
stakes too high to rely on Perry School 
program only.
Benefit-cost analysis
Society, 2 groups considered, 
participants and families and 
'taxpayers'
child's lifetime
(and benefits) for 7 categories: a)program costs, b)child 
care, c)elementary and second. education, d) higher 
education, e)delinquency and crime, f)earnings and 
employment, and g)welfare.
Belfield, CR; 
et al
2005
USA
cost benefit ratio
Up to age 4
The treatment group obtains significantly higher 
earnings. For the general public, higher tax revenues, 
lower criminal justice system expenditures, and 
lower welfare payments easily outweigh program 
costs; they repay $12.90 for every $1 invested.
Program gains come mainly from reduced 
crime by males, and thus subject to 
uncertainty around those assumptions.
Cost-benefit analysis' stated
Societal
Up to age 40
Undiscounted USD 2000 program costs estimated as 
$15,827.  Cost information was taken from school 
district budgets and the program administration unit; 
both operating costs and capital costs are included.
Glewwe, 
Paul; et al
2001
Philippines
1983-1994 Heterogeneity in learning endowments, home 
environment or 'parental tastes' can't fully explain 
why malnourished children performed relatively 
poorly in school, positive relationship persists after 
controlling for such factors. 
In simple CBA $1 invested in early 
childhood nutrition program could 
potentially return $3 worth of gains in 
academic achievement.
Simple CBA stated
none stated
Lifetime assumed as they 
assumed a working age 16-61 
when calculating cost-benefit.
One scenario of benefit assumes a child is given an 
extra half year of earnings $650. Discounted over 15 
years at 3%=$415 5%=$310. Untargeted intervention 
could achieve an average improvement in heigh0for-
aged of 0.6 at $300/child and targeted $600/child.
Reynolds, 
Arthur J.; et 
al
2011
USA
CLS data up to age 26.Net 
present value (all societal costs - 
all societal benefits). Also 
expressed as benefit-cost ratio 
or return on investment.
Those who participated had economic benefits that 
exceeded costs. Preschool program: $10.83 per dollar 
invested (18% annual return), school-age program: 
societal return of $3.97/$1 invested (10% annual 
return) and extended intervention program (4-6 
years) had a return of $8.24 (18%). Males, 1-year 
preschool participants and children from higher risk 
families derived greater benefits.
Findings provide strong evidence that 
sustained programs can contribute to 
well-being for individuals and society.
CBA stated, but not on an RCT and 
no valuation undertaken.
societal
Age 3-26
Preschool average cost per child $5,5597. School-age: 
$2,010, and extended program $12,304. Did not cost CPC 
in kindergarten or in comparison (full day), 
approximated the costs were similar in each.
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Pearson, 
Amber; et al
2014
New Zealand
Yes
yes
Health care resource use estimated for each health 
state based on NZ administrative data.
New Zealand data on cancer incidence and survival, 
and other cause mortality (by sex, age, ethnicity and 
deprivation). HPV prevalence reduction, disability 
weights applied for each disease state, and 
population morbidity estimated from lifetables. 
Cancer incidence rates predicted from regression of 
NZ cancer registry data.
QALYs valued using 
disability weights
QALY
yes
3%
Used PPPs to 
convert from USD to 
NZ dollars 2011
Same level of coverage for boys dominated. 
Vaccination of boys at currently coverage level for girls 
$117,500 per QALY, adding boys to an intensified girls 
only program not cost-effective $247,000/QALY. 
Intensified girls only program is optimal at 
$33,000/QoL.
Scenario analyses explored reductions in vaccine 
cost per dose, and removing her immunity cancer 
reduction benefits. Monte Carlo simulation with 
2,000 draws. All scenario analyses found adding 
boys was not cost-effective.
Coverage achieved in females, herd immunity, 
HPV burden of disease in males, cost of vaccine 
and admin, vaccine efficacy and duration of 
protection, number of diseases.
CBA
Barnett, 
Steven
1985
USA
No, probably in other papers, 
control was assumed to be no 
intervention control
cost of program, child care
Based on assumptions from table 2
none
Estimated benefit to 
society from children up to 
age 19
yes
5%
USD 1981
Positive CB ratio, see table 4. 1 year: $5,525 se $3,200, 2 
years $4,987 se $2,936
Varied discount rate: 3, 5 and 7%, reduced 
benefits by 50% and still exceeds costs
Belfield, CR; 
et al
2005
USA
Just as the control
Important costs of control not 
identified. But benefits for both 
groups were identified.
Cost of the program
Long-term benefits of the program include increased 
educational attainment, earnings profiles, tax 
contributions, lower criminal activity, and welfare 
payments.
None
Monetised in cost-benefit 
ratio
yes
3% and 7%
USD 2000 
n/a Plausible variations on how the net benefits to 
society vary given the program yields strongly 
positive benefits to participants. 
Glewwe, 
Paul; et al
2001
Philippines
no alternative
n/a
Not collected, not intervention
Based on achievement scores and height-for-age
none
none
yes 
3-5%
USD 1994
n/a no 
no
Reynolds, 
Arthur J.; et 
al
2011
USA
Yes, 550 comparison group that 
attended full-day kindergarten in 
in five randomly selected schools. 
The comparison group were 
enrolled in 'usual early 
intervention' available for low-
income children.
Left out kindergarten costs, but 
said it was because the focus was 
on CPC program costs.
Valued as reductions in school remedial services, 
criminal justice system expenditures, victims of 
crime expenditures, child welfare and victimization 
from child abuse and neglect, depression, and 
substance misuse. These were valued and 
considered benefits of the program
Do not describe valuation, but refer to sticking to 
'previous estimation procedures.'  In addition to 
reductions stated in the resource use column, there 
was also reduced mortality due to smoking and 
increases in lifetime earnings and tax revenues.
None not CUA.
Benefits calculated in 
dollar terms. Net present 
value of the program 
(costs - benefits), also 
expressed as benefit-cost 
ratio (benefits/costs) to 
obtain return per $1 
invested.
yes
3%
2007 USD adjusted 
for inflation
CBA Monte Carlo simulations of 10,000 iterations. 
Sensitivity analysis for different model 
assumptions. Discount rate, earnings estimates, 
exclusion of intangible crime victim savings, 
inclusion of smoking benefits.
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CBA
Wang, LY; et 
al
2000
USA
Economic Evaluation of Safer Choices
Arch Pediatric Adolescent Medicine
To evaluate cost-effectiveness and cost benefit of Safer 
Choices school based intervention for high school 
students.
CEA and CBA  of cluster randomised 
trial with follow-up at 7, 19 and 31 
months. Study based on 7 months. 
(CEA)
High school students, 
15-19, 3677 ninth 
grade students
USA, 10 schools in 
northern California 
and 10 in southeast 
Texas randomised to 
receive intervention 
or not.
2 year theory-based multicomponent intervention. 
Primary aim is to reduce number of student engaging in 
unprotected sex, focusing on school wide change to 
influence student behaviour.
Eckermann, 
Simon; et al
2014
Australia
Evaluating return on investment in a 
school based health promotion and 
prevention program: The investment 
multiplier for the Stephanie Alexander 
Kitchen Garden National Program
Social Science & Medicine
To synthesise evidence of attributable impacts on 
student attitudes, lifestyle and behaviour and the 
societal (government, school, and wider community) 
multiplier on initial investment up to and beyond two 
years triangulated with qualitative evidence to enable 
informed assessment of expected long-term community 
impacts and returns from SAKGNP investment.
Return on investment with multiplier 
assessment to provide key evidence to 
assess network engagement, 
ownership and dynamic impacts.
Primary school 
students aged 8-12 
years
School/ community in 
Victoria
The Stephanie Alexander Kitchen Garden National 
Program (SAKGNP) is a school-based programme 
designed to promote pleasurable food education in 
Australian primary schools. Whole school commitment to 
hiring garden and kitchen specialists to support weekly 
lesson, linking to official curriculum, involving community 
volunteers and minimum 2 year commitment.
Heckman, J.; 
et al
2010
USA
The rate of return to the HighScope 
Perry Preschool Program
Journal of Public Economics
Estimate the rate of return to the HighScope Perry 
Preschool program, as previous studies ignore the 
compromises during randomisation and do not report 
standard errors. The rates of return reported account for 
those factors.
Rate of return with benefit-to-cost 
ratios to support their conclusion
Preschool program 
with follow-up data 
into 40s
Ypsilanti, Michigan
see earlier
Tai, T; Bame, 
SI
2010
USA
Cost-Benefit Analysis of Childhood 
Asthma Management through School-
based clinic programs
Journal of Community Health
Examine the cost-benefit of school-based health clinic 
programs (SBHC) in managing childhood asthma 
nationwide for reduction of medical costs of ER, hospital 
and outpatient physician care and savings in opportunity 
social costs of lowering absenteeism and work loss and 
of future earnings due to premature deaths.
CBA using 8 public data sources 5-17 year olds, school-
aged children
Data sources used to 
calculate national 
costs of implementing 
SBHC using multiple 
tertiary datasets.
Modelled the implementation of a school-based health 
clinic in schools to reduce asthma severity and hospital 
costs.
Hoeflmayr, 
David and 
Hanewinkel, 
Reiner
2006
Germany
Do school-based tobacco prevention 
programmes pay off? The cost-
effectiveness of the ‘Smoke-free Class 
Competition’
Public Health Journal of the Royal 
Institute of Public Health
The objective of this study was to determine the cost-
effectiveness of a school-based tobacco prevention 
programme.
Using data from a previous 
effectiveness study of the ‘Smoke-free 
Class Competition’ (SFC), an economic 
analysis was conducted to determine 
the cost-effectiveness of the SFC. 
11-14 year old German 
students
German schools
: To take part in the SFC, classes make the decision to be a 
non-smoking class for 6 months (from autumn to spring). 
The pupils themselves and their teachers monitor the 
smoking status of the pupils and report on it regularly. 
Classes that refrain from smoking can win a number of 
attractive prizes. In the school year 2001/ 2002, 150,566 
German students participated in the SFC, representing 
approximately 4% of the total target population of 11–14-
year-old German students. The effectiveness evaluation 
is based on 2,142 students who participated in the 
programme in the school year 1998/1999.
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Wang, LY; et 
al
2000
USA
Reduce number of sexually 
active high school students and 
increase condom and 
contraception use among 
sexually active students.
Base-case intervention cost $105243, achieving 15% 
increase in condom use and 11% increase in 
contraceptive use within 1 year among 345 sexually 
active students. Cases averted: HIV 0.12, Chlamydia 
24.37, gonorrhoea, 2.77, PID 5.86, and pregnancy 18.5. 
Every dollar invested returns %2.65 in med and social 
costs savings.
Safer choices is CE and cost saving in 
most scenarios considered. Program cost 
data should be routinely collecting 
evaluations of adolescent prevention 
programs.
Model, CEA and CBA of Safer 
Choices
Societal, for medical considered 
public and private sector 
perspectives
1 year
Intervention, cases of HIV and other SDTs averted, and 
pregnancy, lost productivity.
Eckermann, 
Simon; et al
2014
Australia
Return on Australian 
Government investment on 
impacts on student lifestyle 
behaviours, food choices and 
eating habits surveyed across 
students and parents.
2 years minimum, some school 
observed longer
Multiplier impact on total community activity was 
5.07 ($226,737/$44,758); 1.60 attributable to school, 
and 2.47 to wider community activity. All 8 schools 
observed beyond 2 year continued garden and 
kitchen classes with an average 17% scaling up and 
one school fully integrating staff into the curriculum.
Evidence supports the SAKGNP to be a 
successful health promotion program 
with high community network impacts 
and return on investment in practice.
RoI
Australian Government
2 years, + some observed after
Government expenditure, kitchen staff expenditure, 
specialist staff, garden staff and value of volunteer 
time, school contributions, grant and community 
contributions.
Heckman, J.; 
et al
2010
USA
Rate of return, benefit-cost-
ratios
Use data up to age 40
Rates of return generally fall between 7-10%, 
substantially lower than previous literature. Returns 
generally statistically significantly different from 0 
for both men and women and above historical return 
on equity. Benefit-cost ratios support this and range 
from $7 to $12 for every $1 invested.
Analysis provides a lower-bound on true 
rate of return to Perry Preschool 
program, reporting standard errors, and 
exploring sensitivity to alternate 
assumptions.
Rate of return
Societal
Lifetime
Initial program cost per child in undiscounted 2006 USD 
is $17,759.
Tai, T; Bame, 
SI
2010
USA
Cost of implementation (based 
on experiences of 12% of public 
schools that have these 
programs) compared to 
reduction of hospital cost 
absenteeism and premature 
death.
see conclusions Costs: $4.55 Billion compared to savings 
of $1.69 Billion medical costs. Estimated 
savings due to absenteeism and 
premature deaths $23.13 billion. Many 
assumptions made, recommend future 
work.
CBA using 8 public data sources, 
classified as other
hospital and societal
none stated
School nurse staffing multiplied by asthma prevalence 
for 5-17 year olds. Cost is based solely on putting nurse 
into schools = $4.554 billion/year (not included: facility, 
equipment and support staff) but already provided by 
school health services. Cost only include programs to 
run during school hours.
Hoeflmayr, 
David and 
Hanewinkel, 
Reiner
2006
Germany
Number of students prevented 
from becoming established 
smokers.
1 year
In the school year 2001/2002, it is estimated that the 
SFC prevented 3,076 students from becoming 
established smokers, with net benefits of 5.59 Mio. 
Euro (direct net benefits) and 15.00 Mio. Euro (total 
net benefits). The direct benefit/cost ratio was 8.2 
and the total benefit/cost ratio was 3.6.
Data suggest that the SFC is a cost-
effective school-based intervention.
CBA
societal
none stated, alluded to lifetime 
or at least age 28.
The average societal cost saved per smoker avoided 
applied to number of smokers prevented to obtain 
benefit valuations, and cost data of the programme 
were collected and compared against the benefit. Cost 
data were collected from financial statements of the 
operating agency, surveys of regional co-ordinators and 
participating classes (direct and productivity costs). The 
benefit was the product of the number of students 
prevented from becoming established smokers, based 
on a stochastic progression model extending the 
programme’s outcome evaluation, and the (direct and 
indirect) value per prevented smoker.
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Wang, LY; et 
al
2000
USA
Yes, standard, information based, 
HIVE prevention curriculum.
Consequences of control not 
identified however was 
accounted for by cases averted.
Program costs, see table 1
Came from trial which found significant increase in 
condom and contraceptive use.  CE varies depending 
on: HIV prevalence, STD incidence rates, program 
costs, medical care costs for HIV and STDs and 
medical costs of pregnancy.
Not in primary study 
as was one year, but 
reported 
discounting used in 
other studies where 
cost data was used 
for current study.
1994 USD
Intervention cost of $105,243 achieved 15% increase in 
condom use, 11% increase in contraceptive use. For 
every dollar invested in the program, $2.65 in total 
medical and social costs were  saved.
Yes, multivariable sensitivity analysis to 
determine robustness. 6 variables adjusted: 
probability of HIV and other STD transmission, 
HIVE prevalence rate, STD incidence rates, 
condom use per act, contraceptive failure rate, 
percentage of students using contraceptives and 
medical cost per case.
Prevalence of diseases, and transmission 
probabilities
Eckermann, 
Simon; et al
2014
Australia
n/a
n/a
None identified, not already mentioned in costs
Analysis of the four domains of interest 
triangulation.
n/a
n/a
no
none
AUD, but no price 
year stated
n/a none
n/a
Heckman, J.; 
et al
2010
USA
yes
Costs of control not identified, but 
benefits were.
Program costs
Program benefits include education, employment 
and earnings, criminal activity, tax payments, and 
use of the welfare system.
None
Benefits were monetised.
Yes
3%
USD 2006
n/a Yes, present sensitive analyses of plausible 
assumptions in each benefit parameter. 
Alternative assumptions to the costs of crime, 
bring their rate of return estimates down from 
those previously published.
Tai, T; Bame, 
SI
2010
USA
No alternative in this analysis Cost of school nurse staffing nationwide
Reductions in cost come from reductions in: ER, 
hospital costs, outpatient care due to improved 
health status, absenteeism and premature death 
none stated Yes for calculating 
wages lost to 
premature death
3%
USD
Hoeflmayr, 
David and 
Hanewinkel, 
Reiner
2006
Germany
yes Direct (17.28 bn euro) and indirect costs (16.6 bn 
Euro) of smoking in Germany due to forgone labour 
productivity based on human capital method. 
Programmed costs collected from the competition 
schools.
Smoking progression model was used to estimate 
the number of students who were prevented from 
becoming established smokers
n/a
n/a
yes
5%. 0%, 3%, and 10% 
used in sensitivity 
analysis
Euro, doesn't 
specifically state 
price year, alludes to 
2001/2002, but then 
also states other 
years, unclear.
n/a, The direct benefit/cost ratio was 8.2 and the total 
benefit/cost ratio was 3.6.
Sensitivity analysis varying discount rate, 
univariate and multivariate analyses. Monte 
Carlo analysis in 10,000 cycles performed on 
model using Crystal Ball 2000 (Decisioneering 
Inc.)
yes, described during sensitivity analysis on a 
number of parameters.
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Li, Yanping; 
et al
2010
China
The nutrition-based comprehensive 
intervention study on childhood 
obesity in China (NISCOC): a 
randomised cluster controlled trial
Bmc Public Health
To describe the design of a multi-centred random 
controlled school-based clinical intervention for 
childhood obesity in China. Secondary objective is to 
compare the cost-effectiveness of the comprehensive 
intervention strategy with two other interventions, one 
only focuses on nutrition education, the other only 
focuses on physical activity.
Multi-cantered randomised controlled 
trial.
Grade 1 to 5, aged 7-13 
years
6 centres in Beijing, 
Shanghai, Chongqing, 
Shandong province, 
Heilongjiang province 
and Guangdong 
province.
Three interventions included in the present study: 
nutrition education, physical activity intervention and a 
comprehensive interventions including both.
Newbury-
Birch, D.; et al
2013
UK
A feasibility trial of alcohol screening 
and brief interventions for risky 
drinking in young people in a high 
school setting in the UK: Sips jr-high
Alcoholism: Clinical and Experimental 
Research
To answer the following research questions: 'is it 
feasible to deliver screening and brief alcohol 
intervention in schools in England' and 'what are the 
likely eligibility, consent, participation and retention 
rates of young people in a UK-relevant trail of brief 
intervention compared to standard practice?'
Feasibility 3 arm pilot trial with cluster 
randomisation and level of school and 
integrated qualitative process 
evaluation.
Younger adolescents 
(aged 14-15) in Year 10
High schools across 
North Tyneside.
Control arm: standard alcohol advice, which will include a 
leaflet about healthy living. Level one intervention: in 
addition to control, those who screen positively for 
alcohol misuse using the alcohol screening questionnaire 
will take part in a 30 minute personalised session 
delivered by the Learning Mentor. Level 2: in addition to 
control and level 1, young people will attend a 
subsequent one hour session of behaviour change 
counselling.
Abt, Clark 
1966
USA
A COST-EFFECTIVENESS MODEL FOR 
THE ANALYSIS OF TITLE I ESEA PROJECT 
PROPOSALS, PART I-VII
Technical note for Office of Education, 
US department of health, education, 
and welfare
Present design for elementary and secondary education 
cost-effectiveness model for the analysis of Title 1 ESEA 
project proposals.
Computer simulation with empirical 
data being collected for validation. 
Model is not expected to be predictive, 
but indicative of the relative cost-
effectiveness of alternate Title 1 
programs.
School children
USA
Title 1 programs are for the disadvantaged, and are 
directed at increasing learning, through changes in 
student achievement, attitudes and environmental 
factors, social behaviours, and community impacts. 
Brown, H. S.; 
et al
2007
USA
The cost-effectiveness of a school-
based overweight program
International Journal of Behavioural 
Nutrition and Physical Activity
To assess the cost-utility and cost-benefit of a school-
based intervention designed to reduce obesity in 
adulthood.
Four interventions schools and four 
matched control schools were 
randomly selected out of the two 
largest school districts in El Paso.
Students 8-11 years
US schools/primary 
care (n=896)
The Coordinated Approach to Child Health (CATCH) 
interventions includes a classroom curriculum, a physical 
education programme, modifications to the school food 
service, and family and home-based programmes.
Scherrer, CR; 
et al
2006
USA
Public Health sealant delivery 
programs: optimal delivery and the 
cost of practice acts
Public Health Dentistry
Determine optimal combinations of staffing levels and 
sealant stations for school-based sealant programs.
Discrete event simulation model 
(OTHER)
Second graders and 
sixth graders age 8-14
Wisconsin schools. 
Obtained data from IL, 
OH, AZ, NM, CO and 
AL.
A school-based public health intervention to screen 
children for sealants and provide if needed. 
Anderson, R; 
et al
2014
UK
Cost-effectiveness of classroom-based 
cognitive behaviour therapy in 
reducing symptoms of depression in 
adolescents: a trial-based analysis
Journal of Child Psychology and 
Psychiatry
Determine CE of a universally delivered age-appropriate 
CBT programme in school classrooms to reduce 
depression.
Trial-based CEA based on cluster RCT 
comparing classroom-based CBT with 
usual school provision. ( almost CUA)
12-16 years
8 mixed-sex UK 
secondary schools, 
including 3,357 
children between the 
two trial arms
Data collected at baseline, 6 and 12 months.
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Li, Yanping; 
et al
2010
China
Physical examination, body 
composition, blood biochemical 
indices, dietary intake 
situations, physical activities, 
physical measurements, obesity 
related knowledge, cost
1 year (intervention assumed to 
last that long)
protocol protocol Protocol, Alludes to CEA and CBA, 
but doesn't describe methods. 
Classified as cost analysis
none stated
End of intervention assumed
Costs of staff training, intervention materials, teachers 
and school input and supervising fee.
Newbury-
Birch, D.; et al
2013
UK
Total consumption at 12 months 
using the TLFB-28 within 
intervention groups.
12 months, with 6 month follow-
up
protocol protocol Protocol, Does not state, stated 
will use pilot to design economic 
evaluation, classified as cost 
analysis
Broad perspective mentioned for 
entire study
12 months
Will describe the costs of introducing and running the 
brief intervention and will focus on examining what 
school resource data should be collected (and how) in 
terms of ongoing staff and capital costs.
Abt, Clark 
1966
USA
Not an intervention study
Not an intervention study
No actual results, this was a technical note to aid 
those decision makers who might use the model.
The model is not intended a research 
tool rather an evaluation and planning 
tool.
Simulation model
Societal/government, not 
actually stated
None specifically stated. Costs 
projected for the life of the 
program.
Indirect and direct costs of the Title 1 programs
Brown, H. S.; 
et al
2007
USA
No. of overweight cases averted
CATCH trial followed-up over 
three years. Model extrapolated 
to age 40 to 64 years
CER calculated using general population and Hispanic 
estimates. See ICER column.
CER for CATCH was $900 well under  
$30000 threshold and sensitivity analysis 
reveals the results are robust.
Model based on a single trial and 
populated with estimates from 
the literature
Societal
Model extrapolated to ages 40 to 
64 years
Cost of intervention, medical costs, and productivity 
costs.  Medical costs derived from literature on 
hypertension, hypercholesterolemia, type 2 diabetes, 
CVD and stroke. Productivity estimated as difference in 
no. of sick days taken by obese adults compared to non-
obese adults.
Scherrer, CR; 
et al
2006
USA
Optimal quantity of labour and 
capital to minimise program 
costs.
Simulation of programs for 
delivering sealant
For general, direct or indirect supervision it is optimal 
to have only 1 dentist or less. For general 
supervision, its optimal to have dentist and assistants 
come on separate days. Sig saving by reducing 
supervision level.
States could save money by relaxing 
restriction on the type of personnel who 
can deliver sealants in public health 
settings and by productivity gains 
through proper consideration of staffing. 
Savings could be used to improve access 
and reduce disparities.
Model, discrete event simulation
societal/Wisconsin
10-year life of sealants
Staffing costs, travel time, equipment. Did not included 
admin costs.
Anderson, R; 
et al
2014
UK
Individual self-report on care 
costs, QALYs (base on EQ5D) 
symptoms of depression (Short 
mood and feelings 
questionnaire)
12 months
Lower QALYs in CBT group -0.05QALY/person (CI: -.09, -
.005, p=.03) but 'clinically negligible' difference not 
found in complete case analysis. Little evidence of 
any between-arm differences in SMFQ scores or costs 
per person for CBT vs usual school provision 
Universal provision of classroom CBT is 
unlikely to be either more effective or 
less costly than usual school provision.
CEA and CUA attempted, 
classified as cost, but nearly CUA
NHS and Social care
1 school year Sept 2009 to July 
2010
Cost of delivering programme from detailed project 
records of staff time and other expenditure: paid time 
of facilitators, training, ongoing supervision, travel 
costs, printing, and recruiting schools, room hire and 
subsistence.
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Li, Yanping; 
et al
2010
China
Yes, but did not include a do 
nothing approach.
Not enough detail provided
none mentioned
Did not state which outcome measure would be the 
effectiveness measure that would be analysed in the 
CEA/CBA.
none stated
Did not give enough detail
none stated
None stated, RMB 
assumed
Did not state if will calculate an ICER. Did not state if this would be performed.
None
Newbury-
Birch, D.; et al
2013
UK
Yes
Will use the pilot to identify 
important costs and 
consequences.
See costs.
Did not state which outcome measure would be the 
effectiveness measure that would be analysed.
none stated
none
none stated
None stated, GBP 
assumed
Did not state if will calculate an ICER Did not state if this would be performed
none
Abt, Clark 
1966
USA
No, but the aim of this technical 
note was not to evaluate two 
opposing programs, but explain 
how the model worked.
Not an intervention study
Described in the cost simulation part of the model.
Report use of churchman-Ackoff approximate 
measure of value procedure to value outcomes.
n/a
n/a
Yes, mentions 
discounted to 
present value
No rate mentioned
USD
Chart 5 shows info needed to determine incremental 
value per dollar of the Title 1 program being 
implemented.
none
Made up of various sub models: school, 
instructional process, community, cost, 
effectiveness and the simulation
Brown, H. S.; 
et al
2007
USA
Yes,  they were matched
No, seemed to only identify cost 
and benefits of the intervention 
and assume no cost/benefit 
change from control. Medical 
costs assumed to accrue in control 
come from literature.
Intervention costs, medical costs averted (direct 
costs), labour productivity costs.
Used NHIS survey questions on activity limitations to 
weight health states and estimate QALY. Used an 
equation in the appendix.
It is unclear how the 
health states were valued.
QALY and monetary 
benefits
yes
3%
USD 2004
Report CERs instead $900 per QALY gained compared to 
no intervention. When calculating numerator totalled 
costs of intervention less medical costs due to obesity 
(didn't take difference in cost b/t groups). Net benefit 
$68,125
Sensitivity analysis using a triangular distribution 
for 1000 simulations. In all cases intervention 
remained cost-effective and net beneficial.
48 in total varied in sensitivity analysis, see table 
2 and 4.
Scherrer, CR; 
et al
2006
USA
yes 
Costs yes, consequences no
see costs
All assumed. Discuss possible sources of 
effectiveness in discussion, but don't specify its use 
in the analysis.
costs 
yes 
3%
2003 USD, assumed
none Varied sensitivity around dentist's productivity 
by assuming dentists have higher productivity 
than hygienists.
Mainly just costs of the different strategies.
Anderson, R; 
et al
2014
UK
Yes, usual school provision
Yes, for costs used adapted CSRI
Service use, adapted CSRI, health service visits and 
hospital inpatient stays
EQ-5D, cost per QALY and incremental cost per unit 
decrease in SMFQ score
EQ-5D
QALY
no
GBP 2010
Don’t report them calculated, but see table 4. My 
calculations: cost/Daly -£2783, cost/SMFQ £348
none
no model
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Stallard, P; et 
al
2013
UK
A cluster randomised controlled trial to 
determine the clinical effectiveness 
and cost-effectiveness of classroom-
based cognitive-behavioural therapy 
(CBT) in reducing symptoms of 
depression in high-risk adolescents
Health Technology Assessment
This is the same study as Anderson, 2014, but  it is the 
full HTA report. 
Trial-based CEA based on cluster RCT 
comparing classroom-based CBT with 
usual school provision. (CUA)
12-16 years
8 mixed-sex UK 
secondary schools, 
including 3357 
children between the 
two trial arms
Data collected at baseline, 6 and 12 months.
Atherly, 
Adam; et al
2009
USA
An Economic Evaluation of the School-
Based power Breathing Asthma 
Program
Journal of Asthma
Evaluate the cost effectiveness of the 'Power Breathing' 
programme for asthma among middle and high school 
students.
Matched quasi-experimental design 
which matched schools based on grade 
range, enrolment, income and 
race/ethnicity which were then 
randomised to intervention or control 
group.
Adolescents in grades 
6-12 (aimed at ages 11-
19)
8 junior high schools 
and 2 high schools in 
Kansas and Virginia. 
N=524
Designed to be implemented in a school-based setting, 
consists of three 90 minute educational sessions focusing 
on education about asthma, asthma control strategies and 
psychosocial concerns. More detailed description on page 
596.
Babey, Susan 
H.; et al
2014
USA
How can schools help youth increase 
physical activity? An economic analysis 
comparing school-based programs
Preventive Medicine
To assess the following types of school-based 
opportunities to improve physical activity for youth: 
after-school programs, before-school programmes, PE 
classes, extended-day PE, and short physical activity 
breaks during the school day. 
Cost analysis, hypothetical 
intervention applied with estimated 
costs and effects populated with data 
from the literature.
School-aged children
US schools
1. After-school program, typically from 3 to 6 PM. 2. 
Extended school day (40-60 min) with increased time for 
PE class, mandatory for all students. 3. In-class activity 
consisting of to 10-min breaks of structured physical 
activity. 4. Before-school activity program, with volunteer 
or professional supervision available for 30 minutes 
before school during regular school days.
Boyle, J; et al
2007
UK
A randomised controlled trial and 
economic evaluation of direct versus 
indirect and individual versus group 
modes of speech and language therapy 
for children with primary language 
impairment
Health Technology Assessment
To compare language outcomes following direct 
individual therapy working individually , indirect 
individual therapy, direct group therapy and indirect 
group therapy for primary school children with language 
impairment.
2X2 factorial design trial with control 
receiving existing levels of support. 
Includes 'short-run' economic 
evaluation. (non-economic)
6-11 years
School settings in 
Scotland
Compared 4 different strategies
Brassard, P., 
et al
2006
Canada
Evaluation of a school-based 
tuberculosis-screening program and 
associate investigation targeting 
recently immigrated children in a low-
burden country
Pediatrics
Retrospectively evaluate a school-based screening 
program targeting children at high risk for TB infection in 
Montreal, Canada, as well as subsequently investigate 
family and household associates of the schoolchildren 
with latent TB infection (LTBI), based on adherence to 
LTBI therapy and cost-benefit analysis.
Retrospective evaluation of school 
screening for TB in immigrant children
4-18-year-olds
Montreal, Canada 
schools (n=16)
In selected schools, immigrant children were screened 
using the tuberculin skin test (TST). Those who tested 
positive was referred for medical evaluation and the 
family and household associates were also screened.
Curtale, F.; et 
al
2005
Egypt
Control of human fascioliasis by 
selective chemotherapy: Design, cost 
and effect of the first public health, 
school-based intervention 
implemented in endemic areas of the 
Nile Delta, Egypt
Transactions of the Royal Society of 
Tropical Medicine and Hygiene
Assess the efficacy of the programme, and gather 
operational information including cost
Evaluation of a selective screening 
programme
School-aged children 
10-12
Nile Delta
Unclear what was control and what was intervention, not 
well described. Assuming intervention was the selective 
treatment delivered at school, but this comes under 
heading 2.1 The control programme. Must be the name of 
the program.
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Stallard, P; et 
al
2013
UK
Individual self-report on care 
costs, QALYs (base on EQ5D) 
symptoms of depression (Short 
mood and feelings 
questionnaire)
Lower QALYs in CBT group -0.05QALY/person (CI: -.09, -
.005, p=.03) but 'clinically negligible' difference not 
found in complete case analysis. Little evidence of 
any between-arm differences in SMFQ scores or costs 
per person for CBT vs usual school provision.
Universal provision of classroom CBT is 
unlikely to be either more effective or 
less costly than usual school provision.
CEA and CUA, classified at other 
since no report of ICER
NHS and Social care
1 school year Sept 2009 to July 
2010
Cost of delivering programme from detailed project 
records of staff time and other expenditure: paid time 
of facilitators, training, ongoing supervision, travel 
costs, printing, and recruiting schools, room hire and 
subsistence.
Atherly, 
Adam; et al
2009
USA
Cost/symptom free day (gain or 
loss as compared to baseline) 
mean comparison and OLS 
regression with random effects 
(to correct for clustering)
Baseline, post intervention and 
3 month follow-up.
Intervention increased symptom free days and 
control decreased, but not statistically significantly. 
The decline was statistically significant in 
intervention. Hypothesised effect of intervention 
depended on baseline symptoms.
School-based interventions aimed at 
asthma, properly implemented and 
administrated are an appropriate use of 
societal resources.
Stated 'economic evaluation', 
classified as cost analysis as didn't 
quite meet definition of CUA/CEA
societal
3 months
Direct costs associated with medical service use, 
emergency department visits, hospitalizations, 
outpatient care, and prescription drugs as well as cost 
of devices such as peak flow meters. Indirect costs such 
as lost productivity (including parent work absence), 
school absences and waiting times at doctor's office and 
start up implementation costs.
Babey, Susan 
H.; et al
2014
USA
Cost/MET-hours-gained per 
year. 
Wasn't an intervention study so 
no follow-up
Costs and 'cost-effectiveness' varied considerable 
across the four programs. In order of most cost-
effective: in-class physical activity breaks, instructor-
led physical activity before school, extended school 
day with mandatory PE and finally on-sited after-
school programmes.
Inserting activity breaks into the day is 
appropriate  especially when youth must 
sit at a desk all day and adults  have 
sedentary jobs. Inserting routine breaks 
at an early age might translate into 
physical activity breaks in the workplace.
Stated 'economic analysis', 
classified as cost analysis
none stated
None stated explicitly, does say  
annual costs and outcome is MET 
hours/year, so can assume 1 year
Mainly program costs or operational costs estimated, 
costs to family as well, but didn't specify what the costs 
were made up of other than 'out-of-pocket' expenses 
to participate in programme.
Boyle, J; et al
2007
UK
Standardised scores on test of 
expressive and receptive 
language.
Within trial econ evaluation identified indirect group 
therapy as the least costly with individual therapy as 
most costly… effectiveness?
classified as cost analysis
Individual child for outcome
Within trial, had aims to do 
longer-term, but effectiveness 
was not sustained at 12 months 
so unclear whether any longer 
term treatment effects would be 
identified.
Two major components: salary cost associated with 
each mode of delivery and travel cost associated with 
the delivery method
Brassard, P., 
et al
2006
Canada
TST positivity rate
Retrospectively reviewed 
hospital charts from 1998 to 2003
The only predictor of adherence was having more 
than 2 family members brought in for TB screening 
(adjusted OR: 2.0; 95%CI: 1.3-3.3). 78% of associates 
of TST positive children who were positive adhered 
to therapy. Net benefits from both school-based 
screening and associate investigation, as stand alone 
or coordinated.
They demonstrated effectiveness, 
including cost-effectiveness, of a 
targeted, school-based screening 
program in a low-burden country and the 
extra benefit given by adding associates 
to such a program.
'Cost-benefit analysis', classified 
as cost analysis
none stated
None stated explicitly, states 
over the 5-year period so assume 
1998-2003
Total material and labour costs associated with the 
school-screening and associate investigations. Cost of 
treating TB derived from recent CBA of treatment of TB 
in Montreal.
Curtale, F.; et 
al
2005
Egypt
Control of human fascioliasis. In 
terms of prevalence? Intensity? 
Treatment? Primary Outcome 
not well described
Programme screening from 1998 
to 2002
Prevalence in the endemic area was reduced from 
5.6% to 1.2%.
The targeted selective approach was 
appropriate in addressing low prevalence 
infection, effective in reducing 
prevalence rates and transmission of the 
disease, and in the present situation, 
more cost-effective than mass 
distribution.
costing
none stated
none stated
Gives some costs in LEG, but doesn't explain how 
converted to USD and explicitly state the price year that 
all costs are reported in.
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Stallard, P; et 
al
2013
UK
Yes, usual school provision
Yes, for costs used adapted CSRI
Service use, adapted CSRI, health service visits and 
hospital inpatient stays
EQ-5D, cost per QALY and incremental cost per unit 
decrease in SMFQ score
EQ-5D
QALY
no
2010 GBP
Don’t report them calculated, but see table 4. My 
calculations: cost/Daly -£2783, cost/SMFQ £348
none
no model
Atherly, 
Adam; et al
2009
USA
Identified as control, no other 
description except that they 
'identified the costs and outcomes 
of asthma' in both groups.
Didn't consider opportunity cost 
of school time lost due to 
intervention
Compensation to students and staff for participation, 
time spent by students, parents, teachers, school 
nurses, facilitators. Total cost given is $30.37 per 
student.
Symptom free day. Table 1 has effectiveness data, 
but a cost table that correlates to that resource use is 
missing.
Mention asthma related 
quality of life, but don't 
provide any figures.
Symptom free day gained
no
none
USD no price year 
stated
Did not calculate correctly. Based calculation on 
intervention only by multiplying intervention effect on 
baseline days. Costs are not reported for control (even 
though said identified costs and outcomes), so could 
not calculate ICER myself.
none 
none
Babey, Susan 
H.; et al
2014
USA
yes
Costs identified, consequences 
less well thought out. Much of the 
analysis was theoretical with a lot 
of assumptions.
Operating cost per child per year (from previous 
study), family costs such as out-of-pocket costs to 
attend. Did not include potential effect on health 
care costs.
Minutes of moderate to vigorous physical activity, 
assumed, and MET hours - assumed.
none
Metabolic equivalent of a 
task (MET) hours. This was 
standardised so the same 
measure of benefit was 
applied to each 
intervention.
no
none
2012 USD
Based on all comparators gaining the same effect (i.e. 
270 MET hours/year). Incremental not calculated. Cost 
per MET hour gained calculated for the following: after-
school on-site $10.62, after school off-site $11.29, 
Longer day PE $.65-$.98 (405 vs 270 MET hours gained), 
In class $0.008-$0.01, Before school volunteer lead, 
negligible and teacher led $.49.
none 
none
Boyle, J; et al
2007
UK
yes
yes
salary, transportation
Change in total CELF-3 total language score 
No, outcome was change 
in CELF-3 score
no
GBP
Incremental analyses performed but in non-traditional 
way
no
no
Brassard, P., 
et al
2006
Canada
no
No, seemed to only identify 
intervention costs.
Testing, wages and materials, appointments, chest 
radiographs, interpreters
TB cases prevented (estimated), therapy adherence. 
Doesn't describe how benefits were valued.
none
none, not CUA
Yes, but only for 
cases prevented
3%
CAD, no year 
specified
none, 'CBA' Sensitivity analysis varying cost assumptions and 
rate of hospitalization and probability of lifetime 
risk of developing TB. 
None
Curtale, F.; et 
al
2005
Egypt
no
no
Personnel and material costs of providing 
intervention.
infection intensity
none
none, not CUA
no
none
USD, price year not 
stated
Cost per child screened $0.50, cost per child treated 
$2.33
none 
none
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Foster, E. 
Michael
2010
USA
Costs and Effectiveness of the Fast 
Track Intervention for Antisocial 
Behaviour
Journal of Mental Health Policy and 
Economics
The Fast Track intervention is a 10-year, multi-
component prevention program targeting antisocial 
behaviour. The intervention identified children at school 
entry and provided intervention service over a 10-year 
period. This study examined the intervention's impact 
on outcomes affecting societal costs using data through 
late adolescence.
Multi-cohort, muti-site, multi-year 
randomised control trial of program 
participants and comparable children 
and youth in similar schools.
School-aged children 
grade 1-10
US schools within four 
sites (Durham, NC; 
Nashville, TN; Seattle, 
WA; and rural 
Pennsylvania)
High risk children identified in schools and those scoring 
in the top 40% were selected to receive the intervention, 
91% agreed (n=3,274). Intervention delivered from grades 
1 though 10. Parents offered parent training and home 
visiting, academic tutoring, and social skill training. 
Parent and child groups offered 2-hour enrichment 
program. Group meetings held weekly, biweekly, then 
monthly each year on. Social emotional learning program 
PATH adapted in school curriculum.
Gelli, Aulo; et 
al
2009
Italy
The costs and cost-efficiency of 
providing food through schools in 
areas of high food insecurity
Food and Nutrition Bulletin
To estimate the programmatic costs and cost-efficiency 
associated with providing food through schools in food-
insecure, developing-country contexts, by analysing 
global project data from the World Food Programme.
Retrospective cost evaluation in terms 
of specified unit of effect (i.e. unit of 
nutrient delivered).
School-aged children  
Food-insecure 
developing countries
Providing food through schools from the World Food 
Programme.
Gelli, Aulo; et 
al
2011
Italy
New benchmarks for costs and cost-
efficiency of school-based feeding 
programs in food-insecure areas
Food and Nutrition Bulletin
Address the need for systematic estimates of the cost of 
different school feeding modalities, and of the 
determinants of the considerable cost variation among 
countries. The project aimed to update current 
benchmarks for school feeding cost and cost efficiency 
and understand cost drivers and cost-containment 
opportunities.
Retrospective cost evaluation in terms 
of specified unit of effect (i.e. unit of 
nutrient delivered).
School-aged children
Food-insecure 
developing countries
Providing food through schools from the World Food 
Programme.
Gesell, SB; et 
al
2013
USA
Comparative Effectiveness of After-
school programs to increase physical 
activity
Journal of Obesity
Comparative effectiveness analysis  to evaluate the 
difference in the amount of physical activity children 
engaged in when enrolled in a physical activity enhanced 
after school program based in a community rec centre vs 
a standard school-based after-school program
Natural experiment with 54 children 
attending community ASP and 37 
attending school-based ASP (cost 
analysis). An observational prospective 
cohort and natural experiment in 
Nashville, TN. 
Aged 5-13
Nashville, TN
Both ASP followed similar formats from 3-6PM after 
school, time for snack, homework and play and did not 
focus on a single activity. Intervention set in community 
rec and had staff led games. School ASP set in cafeteria 
had arts and crafts and playing in playground.
Guay, M.; et 
al
2003
Canada
Effectiveness and cost comparison of 
two strategies for hepatitis B 
vaccination of schoolchildren
Canadian Journal of Public Health
To compare the effectiveness and costs of school-based 
and clinic base hepatitis B vaccine programmes.
Cost-effectiveness analysis of multi-
centre trial in 2 community clinics and 
55 schools, authors state quasi-
experimental. Reclassified by CRD as 
cost consequence as no summary 
measure of benefit.
8-9 (grade 4 in 
Canada)
School, community 
care, Monteregie, 
Canada
Natural experiment where one community clinic replaced 
school-based vaccine programme with vaccine offered in 
community clinics after school hours.
Joseph, C. L.; 
et al
2007
USA
A web-based, tailored asthma 
management program for urban 
African-American high school students
American journal of respiratory and 
critical care medicine
Develop and evaluate a multimedia, web-based asthma 
management program to specifically target urban high 
school students. The program uses 'tailoring' in 
conjunction with theory-based models to alter 
behaviour through individualized health messages based 
on the user's beliefs, attitudes and personal barriers to 
change.
RCT, Students reporting asthma 
symptoms randomised to tailored web 
programme versus generic asthma 
websites. N=314
9th through 11th 
graders, average age 
15
Six Detroit public high 
schools
Web-based programme that focuses on three core 
behaviours: controller medication adherence, rescue 
inhaler availability, and smoking cessation/reduction. 
Four education computer session that uses normative and 
positive feedback. Core behaviour status determined at 
session 1 and reassessed during sessions 2-4.
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Foster, E. 
Michael
2010
USA
Impact on societal cost
10 years
The intervention lacked both the breadth and depth 
of effects on costly outcomes to demonstrate cost-
effectiveness or even effectiveness
The most intensive psychosocial 
intervention ever fielded did not 
produce meaningful and consistent 
effects on costly outcomes. The lack of 
effects through high school suggest that 
the intervention will not become cost-
effective as participants progress through 
adulthood.
costing study
payer perspective
10 years
Didn't actually cost all resource use. Asked about health 
service use, criminal activity, school service use, 
substance abuse and financial assistance and tested for 
difference between groups using regressions or 
survival models. Prior analysis was the intervention 
cost $58,000/child, and did report mental health 
services costs $6,249 vs $4,905 control vs intervention 
and general health $6,572 vs $5,466, but not enough to 
offset cost of program.
Gelli, Aulo; et 
al
2009
Italy
Yearly expenditure per child
None, assumed WFP will 
continue
Average yearly expenditure US$21.59 per child 
ranging from $11 to $52. Fortified biscuit most CE in 
terms of micronutrient delivery, onsite meals best 
for total calories. Transportation and logistics main 
cost drivers.
Choice of program objectives will dictate 
type of food. Fortified biscuits can 
provide substantial nutritional inputs at a 
fraction of the cost of school meals, 
making an appealing option.
costing study
WFP assumed, none stated
none stated
From WFP Standard Project Reports: expenditures, 
beneficiaries, and food distribution. From WFP Country 
Offices' estimated year expenditure by beneficiary.
Gelli, Aulo; et 
al
2011
Italy
Standardized yearly average 
school feeding cost per child
None, assumed WFP will 
continue
Average school feeding cost per child non including 
school-evaluation costs was US$48.  Cost was lowest 
for biscuit programs at US$23 and highest for take-
home  ration programmes reaching families US$75. 
Combination on-site and take home $61.
Both costs and effects should be 
considered carefully when designing 
school feeding interventions. The 
average costs of school feeding 
estimated are higher than those found in 
earlier studies but fall within range of 
earlier studies.
costing study
WFP assumed, none stated
none stated
The standardised costs =cost per beneficiary project 
expenditure, number of on-site feeding days, standard 
parameter for ration kcals per modality, planned ration 
kcals, theoretical food tonnage and actual food tonnage 
delivered.
Gesell, SB; et 
al
2013
USA
Physical activity using ActiGraph 
GTiM accelerometers.
12 weeks
At baseline, 43% of the multi-ethnic sample was 
overweight/obese, the mean age was 7.9 years.  Cost 
analysis suggested that children attending tradition 
school-based ASPs, at an average cost of $17.67 per 
day would need an additional daily investment of 
$1.59 per child  for 12 weeks to increase their 
moderate-vigorous physical activity.
A low-cost, alternative after-school 
program featuring adult-led physical 
activities in a community recreation 
centre was associated with increased 
physical activity compared to standard-of-
care school-based-after-school programs.
States CEA, but no ICER, costing 
study
societal inferred
12 weeks
Just implementation costs for 12 week study period = 
$1184 per child ($19.25 daily per child) vs $1087 per child 
($17.67 daily per child) for school based ASP.
Guay, M.; et 
al
2003
Canada
Percentage of school cohort 
vaccinated
None, vaccine
With community clinics vaccine coverage fell to 73%, 
compared to over 90% in schools. Societal costs were 
$63 in community clinic and $40 in school.
Results demonstrate the advantage of a 
school versus community based 
immunization programme.
Authors did not derive a summary 
measure of health benefit, 
therefore CCA
societal
1 year
Only costs that varied between programmes counted 
(i.e. cost of vaccine not included). Measured costs: 
labour costs in clinic, running expenses of clinic, labour 
costs in the school, other costs, and cost incurred by the 
parents on taking their children to the clinic.
Joseph, C. L.; 
et al
2007
USA
Number of symptom days in the 
last 2 weeks.
12 months
12 months treatment students report fewer symptom 
days 0.5(0.4-0.8), p=0.003; symptom-nights 0.4(0.2-
0.8), p=0.009; school days missed 0.3(0.1-0.7), 
p=0.006; restricted activity days 0.5(0.3-0.8), p=0.02; 
and hospitalisations 0.2(0.2-0.9), p=0.01.
Cost estimates were $6.66 per 
participating treatment group student. A 
web-based tailored approach to changing 
negative asthma management 
behaviours is economical, feasible and 
effective in  improving asthma outcomes 
in a traditionally hard-to-reach 
population.
costing study
none stated
12 months
Referral coordinator labour costs $6.66 ($8.05 per 
treatment student referred and $11.73/student 
contacted.
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Foster, E. 
Michael
2010
USA
No, just described as control 
group.
No
Yes, see costs, collected important resource use but 
didn't report costs associated with each group in a 
table. Some figures reported in text i.e. health care 
use, but not all.
It is not clear what the overall main effectiveness 
measure was. It can be inferred effect would have 
measured by a decrease in societal resources (i.e. 
cost savings as compared to the control).
none
none
no
none
USD, no price year 
stated
n/a no
n/a
Gelli, Aulo; et 
al
2009
Italy
No, an evaluation of programmes 
already implemented
There isn't really an appropriate 
control
see costs
Nutrient/kcal delivered
none
none
no
none
USD, no price year 
stated
Not ICER, but reported cost/nutrient delivered. 
Standardised beneficiary $21.59 ($4.51-$96.81); 
cost/100kcal $3.60; cost/mg iron $2.33; cost/100mg 
vitamin A $8.73; and cost/100mg iodine $813.32
no
no
Gelli, Aulo; et 
al
2011
Italy
No, an evaluation of programmes 
already implemented
No appropriate control
see costs
Food quantity, calories, proteins, and micronutrient 
content delivered were used to assess the cost-
efficiency.
none
none
no
none
USD, no price year 
stated
No ICER, but reported cost/child. School feeding 
project cost/child $29, Standardized school feeding 
cost/child $48, standardised range $15-$213.
no
no
Gesell, SB; et 
al
2013
USA
no
no
Implementation costs, facility costs, staff costs
Physical activity, body fat percentage, fitness
none no
none
USD 2010
No ICER, costing study. none
none
Guay, M.; et 
al
2003
Canada
yes
Yes, table two reports costs to 
clinics, schools, parents and a unit 
cost/student vaccinated.
see costs
Community vaccine rate 73%, school 90-95%.
none
none
No
none
CAD 1997-8, not 
stated directly
n/a, but mean costs and effects available to calculate. 
Most expensive school strategy dominates community 
strategy.
no
none
Joseph, C. L.; 
et al
2007
USA
yes
Does not report costs clearly for 
each alternative in a table.
Referral contact, average 31 minutes per student, 
hospitalisations, ED visits
Symptom days, asthma severity, ED visits, 
hospitalisations
Mention Disease specific 
QoL questionnaire 
developed by Juniper et 
al, 1994.
Not clear, report QOL 
domains but not mention 
of scale.
no
none
USD, no price year 
stated
none stated none
none
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Meng; et al
2013
China
BMI 
One academic year
The comprehensive intervention was the only 
combination to lower BMI significantly as compared 
to its control. BMI and BAZ increment was 0.65 
kg/m2(SE 0.09) and 0.01(SE0.11) which was 
significantly lower than the control (0.82+-0.09 for 
BMI, 0.10+-0.11 for BAZ).
The school-based integrated obesity 
intervention program was cost-effective 
for children in urban China.
CEA, but only CERs reported, 
classified as cost analysis
State social perspective, assume 
meant societal.
1 academic year
Costs collected by retrospective interview of project 
coordinator in each centre. Collected a) intervention 
costs; b) evaluation costs; and c)the development cost 
on structuring the program before the intervention.
Salisbury, C.; 
et al
2002
UK
Attendance for asthma review, 
symptom control, and quality of 
life
Six months
See summary outcomes for primary outcome results. 
Those at school clinics had greater knowledge of 
asthma (+0.38, 95% CI= 0.19 to 0.56), most positive 
attitudes ( +0.21, 95%CI = 0.05 to 0.36), and better 
inhaler technique (P<0.001).
The schools asthma clinic increased 
uptake of asthma reviews. There were 
improvements in various process 
measures,, but not in clinical outcomes.
Not a formal economic 
evaluation, but could potentially 
conduct one if the right 
information is given, cost analysis
NHS
none mentioned
Economic outcomes were total costs of different 
models of asthma care, taking into account 
consultations in school, practice or hospital, and the 
costs of drug treatment.
Shemilt, I.; et 
al
2004
UK
Not specified, key outcomes 
defined by balance sheet 
approach from broad cost-
benefit perspective.
No significant impact on outcomes, conduct was only 
variable to show significant decrease due to funding 
but may be by chance. Some signs in unexpected 
direction.
Little quantitative evidence that the 
clubs had impacted on health, education 
or social outcomes. Levels of funding 
were not significant determinant of 
observed outcomes in either type of 
school (primary/secondary).
Cost analysis
Not specified, alluded to multiple 
levels
1 year
Funds associated with setting up and maintaining 
breakfast clubs
Wang, Li Yan; 
et al
2003
USA
Cases of adulthood overweight 
prevented and QALYs saved.
2 years
Base-case assumptions, intervention cost $33,677 or 
$14 per student per year. The program would prevent 
1.9% of the female students from becoming 
overweight adults resulting in 4.1 estimated QALYs 
saved. $4305 per QALY saved and net saving to society 
of $7,313.
The Planet Health program is cost-
effective and cost-saving as 
implemented. School-based prevention 
programs of this type are likely to be cost-
effective uses of public funds and 
warrant careful consideration by policy 
makers and program planners.
CEA stated, classified as cost 
analysis
societal
25 years, from age 40 to 65.
Intervention costs estimated from retrospective cost 
analysis of the program. Estimated medical costs saved 
by intervention as costs averted per case of adulthood 
overweight prevented. Finally costs of lost productivity 
averted per case of adult overweight prevented. All 
projected costs, based on a lot of assumptions.
Young, T. L.; 
et al
2003
USA
Satisfaction questionnaires 
completed by providers, nurses, 
children and parents.
2 years
Provider, nurse, child and parent satisfaction were 
high. Average family savings per encounter were 3.4 
hours of work time ($43) and $177 in emergency 
department or $54 in physician costs. Including travel 
saving for families ranged $101 to $224 per 
encounter.
Telehealth technology was effective in 
delivering Pediatric acute care to 
children.  It was an acceptable alterative 
to traditional health care delivery. The 
POTS-based technology helps to make 
this cost-effective alternative for 
improving access to primary and 
psychiatric health care for underserved 
children.
Not an economic evaluation.
Societal assumed
2 years
Cost of technology and training, school nurse, and 
consultant time. This was compared to the average cost 
of a visit to the ED or paediatrician. Potential savings to 
parents included time away from work and travel 
avoided by having their child's condition diagnosed and 
treated in the school telehealth program.
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Meng; et al
2013
China
The Costs and Cost-Effectiveness of a 
School-Based Comprehensive 
Intervention Study on Childhood 
Obesity in China
Plos One
To evaluate the costs and cost-effectiveness of a 
comprehensive intervention program for childhood 
obesity.
A multi-centre randomised controlled 
trial conducted in six large cites during 
2009-2010.
Primary school 
students aged 6-13 
(n=8301)
Schools in Beijing and 
5 other cities.
Three interventions were compared: Nutrition education, 
PA, and comprehensive intervention which was a 
combination of nutrition and PA.
Salisbury, C.; 
et al
2002
UK
A randomised controlled trial of clinics 
in secondary schools for adolescents 
with asthma
British Journal of General Practice
To compare a nurse-led clinic in schools versus car in 
general practice for adolescents with asthma.
RCT in four schools with parallel 
observational study in two schools. 
From the detail provided, does not 
appear to be a formal economic 
evaluation.
Adolescents 12-14
Six comprehensive 
schools in the North 
Bristol NHS Trust
In the randomised trial, pupils were invited to attend 
asthma review at a nurse-led clinic either in school, or in 
general practice. The parallel observation study 
compared pupils invited to practice care within and 
outside the randomised trial.
Shemilt, I.; et 
al
2004
UK
A national evaluation of school 
breakfast clubs: where does economic 
fit in?
Child: Care, Health and Development
Describe the economics of UK school breakfast clubs, 
estimate costs and investigate relationship between 
costs and outcomes.
Cluster RCT aim (didn't happen) with 
postal survey of one year follow-up, 
secondary econ analysis (other)
Primary and 
secondary school
English schools 
serving deprived 
areas
Improve children's nutrition and education by providing 
breakfast to children who might otherwise start the day 
without eating.
Wang, Li Yan; 
et al
2003
USA
Economic Analysis of a School-Based 
Obesity Prevention Program
Obesity Research
To assess the cost-effectiveness and cost-benefit of 
Planet Health, a school-based intervention designed to 
reduce obesity in youth of middle-school age children.
CEA stated of RCT of Planet Health RCT girls 10-14, model 
projections women 40-
65
Middle schools
Planet Health is a school-based intervention designed to 
reduce obesity in youth of middle-school age. An 
interdisciplinary curriculum was infused into four major 
subject areas in into physical education focusing on 
television viewing, decreasing consumption of high-fat 
foods, increasing fruit and vegetable intake and 
moderate and vigorous physical activity.
Young, T. L.; 
et al
2003
USA
Effectiveness of school-based 
telehealth care in urban and rural 
elementary schools
Pediatrics
To evaluate the quality and cost effectiveness of health 
care provided in urban and rural elementary school-
based telehealth centres, using plain old telephone 
system (POTS) technology.
A prospective study using and 
exploratory design. Used a 
convenience sample of students who 
had parental consent.
Students aged 6 to 12
1 urban and 2 rural 
elementary schools, 
one rural school 
dropped out, so just 2.
Each school was staffed with a full-time school nurse and 
part-time mental health therapist. The consultant clinical 
site was staffed by paediatricians and Pediatric nurse 
practitioners. POTS uses regular telephone lines as this is 
simpler and less expensive to operate. Each school had 
two lines and a fax and POTS transmitter sending ears, 
nose, and throat endoscope to a clinical site.
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Meng; et al
2013
China
Yes, but each alternative seemed 
to have a separate control in each 
area.
Detailed costs were described, 
but inclusion of evaluation costs 
was questionable.
Labour, training, materials, travel and 
accommodation.
BMI, BMI z-score reduction and cases of overweight 
and obesity prevented, estimated based on 
observed BMI reduction in intervention and applied 
to control.
none
None, see effectiveness 
data
no
none
USD 2010
Calculated CERs and effects was difference between 
before and after BMI, not a comparison between 
interventions. Can calculate yourself from tables 2 and 
4: Control vs Nutrition = 52.8/(.74-.72)= $2640/BMI 
reduction point Nutrition vs PA =(52.3-52.8)/(.76-.74)= -
$25. PA vs Combi PA dominates in all cities, more 
effective and less costly. Not what the authors 
conclude.
no
none
Salisbury, C.; 
et al
2002
UK
Yes, the control was described as 
normal care.
Does not give enough detail, e.g. 
'resource use were collected from 
clinic records, general practice 
records, and follow-up 
questionnaires' 
See left. Tables do give details of resource use. 
Practice costs include doctor consultations, practice 
nurse consultations, and drug costs. School asthma 
clinic costs include nurse salaries, admin salaries, 
postage and consumables. Hospital costs include 
admissions, outpatient, and A&E visits.
Proportion of patients who had a review for asthma 
in six months, and HRQoL as measured by the 
Paediatric Quality of Life questionnaire, 
standardised UK version, PAQLQ.
No mention of conversion 
of utility scores to QALY.
None.
no
n/a
GBP no year stated.
None stated, mean costs given: School £56.63, GP 
£38.11 difference =£18.52. Difference in means for 
Quality of life -0.06. Negative ICER result, no CE plane 
given or bootstrap performed.
None
n/a
Shemilt, I.; et 
al
2004
UK
Wang, Li Yan; 
et al
2003
USA
no
no
Not identified in retrospective cost analysis except 
cost described.
CER = (C-NA)/NQ and net benefit =NA+NB - C, had to 
estimate C, N, Q, and B. Individual estimates of 
QALYs and productivity loss costs not available in the 
literature. All effectiveness data estimated from 
literature/their own methods.
QALY estimated by author
QALY
yes
3%
1996 USD
CER = $4,305, not an ICER Sensitivity analysis varying 10 parameters, one-
way and all together. See Table 1
See table 1, most parameters estimates from 
literature, or author's calculations. Difficult to tell 
how heterogeneous the estimates from 
literature are to the current study's population of 
interest.
Young, T. L.; 
et al
2003
USA
No alternative included in 
observation, rather alternative 
forms of medicine i.e. visit to 
ED/paediatrician described when 
making cost savings assumptions.
No
See costs, no additional resource use collected.
No effectiveness data collected except relating to 
satisfaction. This was an observation study so 
findings were descriptive.
none
none
no
none
USD, no year stated
none none
none
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Kristensen, 
Alyson H.; et 
al
2014
USA
Reducing Childhood Obesity through 
US Federal Policy A Microsimulation 
Analysis
American Journal of Preventive 
Medicine
To estimate the impact of three federal policies to 
reduce childhood obesity prevalence in 2032 after 20 
years of implementation.
Markov microsimulation model of 
policy impacts on diet/physical activity 
and BMI
School-aged 
population, 6-18 years
USA national policy, 
schools
Three federal policies simulated: 1) after school physical 
activity programs, 2) sugar sweetened beverage excise 
tax, and 3) ban on fast food television advertising 
targeting children.
Bruzzese, 
Jean-Marie; 
et al
2006
USA
Using School Staff to Establish a 
Preventive Network of Care to 
Improve Elementary School Students' 
Control of Asthma
Journal of School Health
Test the efficacy of a preventive care network for 
children with asthma which included 1) school nurses 
coordinating relationships between families, primary 
care providers (PCP) and school personnel and 2) school 
personnel and PCPs receiving training regarding asthma 
management.
Randomised controlled design of 44 
schools from the 5 boroughs of NYC.
Kindergarten to grade 
5. Age approx. 5-11.
US schools/primary 
care (n=591)
School health team consisting of full-time school nurse, 
school physician (2 days/month), public health assistant 
(2-3 days/week), teacher/administrator and parent. 
Participated in 3 day training workshop then worked with 
parents to develop an asthma management plan.
Massoni, 
Sebastien; et 
al
2012
France
How to Improve Pupils' Literacy? A 
Cost-Effectiveness Analysis of a French 
Educational Project
Economics of Education Review
Evaluate the Action Lecture program and use the 
estimation of impact on academic achievement to 
conduct a cost-effectiveness analysis and take a 
reduction of the class size program as a benchmark.
Non-randomised intervention and 
control study. Schools had to apply, and 
as not many did all who applied were 
admitted. Control schools have to be 
sourced separately and agree to 
participate. Use a difference in 
difference method.
Paris nursery and 
primary schools, six 
schools, over 400 
participants.
Unconventional intervention in which pupils don't have 
any courses for 2 weeks, but work together on a specific 
topic with different activities (reading, research, museum 
visit, writing, etc.). The goal is to develop the takes for 
reading and discovery and increase motivation to attend 
school.
Wade, T. J.; 
et al
2008
USA
Improvements in health-related 
quality of life among school-based 
health centre users in elementary and 
middle school
Ambulatory Pediatrics : the official 
journal of the Ambulatory Pediatric 
Association
To examine the role of school-based health centres 
(SBHCs) on changes in student health-related quality of 
life over a 3-year period among elementary and middle 
school students.
Three-year longitudinal prospective 
study.
Kindergarten to grade 
8. Approximately age 
5 to 14.
Four intervention 
elementary schools 
and four comparison 
schools
SBHC in elementary schools. Most research on SBHC is for 
adolescents and reports improved student health. The 
research for SBHC in elementary schools improves access 
and reduces emergency department use, but it is unclear 
whether improvements in health translate to younger 
students.
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Authors
Year of 
Publication
Country of 
Origin
Primary Outcome
Follow-up
Results (OR, RR, risk ratio, CI, p-value, mean diff) Conclusions Type of evaluation
Viewpoint/perspective
Time horizon
Costs
Non-economic evaluations
Kristensen, 
Alyson H.; et 
al
2014
USA
BMI and changes in percentage 
of overweight or obese youth
20 years
Afterschool physical activity programs would reduce 
obesity most among 6-12 year-olds (1.8 percentage 
points) and advertising ban would reduce obesity the 
least (0.9 percentage points). Sugar sweetened 
beverages excise tax would reduce obesity most  13-
18 years (2.4 percentage points).
All three policies would reduce 
childhood obesity prevalence by 2032, 
however a national $0.01/ounce SSB 
excise tax is the best option.
Markov microsimulation model, 
on effects alone
none stated
20 years
Not actually modelled, only policy impacts were 
modelled on decreasing childhood obesity prevalence
Bruzzese, 
Jean-Marie; 
et al
2006
USA
No. of days with symptoms
2 years
Few improvements in health outcomes achieved, no 
impact on use of urgent health care services, school 
attendance, or caregiver's QoL.
1) school staff has limited time for 
asthma care; partnerships may be 
required with medical centres, 2) 
community clinicians need better links to 
school health services, and 3) families 
need better connections to school health 
services and community clinicians.
Non-economic but did include 
QoL and resource use.
none stated
none stated
Massoni, 
Sebastien; et 
al
2012
France
Because didn't evaluate any 
achievements had to add them 
in with questionnaires before 
and after. Primary outcome: 
impact of project.
5 months
The Action lecture had a positive impact on academic 
results and reading attitudes. The authors state the 
programme is cost-effective but then never actually 
give any costs.
Impact of Action Lecture were positive 
and more efficient than a class size 
reduction programme.
Authors state CEA, no costs 
actually reported, non-economic.
none stated
None stated, 2 months assumed
*Notes cont. Makes a good point in discussion how 
education isn't standardised like medicine, few 
economic evaluations and no common indicator of 
benefit such as QALY.
Wade, T. J.; 
et al
2008
USA
HRQoL as measured annually by 
the PedsQL 4.0 self-report, and 
parent proxy-reported scores.
3 years
Adjusting for school and individual-level covariates, 
there was a significant improvement in student-
reported HRQoL over the 3 years compared to the 
comparison group. Other significant predictors 
included age, gender, health insurance, and 
household income. There were no differences across 
groups from parent proxy reports of HRQoL.
The SBHC model of health care delivery 
improves student-reported HRQoL 
among younger, elementary, and middle 
school children. It appears to influence 
children with impeded access to care 
who can benefit most.
Not an economic evaluation, but 
picked up to use of HRQoL 
measure. This is a multivariate 
regression analysis using 
prospective data.
not stated
none stated
No attempt to measure costs
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Authors
Year of 
Publication
Country of 
Origin
Alternatives described?
Important costs and consequences 
of each alternative identified?
Resource use
Effectiveness data
Type of preference 
measure
Measure of benefit (QALY, 
DALY)
Use of discounting?
Rate used
Currency
ICER Analysis of uncertainty
Model Parameters
Non-economic evaluations
Kristensen, 
Alyson H.; et 
al
2014
USA
yes
No, only consequences
none  
Estimated average effect size from PubMed search 
from 2000-2012 and modified as needed due to 
varied nature of evidence.
none
none
no
none
USD but only used as 
a modelled strategy 
excise tax
none  none
Age, race, BMI, physical activity, diet, program 
specific parameters in table 2
Bruzzese, 
Jean-Marie; 
et al
2006
USA
Nurse time recorded, number of urgent visits to 
clinician, ED visits, and hospitalizations collected but 
not costed.
Pediatric Asthma Caregiver's Quality of Life 
Questionnaire (PACQLQ)
Massoni, 
Sebastien; et 
al
2012
France
Yes, but control was limited as the 
evaluation was described as being 
quite intrusive
no
none
Points in reading scores
none
none
no
none
none
Stated as 208.5 points per teaching position for class 
size reduction and 280 points per teaching position for 
the Action lecture programme.
no
none
Wade, T. J.; 
et al
2008
USA
Comparison school group that 
didn't have a SBHC.
No
not identified
HRQoL as measured by PedsQL 4.0 self-report and 
parent proxy report
HRQoL not transformed 
into QALYs
none
no 
none
none
none Conducted two sets of analyses, with and 
without income included in the regressions. Also 
conducted bivariate analysis with users and 
nonusers of the SBHCs.
None
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Appendix 4: CHEERS Checklist
 
CHEERS Item No. 1 2 3 4 5 6 7 8 9 10 11a 11b 12 13a 13b 14 15 16 17 18 19 20a 20b 21 22 23 24
Study 
No.
Author, Year
1 Abt, C; 1966 cost analysis √ √ √
2 Anderson, R; 2014 √, cost analysis √ √ √ √ √ √ √ √ √ √ √ √
3 Ansell, J.; 2002 √ √ √ √ √ n/a n/a n/a √ n/a n/a √
4 Atherly, A; 2009 √, cost analysis √ √ √ √ n/a √ n/a n/a n/a n/a n/a n/a √ √
5 Babey, S; 2014 cost analysis √ √ √ √ √ n/a √ n/a n/a n/a n/a n/a √ n/a n/a √ √ √
6 Barber, S; 2013 √, protocol √ √ √ √ √ √ √ √
7 Barnett, S; 1985 √, CBA √ √ √ √ √ √ √ √ √ √ √
8 Barrett, J; 2015 √ √ √ √ √ √ √ √ √ n/a √ n/a n/a √ √ n/a √ √ √ √
9 Beets, M; 2014 √, protocol √ √ √ √ √
10 Belfield, CR; 2005 √, CBA  √ √ √ √ √ √ n/a √ √ √
11 Bertrand, E; 2011 √ √ √ √ √ √ √ √ √ n/a √ n/a n/a √ √ √ √ n/a n/a √
12 Blakely, T; 2014 √ √ √ √ √ √ √ √ √ n/a √ n/a √ √ √ √ √ √ n/a √ √ √ √ √
13 Boyle, J; 2007 √, cost analysis √ √ √
14 Brassard, P; 2006 √, cost analysis √ √ √ √ √ n/a n/a n/a n/a n/a n/a n/a √
15 Brooker, S; 2010 √, protocol √ √ √ √ √ √ √ √ √
16 Brown, H; 2007 √, cost analysis √ √ √ √ √ √ √ √ √ √ √ √ √
17 Bruzzese, J; 2006 non-economic √ n/a √
18 Carabin, H.; 2000 √ √ √ √ √ √ √ n/a n/a n/a √ √ n/a √ √ √
19 Chestnutt, I; 2012 √, protocol √ √ √ √ √ √ √ √
20 Cooper, K.; 2012 √ √ √ √ √ √ √ √ n/a n/a √ √ n/a √ n/a √ √ √
21 Crowley, D; 2014 √ √ √ √ √ √ n/a n/a n/a √ n/a n/a √ √ √
22 Curtale, F.; 2005 cost analysis √ √ n/a n/a n/a n/a n/a n/a n/a √
23 Eckermann, S; 2014 other √ √ √ √ √ n/a n/a n/a n/a n/a n/a n/a √ n/a n/a n/a n/a √ √
24 Ford, T; 2012 √, protocol √ √ √ √ √ √ √ n/a √ √
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CHEERS Item No. 1 2 3 4 5 6 7 8 9 10 11a 11b 12 13a 13b 14 15 16 17 18 19 20a 20b 21 22 23 24
Study 
No.
Author, Year
25 Foster, E; 2006 √ √ √ √ √ √ √ √ √ √ √ n/a n/a n/a √ n/a n/a √ n/a √ √ √ √
26 Foster, E; 2010 √, cost analysis √ √ √ √ √ √ √ n/a n/a √ n/a n/a n/a √ n/a n/a n/a √ √ √
27 Foster, J; 2013 √ √ √ √ n/a n/a n/a n/a √ √ n/a √
28 Frick, K; 2004 √ √ √ √ √ √ √ √ √ √ √ √ √ √
29 Gelli, A; 2009 cost analysis √ √ √ √ √ n/a n/a √ n/a n/a n/a √ n/a √ √
30 Gelli, A; 2011 cost analysis √ √ √ √ √ n/a n/a √ n/a n/a n/a √ n/a √ √
31 Gerald, J; 2010 √ √ √ √ √ √ √ √ √ √ n/a √ n/a √ √ √ √ n/a √ √ √
32 Gesell, S; 2013 √, cost analysis √ √ √ √ √ √ √ √
33 Glewwe, P; 2001 √, CBA √ √ √ √ n/a n/a n/a n/a n/a √ n/a n/a √ n/a n/a n/a n/a n/a √ √
34 Guay, M.; 2003 cost analysis √ √ √ √ √ √ √ n/a n/a √ n/a √ n/a n/a √ n/a n/a √
35 Heckman, J; 2010 √, CBA √ √ √ √ √ √ n/a √ √ √ √ √ √ √
36 Hoeflmayr, D; 2006 √, CBA √ √ √ √ √ √ √ n/a n/a n/a n/a n/a n/a √ √ √
37
Hollingworth, W.; 
2012
√ √ √ √ √ √ √ √ √ √ n/a n/a √ n/a √ n/a n/a √ n/a √ √ n/a n/a √ √ √
38 Joseph, C; 2007 cost analysis √ √ √ √ √ n/a √ n/a n/a n/a n/a n/a √ √ √
39 Kesztyues, D; 2013 √ √ √ √ √ √ √ √ √ n/a n/a n/a √ n/a n/a √ n/a n/a √ √
40 Konig, H; 2004 √ √ √ √ √ √ √ √ √ √ n/a √ n/a √ √ √ √ √ n/a √ √ √ √
41 Kowada, A; 2012 √ √ √ √ √ √ √ √ √ n/a √ n/a √ √ √ n/a √ √ √
42 Levaux, H; 2001 √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √
43 Li, Y; 2010 √, protocol √ √ √ √ √ √
44 Liping, M; 2013 √, cost analysis √ √ √ √ √ √ n/a n/a √ n/a √ n/a n/a n/a n/a √ √ √
45 Miller, T.; 2013 √ √ √ √ √ √ √ √ √ n/a √ √ n/a √ n/a n/a √ √ n/a n/a √ √ √
46 Moodie, M; 2009 √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √
47 Moodie, M; 2013 √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √
48 Moodie, M; 2010 √ √ √ √ √ √ √ √ √ n/a n/a √ √ √ n/a √ √ √
49 Muenning, P; 2007 √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √
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CHEERS Item No. 1 2 3 4 5 6 7 8 9 10 11a 11b 12 13a 13b 14 15 16 17 18 19 20a 20b 21 22 23 24
Study 
No.
Author, Year
50 Muenning, P; 2014 √ √ √ √ √ √ √ √ √ √ √ √ √ √ √
51 Newbury-Birch, D.; 
2013
√, protocol √ √ √ √
53 Noyes, K; 2012 √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √
54 Pearson, A; 2014 √ √ √ √ √ √ √ n/a n/a n/a √ √ √ √ n/a √ √ √ √
55 Philipsson, A.; 2013 √ √ √ √ √ √ √ √ √ n/a n/a n/a √ n/a n/a √ √ n/a n/a √ √ √
56 Quach, J.; 2013 √, protocol √ √ √ √ √ √ √ √ √ √
57 Rein, D; 2012 √ √ √ √ √ √ √ √ √ √ n/a n/a n/a √ √ √ √ √ n/a √ √ √
58 Reynolds, A; 2011 √, CBA √ √ √ √ √ √ √ √ √ √ n/a √ n/a n/a √ √ √ √ √
59 Rush, E; 2014 √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √
60 Salisbury, C.; 2002 cost analysis √ √ √ √ √ V √ √ √
61 Scherrer, C; 2006 cost analysis √ √ √ √ √ √ √ √ √ √ √
62 Shemilt, I; 2004 cost analysis √ √ √ √ √
63 Shepherd, J; 2010 √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √
64 Simon, E; 2013 √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √
65 Stallard, P; 2013 √, cost analysis √ √ √ √ √ √ √ √ √ √ √ √
66 Tai, T; 2010 √, CBA √ √ √ √ n/a √ n/a √ √ √ n/a √
67 te Velde, S; 2011 CBA √ √ √ √ √ √ √ n/a √ n/a √ √ √ n/a √ √ √ √
68 Tengs, T; 2001 √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √
69 Vijge, S; 2008 √ √ √ √ √ √ √ √ √ √ √ √ √
70 Wade, T; 2008 non-economic √ √ √ √ n/a n/a n/a n/a √ √
71 Wang, L; 2000 √ √ √ √ √ √ √ √ √ √ √ √ √ √ √
72 Wang, L; 2001 √ √ √ √ √ √ √ √ √ √ √ √ √
73 Wang, L; 2003 √, cost analysis √ √ √ √ √ √ √ n/a n/a √ √ n/a √ √ √
74 Wang, L; 2008 √ √ √ √ √ √ √ √ √ √ √ √ √ √ √
75 Wang, L; 2011 CBA √ √ √ √ √ √ √ √ n/a √ n/a √ √ √ n/a √ √ √ √
76 Young, T; 2003 √, cost analysis √ √ √ √ √
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Appendix 5: PRISMA Checklist 
Section/topic  # Checklist item  
Reported in 
section #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  3 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions 
and implications of key findings; systematic review registration number.  
na 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  3.1 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
3.2.1 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
na 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale.  
3.2.1 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
Appendix 1 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
Appendix 1 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
3.2.2, 3.2.3 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
3.2.4 
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Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
3.2.4 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis.  
3.2.3, 3.2.4 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  na 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
3.2.5 
  
Section/topic  # Checklist item  
Reported 
on page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
3.2.2, 
3.2.3 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified.  
3.2.5 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.  
3.3 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations.  
Appendix 
3 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  Appendix 
4 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
a) 
Appendix 
3, b) na 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  na 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  Appendix 
4 
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Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).  na 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers).  
3.4.1 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
3.4.2 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.  3.5 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review.  
na 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. 
doi:10.1371/journal.pmed1000097  
For more information, visit: www.prisma-statement.org.  
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Appendix 6: CHEERS checklist—Items to include when reporting economic evaluations of 
health interventions 
Section/item Item 
No 
Recommendation Reported 
in section 
number 
Title and abstract 
Title 1 Identify the study as an economic evaluation or use more 
specific terms such as “cost-effectiveness analysis”, and 
describe the interventions compared. 
 4 
Abstract 2 Provide a structured summary of objectives, perspective, 
setting, methods (including study design and inputs), results 
(including base case and uncertainty analyses), and 
conclusions. 
 
N/A see 
abstract 
Introduction 
Background and 
objectives 
3 Provide an explicit statement of the broader context for the 
study. 
 4.1 
  
Present the study question and its relevance for health policy 
or practice decisions. 
4.3.2 
Methods 
Target population and 
subgroups 
4 Describe characteristics of the base case population and 
subgroups analysed, including why they were chosen. 
4.4.1 
 
Setting and location 5 State relevant aspects of the system(s) in which the decision(s) 
need(s) to be made. 
4.3.1 
 
Study perspective 6 Describe the perspective of the study and relate this to the 
costs being evaluated. 
4.4.1 
Comparators 7 Describe the interventions or strategies being compared and 
state why they were chosen. 
4.3.1, 
4.3.3 
Time horizon 8 State the time horizon(s) over which costs and consequences 
are being evaluated and say why appropriate. 
4.4.1 
Discount rate 9 Report the choice of discount rate(s) used for costs and 
outcomes and say why appropriate. 
4.4.1 
Choice of health 
outcomes 
10 Describe what outcomes were used as the measure(s) of 
benefit in the evaluation and their relevance for the type of 
analysis performed. 4.3.3.1 
Measurement of 
effectiveness 
11a Single study-based estimates: Describe fully the design 
features of the single effectiveness study and why the single 
study was a sufficient source of clinical effectiveness data. 
4.3.3, 
4.4.3 
 
11b Synthesis-based estimates: Describe fully the methods used for 
identification of included studies and synthesis of clinical 
effectiveness data. 
N/A 
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Section/item Item 
No 
Recommendation Reported 
in section 
number 
Measurement and 
valuation of 
preference based 
outcomes 
12 If applicable, describe the population and methods used to 
elicit preferences for outcomes. 
4.2.1.2 
Estimating resources 
and costs 
13a Single study-based economic evaluation: Describe approaches 
used to estimate resource use associated with the alternative 
interventions. Describe primary or secondary research methods 
for valuing each resource item in terms of its unit cost. 
Describe any adjustments made to approximate to opportunity 
costs. 
4.4.2 
 
 
13b Model-based economic evaluation: Describe approaches and 
data sources used to estimate resource use associated with 
model health states. Describe primary or secondary research 
methods for valuing each resource item in terms of its unit 
cost. Describe any adjustments made to approximate to 
opportunity costs. 
N/A 
Currency, price date, 
and conversion 
14 Report the dates of the estimated resource quantities and unit 
costs. Describe methods for adjusting estimated unit costs to 
the year of reported costs if necessary. Describe methods for 
converting costs into a common currency base and the 
exchange rate. 
 
4.4.2.1 
 
Choice of model 15 Describe and give reasons for the specific type of decision-
analytical model used. Providing a figure to show model 
structure is strongly recommended. 
N/A 
Assumptions 16 Describe all structural or other assumptions underpinning the 
decision-analytical model. 
N/A 
Analytical methods 17 Describe all analytical methods supporting the evaluation. This 
could include methods for dealing with skewed, missing, or 
censored data; extrapolation methods; methods for pooling 
data; approaches to validate or make adjustments (such as half 
cycle corrections) to a model; and methods for handling 
population heterogeneity and uncertainty. 
 
4.4.4 
Results 
Study parameters 18 Report the values, ranges, references, and, if used, probability 
distributions for all parameters. Report reasons or sources for 
distributions used to represent uncertainty where appropriate. 
Providing a table to show the input values is strongly 
recommended. 
 
5.3-5.6 
Incremental costs and 
outcomes 
19 For each intervention, report mean values for the main 
categories of estimated costs and outcomes of interest, as well 
as mean differences between the comparator groups. If 
applicable, report incremental cost-effectiveness ratios. 
 
5.6 
Characterising 
uncertainty 
20a Single study-based economic evaluation: Describe the effects 
of sampling uncertainty for the estimated incremental cost and 
incremental effectiveness parameters, together with the impact 
of methodological assumptions (such as discount rate, study 
perspective). 
 
5.6, 5.7 
 
20b Model-based economic evaluation: Describe the effects on the 
results of uncertainty for all input parameters, and uncertainty 
related to the structure of the model and assumptions. 
N/A 
Characterising 
heterogeneity 
21 If applicable, report differences in costs, outcomes, or cost-
effectiveness that can be explained by variations between 
subgroups of patients with different baseline characteristics or 
other observed variability in effects that are not reducible by 
more information. 
N/A 
Discussion 
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Section/item Item 
No 
Recommendation Reported 
in section 
number 
Study findings, 
limitations, 
generalisability, and 
current knowledge 
22 Summarise key study findings and describe how they support 
the conclusions reached. Discuss limitations and the 
generalisability of the findings and how the findings fit with 
current knowledge. 
 
5.7, 5.8 
Other 
Source of funding 23 Describe how the study was funded and the role of the funder 
in the identification, design, conduct, and reporting of the 
analysis. Describe other non-monetary sources of support. 
 
4.3 
Conflicts of interest 24 Describe any potential for conflict of interest of study 
contributors in accordance with journal policy. In the absence 
of a journal policy, we recommend authors comply with 
International Committee of Medical Journal Editors 
recommendations. 
 
4.3 
 
  
289 
 
 
Appendix 7: Stata syntax for scoring SDQ replicated from SDQinfo.org website 
SDQ: Generating scores in STATA 
The scoring algorithm is based on the 25 variables plus impact items for each 
questionnaire. The algorithm expects to find these variables with specific names: the first 
letter of each variable name is 'p' for the parent SDQ, 's' for the self-report SDQ and 't' for 
the teacher SDQ. After this first letter, the variable names are as follows: 
consid = Item 1 : considerate 
restles = Item 2 : restless 
somatic = Item 3 : somatic symptoms 
shares = Item 4 : shares readily 
tantrum = Item 5 : tempers 
loner = Item 6 : solitary 
obeys = Item 7 : obedient 
worries = Item 8 : worries 
caring = Item 9 : helpful if someone hurt 
fidgety = Item 10 : fidgety 
friend = Item 11 : has good friend 
fights = Item 12 : fights or bullies 
unhappy = Item 13 : unhappy 
popular = Item 14 : generally liked 
distrac = Item 15 : easily distracted 
clingy = Item 16 : nervous in new situations 
kind = Item 17 : kind to younger children 
lies = 
Item 18 : lies or cheats [for the SDQ for 2-4 year olds, replace 'lies' with 
'argues'] 
bullied = Item 19 : picked on or bullied 
helpout = Item 20 : often volunteers 
reflect = Item 21 : thinks before acting 
steals = Item 22 : steals [for the SDQ for 2-4 year olds, replace 'steals' with 'spite'] 
oldbest = Item 23 : better with adults than with children 
afraid = Item 24 : many fears 
attends = Item 25 : good attention 
ebddiff = Impact question: oveall difficulties in at least one area 
distres = Impact question: upset or distressed 
imphome = Impact question: interferes with home life 
impfrie = Impact question: interferes with friendships 
impclas = Impact question: interferes with learning 
impleis = Impact question: interferes with leisure 
For each of these items, if the first response category (not true, no, not at all) has been 
selected, this is coded as zero, the next response category (somewhat true, yes-minor, just a 
little) is coded as one and so on. 
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For each informant, the algorithm generates six scores. The first letter of each derived 
variable is 'p' for parent-based scores, 's' for self-report-based scores and 't' for teacher-
based scores. After this first letter, the names of the scores are as follows: 
emotion = emotional symptoms 
conduct = conduct problems 
hyper = hyperactivity/inattention 
peer = peer problems 
prosoc = prosocial 
ebdtot = total difficulties 
impact = impact 
 
*** Recoding variables and then scoring the parent SDQ scores 
 
recode pobeys (0=2) (1=1) (2=0) (else=.), gen(qobeys) 
recode preflect (0=2) (1=1) (2=0) (else=.) , gen(qreflect) 
recode pattends (0=2) (1=1) (2=0) (else=.), gen(qattends) 
recode pfriend (0=2) (1=1) (2=0) (else=.), gen(qfriend) 
recode ppopular (0=2) (1=1) (2=0) (else=.), gen(qpopular) 
 
recode pdistres (0=0) (1=0) (2=1) (3=2) (.=0), gen(qqdistres) 
recode pimphome (0=0) (1=0) (2=1) (3=2) (.=0), gen(qqimphome) 
recode pimpfrie (0=0) (1=0) (2=1) (3=2) (.=0), gen(qqimpfrie) 
recode pimpclas (0=0) (1=0) (2=1) (3=2) (.=0), gen(qqimpclas) 
recode pimpleis (0=0) (1=0) (2=1) (3=2) (.=0), gen(qqimpleis) 
 
egen nemotion=robs(psomatic pworries punhappy pclingy pafraid) 
egen pemotion=rmean(psomatic pworries punhappy pclingy pafraid) if 
nemotion>2 
replace pemotion=round(pemotion*5) 
 
egen nconduct=robs(ptantrum qobeys pfights plies psteals) 
egen pconduct=rmean(ptantrum qobeys pfights plies psteals) if nconduct>2 
replace pconduct=round(pconduct*5) 
 
egen nhyper=robs(prestles pfidgety pdistrac qreflect qattends) 
egen phyper=rmean(prestles pfidgety pdistrac qreflect qattends) if 
nhyper>2 
replace phyper=round(phyper*5) 
 
egen npeer=robs(ploner qfriend qpopular pbullied poldbest) 
egen ppeer=rmean(ploner qfriend qpopular pbullied poldbest) if npeer>2 
replace ppeer=round(ppeer*5) 
 
egen nprosoc=robs(pconsid pshares pcaring pkind phelpout) 
egen pprosoc=rmean(pconsid pshares pcaring pkind phelpout) if nprosoc>2 
replace pprosoc=round(pprosoc*5) 
 
egen nimpact=robs(pdistres pimphome pimpfrie pimpclas pimpleis) 
gen pimpact=qqdistres+qqimphome+qqimpfrie+qqimpclas+qqimpleis if 
(nimpact!=0) 
replace pimpact=0 if pebddiff==0 
 
drop qobeys qreflect qattends qfriend qpopular qqdistres qqimphome 
qqimpfrie qqimpclas qqimpleis nemotion nconduct nhyper npeer nprosoc 
nimpact 
 
gen pebdtot=pemotion+pconduct+phyper+ppeer 
 
*** Recoding variables and then scoring the child SDQ scores 
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recode sobeys (0=2) (1=1) (2=0) (else=.), gen(robeys) 
recode sreflect (0=2) (1=1) (2=0) (else=.) , gen(rreflect) 
recode sattends (0=2) (1=1) (2=0) (else=.), gen(rattends) 
recode sfriend (0=2) (1=1) (2=0) (else=.), gen(rfriend) 
recode spopular (0=2) (1=1) (2=0) (else=.), gen(rpopular) 
 
recode sdistres (0=0) (1=0) (2=1) (3=2) (.=0), gen(rrdistres) 
recode simphome (0=0) (1=0) (2=1) (3=2) (.=0), gen(rrimphome) 
recode simpfrie (0=0) (1=0) (2=1) (3=2) (.=0), gen(rrimpfrie) 
recode simpclas (0=0) (1=0) (2=1) (3=2) (.=0), gen(rrimpclas) 
recode simpleis (0=0) (1=0) (2=1) (3=2) (.=0), gen(rrimpleis) 
 
egen nemotion=robs(ssomatic sworries sunhappy sclingy safraid) 
egen semotion=rmean(ssomatic sworries sunhappy sclingy safraid) if 
nemotion>2 
replace semotion=round(semotion*5) 
 
egen nconduct=robs(stantrum robeys sfights slies ssteals) 
egen sconduct=rmean(stantrum robeys sfights slies ssteals) if nconduct>2 
replace sconduct=round(sconduct*5) 
 
egen nhyper=robs(srestles sfidgety sdistrac rreflect rattends) 
egen shyper=rmean(srestles sfidgety sdistrac rreflect rattends) if 
nhyper>2 
replace shyper=round(shyper*5) 
 
egen npeer=robs(sloner rfriend rpopular sbullied soldbest) 
egen speer=rmean(sloner rfriend rpopular sbullied soldbest) if npeer>2 
replace speer=round(speer*5) 
 
egen nprosoc=robs(sconsid sshares scaring skind shelpout) 
egen sprosoc=rmean(sconsid sshares scaring skind shelpout) if nprosoc>2 
replace sprosoc=round(sprosoc*5) 
 
egen nimpact=robs(sdistres simphome simpfrie simpclas simpleis) 
gen simpact=rrdistres+rrimphome+rrimpfrie+rrimpclas+rrimpleis if 
(nimpact!=0) 
replace simpact=0 if sebddiff==0 
 
drop robeys rreflect rattends rfriend rpopular rrdistres rrimphome 
rrimpfrie rrimpclas rrimpleis nemotion nconduct nhyper npeer nprosoc 
nimpact 
 
gen sebdtot=semotion+sconduct+shyper+speer 
 
*** Recoding variables and then scoring the teacher SDQ scores 
 
recode tobeys (0=2) (1=1) (2=0) (else=.), gen(uobeys) 
recode treflect (0=2) (1=1) (2=0) (else=.) , gen(ureflect) 
recode tattends (0=2) (1=1) (2=0) (else=.), gen(uattends) 
recode tfriend (0=2) (1=1) (2=0) (else=.), gen(ufriend) 
recode tpopular (0=2) (1=1) (2=0) (else=.), gen(upopular) 
 
recode tdistres (0=0) (1=0) (2=1) (3=2) (.=0), gen(uudistres) 
recode timpfrie (0=0) (1=0) (2=1) (3=2) (.=0), gen(uuimpfrie) 
recode timpclas (0=0) (1=0) (2=1) (3=2) (.=0), gen(uuimpclas) 
 
egen nemotion=robs(tsomatic tworries tunhappy tclingy tafraid) 
egen temotion=rmean(tsomatic tworries tunhappy tclingy tafraid) if 
nemotion>2 
replace temotion=round(temotion*5) 
 
egen nconduct=robs(ttantrum uobeys tfights tlies tsteals) 
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egen tconduct=rmean(ttantrum uobeys tfights tlies tsteals) if nconduct>2 
replace tconduct=round(tconduct*5) 
 
egen nhyper=robs(trestles tfidgety tdistrac ureflect uattends) 
egen thyper=rmean(trestles tfidgety tdistrac ureflect uattends) if 
nhyper>2 
replace thyper=round(thyper*5) 
 
egen npeer=robs(tloner ufriend upopular tbullied toldbest) 
egen tpeer=rmean(tloner ufriend upopular tbullied toldbest) if npeer>2 
replace tpeer=round(tpeer*5) 
 
egen nprosoc=robs(tconsid tshares tcaring tkind thelpout) 
egen tprosoc=rmean(tconsid tshares tcaring tkind thelpout) if nprosoc>2 
replace tprosoc=round(tprosoc*5) 
 
egen nimpact=robs(tdistres timpfrie timpclas) 
gen timpact=uudistres+uuimpfrie+uuimpclas if (nimpact!=0) 
replace timpact=0 if tebddiff==0 
 
drop uobeys ureflect uattends ufriend upopular uudistres uuimpfrie 
uuimpclas nemotion nconduct nhyper npeer nprosoc nimpact 
 
gen tebdtot=temotion+tconduct+thyper+tpeer  
 
The predictive algorithm was converted into STATA syntax by Anna Goodman, Richard 
Rowe and Ye Gan 
 
Last modified : 8/01/10 
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Appendix 8: Cost-effectiveness planes and CEACs for all sensitivity analyses  
 
SA0: Base-case Adolescent Values 
 
SA1: SDQ Total Difficulties (CEA) 
  
SA2: SDQ Prosocial Behaviour (CEA) 
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SA3: CHU9D mapped from SDQ (Equation 10)  
 
SA4: CHU9D estimated from original tariff (UK adults) 
 
SA5: Training and material costs not annuitised 
 
  
-1
0 0
1
0
0
2
0
0
3
0
0
In
c
re
m
e
n
ta
l 
c
o
s
ts
 (
£
)
-.01 0 .02 .04
Incremental QALYs
SA4 Cost-effectiveness Plane
0
.2
.4
.6
.8
1
P
ro
b
a
b
ili
ty
 t
h
a
t 
R
o
E
 i
s
 c
o
s
t-
e
ff
e
c
ti
v
e
0 10000 20000 30000 40000 50000
Cost-effectiveness threshold
SA4 Cost-effectiveness Acceptability Curve
-1
0
0
0
1
0
0
2
0
0
3
0
0
In
c
re
m
e
n
ta
l 
c
o
s
ts
 (
£
)
-.04 -.02 0 .02 .04 .06
Incremental QALYs
SA6 Cost-effectiveness plane
0
.2
.4
.6
.8
1
P
ro
b
a
b
ili
ty
 t
h
a
t 
R
o
E
 i
s
 c
o
s
t-
e
ff
e
c
ti
v
e
0 10000 20000 30000 40000 50000
Cost-effectiveness threshold
SA6 CEAC
-1
0 0
1
0
0
2
0
0
3
0
0
4
0
0
In
c
re
m
e
n
ta
l 
c
o
s
ts
 (
£
)
-.04 -.02 0 .02 .04 .06 .08
Incremental QALYs
SA8 Cost-effectiveness Plane
.2
.4
.6
.8
1
P
ro
b
a
b
ili
ty
 t
h
a
t 
R
o
E
 i
s
 c
o
s
t-
e
ff
e
c
ti
v
e
0 10000 20000 30000 40000 50000
Cost-effectiveness threshold
SA8 Cost-effectiveness Acceptability Curve
295 
 
 
SA6: Training and material costs annuitised over 3 years  
 
SA7: Use of more traditional 3.5% discount rate for costs and outcomes 
 
SA8: Available-case analysis assuming MCAR 
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AV0: CHU9D estimated from original tariff (UK adults) 
 
AV1: SDQ Total Difficulties (CEA) 
 
AV2: SDQ Prosocial Behaviour (CEA) 
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AV3: CHU9D mapped from SDQ (Equation 10) 
 
AV4: CHU9D estimated from alternative tariff (Australian adolescents) 
 
AV5: Training and material costs not annuitised 
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AV6: Training and material costs annuitised over 3 years 
 
AV7: Use of more traditional 3.5% discount rate for costs and outcomes 
 
AV8: Available-case analysis assuming MCAR 
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